nicotine has been researched along with Substance Withdrawal Syndrome in 1544 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 158 (10.23) | 18.7374 |
| 1990's | 296 (19.17) | 18.2507 |
| 2000's | 492 (31.87) | 29.6817 |
| 2010's | 498 (32.25) | 24.3611 |
| 2020's | 100 (6.48) | 2.80 |
| Authors | Studies |
|---|---|
| Fryxell, KJ; Hudson, AD; Locklear, LL; Murphy, RL; Niaz, MH; Walton, RL | 1 |
| Avelar, AJ; George, O | 1 |
| Bansal, N; Khurana, K; Kumar, M | 1 |
| Al-Harrasi, A; Behl, T; Bhatia, S; Bungau, S; Khan, H; Khan, N; Rather, IIG; Sehgal, A; Sharma, A; Sharma, N; Singh, S | 1 |
| Blank, MD; Douglas, AE; Felicione, NJ; McClernon, FJ | 1 |
| Aotani, D; Guo, T; Hattori, R; Jinno, T; Kataoka, H; Koyama, H; Kuga, Y; Matsumura, S; Ogawa, K; Shimizu, Y; Takeda, K; Tanaka, T; Yagi, T | 1 |
| Girard, M; Lacroix, A; Lourmière, G; Nubukpo, P | 1 |
| Castillo, J; Deshpande, HU; Fedota, JR; Ross, TJ; Salmeron, BJ; Stein, EA | 1 |
| Gipson-Reichardt, CD; Kaplan, BA; Koffarnus, MN; Rzeszutek, MJ | 1 |
| Rash, CJ; Sharbin, GK | 1 |
| Chakraborti, Y; Coffman, DL; Piper, ME | 1 |
| Behm, FM; Botts, DR; Botts, TL; Rose, JE; Willette, PN | 1 |
| Espinoza, VE; Giner, P; Liano, I; Mendez, IA; O'Dell, LE | 1 |
| George, TP; Johnstone, S; Rabin, RA; Sorkhou, M | 1 |
| Andreasen, JT | 1 |
| Arakaki, S; Minami, M | 1 |
| De Aquino, JP; DeVito, EE; Gueorguieva, R; Meyerovich, J; Parida, S; Sofuoglu, M; Xie, C | 1 |
| Cao, W; Duffy, KA; Epperson, CN; Johnson, RL; Kuzma, A; Loughead, J; Novick, AM; Sammel, MD; Sofuoglu, M; Strasser, AA | 1 |
| Chaudhary, S; Chen, Y; Dhingra, I; Fucito, L; Li, CR | 1 |
| Anderson, E; Fisher, M; Keady, J; LeMalefant, R; Turner, J | 1 |
| Gallagher, R; Williscroft, D | 1 |
| Janwantanakul, P; Klinsophon, T; Thaveeratitham, P | 1 |
| Aranda, M; Castañeda, K; Castro-Gutierrez, R; Cruz, B; Flores, RJ; Gadad, BS; Hinojosa, CA; O'Dell, LE; Roberto, M; Roychowdhury, S; Spencer, CT; Vozella, V | 1 |
| Cropsey, KL; Gamble, KL; Hawes, ES; Mildrum Chana, S; Palenski, PE; Thomas, SJ; Wolford-Clevenger, C | 1 |
| Cao, W; Duffy, KA; Epperson, CN; Johnson, RL; Kuzma, A; Loughead, J; Morrow, AL; Novick, AM; Sammel, MD; Sofuoglu, M; Strasser, AA | 1 |
| Addy, NA; Bagdas, D; Harris, L | 1 |
| Behnood-Rod, A; Bruijnzeel, AW; Chellian, R | 1 |
| Chen, YH; Chow, LH; Huang, EY; Hung, HY; Kao, JH; Tsai, AL | 1 |
| Cox, S; Dawkins, L; Hunter, S; Kimber, C; Notley, C; Zaidell, L | 1 |
| Gex, KS; Gray, KM; McClure, EA; Walters, KJ | 1 |
| Damaj, MI; MacLeod, L; Mignogna, KM; Miles, MF; Rokita, JL; Smith, ML | 1 |
| Ahmadi-Soleimani, SM; Amiry, GY; Azhdari-Zarmehri, H; Beheshti, F; Haidary, M | 1 |
| Besson, M; Canonne, C; Danckaert, A; David, V; de Chaumont, F; Forget, B; Lakosa, A; Marti, F; Maskos, U; Rahimian, A; Reynolds, LM; Tahraoui, S; Tochon, L; Tomasi, F | 1 |
| Burkard, T; Christ-Crain, M; Coynel, D; Erlanger, TE; Hemkens, LG; Jeanloz, N; Lengsfeld, S; Meienberg, A; Speich, B; Vogt, DR; Winzeler, B; Zanchi, D | 1 |
| Alkhlaif, Y; Damaj, MI; El-Halawany, M; Hamouda, AK; Park, A; Toma, W | 1 |
| Goodwin, C; Murphy, CM; Onu, MC; Tidey, JW; Williams, DM | 1 |
| Carrette, LLG; Collazo, A; Davoudian, PA; George, O; Kimbrough, A; Kwan, AC | 1 |
| Audrain-McGovern, J; DeAtley, T; Johnson, AC; Mercincavage, M; Stone, MD; Strasser, AA | 1 |
| Alkhlaif, Y; Buczynski, MW; Buzzi, B; Damaj, MI; Koseli, E; Lichtman, AH; Mustafa, MA; Parker, A | 1 |
| Fei, Y; Shao, J; Wang, L; Xiao, J; Yang, J; Zou, S | 1 |
| Anderson, AS; Bradford, DE; Curtin, JJ; DeYoung, KA; Fox, AS; Islam, S; Kaplan, CM; Kim, HC; Piper, ME; Shackman, AJ; Smith, JF | 1 |
| Braida, D; Dellarole, I; Morara, S; Ponzoni, L; Sala, M | 1 |
| Ahmadi-Soleimani, SM; Amiry, GY; Beheshti, F; Khordad, E; Masoudi, M | 1 |
| Lamprea, MR; Novoa, C; Ortega, LA; Solano, JL | 1 |
| Borges, AM; Farris, SG; Kibbey, MM; Leyro, TM; Rosen, RL; Steinberg, ML | 1 |
| Ahmadi-Soleimani, SM; Azizi, H; Rezayof, A; Torabi, M | 1 |
| de Guglielmo, G; George, O; Kallupi, M; Larrosa, E | 1 |
| Behnood-Rod, A; Bruijnzeel, AW; Chellian, R; Febo, M; Knight, P; Lyons, H; Panunzio, S; Tan, S; Wilson, R; Xue, S | 1 |
| Barrett, EL; Chu, KH; Colditz, JB; James, AE; Primack, BA; Shensa, A; Sidani, JE | 1 |
| Barrett, SP; Darredeau, C; Good, KP; Helmick, C; Newman, AJ; Perry, RN; Schlagintweit, HE | 1 |
| Aveyard, P; Hong, B; Klemperer, E; Lindson, N; Ordóñez-Mena, JM | 1 |
| Adeluyi, A; Chan, SSL; Cole, RD; Davis, SW; Fisher, ML; Freeman, LR; Galloway, A; Guerin, L; Ortinski, PI; Turner, JR; Wyatt, MD | 1 |
| Hsu, LM; Keeley, RJ; Lu, H; Mayer, TE; Stein, EA; Yang, Y | 1 |
| Candiotti, KA; Gitlin, M; Rodriguez-Blanco, YF; Sevilla, A; Su, C; Weller, R; Wu, J; Yang, J; Zhang, Y; Zheng, C | 1 |
| Ditre, JW; Heckman, BW; LaRowe, LR; Powers, JM | 1 |
| Cole, RD; Gould, TJ; Kutlu, MG; Matchanova, A; Parikh, V; Zimmerman, M | 1 |
| Cole, M; Gilpin, NW; Kelley, LK; Kerr, TM; Montanari, C | 1 |
| Addo, N; Benowitz, NL; Harvanko, AM; Nardone, N; St Helen, G | 1 |
| Breland, A; Eissenberg, T; Hiler, M; Karaoghlanian, N; Maloney, S; Shihadeh, A; Talih, S | 1 |
| Casserly, AP; Gardner, PD; Molas, S; Smith, CB; Tapper, AR; Tsuji, J; Weng, Z; Zhao-Shea, R | 1 |
| Bergeria, CL; Davis, DR; Gaalema, DE; Heil, SH; Higgins, ST; Hughes, JR; Priest, J; Sigmon, SC; Stitzer, ML; Streck, JM; Tidey, JW; Villanti, AC | 1 |
| Gilbert, DG; McDaniel, JT; Rabinovich, NE | 1 |
| Alexander, AC; Businelle, MS; Hébert, ET; Kendzor, DE; Olurotimi, O; Ra, CK | 1 |
| Caine, SB; Carlezon, WA; Desai, RI; Holloway, IL; Meloni, EG; Ridener, E; Robble, MA; Webber, CJ | 1 |
| Ahmad, SM; Hamid, A; Lutfy, K; Marquez, P; Nega, S | 1 |
| Noll-Hussong, M | 1 |
| Arreguin, MC; Carcoba, LM; Correa, VL; Cruz, B; Flores, RJ; Mendez, IA; O'Dell, LE; Uribe, KP | 1 |
| Behnood-Rod, A; Bruijnzeel, AW; Chellian, R; Febo, M; Knight, P; Wilks, I; Wilson, R | 1 |
| Leslie, FM | 1 |
| Im, HI; Kim, B | 1 |
| Allan, NP; Blumenthal, H; Budney, AJ; Cloutier, R; Knapp, AA; Lord, SE; Moradi, S | 1 |
| Aiello, S; Casarrubea, M; Colangeli, R; Crescimanno, G; Davies, C; Deidda, G; Di Giovanni, G; Pierucci, M; Santangelo, A | 1 |
| Barrett, SP; Schlagintweit, HE; Spinella, TC | 1 |
| Conklin, CA; Jakicic, JM; Joyce, CJ; Kupfer, DJ; Mumma, JM; Salkeld, RP; Soreca, I; Vella, EJ | 1 |
| Abbas, M; Al-Rashida, M; Esmaeilpour, K; Joushi, S; Masoumi-Ardakani, Y; Rauf, K; Rehman, NU | 1 |
| Braida, D; Brennan, CH; Ponzoni, L; Sala, M; Teh, MT; Torres-Perez, JV | 1 |
| Baker, TB; Beckham, JC; Cook, JW; Kaye, JT | 1 |
| Prados, J; Sal, F; Urcelay, GP | 1 |
| Gilbert, DG; Newcomer, JW; Pergadia, ML | 1 |
| Al-Halabi, S; Bobes Bascarán, T; Bobes, J; Díaz-Mesa, EM; Elizagarate, E; Galván, G; García-Álvarez, L; García-Portilla, MP; Jaén-Moreno, MJ; Sáiz Martínez, PA; Sarramea, F | 1 |
| Castillo, J; Fedota, JR; Matous, AL; McKenna, MR; Menon, V; Ross, TJ; Salmeron, BJ; Stein, EA | 1 |
| Brygider, S; Głowacka, U; Litwa, E; Maćkowiak, M; Nikiforuk, A; Wesołowska, J; Zaniewska, M | 1 |
| Edmiston, J; Graff, D; Liu, J; Sarkar, M; Vansickel, A; Wang, J | 1 |
| Al-Obaidi, HJ; Al-Qudah, RA; Alfayoumi, I; Barakat, MM; Basheti, I; Jirjees, FJ | 1 |
| Correa-Alfonzo, P; Espinoza, VE; Khan, AM; Matos-Ocasio, F; O'Dell, LE | 1 |
| Li, CJ; Lu, ZJ; Qiu, HB; Shen, L; Wei, K; Xu, HH; Zhao, L; Zhu, CC | 1 |
| Carcoba, LM; DeBiasi, M; Mendez, IA; O'Dell, LE; Ortegon, S; Uribe, KP | 1 |
| Bauer, AM; Cinciripini, P; Fox, E; George, TP; Hatzell, J; Hawk, L; Hitsman, B; Leone, F; Lerman, C; Paul Wileyto, E; Purnell, J; Quinn, M; Schnoll, R; Tyndale, RF | 1 |
| Harris, AC | 2 |
| Benowitz, NL; Prochaska, JJ; Schnellbaecher, M; Skan, J; Vogel, EA | 1 |
| Akinola, LS; Alkhlaif, Y; Bautista, MR; Carper, M; Chen, YC; Damaj, MI; Fowler, CD; Garai, S; Hamouda, AK; Jackson, A; Thakur, GA; Toma, WB | 1 |
| Behnood-Rod, A; Bruijnzeel, AW; Bruijnzeel, DM; Chellian, R; Pandy, V; Wilson, R | 1 |
| Boomhower, B; Carrette, LLG; Dowling, J; Fitzgerald, RL; George, O; Hanham, K; Hoffman, M; Kallupi, M; Momper, JD; Sepulveda, Y; Smith, LC; Suhandynata, RT; Tieu, L | 1 |
| Mahmood, S; Nik Mohamed, MH; Rahman, A | 1 |
| Kobayashi, K; Murashita, T; Nishitani, N; Ohmura, Y; Yoshida, T; Yoshioka, M | 1 |
| Hughes, JR; Kirshenbaum, AP | 1 |
| Huang, Y; Johnson, B; Li, JX; Liu, J; Wu, R; Zhang, Y | 1 |
| al'Absi, M; Allen, S; Anker, JJ; Nakajima, M; Raatz, S | 1 |
| Freels, TG; Klenowski, PM; Molas, S; Tapper, AR; Zhao-Shea, R | 1 |
| Bian, LH; Guo, JY; Li, QY; Luo, J; Shi, JL; Wang, XM; Yao, ZW | 1 |
| Aveyard, P; Hollands, GJ; Sutton, S | 1 |
| Aypar, B; Balkan, B; Birdogan, A; Gokmen, RC; Gozen, O; Kanit, L; Keser, A; Koylu, EO; Ozturk Bintepe, M; Salur, E; Tuzcu, F | 1 |
| Chappell, K; Ferguson, SG; Jacobson, GA; Lu, W; Patel, R; Schüz, N; Walters, JAE | 1 |
| Carcoba, LM; Cruz, B; Flores, RJ; Francis, W; Hinojosa, CA; Ibarra, M; Nazarian, A; O'Dell, LE; Pipkin, JA | 1 |
| Addicott, MA; Brandon, TH; Drobes, DJ; Evans, DE; Oliver, JA; Potts, GF | 1 |
| Aronson, SE; Lesage, E; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Havermans, A; Riedel, WJ; van den Hurk, J; van Schayck, OCP; Vuurman, EFPM | 1 |
| Batsikadze, G; Grundey, J; Hasan, A; Kuo, MF; Nitsche, MA; Paulus, W | 1 |
| Baker, TB; Chu, W; Cook, JW; Lanza, ST; Piper, ME | 1 |
| Webb, A | 1 |
| Abrams, K; Cieslowski, K; Johnson, S; Krimmel, S; Kryder, C; Melum, A; Strnad, H | 1 |
| Eissenberg, T; Foulds, J; Hobkirk, AL; Hrabovsky, S; Nichols, TT; Richie, J; Veldheer, S; Wilson, SJ; Yingst, JM | 1 |
| Mayor, S | 1 |
| Karelitz, JL; Michael, VC; Perkins, KA | 1 |
| Belluzzi, JD; Leslie, FM; Malagon, AM; Yasuda, D; Yuan, M; Zaveri, NT | 1 |
| Arias, A; Gueorguieva, R; Jane, JS; Krystal, JH; O'Brien, E; O'Malley, SS; Petrakis, IL; Ralevski, E; Sevarino, KA | 1 |
| Benowitz, NL; Cinciripini, P; George, TP; Hawk, LW; Lerman, C; Morales, M; Nollen, NL; Peng, AR; Schnoll, R; Tyndale, RF; Wileyto, EP | 1 |
| Becoña, E; Fernández Del Río, E; López-Durán, A; Martínez, Ú; Martínez-Vispo, C; Míguez, MC; Piñeiro, B; Rodríguez-Cano, R | 1 |
| Bhugra, D; Castaldelli-Maia, JM; de Andrade, AG; Gonzalez, MO; Goudriaan, AE; Périco, CA; Waisman Campos, M | 1 |
| Harris, AC; Krueger, M; LeSage, MG; Muelken, P; Smethells, JR | 1 |
| Cannon, TD; Gupta, R; He, L; Hiekkalinna, TS; Kaprio, J; Korhonen, T; Loukola, A; Madden, PAF; Milani, L; Ollikainen, M; Perola, M; Qaiser, B; Ripatti, S; Salomaa, V; Therman, S; Zheutlin, AB | 1 |
| Huh, J; Kirkpatrick, MG; Leventhal, AM; Liautaud, MM; Monterosso, J; Pang, RD | 1 |
| Gillies, M; Griffith, DM; Ng, KT | 1 |
| Buta, E; Cavallo, DA; Green, BG; Gueorguieva, R; Jatlow, P; Kong, G; Krishnan-Sarin, S; O'Malley, SS | 1 |
| Alkhlaif, Y; Bagdas, D; Damaj, IM; Jackson, A; Park, AJ | 1 |
| Bekiroglu, K; Lagoa, CM; Lanza, ST; Piper, ME; Russell, MA | 1 |
| Carcoba, LM; Flores, RJ; Natividad, LA; O'Dell, LE | 1 |
| Adermark, L; Andrén, A; Ericson, M; Morud, J; Söderpalm, B; Strandberg, J | 1 |
| Balestrieri, SG; Bidwell, LC; Colby, SM; Knopik, VS; Tidey, JW | 1 |
| Cox, CM; Faulkner, P; Ghahremani, DG; Hellemann, GS; London, ED; Petersen, N; Tyndale, RF | 1 |
| Chellian, R; Mohamed, Z; Pandy, V | 1 |
| Breland, A; Eissenberg, T; Hiler, M; Karaoghlanian, N; Lipato, T; Lopez, A; Maloney, S; Ramôa, C; Shihadeh, A; Spindle, T | 1 |
| Bagdas, D; Hamouda, AK; Imad Damaj, M; Jackson, A | 1 |
| Chang, S; Cho, HW; Choe, ES; Kim, HY; Kim, J; Lee, DK; Oh, JH; Ryu, IS; Seo, JW; Seo, SY; Shim, I; Yang, JH; Yoon, SS | 1 |
| Bakhshaie, J; Langdon, KJ; Leventhal, AM; Schmidt, NB; Zvolensky, MJ | 1 |
| Borkar, CD; Kokare, DM; Sagarkar, S; Sakharkar, AJ; Subhedar, NK | 1 |
| Bush, J; Koch, A; Martin, C; O'Connell, G; Savioz, R; Walele, T | 1 |
| Bullen, C; Grace, RC; Laugesen, M; Tucker, MR | 1 |
| Boileau, I; Di Ciano, P; Hendershot, CS; Houle, S; Lagzdins, D; Le Foll, B; Mansouri, E; Tyndale, RF; Wilson, AA | 1 |
| Lee, AM; Maertens, JJ; Mason, MM; O'Rourke, KY; Touchette, JC | 1 |
| Bunn, JY; Heil, SH; Higgins, ST; Sigmon, SC; Streck, JM | 1 |
| Klenowski, PM; Tapper, AR | 1 |
| Benowitz, N; Dermody, SS; Donny, EC; Hatsukami, D; Luo, X; McClernon, FJ; Smith, TT; Tidey, JW; Vandrey, R | 1 |
| Ding, X; Fedota, JR; Gu, H; Matous, AL; McKenna, MR; Ross, TJ; Salmeron, BJ; Stein, EA | 1 |
| Damaj, MI; Jackson, A; Papke, RL | 1 |
| D'Aniello, E; Damaj, MI; Di Marzo, V; Donvito, G; Giordano, C; Guida, F; Ignatowska-Jankowska, BM; Jackson, A; Lichtman, AH; Maione, S; Mechoulam, R; Muldoon, P; Mustafa, MA; Parker, L; Petrie, GN; Piscitelli, F; Sim-Selley, L; Smoum, R; Vitale, RM | 1 |
| Baker, NL; Germeroth, LJ; Saladin, ME | 1 |
| Blendy, JA; Brynildsen, JK; Jin, S; Kim, SF; Lee, BG; Perron, IJ | 1 |
| Cryan, JF; Jacobson, LH; Li, X; Slattery, DA; Vlachou, S | 1 |
| Cassidy, RN; Cioe, PA; Colby, SM; Hatsukami, D; Jackson, KM; Krishnan-Sarin, S; Tidey, JW | 1 |
| De Vita, MJ; Ditre, JW; Kosiba, JD; LaRowe, LR; Zale, EL | 1 |
| Alkhlaif, Y; Bagdas, D; Carroll, FI; Damaj, MI; Ditre, JW; Jackson, A | 1 |
| Cox, S; Dawkins, L; Doig, M; Goniewicz, M; Kimber, C; Kośmider, L; McRobbie, H | 1 |
| Bading, H; Baur, K; Bengtson, CP; Bernardi, RE; Hach, A; Spanagel, R | 1 |
| Chen, YH; Chiang, YH; Chou, YC; Hoffer, BJ; Huang, EY; Kao, JH; Kuo, TT; Miller, J | 1 |
| Jin, X; Markou, A; Marks, MJ; McClure-Begley, TD; Semenova, S; Tadman, MP | 1 |
| Al-Mrayat, YD; Khara, M; Okoli, CTC; Shelton, CI | 1 |
| Cather, C; Dodds, EB; Evins, AE; Fava, M; Hanly, A; Hudziak, V; Mischoulon, D; Nadal, M; Pachas, GN; Schoenfeld, DA; Schuster, RM; Sobolewski, S; Stoeckel, L; Ulysse, C; Zhang, H | 1 |
| Faulkner, P; Ghahremani, DG; Hellemann, G; London, ED; Tyndale, RF | 1 |
| Brodsky, M; Lambe, EK; Morton, G; Nasirova, N; Sivakumaran, S; Sparks, DW; Turner, EE | 1 |
| Anderson, A; Burstein, ES; Campbell, JR; Elayoubi, J; Goyarzu, P; Henceroth, MM; Izygon, J; Madison, CA; Malin, DH; Ward, CP | 1 |
| Callas, PW; Hughes, JR | 1 |
| Ditre, JW; Kosiba, JD; LaRowe, LR; Zale, EL | 1 |
| al'Absi, M; Allen, S; Hodges, JS; Lemieux, A | 1 |
| al'Absi, M; Lemieux, A; Nakajima, M | 1 |
| al'Absi, M; Allen, SS; Benowitz, NL; Carmella, SG; Chen, M; Cinciripini, PM; Denlinger-Apte, R; Donny, EC; Drobes, DJ; Hatsukami, DK; Hecht, SS; Jensen, JA; Koopmeiners, JS; Lane, T; Le, CT; Leischow, S; Luo, K; Luo, X; McClernon, FJ; Murphy, SE; Paiano, V; Robinson, JD; Severson, H; Sipe, C; Strasser, AA; Strayer, LG; Tang, MK; Vandrey, R | 1 |
| Benowitz, NL; Dempsey, DA; Edwards, KC; Liakoni, E; Nardone, N; St Helen, G; Tyndale, RF | 1 |
| Kawamura, K; Morioka, I; Yamada, K | 1 |
| Inzamam Ali, M; Menakuru, S | 1 |
| Akimoto, H; Kobayashi, D; Michiyama, Y; Negishi, A; Nemoto, T; Oshima, S | 1 |
| Cox, C; Faulkner, P; Ghahremani, DG; Ginder, N; Hellemann, G; London, ED; Paterson, NE; Tyndale, RF | 1 |
| Carpenter, MJ; Dahne, J; Germeroth, LJ; Heckman, BW; Mathew, AR; Saladin, ME; Santa Ana, EJ | 1 |
| George, O; Janda, KD; Kallupi, M; Xue, S; Zhou, B | 1 |
| Bedi, G; Comer, SD; Cooper, ZD; Foltin, RW; Haney, M; Herrmann, ES; Ramesh, D; Reed, SC | 1 |
| Bassett, DS; Hitsman, B; Lydon-Staley, DM; Schnoll, RA | 1 |
| Mathews, HL; Stitzel, JA | 1 |
| Abreu-Villaça, Y; da Silva Gonçalves, B; Filgueiras, CC; Leal-Rocha, PH; Manhães, AC; Ribeiro-Carvalho, A | 1 |
| Abreu-Villaça, Y; Dutra-Tavares, AC; Filgueiras, CC; Guimarães, VMS; Manhães, AC; Nunes-Freitas, A; Ribeiro-Carvalho, A | 1 |
| Carroll, AJ; Hitsman, B; Hole, A; Jao, NC; Kalhan, R; Langer, C; Leone, F; Lubitz, SF; Miele, A; Patel, J; Paul Wileyto, E; Schnoll, R; Veluz-Wilkins, A | 1 |
| Cropsey, KL; Hugley, MJ; Nguyen, AT; Sisson, ML; Wolford-Clevenger, C | 1 |
| Bagosi, Z; Balangó, B; Bokor, P; Buzás, A; Csabafi, K; Palotai, M; Pintér, D; Simon, B; Szabó, G; Telegdy, G | 1 |
| Bimonte-Nelson, HA; Gipson, CD; Goenaga, J; Koebele, SV; Leyrer-Jackson, JM; McClure, EA; Namba, MD; Phan, S; Piña, J; Powell, GL; Prakapenka, AV | 1 |
| Breland, A; Eissenberg, T; Hiler, M; Lipato, T; Maloney, SF; Ramôa, C; Soule, EK | 1 |
| Gilbert, DG; Gilbert-Matuskowitz, EA; Klein, KP; Pergadia, ML; Rabinovich, NE | 1 |
| Barrett, ST; Bevins, RA; Thompson, BM | 1 |
| Thomas, SP | 1 |
| Baker, TB; Cook, JW; Piper, ME; Schlam, TR; Smith, SS | 1 |
| De La Garza, R; Holst, M; Salas, R; Shuman, SL; Yammine, L; Yoon, JH | 1 |
| Dannals, RF; Kuwabara, H; McCaul, ME; Wand, GS; Wong, D; Xu, X | 1 |
| Allenby, C; Ashare, RL; Bernardo, L; Cao, W; Falcone, M; Lerman, C; Loughead, J; Pruessner, J; Wileyto, EP | 1 |
| Alkhlaif, Y; Contreras, KM; Damaj, MI; Jackson, AB; Toma, W | 1 |
| Alayoubi, H; Alkhlaif, Y; AlOmari, D; Bagdas, D; Carper, M; Damaj, MI; Diester, CM; Poklis, JL; Riley, J | 1 |
| Babalonis, S; Comer, SD; Fraser, H; Jones, JD; Kelsh, D; Lofwall, MR; Marcus, R; Martinez, DM; Martinez, S; Nunes, EV; Paterson, B; Vince, B; Walsh, SL | 1 |
| Behnood-Rod, A; Bruijnzeel, A; Levin, B; Tan, S; Wilks, I | 1 |
| Arreguin, MC; Carcoba, LM; Correa, VL; Flores, RJ; O'Dell, LE | 1 |
| Damaj, MI; Jackson, KJ; McIntosh, JM; Muldoon, PP; Sanjakdar, SS | 1 |
| Gelernter, J; Herman, AI; Jatlow, PI; Listman, JB; Sofuoglu, M | 1 |
| Hitsman, B; Leone, FT; Schnoll, RA | 1 |
| Chopde, CT; Thakre, PP; Tundulwar, MR; Ugale, RR | 1 |
| Langdon, KJ; Leventhal, AM; Rosenfield, D; Steeves, D; Stewart, S; Zvolensky, MJ | 1 |
| Alajaji, M; Bowers, MS; Damaj, MI; Knackstedt, L | 1 |
| Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Abrams, K; Bertoli, G; Cosci, F | 1 |
| Cordero, KA; Gould, TJ; Leach, PT | 1 |
| Gates, KM; Molenaar, PC; Nichols, TT; Wilson, SJ | 1 |
| de Boer, P; Edgar, CJ; Kezic, I; Salih, HM; Wesnes, KA | 1 |
| Fagerström, KO; Kuster, M; Meyer, A; Scherr, A; Seiffert, B; Stolz, D; Tamm, M | 1 |
| Ahmed, T; Allan, J; Gordon, R; Ragg, M | 1 |
| Blendy, JA; Carlson, GC; Gould, TJ; Poole, RL; Turner, JR; Wilkinson, DS | 1 |
| Miyasato, K | 1 |
| Handa, S | 1 |
| Beard, E; Brown, J; Gillison, F; Hajek, P; Locker, J; McEwen, A; McRobbie, H; West, R | 1 |
| Boulter, J; Byun, JS; Fowler, CD; Gould, TJ; Kenny, PJ; Leach, P; Lotfipour, S; Murphy, NP | 1 |
| Damaj, MI; Ignatowska-Jankowska, BM; Lichtman, AH; Muldoon, PP | 1 |
| Concheiro-Guisan, M; Gold, JM; Hahn, B; Harvey, AN; Holcomb, HH; Huestis, MA | 1 |
| Gould, TJ; Wilkinson, DS | 2 |
| Berg, A; Foulds, J; Franzon, M; Galaznik, A; Hughes, JR; Russ, C; Yu, CR; Zou, KH | 1 |
| Dani, JA; De Biasi, M | 2 |
| D'Souza, MS; Markou, A | 1 |
| Drobes, DJ; Evans, DE; Jentink, KG; Maxfield, ND; Oliver, JA; Van Rensburg, KJ | 1 |
| Barbier, E; Chen, X; Damaj, MI; Jackson, KJ; Wang, JB | 1 |
| Aguilar, MA; Aracil-Fernández, A; Berbel, P; García-Gutiérrez, MS; Maldonado, R; Manzanares, J; Martín-García, E; Miñarro, J; Navarrete, F; Navarro, D; Rodríguez-Arias, M | 1 |
| Cohen, A; Edwards, S; George, O; Koob, GF; Leão, RM; Schulteis, G; Treweek, J | 1 |
| Croghan, IT; Ebbert, JO; Hurt, RD; Schroeder, DR | 1 |
| Bloom, EL; Brown, RA; Gifford, EV; Hayes, SC; Kahler, CW; Lejuez, CW; Minami, H; Reed, KM; Strong, DR; Zvolensky, MJ | 1 |
| Alexander, JC; Bruijnzeel, AW; Igari, M; Ji, Y; Papke, RL; Qi, X | 1 |
| Corcoran, O; Dawkins, L | 1 |
| Barclay, E; Goyarzu, P; Magallanes, N; Malin, DH; Mathews, H; Mills, WR; Moon, WD; Negrete, AP; Stephens, B; Vela, AJ | 1 |
| Blendy, JA; Everett, L; Jepson, C; Kaestner, KH; Lee, B; Lerman, C; Ray, R; Turner, JR; Xiang, J | 1 |
| Harrison, AA; Kolokotroni, KZ; Rodgers, RJ | 2 |
| Ables, JL; Antolin-Fontes, B; Dougherty, JD; Frahm, S; Görlich, A; Ibañez-Tallon, I; Slimak, MA | 1 |
| Baiamonte, BA; Baynes, BB; Gilpin, NW; Roltsch, EA; Sabino, V; Valenza, M; Whitaker, AM | 1 |
| Driskill, LM; Foster, S; Gillaspy, SR; Hale, JJ; Meier, E; Oliver, ER; Siegel, MB; Wagener, TL; Warner, ML | 1 |
| Haffen, E; Monnin, J; Pedron, S; Sechter, D; Van Waes, V | 1 |
| Hall, SE; Hall, SM; Hickman, N; Kim, R; Leyro, TM; Prochaska, JJ | 1 |
| Arora, SK; Rehni, AK; Singh, TG | 1 |
| Gardner, PD; Liu, L; Pang, X; Tapper, AR; Zhao-Shea, R | 1 |
| Harris, AC; Manbeck, KE; Schmidt, CE; Shelley, D | 2 |
| Dunsiger, S; Emerson, J; Gwaltney, CJ; Miranda, R; Monti, PM; Ussher, M; Williams, DM | 1 |
| Cramp, A; De Jesus, S; Faulkner, G; Fitzgeorge, L; Harper, T; Mottola, MF; Prapavessis, H; Selby, P; Ussher, M | 1 |
| Ciccolo, JT; Comstock, BA; Dunn-Lewis, C; Flanagan, SD; Fragala, MS; Hatfield, DL; Ho, JY; Kraemer, WJ; Maladouangdock, J; Maresh, CM; Szivak, TK; Vingren, JL; Volek, JS | 1 |
| Giovino, GA; Homish, GG; Kozlowski, LT; Smith, PH | 1 |
| DeVito, EE; Herman, AI; Sofuoglu, M; Valentine, GW; Waters, AJ | 1 |
| Benowitz, NL; Delucchi, KL; Hall, SM; Hendricks, PS | 1 |
| Carroll, AJ; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Kiguchi, N; Kishioka, S; Kobayashi, Y; Maeda, T; Ozaki, M; Saika, F; Ueno, K; Wakida, N; Yamamoto, C | 1 |
| Fowler, JC; Froeliger, B; Lee, TH; Szabo, ST | 1 |
| Blendy, JA; DeDominicis, KE; Forcelli, PA; Hussmann, GP; Kellar, KJ; Klehm, J; Lindstrom, J; Richardson, JR; Sahibzada, N; Turner, JR; Wolfe, BB; Xiao, Y; Yasuda, RP | 1 |
| Cesari, P; Komeilipoor, N; Nitsche, MA; Rafal, RD; Vicario, CM | 1 |
| Card, J; Seidler, FJ; Slotkin, TA | 1 |
| Caine, SB; Collins, GT; Lanier, RK; Mello, NK; Thomsen, M; Wright, C | 1 |
| Csala, I; Dome, B; Dome, P; Faludi, G; Kaunisto, M; Kovacs, G; Lazary, J | 1 |
| Anestis, JC; Batten, SR; Guenthner, G; Kelly, TH; Lile, J; Martin, CA | 1 |
| Cameron, A; Cobb, C; Cohn, AM; Ehlke, S; Hagman, BT; Mitchell, JN | 1 |
| Aso, E; Balerio, GN; Maldonado, R; Moutinho, LM; Varani, AP | 1 |
| Choi, JS; Gwak, AR; Hwang, JY; Jung, HY; Kwon, JS; Lee, JY; Park, CB; Park, SM; Seol, JM | 1 |
| Chen, H; Sharp, BM; Yu, G | 1 |
| Adoff, MD; Blendy, JA; Gould, TJ; Wilkinson, DS; Yildirim, E | 1 |
| Alexander, JC; Bauzo, RM; Bruijnzeel, AW; Corrie, LW; Ji, Y; Qi, X; Yamada, H | 1 |
| Ghahremani, DG; London, ED | 1 |
| Gu, H; Lerman, C; Loughead, J; Ruparel, K; Stein, EA; Yang, Y | 1 |
| Blendy, JA; Turner, JR; Yohn, NL | 1 |
| Bhatter, M; Leischow, SJ; Nides, MA; Simmons, M | 1 |
| Bowker, KA; Coleman, T; Cooper, S; Lewis, S; Vaz, LR | 1 |
| Branstetter, SA; Dino, G; Horn, K; Mercincavage, M | 1 |
| Dermody, SS; Donny, EC | 1 |
| Dani, JA; Dao, DQ; De Biasi, M; Perez, EE; Teng, Y | 1 |
| Howell, D; McPherson, S; Roll, J; Shishani, K | 1 |
| Rahman, S; Roni, MA | 1 |
| Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; de Higes Martinez, E; de Lucas Ramos, P; Jimenez Ruiz, CA; Lorza Blasco, JJ; Riesco Miranda, JA; Signes-Costa Minaya, J; Solano Reina, S | 1 |
| Ashare, RL; Schmidt, HD | 1 |
| Alexander, JC; Bruijnzeel, AW; Guerra, V; Ji, Y; Ormerod, BK; Qi, X; Shan, Z | 1 |
| Alekseeva, EV; Kolpakov, AA; Nazarova, GA; Sudakov, SK | 1 |
| Gould, TJ; Simmons, SJ | 1 |
| Cinciripini, PM; Cui, Y; Engelmann, JM; Gilbert, DG; Gritz, ER; Robinson, JD; Versace, F; Waters, AJ | 1 |
| Carcoba, LM; Castañeda, E; Ferree, PL; Moss, DE; Natividad, LA; O'Dell, LE; Orfila, JE; Pipkin, JA; Torres, OV | 1 |
| Bagdas, D; Damaj, MI; Muldoon, PP; Tyndale, RF; Zhu, AZ | 1 |
| Kiguchi, N; Kishioka, S; Kobayashi, Y; Saika, F | 1 |
| Biała, G; Budzyńska, B; Kruk-Słomka, M; Michalak, A; Polak, P | 1 |
| Connor, DA; Gould, TJ; Poole, RL | 1 |
| Drobes, DJ; Evans, DE; Jentink, KG; Lin, HY; MacQueen, DA; Park, JY | 1 |
| Al'Absi, M; Nakajima, M | 2 |
| Gruca, P; Lason-Tyburkiewicz, M; Litwa, E; Papp, M; Willner, P | 1 |
| Bray, SR; De Jesus, S; Fong, AJ; Prapavessis, H | 1 |
| Cunningham, CS; McMahon, LR; Moerke, MJ | 1 |
| Patel, G | 1 |
| Balerio, GN; Moutinho Machado, L; Varani, AP | 1 |
| Markou, A; Marks, MJ; Stoker, AK | 1 |
| Asal, NJ; Orr, KK | 1 |
| D'Souza, MS; Der-Avakian, A; Heath, AC; Madden, PAF; Markou, A; Pergadia, ML; Pizzagalli, DA; Shiffman, S | 1 |
| Guillot, CR; Leventhal, AM; Zvolensky, MJ | 1 |
| Breland, AB; Eissenberg, T; Karaoghlanian, NV; Shihadeh, AL; Spindle, TR | 1 |
| Barrett, SP; Dar, R | 1 |
| Abdullah, RA; Chen, J; Chen, X; Cravatt, BF; Damaj, MI; Harenza, JL; Lichtman, AH; Miles, MF; Muldoon, PP; Sim-Selley, LJ | 1 |
| Barrett, SP; Collins, JL; Copp, SR; Dar, R | 1 |
| Bullen, C | 1 |
| Becoña, E; Brandon, TH; Fernández del Río, E; López-Durán, A; Martínez, Ú; Piñeiro, B | 1 |
| Liu, XW; Liu, Z; Lu, SF; Yu, AL; Zhang, ZW | 1 |
| Adams, S; Attwood, AS; Munafò, MR | 1 |
| Callas, PW; Dash, M; Hughes, JR | 1 |
| Bloom, EL; Brown, RA; Hayes, SC; Minami, H; Reed, KM | 1 |
| Adriaens, K; Baeyens, F; Declerck, P; Van Gucht, D | 1 |
| Gould, TJ; Holliday, E; Kutlu, MG; Leach, PT | 1 |
| Baker, TB; Cook, JW; Fiore, MC; Leventhal, AM; Piper, ME; Schlam, TR | 1 |
| Fay, M; Green, J; Kirshenbaum, A; Parks, A; Phillips, J; Roy, T; Stone, J | 1 |
| Chwalek, M; Clarke, L; Cohen, A; Contet, C; Crawford, E; Freiling, J; George, O; Grieder, TE; Herman, MA; Kieffer, BL; Koebel, P; Koob, GF; Maal-Bared, G; Repunte-Canonigo, V; Roberto, M; Sanna, PP; Sawchenko, PE; Schlosburg, JE; Tan, LA; Tapper, AR; van der Kooy, D; Vargas-Perez, H | 1 |
| Dawkins, L; Kimber, C; Puwanesarasa, Y; Soar, K | 1 |
| Connor, DA; Gould, TJ; Yildirim, E | 1 |
| Damaj, MI; De Biasi, M; Jackson, KJ; Muldoon, PP | 1 |
| Bois, F; Carson, RE; Cosgrove, KP; Esterlis, I; Glahn, DC; Kloczynski, T; Krystal, JH; Lancaster, J; McKay, R; O'Malley, S; Perkins, E; Pittman, B | 1 |
| Ables, JL; Antolin-Fontes, B; Görlich, A; Ibañez-Tallon, I | 1 |
| Antonelli, MC; Balerio, GN; Bettler, B; Machado, LM; Pedrón, VT; Varani, AP | 1 |
| Drobes, DJ; Evans, DE; Oliver, JA; Sutton, SK | 1 |
| Boumaza, S; Brazo, P; Lebain, P | 1 |
| Gelernter, J; Herman, AI; Jensen, KP; Kranzler, HR; Morean, ME; Sofuoglu, M | 1 |
| Lewis, AS; Mineur, YS; Picciotto, MR; van Schalkwyk, GI | 1 |
| Dani, JA; De Biasi, M; McLaughlin, I | 1 |
| Gilmore, J; Grant, DM; Judah, MR; Lechner, WV; Meier, E; Mills, AC; Wagener, TL; Wiener, JL | 1 |
| Kalayasiri, R; Limsanon, T | 1 |
| Addicott, MA; McClernon, FJ; Sweitzer, MM | 1 |
| Kanit, L; Nesil, T; Pogun, S; Ugur, M | 1 |
| Chopde, CT; Kotagale, NR; Taksande, BG; Umekar, MJ | 1 |
| Anastasia, A; Blendy, JA; Hempstead, BL; Lee, BG; Lee, FS | 1 |
| Piper, ME | 1 |
| Curran, HV; Das, RK; Freeman, TP; Hindocha, C; Lawn, W; Mokrysz, C; Morgan, CJ | 1 |
| Carcoba, LM; Ferree, P; O'Dell, LE; Pipkin, JA; Torres, OV | 1 |
| Carpenter, MJ; Gray, KM; McClure, EA; Saladin, ME; Tiffany, ST; Wray, JM | 1 |
| Karelitz, JL; Perkins, KA | 1 |
| Ashare, RL; Kable, JW | 1 |
| Borland, R; Brady, K; Carpenter, MJ; Cummings, KM; Fong, GT; Hartwell, K; Hyland, A; Kasza, KA; McKee, SA; Smith, PH | 1 |
| Brown, RA; Delucchi, K; Fromont, SC; Hall, SM; Prochaska, JJ; Ramo, DE; Young-Wolff, KC | 1 |
| Cosgrove, KP; Mazure, CM; McKee, SA; Mineur, YS; Picciotto, MR; Smith, PH; Verplaetse, TL; Weinberger, AH | 1 |
| De Biasi, M; Perez, E; Quijano-Cardé, N | 1 |
| Abramson, MJ; Bonevski, B; Dooley, MJ; George, J; Poole, SG; Taylor, S; Thomas, D; Weeks, GR | 1 |
| Bez, J; Dinter, C; Hermann, D; Hoffmann, H; Kiefer, F; Koopmann, A; Lemenager, T; Reinhard, I; Wiedemann, K; Winterer, G | 1 |
| DeGroot, SR; Gao, G; Gardner, PD; George, O; Liu, L; Martin, GE; Pang, X; Rando, OJ; Su, Q; Tapper, AR; Vallaster, M; Zhao-Shea, R | 1 |
| Baig, MR; Bishnoi, RJ; Brown, FW | 1 |
| DiFranza, JR | 3 |
| DeVito, EE; Gelernter, J; Herman, AI; Jensen, KP; Sofuoglu, M; Valentine, GW | 1 |
| Aveyard, P; McNeill, A; Munafò, MR; Taylor, A; Taylor, G | 1 |
| Beard, E; Brown, J; Goniewicz, ML; Nelson, VA; Shahab, L; Sheals, K; West, R | 1 |
| Alenina, N; Bader, M; Chen, W; Filip, M; Fröhler, S; Kuśmider, M; McCreary, AC; Wydra, K; Zaniewska, M | 1 |
| Carroll, FI; Damaj, MI; Jackson, A; Jackson, KJ | 1 |
| Bruijnzeel, AW; Guzhva, L; Ji, Y; Qi, X | 1 |
| al'Absi, M; Allen, AM; Allen, SS; Huttlin, EA; Tosun, NL | 1 |
| Braida, D; Cannazza, G; Castellana, CN; Clementi, F; Fasoli, F; Gallesi, G; Gotti, C; Lucini, V; Moretti, M; Mucchietto, V; Ponzoni, L; Sala, M; Zoli, M | 1 |
| al'Absi, M; Allen, S; Hatsukami, DK; Lemieux, A; Nakajima, M | 1 |
| Durazzo, TC; Meyerhoff, DJ; Murray, DE | 1 |
| Anna Aldi, G; Cosci, F; Nardi, AE | 1 |
| Blazekovic, S; Gariti, P; Goelz, PM; Hitsman, B; Kaufmann, A; Leone, FT; Powers, L; Schnoll, RA; Tyndale, RF; Veluz-Wilkins, A | 1 |
| Beckham, JC; Calhoun, PS; Dennis, MF; Kirby, AC; Vrana, SR | 1 |
| Abdolahi, A; Benesch, CG; Block, RC; Scott, BE; Spitzer, EM; van Wijngaarden, E; Wang, HZ; Williams, GC | 1 |
| Fedota, JR; Stein, EA | 1 |
| Alsharari, SD; Damaj, MI; Jackson, A; Kabbani, N; King, JR; Muldoon, PP; Nordman, JC; Tyndale, RF; Zhu, AZ | 1 |
| Ding, Y; Shi, W; Wang, Q; Xie, G; Yu, A; Zhang, Z | 1 |
| al'Absi, M; Benowitz, NL; Carmella, SG; Cinciripini, PM; Denlinger, RL; Dermody, SS; Donny, EC; Drobes, DJ; Hatsukami, DK; Hecht, SS; Jensen, J; Koopmeiners, JS; Lane, T; Le, CT; McClernon, FJ; Montoya, ID; Murphy, SE; Robinson, JD; Stitzer, ML; Strasser, AA; Tidey, JW; Tindle, H; Vandrey, RG | 1 |
| DiFranza, JR; Engels, RC; Kleinjan, M | 1 |
| Downey, LA; Hayley, AC | 1 |
| Magee, JC; Winhusen, T | 1 |
| Eissenberg, T; Foulds, J; Hrabovsky, S; Nichols, TT; Richie, J; Veldheer, S; Wilson, SJ; Yingst, JM | 1 |
| Hironaka, N; Itasaka, M; Miyata, H | 1 |
| Fatima, S; Ganji, S; Karimian, M; Motaghinejad, M | 1 |
| Hassanshahi, G; Pourshanazari, AA; Zeinivand, M | 1 |
| Fasoli, F; Gotti, C; Marks, MJ; McClure-Begley, T; Moretti, M; Pistillo, F; Zoli, M | 1 |
| Jensen, KP; Sofuoglu, M | 1 |
| Harris, AC; Muelken, P; Schmidt, CE; Shelley, D; Tally, L | 1 |
| Bowers, MS; Damaj, MI; Jackson, A; Maldoon, PP | 1 |
| Martin, C; Savioz, R; Sharma, G; Walele, T; Williams, J | 1 |
| Cole, RD; Gould, TJ; Parikh, V; Patel, PJ; Poole, RL | 1 |
| Berlin, I; Heishman, SJ; Singleton, EG | 1 |
| Baker, TB; Bolt, DM; Fiore, MC; Fraser, DL; Piper, ME; Smith, SS; Stein, JH | 1 |
| Ditre, JW; Kosiba, JD; Maisto, SA; Zale, EL; Zvolensky, MJ | 1 |
| Campbell, K; Devji, T; Hopkins, R; Khoudigian, S; Lytvyn, L; O'Reilly, D | 1 |
| Anzai, NE; Fromont, SC; Prochaska, JJ; Soyster, P | 1 |
| al'Absi, M; Denlinger, RL; Dermody, SS; Donny, EC; Drobes, DJ; Hatsukami, DK; Pacek, LR; Tidey, JW; Vandrey, R | 1 |
| Anderson, JM; Carson, RE; Cosgrove, KP; Deluliis, G; Gao, H; Hillmer, AT; Huang, Y; Kloczynski, T; Labaree, D; O'Malley, SS; Pittman, B; Sandiego, CM | 1 |
| Dierker, LC; Hedeker, D; Mermelstein, RJ; Piasecki, TM | 1 |
| Seidler, FJ; Skavicus, S; Slotkin, TA; Stadler, A | 1 |
| Gardner, PD; Liu, L; McIntosh, JM; Ngolab, J; Pang, X; Tapper, AR; Zhao-Shea, R | 1 |
| Barrett, SP; Schlagintweit, HE | 1 |
| Farrer, LA; Gelernter, J; Herman, AI; Jensen, KP; Kranzler, HR; Smith, AH; Sofuoglu, M | 1 |
| Asfar, T; Auf, R; Ben Taleb, Z; Jaber, R; Maziak, W; Ward, KD | 1 |
| Ashare, RL; Bernardo, L; Cao, W; Falcone, M; Gur, R; Hopson, R; Lerman, C; Loughead, J; Pruessner, JC; Ruparel, K | 1 |
| Becker, JAJ; Kieffer, BL; Le Merrer, J | 1 |
| Cahill, K; Fanshawe, TR; Lancaster, T; Lindson-Hawley, N; Thomas, KH | 1 |
| Corcoran, O; Dawkins, LE; Doig, M; Feyerabend, C; Kimber, CF | 1 |
| Kim, KW; Park, H; Yoon, IY | 1 |
| Bade, EJ; Hartell, EC; Lee, AM; O'Rourke, KY; Touchette, JC | 1 |
| Cai, MT; Liu, DH; Xu, YL; Zhang, ZL; Zuo, YM | 1 |
| Audrain-McGovern, JE; Blazekovic, S; Hitsman, B; Leone, FT; Schnoll, RA; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Biechl, AC; Buadze, A; Eich, D; Fisher, CE; Frei, A; Hiestand, N; Huber, A; Liebrenz, M; Nellen, R | 1 |
| Gould, TJ; Huang, P; Kutlu, MG; Liu-Chen, LY; Oliver, C | 1 |
| Buhidma, Y; Jackson, A; Shoaib, M; Silk, S | 1 |
| Drobes, DJ; Evans, DE; Jentink, KG; Lin, HY; Park, JY; Sutton, SK | 1 |
| Bruijnzeel, AW; Febo, M; Guzhva, L; Qi, X; Shan, Z; Wang, KKW; Yang, Z | 1 |
| Akanni, OO; Olashore, AA; Opondo, PR | 1 |
| Coen, K; Funk, D; Hope, BT; Lê, AD; Shaham, Y; Tamadon, S | 1 |
| Albelda, B; Audrain-McGovern, J; Cao, W; Falcone, M; Gur, RC; Kurtz, MM; Lerman, C; Loughead, J; Wileyto, EP | 1 |
| Kotlyar, M; Mills, AM; Pakhomov, SV; Teeple, W | 1 |
| Bagosi, Z; Balangó, B; Bokor, P; Buzás, A; Csabafi, K; Jászberényi, M; Palotai, M; Pintér, D; Simon, B; Szabó, G | 1 |
| Arger, CA; Bergeria, CL; Bunn, JY; Davis, DR; Durand, H; Gaalema, DE; Heil, SH; Higgins, ST; Miller, ME; Pacek, LR; Priest, JS; Redner, R; Sigmon, SC; Stitzer, ML; Streck, JM; Tidey, JW; Vandrey, R; Zvorsky, I | 1 |
| Berrendero, F; Busquets-Garcia, A; de la Torre, R; Di Marzo, V; Flores, Á; Maldonado, R; Marsicano, G; Ozaita, A; Pastor, A; Plaza-Zabala, A; Saravia, R | 1 |
| Cador, M; Caillé, S; Rubino, T; Simonnet, A; Zamberletti, E | 1 |
| Breland, AB; Eissenberg, T; Hiler, M; Lopez, AA; Maloney, S | 1 |
| Bush, J; Craige, S; Cravo, AS; Martin, C; Savioz, R; Sharma, G; Walele, T | 1 |
| Bogdanova, NG; Sudakov, SK | 1 |
| Edwards, KN; Edwards, S; Farooq, MA; Gilpin, NW; Itoga, CA; McGinn, MA; Paulsen, RI; Reppel, JE; Whitaker, AM | 1 |
| Kerr, A; McVey, JT; Van Haren, F; Wood, AM | 1 |
| Fisher, ML; Huang, G; LeMalefant, RM; Turner, JR; Zhou, L | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Smith, SS | 1 |
| Gilbert, DG; Rabinovich, NE; Zuo, Y | 1 |
| Bruijnzeel, AW | 1 |
| Cobb, CO; Cohn, A; Ehlke, S | 1 |
| Cox, CM; Faulkner, P; Ghahremani, DG; Hellemann, GS; Kazanjian, AS; London, ED; Lotfipour, S; Paterson, N; Petersen, N; Tyndale, RF; Vigil, C | 1 |
| Zielonka, TM | 1 |
| Antczak, A; Pietras, T; Poznański, M | 1 |
| Bagdas, D; Damaj, MI; Elhassan, S | 1 |
| Amiot, E; Hatsukami, DK; Kotlyar, M; Le, C; Lindgren, BR; Mills, AM; Vuchetich, JP | 1 |
| Allan, AM; Anderson, J; Brandon, V; Burge, MR; Hamidovic, A; Khafaja, M; Ray, G | 1 |
| Bagdas, D; Carroll, FI; Damaj, MI; Greenwald, M; Jackson, A; Lichtman, AH; Miles, MF; Muldoon, PP | 1 |
| D'Souza, MS; Norman, H | 1 |
| Ding, Y; Li, C; Wang, Q; Wu, S; Xu, P; Yu, A; Zhang, X; Zhang, Z; Zhu, W | 1 |
| Hutchison, KE; McGeary, JE; Miranda, R; Monti, PM; Rohsenow, DJ; Sirota, AD; Swift, RM; Tidey, JW | 1 |
| Berrettini, W; Dackis, C; Gariti, P; Heitjan, DF; Leone, F; Lerman, C; Perkins, KA; Pinto, A; Schnoll, RA; Siegel, S; Wileyto, EP | 1 |
| DiFranza, JR; Ursprung, WW | 1 |
| Aveyard, P; David, SP; Guo, B; Johnstone, EC; Lerman, C; Munafò, MR; Murphy, MF | 1 |
| McEwen, A; McRobbie, H; West, R | 1 |
| Abreu-Villaça, Y; Filgueiras, CC; Guthierrez, MC; Manhães, AC | 1 |
| Balfour, DJ; Markou, A; Paterson, NE | 1 |
| Cooney, JL; Cooney, NL; McKee, SA; O'Malley, SS; Toll, BA | 1 |
| Oliveira, DL; Petersen, SR; Roberts, JL; Romanovsky, AA; Steiner, AA | 1 |
| Hébert, R | 4 |
| Bishop, SF; Lauzon, NM; Laviolette, SR; Sun, N; Tan, H | 1 |
| Arends, MA; Fowler, CD; Kenny, PJ | 1 |
| Abrams, AL; Brody, AL; Costello, MR; Farahi, J; London, ED; Mandelkern, MA; Mukhin, AG; Olmstead, RE; Rose, JE; Scheibal, D | 1 |
| Miles, MP | 1 |
| Breitmeyer, BG; Leventhal, AM; Li, Y; Miller, EK; Tapia, E; Waters, AJ | 1 |
| Auerback, GM; Benowitz, NL; Moscicki, AB; Rubinstein, ML | 1 |
| Carter, BL; Cinciripini, PM; Lam, CY; Minnix, JA; Robinson, JD; Wetter, DW | 1 |
| Fletcher, PJ; Higgins, GA; Lê, AD | 1 |
| Semba, J; Wakuta, M | 1 |
| Shiffman, S | 2 |
| Drobes, DJ; Evans, DE | 1 |
| Arredondo, C; Celio, M; Cromp, D; Fong, D; Fortmann, SP; Hayward, C; Killen, JD; Murphy, G; Pandurangi, M; Schatzberg, AF | 1 |
| Hironaka, N; Miyasato, K; Miyata, H; Nakamura, K; Takada, K; Yanagita, T | 1 |
| Rose, JE | 2 |
| Berger, SS; Grunberg, NE; Hamilton, KR; Perry, ME | 2 |
| Atzori, G; Boyle, J; Durcan, MJ; Kotler, ML; Lemmonds, CA | 1 |
| Dani, JA; Placzek, AN | 1 |
| Markou, A; Paterson, NE | 3 |
| Perkins, KA | 1 |
| Caggiula, AR; Chaudhri, N; Donny, EC; Liu, X; Palmatier, MI; Sved, AF | 1 |
| Goedeker, KC; Tiffany, ST; Warthen, MW | 1 |
| Gould, TJ; Portugal, GS | 2 |
| Mooney, M; O'Malley, SS; Sofuoglu, M; Waters, AJ | 1 |
| Baraban, JM; Han, S; Miskimon, M; Reti, IM; Rosen, JB | 1 |
| Bolser, DC; Davenport, PW; Duke, RK; Robertson, E; Vovk, A | 1 |
| Hedden, S; Kalivas, PW; Knackstedt, LA; LaRowe, S; Malcolm, R; Mardikian, P; Markou, A; Upadhyaya, H | 1 |
| Khroyan, TV; O'Dell, LE | 1 |
| Bruijnzeel, AW; Isaac, SK; Marcinkiewcz, CA; Marshall, A; Prado, MM; Rylkova, D | 1 |
| Glautier, S; Kalamboka, N; Remington, B | 1 |
| Balfour, DJ | 4 |
| Goyarzu, P; Malin, DH | 1 |
| Goldberg, SR; Le Foll, B | 2 |
| Aubin, HJ | 1 |
| Dent, LA; Harris, KJ; Noonan, CW | 1 |
| Gould, TJ; Raybuck, JD | 1 |
| Bruijnzeel, AW; Isaac, S; Prado, M | 1 |
| Drobes, DJ; Evans, DE; Maxfield, N; Park, JY | 1 |
| Cahill, K; Lancaster, T; Stead, L | 1 |
| Briski, J; Fonte, C; Lerman, C; Perkins, KA; Scott, J | 1 |
| Davis, JA; Gould, TJ | 3 |
| Boulter, J; De Biasi, M; Salas, R; Sturm, R | 1 |
| Dandekar, MP; Kokare, DM; Nakhate, KT; Subhedar, NK | 2 |
| Coppola, S; Harrison, EL; McKee, SA | 1 |
| Damaj, MI; Jackson, KJ | 1 |
| Dawkins, L; Pickering, A; Powell, J; Powell, JH; West, R | 3 |
| Bárkai, Z; Hornyak, M; Jaehne, A; Loessl, B; Riemann, D | 1 |
| Cobb, CO; Eissenberg, T; Weaver, MF | 1 |
| Aveyard, P; Barton, P; Connock, M; Fry-Smith, A; Moore, D; Wang, D | 1 |
| Ferguson, SG; Gritz, ER; Henningfield, JE; Shiffman, S | 1 |
| Murphy, NP; Sakoori, K | 1 |
| Seidler, FJ; Slotkin, TA | 1 |
| Maldonado, R; Trigo, JM; Zimmer, A | 1 |
| Harris, AC; Keyler, DE; LeSage, MG; Pentel, PR; Roiko, SA | 1 |
| Boogerd, EA; Engels, RC; Van Zundert, RM; Vermulst, AA | 1 |
| Brands, B; Elkader, AK; Selby, P; Sproule, BA | 1 |
| Donny, EC; Jones, M | 1 |
| Bullen, C; Hajek, P; Laugesen, M; Lin, RB; McRobbie, H; Senior, H; Thornley, S; Whittaker, R | 2 |
| Abreu-Villaça, Y; Filgueiras, CC; Lima, CS; Manhães, AC; Medeiros, AH; Ribeiro-Carvalho, A; Siqueira, NR | 1 |
| Batis, J; Bois, F; Cosgrove, KP; Esterlis, I; Kloczynski, T; Krishnan-Sarin, S; Maciejewski, PK; O'Malley, S; Perry, E; Seibyl, JP; Staley, JK; Stiklus, S; Tamagnan, G | 1 |
| Hu, MC; Kandel, DB; Yamaguchi, K | 1 |
| Bidja, AH; Coudron, T; Eterović, VA; Fattore, AL; Pagán, OR; Rowlands, AL; Urban, KR | 1 |
| Cagniard, B; Murphy, NP; Shoaib, M; Wing, VC | 1 |
| Rigotti, NA; Thorndike, AN | 1 |
| Behm, FM; Herskovic, JE; Rose, JE; Westman, EC | 1 |
| Araujo, RB; Castro, Mda G; Oliveira, Mda S; Pedroso, RS | 1 |
| Vujanovic, AA; Zvolensky, MJ | 1 |
| Kahler, CW; Leventhal, AM; Metrik, J; Monti, PM; Spillane, NS | 1 |
| Damaj, MI; Jackson, KJ; Martin, BR; Miles, MF; Walters, CL | 1 |
| Dandekar, MP; Kamdi, SP; Kokare, DM; Nakhate, KT; Subhedar, NK | 1 |
| Brunzell, DH; Damaj, MI; Jackson, KJ; McIntosh, JM; Sanjakdar, SS | 1 |
| Dugas, E; Gervais, A; Lagerlund, M; Meshefedjian, G; O'Loughlin, J; Wileyto, P | 1 |
| Harris, LS; Kwilasz, AJ; Vann, RE | 1 |
| Cao, D; Conrad, M; King, A; McNamara, P | 1 |
| Natividad, LA; O'Dell, LE; Tejeda, HA; Torres, OV | 1 |
| Balaji, G; Dixon, H; Lewis, KE; Lewis, MJ; Syed, Y | 1 |
| Bergman, J; Gibson, LE; Johnson, K; Marshall, EC; Zvolensky, MJ | 1 |
| Hadjiconstantinou, M; McCarthy, MJ; Neff, NH; Zhang, H | 2 |
| Dinter, C; Grosshans, M; Kiefer, F; Koopmann, A; Mann, K; Nakovics, H; Richter, A; Rockenbach, C; von der Goltz, C; Wiedemann, K; Winterer, G | 1 |
| Carchman, RA; Coggins, CR; Heidbreder, C; Murrelle, EL | 1 |
| Duchemin, AM; Hadjiconstantinou, M; Neff, NH; Zhang, H | 2 |
| Croghan, IT; Danaher, BG; Ebbert, JO; Schroeder, DR; Severson, HH | 2 |
| Cohen, LM; Cook, K; Cortez-Garland, M; Vanderveen, JW | 1 |
| Courvoisier, DS; Etter, JF | 1 |
| Mattioli, L; Perfumi, M | 1 |
| Baker, TB; Bolt, DM; Japuntich, SJ; Piper, ME; Schlam, TR | 1 |
| Dickinson, A; Duka, T; Hogarth, L | 1 |
| Faulkner, G; Scerbo, F; Taylor, A; Thomas, S | 1 |
| Carpenter, MJ; Gray, KM | 1 |
| Chan, PY; Davenport, PW | 1 |
| Burgess, C; Caldwell, B; Crane, J | 1 |
| Glass, M; Kuzla, N; Langer, C; Leone, F; Martinez, E; Miyamoto, C; Ridge, JA; Schnoll, RA; Tatum, KL; Weber, DM; Wileyto, EP | 1 |
| Conklin, CA; Giedgowd, GE; Karelitz, JL; Perkins, KA; Sayette, MA | 1 |
| Filip, M; McCreary, AC; Wydra, K; Zaniewska, M | 1 |
| Noda, K; Saku, K; Tsukahara, H | 1 |
| Barrett, SP | 1 |
| Alexander, MR; Blair, MB; Ennifar, S; Fattom, A; Goyarzu, P; Magallanes, N; Malin, DH; McDavid, L; Moon, WD; Spurgeon, JL | 1 |
| Bauzo, RM; Bishnoi, M; Bruijnzeel, AW; Derendorf, H; Keijzers, KF; Kobeissy, FH; Sabarinath, SN; Shah, HP; Small, E; van Tuijl, IA; Yamada, H | 1 |
| Berlin, I; Covey, LS; Hu, MC; Nunes, EV; Weissman, J; Winhusen, T | 1 |
| Carroll, FI; Damaj, MI; Jackson, KJ; Negus, SS | 1 |
| Bühler, M; Fehr, C; Graf, C; Kobiella, A; Mann, K; Smolka, MN; Vollstädt-Klein, S | 1 |
| Bullen, C; Glover, M; Laugesen, M; Lin, R; McRobbie, H; Thornley, S | 1 |
| Cole, M; George, O; Grieder, TE; Koob, GF | 1 |
| Reichle, ED; Sayette, MA; Schooler, JW | 1 |
| Beaver, JD; Beckmann, CF; Cole, DM; Durcan, MJ; Long, CJ; Matthews, PM | 1 |
| Foulds, J | 2 |
| Amir, NA; Awaisu, A; Hashim, MI; Hassali, MA; Mohamad, MH; Omar, CG; Samsudin, S; Shafie, AA | 1 |
| Harris, AC; Keyler, DE; Lesage, MG; Mattson, C; Pentel, PR | 1 |
| Lajtha, A; Sershen, H | 1 |
| Carpenter, MJ; Hughes, JR; Naud, S | 1 |
| Bullen, C; Glover, M; Grigg, M; Howe, C; Laugesen, M; Lin, RB; McRobbie, H; Rodgers, A; Walker, N; Wallace-Bell, M; Whittaker, R | 1 |
| Benowitz, NL | 6 |
| Cohen, RA; David, SP; Finnerty, CE; Jerskey, BA; Mulligan, RC; Niaura, RS; Sweet, LH | 1 |
| Der-Avakian, A; Markou, A | 1 |
| Blough, BE; Carroll, FI; Damaj, MI; Grabus, SD; King, LS; Lukas, RJ; Navarro, HA; Vann, RE; Warner, JA; Wiley, JL | 1 |
| Bauer, B; Croghan, IT; Ebbert, JO; Prasad, K; Schroeder, DR; Sood, A | 1 |
| Benowitz, NL; Friedman, L; Mumenthaler, MS; Noda, A; Taylor, JL; Yesavage, JA | 1 |
| Hiroi, N; Scott, D | 1 |
| Ioannides-Demos, LL; McNeil, JJ; Piccenna, L | 1 |
| Markou, A; Semenova, S | 2 |
| Cobb, CO; Eissenberg, TE; Vansickel, AR; Weaver, MF | 1 |
| Curtin, JJ; Hogle, JM; Kaye, JT | 1 |
| Zellweger, JP | 1 |
| Meyer, A; Stolz, D | 1 |
| Alexander, JC; Bishnoi, M; Bruijnzeel, AW; Ford, J; Keijzers, KF; Pasek, TM; van Tuijl, IA; Yamada, H; Yavarovich, KR | 1 |
| Agrawal, A; Bucholz, KK; Heath, AC; Madden, PA; Martin, NG; Pergadia, ML | 1 |
| Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J | 1 |
| de Ruiter, MB; Goudriaan, AE; Oosterlaan, J; van den Brink, W; Veltman, DJ | 1 |
| Le Foll, B; Novak, G; Seeman, P | 1 |
| Baker, TB; Cook, JW; Jorenby, DE; Piper, ME; Schlam, TR | 1 |
| Batis, JC; Bois, F; Cosgrove, KP; Esterlis, I; Kloczynski, T; McKee, S; Mitsis, EM; Perry, E; Picciotto, MR; Seibyl, JP; Staley, JK; Stiklus, SM | 1 |
| Froeliger, B; Kozink, RV; Lutz, AM; McClernon, FJ; Rose, JE | 1 |
| Reynaert, C; Tordeurs, D; Zdanowicz, N | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Kotlyar, M; Lindgren, BR; Murphy, SE; Stepanov, I | 1 |
| Blendy, JA; Castellano, LM; Turner, JR | 1 |
| Busch, AM; Kahler, CW; Leventhal, AM; Spillane, NS | 1 |
| Hadjiconstantinou, M; Neff, NH | 1 |
| O'Dell, LE | 1 |
| Cahill, K; Lancaster, T; Stead, LF | 3 |
| Bullen, C; Glover, M; Grigg, M; Howe, C; Laugesen, M; McRobbie, H; Vander Hoorn, S; Walker, NK; Whittaker, R | 1 |
| Ahtee, L; Castrén, E; Kaste, K; Kivinummi, T; Rantamäki, T | 1 |
| Banerjee, D; Finn, MG; Froestl, W; Guery, S; Kaupmann, K; Markou, A; Paterson, NE; Vlachou, S | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR; Sood, A | 1 |
| Eissenberg, T; Ibrahim, I; Khalil, R; Maziak, W; Rastam, S; Ward, KD | 1 |
| McEwen, A; Shahab, L; West, R | 1 |
| Chandra, S; Scharf, D; Shiffman, S | 1 |
| Calapai, G; Caputi, AP; Mannucci, C; Navarra, M; Pieratti, A; Russo, GA | 1 |
| de Bruin, NM; Kloeze, BM; McCreary, AC | 1 |
| Domino, EF; Jutkiewicz, EM; Ohmura, Y | 1 |
| Díaz Cerezo, S; Martí Sánchez, B; Navarro Artieda, R; Sanz De Burgoa, V; Sicras Mainar, A | 1 |
| Abreu-Villaça, Y; Filgueiras, CC; Lima, CS; Manhães, AC; Nunes-Freitas, AL; Ribeiro-Carvalho, A | 1 |
| Baker, TB; Bolt, DM; Cook, JW; Hefner, KR; Kaye, JT; Kim, SY; Loh, WY; Piper, ME; Schlam, TR; Sheffer, MA; Smith, SS | 1 |
| Douaihy, A; Fabian, T; Fichter-DeSando, C; Scharf, D | 1 |
| Hooten, WM; Mantilla, CB; Shi, Y; Warner, DO; Weingarten, TN | 1 |
| Afessa, B; Cartin-Ceba, R; Hays, JT; Warner, DO | 1 |
| Burroughs, D; Harris, AC; Lesage, MG; Pentel, PR; Staley, MD | 1 |
| Aydin, C; Isgor, C; Oztan, O | 2 |
| Commons, KG; Sperling, R | 1 |
| Edwards, AC; Kendler, KS | 1 |
| Gur, RC; Lerman, C; Loughead, J; O'Donnell, GP; Ray, R; Ruparel, K; Senecal, N; Siegel, S; Wileyto, EP | 1 |
| Simon, JA | 1 |
| Baron, S; Kim, M; Patil, T; Raffa, RB; Rawls, SM; Song, K; Tallarida, CS; Ward, S | 1 |
| Bannon, LC; Beaver, JD; Cole, DM; Durcan, MJ; Long, CJ; Matthews, PM; Mishra, RG | 1 |
| Javitz, HS; Lerman, C; Swan, GE | 1 |
| Cinciripini, PM; Cofta-Woerpel, L; Li, Y; McClure, JB; Urbauer, D; Wetter, DW | 1 |
| Abrams, D; Evatt, DP; Greenberg, BD; Haber, S; Leventhal, AM; Niaura, R; Strong, DR | 1 |
| Bullen, C; Etter, JF | 1 |
| Hajek, P; McRobbie, H; West, O | 1 |
| Barrett, SP; Wagner, E | 1 |
| Domino, EF; Jutkiewicz, EM; Ohmura, Y; Zhang, A | 1 |
| Christian Manhães, A; Claudio-Neto, S; de Moura, EG; de Oliveira, E; Lisboa, PC; Passos, MC; Pinheiro, CR; Santos-Silva, AP | 1 |
| Balerio, GN; Calvo, M; Moutinho, LM; Varani, AP | 1 |
| Abrams, K; Bresslour, M; Jalan, A; Leger, K; Merrill, A; Schlosser, L | 1 |
| De Biasi, M; Paolini, M | 1 |
| Lester, RA | 1 |
| Gould, TJ; Kenney, JW; Portugal, GS; Sullivan, C; Wilkinson, DS | 1 |
| Dorner, TE; Groman, E; Tröstl, A; Womastek, I | 1 |
| Dani, JA; Dong, Y; Doyon, WM; Zhang, L | 1 |
| Herman, AI; McKee, SA; Sofuoglu, M; Waters, AJ | 1 |
| Becker, JA; Befort, K; Darcq, E; Dembele, D; Filliol, D; Gardon, O; Kieffer, BL; Le Merrer, J | 1 |
| Froeliger, B; Kozink, RV; McClernon, FJ; Modlin, L; Wang, L | 1 |
| Domino, EF; Jutkiewicz, EM; Ohmura, Y; Yoshioka, M | 1 |
| Markou, A; Olivier, B; Stoker, AK | 2 |
| Dent, G; Jaeger, J; Turetsky, BI; Zukin, SR | 1 |
| Arora, S; Rehni, AK; Singh, TG | 2 |
| Liebman, AK; Lockhart, AC; Regan, S; Reyen, M; Richards, AE; Rigotti, NA | 1 |
| Astarita, G; Caprioli, G; Ciccocioppo, R; Cippitelli, A; Duranti, A; Kallupi, M; Piomelli, D; Rodrìguez de Fonseca, F; Sagratini, G; Stopponi, S; Ubaldi, M | 1 |
| Biala, G; Budzynska, B; Polak, P | 1 |
| Alexander, JC; Bishnoi, M; Bruijnzeel, AW; Ford, J; Ji, Y; Rogers, JA; Scheick, S | 1 |
| Caggiula, AR; Coddington, S; Donny, EC; Sheppard, J; Sved, AF; Sweitzer, M; Verdecchia, N; Weaver, MT | 1 |
| Bauzo, RM; Bruijnzeel, AW | 1 |
| Ammerman, S; Bailey, SR; Crew, EE; Killen, JD; Riske, EC; Robinson, TN | 1 |
| Adoff, M; André, JM; Gould, TJ; Kenney, JW; Marks, MJ; Portugal, GS; Tadman, MP; Yildirim, E | 1 |
| George, O; George, SR; Grieder, TE; Laviolette, SR; Le Foll, B; Tan, H; van der Kooy, D | 1 |
| Grace, AA; Sesia, T | 1 |
| Batra, A; Lauri, H; Mann, K; Perfekt, R; Tønnesen, P | 1 |
| Herman, AI; Jatlow, P; Nadim, H; Sofuoglu, M | 1 |
| Bois, F; Cosgrove, KP; Esterlis, I; Kirk, K; Krishnan-Sarin, S; Lee, D; McKee, SA; O'Malley, SS; Seibyl, JP; Staley, JK; Stiklus, SM | 1 |
| Berlin, I; Covey, LS; Hu, MC; Winhusen, T | 1 |
| Dawkins, L; Hasna, S; Soar, K; Turner, J | 1 |
| Blendy, JA; Gould, TJ; Portugal, GS; Turner, JR; Wilkinson, DS | 1 |
| Cohen, A; George, O; Koob, GF | 1 |
| Hurlemann, R; Mihov, Y | 1 |
| Fryxell, KJ; Locklear, LL; McDonald, CG; Smith, RF | 1 |
| Baker, TB; Bolt, D; Cook, JW; Loh, WY; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Natividad, LA; O'Dell, LE; Orfila, JE; Tejeda, HA; Torres, OV | 1 |
| Holm, JE; Petros, TV; Poltavski, DV | 1 |
| Ashare, RL; Blair, IA; Leone, F; Mesaros, AC; Strasser, AA; Tang, KZ | 1 |
| Herman, AI; Li, Y; Sofuoglu, M; Waters, AJ | 1 |
| Czambel, RK; Karwoski, TE; Rhodes, ME; Rubin, RT; Skwara, AJ | 1 |
| Damaj, MI; Lichtman, AH; Muldoon, PP; Parsons, LH | 1 |
| Binkert, CA; Graf, N; Gutzeit, A; Hergan, K; Mutschler, J; Rössler, W; Spanaus, KS | 1 |
| Blendy, JA; Hilario, MR; Turner, JR | 1 |
| Blendy, JA; Gould, TJ; Turner, JR; Wilkinson, DS | 1 |
| Leventhal, AM; Pitts, SR | 1 |
| Baker, TB; Cook, JW; Fiore, MC; Piper, ME; Schlam, TR | 1 |
| Leyro, TM; Zvolensky, MJ | 1 |
| Buczynski, MW; Natividad, LA; O'Dell, LE; Parsons, LH; Torres, OV | 1 |
| Calapai, G; Calzavara, E; Caputi, AP; Mannucci, C; Navarra, M | 1 |
| Hendricks, PS | 1 |
| Evans, SE; Hoffman, AC | 1 |
| Mikkelsen, K; Tønnesen, P | 1 |
| Bruno, CM; Caponnetto, P; Keller, E; Polosa, R | 1 |
| Croucher, R; Csikar, J; Dahiya, M; Kassim, S; Ross, L; Shanbhag, S | 1 |
| Chavkin, C; Chavkin, NW; Gustin, RM; Hagan, CE; Lemos, JC; Messinger, DI; Neumaier, JF; Schattauer, SS; Schindler, AG; Shankar, H; Smith, JS | 1 |
| Chen, X; Damaj, MI; Jackson, KJ; Sanjakdar, SS | 1 |
| Antal, M; Barabás, K; Forster, A; Nagy, K; Ramseier, CA; Zalai, Z | 1 |
| Abdel, AY; Baynes, B; George, O; Gilpin, NW; Weil, MT; Whitaker, AM | 1 |
| Binkert, CA; Brügger, M; Froehlich, JM; Graf, N; Grosshans, M; Gutzeit, A; Herdener, M; Hergan, K; Kos, S; Meier, D; Mutschler, J; Reischauer, C; Schubert, T; Straka, M; Sutter, R | 1 |
| al'Absi, M; Grabowski, J; Nakajima, M | 1 |
| Camfield, DA; Kras, M; Kure, C; Pipingas, A; Scholey, AB; Silberstein, RB; Stough, C; Zangara, A | 1 |
| Aveyard, P; Hankins, M; Hollands, GJ; Marteau, TM; McDermott, MS | 1 |
| Okere, CO; Waterhouse, BD | 1 |
| Ellouze, M; Kallel, S; Karoui, A; Triki, Z | 1 |
| Imad Damaj, M; Jackson, KJ | 1 |
| Crowe, E; Dawkins, L; Turner, J | 1 |
| Brunzell, DH; Lynch, WJ; Moore, CF; Sanchez, V | 1 |
| Jorenby, D | 1 |
| Sutherland, G | 1 |
| Butelman, ER; Kellogg, SH; Kreek, MJ; Mathieu-Kia, AM | 1 |
| Ichino, N; Ishiguro, H; Nagatsu, T; Nishii, K; Sawada, H; Yamada, K | 2 |
| Bishop, C; Coscina, DV; Parker, GC | 2 |
| Hanoune, J; Monory, K; Nomikos, GG; Tzavara, ET | 1 |
| Araki, H; Gomita, Y; Suemaru, K; Yasuda, K | 1 |
| Gatch, MB; Jung, ME; Lal, H | 1 |
| Higgins, ST; O'Neill, SC; Tidey, JW | 1 |
| Fiore, MC; Sims, TH | 1 |
| Cousins, MM; Seidler, FJ; Slikker, W; Slotkin, TA; Xu, Z | 1 |
| Gómez, J; Klein, M; Payaslian, S; Prigioni, A | 1 |
| Castañé, A; Ledent, C; Maldonado, R; Parmentier, M; Valjent, E; Valverde, O | 1 |
| Bye, A; Gomeni, R; Iavarone, L; Milleri, S; Squassante, L; Teneggi, V | 1 |
| Bye, A; Milleri, S; Squassante, L; Teneggi, V; Tiffany, ST; Ziviani, L | 2 |
| Dallery, J; Houtsmuller, EJ; Pickworth, WB; Stitzer, ML | 1 |
| Breland, AB; Buchhalter, AR; Eissenberg, T; Evans, SE | 1 |
| Griffiths, RR; Jones, HE | 1 |
| Baxter, LR; Bota, RG; Brody, AL; Childress, AR; Ho, ML; Jarvik, ME; Lee, GS; London, ED; Madsen, D; Mandelkern, MA; Saxena, S | 1 |
| Berrendero, F; Kieffer, BL; Maldonado, R | 1 |
| Busto, UE; Cárdenas, L; Corrigall, WA; MacDonald, A | 1 |
| Fortmann, SP; Hayward, C; Killen, JD; Schatzberg, A; Varady, A | 1 |
| Marks, JL; Mehringer, AM; Namenek Brouwer, RJ; Pomerleau, CS; Pomerleau, OF; Saules, KK; Snedecor, SM | 1 |
| Chimonas, E; Diamantopoulos, I; Giannakoulas, G; Katramados, A; Melas, N | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Piasecki, TM; Smith, SS | 3 |
| Hull, JG; Martin, CS; Perrott, MA; Sayette, MA; Wertz, JM | 1 |
| Avenet, P; Bergis, OE; Besnard, F; Biton, B; Caille, D; Cohen, C; Coste, A; Curet, O; Galli, F; Gardes, A; George, P; Graham, D; Jegham, S; Leonardon, J; Lochead, AW; Oblin, A; Perrault, G; Scatton, B; Sgard, F; Soubrie, P; Voltz, C | 1 |
| Parrott, AC | 3 |
| Bruijnzeel, AW; Cryan, JF; Markou, A; Skjei, KL | 1 |
| Besheer, J; Bevins, RA | 2 |
| Markou, A; Skjei, KL | 1 |
| Calapai, G; Caputi, AP; Catania, MA; Crupi, A; Firenzuoli, F; Mannucci, C | 1 |
| Aldrich, TK; Appel, DW | 1 |
| Fagerström, K; Groman, E | 1 |
| Cook, MR; Gerkovich, MM; Graham, C; Hoffman, SJ; Peterson, RC | 1 |
| Cort, N; Haustein, H; Haustein, KO; Krause, J; Rasmussen, T | 1 |
| Badger, GJ; Heil, SH; Higgins, ST; Holmes, HW; Tidey, JW | 1 |
| Leischow, SJ; Muramoto, ML; Ranger-Moore, J | 1 |
| Eisen, SA; Lyons, MJ; Madden, PA; Scherrer, JF; True, WR; Tsuang, M; Xian, H | 2 |
| Allen, SS; Christianson, D; Hatsukami, DK | 1 |
| Brauer, LH; Hatsukami, DK; Jensen, J; Mooney, M; Pentel, PR; Schulte, S; Sofuoglu, M | 1 |
| Gasparini, F; Kenny, PJ; Markou, A | 1 |
| Cooney, JL; Cooney, NL; Kranzler, HR; Oncken, CA; Pilkey, DT | 1 |
| Puura, A | 1 |
| Corwin, EJ; Klein, LC | 1 |
| Hider, A; Hjalmarson, A; Lebargy, F; Sweet, R; Tonstad, S; Townsend, J; Tønnesen, P; Van Spiegel, PI | 1 |
| Bespalov, A; Markou, A; Semenova, S | 1 |
| Bellinger, L; Bullard, RL; Cepeda-Benito, A; Wellman, PJ | 1 |
| Goletiani, NV; Jaszyna-Gasior, M; Mello, NK; Mendelson, JH; Mutschler, NH; Sholar, MB; Siegel, AJ | 1 |
| Ruotsalainen, H | 1 |
| Camí, J; Farré, M | 1 |
| Allen, S; Hanson, K; Hatsukami, D; Jensen, S | 1 |
| Damaj, MI; Kao, W; Martin, BR | 1 |
| Khazaal, Y; Krenz, S; Zullino, DF | 1 |
| ROSENBERG, A | 1 |
| SCHIEVELBEIN, H | 1 |
| HAGENBUCHNER, K | 1 |
| FARAGO, I | 1 |
| BROWN, CT | 1 |
| KNEPPER, R | 1 |
| JOST, F | 1 |
| JOCHUM, K; JOST, F; TUBA, J | 1 |
| Catalano, HN; Galimerti, H; Hunter, B; Nine, C | 1 |
| Gilmore, A; McKee, M; Novotny, T | 1 |
| Glover, ED; Glover, PN; Payne, TJ | 1 |
| Corwin, EJ; Klein, LC; Stine, MM | 1 |
| Dhawan, K; Kumar, S; Sharma, A | 1 |
| Bates, JE; Behm, FM; Rose, JE; Salley, A; Westman, EC | 1 |
| Bates, JE; Behm, FM; Rose, JE; Westman, EC | 1 |
| Maeda, J; Semba, J; Suhara, T; Wakuta, M | 1 |
| Gillison, F; Hajek, P; McRobbie, H | 1 |
| Debaere, S; Havermans, RC; Jansen, AT; Smulders, FT; Wiers, RW | 1 |
| Dadmarz, M; Vogel, WH | 1 |
| Britt, DM; Burkholder, GJ; David, SP; Day, A; Griffiths, SE; Hutchison, K; Johnstone, E; Murphy, M; Niaura, R; Papandonatos, GD; Shadel, WG; Stumpff, J; Walton, RT | 1 |
| Garcia, SJ; Seidler, FJ; Slikker, W; Slotkin, TA; Tate, CA; Xu, Z | 1 |
| Babb, D; Hatsukami, DK; Sofuoglu, M | 1 |
| Fekkes, D; Spijkerman, R; Van Den Eijnden, R | 1 |
| Hajek, P; McRobbie, H | 1 |
| García Thuring, L; Iruela Cuadrado, L; Martínez Vigo, M | 1 |
| Bonnier, C; Fiasse, L; Galanti, L; Godding, V; Lebecque, P; Longueville, E; Michel, M; Robert, A | 1 |
| Jarvis, MJ | 1 |
| Abreu-Villaça, Y; Cousins, MM; Seidler, FJ; Slotkin, TA; Tate, CA | 1 |
| Cook, JW; Hedeker, D; McChargue, D; Spring, B | 1 |
| Griffiths, RR; Sigmon, SC; Sobel, BF | 1 |
| Bolliger, CT; Diacon, AH; Schuurmans, MM; van Biljon, X | 1 |
| Changeux, JP; Damaj, I; Evrard, A; Salmon, AM | 1 |
| Johnston, JA; Tonstad, S | 1 |
| Budde, H; Karow, AC; Schmidt, LG; Smolka, MN | 1 |
| Burke, M; Foulds, J; Steinberg, M; Williams, JM; Ziedonis, DM | 1 |
| Hajek, P; West, R | 2 |
| Lowe, AS; Shoaib, M; Williams, SC | 1 |
| Jin, WQ; Liu, ZH | 1 |
| Hébert Eb, R | 1 |
| Avarguès, P; Deroudilhe, G; Hervé, Y; Labadie, P; Tran-Van, D | 1 |
| Bruijnzeel, AW; Ghozland, S; Koob, GF; Markou, A; O'Dell, LE | 1 |
| Cohen, C; Griebel, G; Perrault, G; Soubrié, P | 1 |
| Pandey, SC; Pluzarev, O | 1 |
| Bizarro, L; Shoaib, M | 1 |
| Batman, AM; Damaj, MI; Grabus, SD; Martin, BR; Sellers, E; Tyndale, RF | 1 |
| Gilbert, D; Shiffman, S; West, R | 1 |
| Bruijnzeel, AW; Markou, A | 2 |
| al'Absi, M; Cohen, LM; Collins, FL | 1 |
| Feinsilver, SH; Greenberg, H; Htoo, A; Talwar, A | 1 |
| Drucker-Colín, R; Haro, R | 1 |
| Baker, KM; Bonn-Miller, MO; Brown, RA; Feldner, MT; Leen-Feldner, E; Zvolensky, MJ | 1 |
| Corrigall, WA; Engleman, EA; Rahman, S; Zhang, J | 1 |
| Gill, P; Hall, SM; Prochaska, JJ | 1 |
| Fryer, GE; Kick, S; Miyoshi, T; Prochazka, AV; Steinbrunn, C | 1 |
| De Biasi, M; Pieri, F; Salas, R | 1 |
| Aso, E; Balerio, GN; Berrendero, F; Maldonado, R; Murtra, P | 1 |
| Crespo Galán, I; Gómez de Heras, R; González Cuevas, G; López-Moreno, JA; Navarro, M; Rodríguez de Fonseca, F; Trigo-Díaz, JM | 1 |
| Audrain-McGovern, J; Jepson, C; Kaufmann, V; Lerman, C; Perkins, KA; Pickworth, WB; Rukstalis, M; Strasser, AA; Wileyto, EP | 1 |
| Berrendero, F; Bilkei-Gorzo, A; Galeote, L; Maldonado, R; Mendizábal, V; Robledo, P; Zimmer, A | 1 |
| Allen, SS; Bade, T; Center, B; Hatsukami, DK | 1 |
| Mitchell, SH | 2 |
| Etter, JF | 2 |
| Domino, EF; Guthrie, S; Heitzeg, MM; Koeppe, RA; Ni, L; Xu, Y; Zubieta, JK | 1 |
| Katsura, M; Ohkuma, S | 1 |
| Girdler, SS; Light, KC; Maixner, W; Moretz, RL; Naftel, HA; Stewart, PW | 1 |
| Berlin, I; Heishman, SJ; Notides, C; Singleton, EG; Vorspan, F; Warot, D | 1 |
| Hida, T; Ichino, N; Ishiguro, H; Nagatsu, T; Nishii, K; Sawada, H; Yamada, K | 1 |
| Gilbert, DG; McClernon, FJ | 1 |
| Hughes, JR; Keely, JP | 1 |
| DiFranza, JR; Wellman, RJ | 1 |
| Mehringer, AM; Ninowski, R; Pomerleau, CS; Pomerleau, OF; Sen, A; Snedecor, SM | 1 |
| Bremann, L; Hvidberg, S; Nilsson, F; Pisinger, C; Thomsen, C; Tønnesen, P; Wennike, P; Westin, A | 1 |
| Bazar, KA; Daniel, SM; Gerber, A; Lee, PY; Yun, AJ | 1 |
| Lee, HJ; Lee, JH | 1 |
| Batini, C; Champagnat, J; Silva-Barrat, C; Szente, M; Velluti, J | 1 |
| Miranda, M; Slachevsky, A; Venegas, P | 1 |
| Grabus, SD; Imad Damaj, M; Martin, BR | 1 |
| Ames, SC; Offord, KP; Patten, CA; Schroeder, DR; Warner, DO | 1 |
| Henry, B; Jonkman, S; Markou, A; Semenova, S | 1 |
| Coppel, E; Delarue, A; Demazières, A; Fleury, C; Gilles, C; Lagrue, G; Laur, C; Luthringer, R; Roegel, JC | 1 |
| Culligan, K; Kosten, T; Mouratidis, M; Sofuoglu, M; Yoo, S | 1 |
| Kenny, PJ; Markou, A | 3 |
| Eisenberg, MJ; Ludvig, J; Miner, B | 1 |
| Bechara, A; Naqvi, NH | 1 |
| Balster, RL; Beardsley, PM; Vann, RE | 1 |
| Granger, RH | 1 |
| Brown, RA; Kahler, CW; Lejuez, CW; Strong, DR; Zvolensky, MJ | 1 |
| Delgado, MR; Fiez, JA; Sayette, MA; Wilson, SJ | 2 |
| Shoaib, M; Warner, C | 1 |
| Berrettini, W; Epstein, LH; Hawk, L; Jepson, C; Kaufmann, V; Lerman, C; Niaura, R; Patterson, F; Restine, S; Rukstalis, M; Wileyto, EP | 1 |
| Braus, DF; Bühler, M; Heinz, A; Klein, S; Mann, K; Smolka, MN; Zimmermann, U | 1 |
| Biggio, G; Brundu, A; Concas, A; Marra, C; Porcu, P; Sogliano, C | 1 |
| Abdullah, AS; Chan, SS; Hedley, AJ; Lam, TH | 1 |
| Erwin, DS; Jennings, RE; Khambati, HN; Lake, JR; Malin, DH; Meyers-Paal, RL; Montellano, AL; Perales, BA; Presley, SE; Smith, TD | 1 |
| Lerman, C; Perkins, KA; Stitzer, M | 1 |
| Davis, JA; Gould, TJ; James, JR; Siegel, SJ | 1 |
| Patterson, SM; Vanderkaay, MM | 1 |
| Baker, L; Quibell, R | 1 |
| Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Green, MF; Henderson, DC; Rigotti, NA; Schoenfeld, DA | 1 |
| Martin-Garcia, E; Pallares, M | 1 |
| Abrams, K; Feldner, MT; Gibson, LE; Gregor, K; Leen-Feldner, EW; Zvolensky, MJ | 1 |
| Balabanis, MH; Ferguson, SG; Gwaltney, CJ; Shadel, WG; Shiffman, S | 1 |
| Barik, J; Wonnacott, S | 1 |
| Garzotti, M; Heidbreder, CA; Mugnaini, M; Pilla, M; Repeto, P; Sartori, I; Tessari, M | 1 |
| de Villiers, SH; Gordon, S; Johansson, AM; Kalayanov, G; Lindblom, N; Markou, A; Schilström, B; Semenova, S; Svensson, TH | 1 |
| Evans, M; Rashid, M; Ussher, M; West, R | 1 |
| Barenboim, E; Goldstein, L; Grossman, A; Landau, DA | 1 |
| de Vos, A; Fiore, M; Hatsukami, DK; Horwith, G; Jorenby, D; Koopmeiners, J; Pentel, PR; Rennard, S | 1 |
| Cousins, MM; Seidler, FJ; Slotkin, TA; Tate, CA | 1 |
| Cavun, S; Göktalay, G; Hamilton, JR; Levendusky, MC; Millington, WR | 1 |
| Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW | 1 |
| Kosten, T; Mouratidis, M; Poling, J; Sofuoglu, M | 1 |
| Warner, DO | 1 |
| al'Absi, M | 1 |
| Jonkman, S; Markou, A | 1 |
| Blakeslee, A; Cooney, JL; Cooney, NL; Dubin, JA; Jatlow, P; Krishnan-Sarin, S; Makuch, R; McKee, SA; Meandzija, B; O'Malley, SS; Romano-Dahlgard, D; Wu, R | 1 |
| Adson, DE; al'absi, M; Brauer, LH; Bronars, CA; Candell, S; Finocchi, ME; Harris, J; Hatsukami, DK; Kotlyar, M; Robiner, W; Thuras, P | 1 |
| Aw, A; Barrett, SP; Dagher, A; Kelly, JT; McBride, D | 1 |
| Bruijnzeel, AW; Goldberger, BA; Koob, GF; Markou, A; Merves, ML; O'Dell, LE; Parsons, LH; Richardson, HN; Smith, RT | 1 |
| Ahtee, L; Marttila, K; Raattamaa, H | 1 |
| Burroughs, D; LeSage, MG; Pentel, PR | 1 |
| Bellomo, M; Calapai, G; Caputi, AP; Mannucci, C; Tedesco, M | 1 |
| Heath, AC; Madden, PA; Martin, NG; Pergadia, ML | 1 |
| Besson, M; Cazala, P; Changeux, JP; Cormier, A; David, V; Granon, S; Suarez, S | 1 |
| Blank, M; Eissenberg, T; Evans, SE; Sams, C; Weaver, MF | 1 |
| Aubin, HJ; Demazières, A; Dupont, C; Lagrue, G; Luthringer, R | 1 |
| Castañé, A; Ledent, C; Maldonado, R; Soria, G; Valverde, O | 1 |
| Baile, WF; Carter, BL; Cinciripini, PM; de Moor, CA; Lam, C; Robinson, JD; Wetter, DW; Wu, X | 1 |
| Stalnikowicz, R | 1 |
| Mooney, ME; Sofuoglu, M | 1 |
| Ahtee, L; Mijatovic, J; Piepponen, TP; Tuominen, RK; Vihavainen, T | 1 |
| Ferguson, SG; Hellebusch, SJ; Shiffman, S | 1 |
| De Witte, P; Dravolina, O; Lallemand, F; Ward, RJ | 1 |
| Allen, V; Brody, AL; Chefer, SI; Farahi, J; Jou, J; Koren, AO; London, ED; Mandelkern, MA; Mukhin, AG; Olmstead, RE; Scheibal, D; Tiongson, E | 1 |
| Badawy, AA; Huebner, A; Krimphove, M; Morgenstern, R; Saellstroem Baum, S; Spies, CD | 1 |
| Bruijnzeel, AW; Gold, MS; Wilson, C; Zislis, G | 1 |
| Berrettini, WH; Jepson, C; Lerman, C; Lynch, KG; O'Malley, S; Patterson, F; Perkins, K; Ray, R; Rukstalis, M; Strasser, A | 1 |
| Bleich, S; Kornhuber, J; Lunkenheimer, B; Lunkenheimer, J; Schlabeck, M; Sperling, W; Thuerauf, N; Wiltfang, J | 1 |
| Dicpinigaitis, PV; Sakalauskas, R; Sitkauskiene, B; Stravinskaite, K | 1 |
| Mohajeri, S; Zarrindast, MR | 1 |
| Balster, RL; Chen, SA; Koob, GF; Markou, A; O'Dell, LE; Paterson, NE; Smith, RT; Specio, SE; Zorrilla, EP | 1 |
| Fornari, A; Lippi, G; Pedrazzi, P; Picciotto, MR; Zini, I; Zoli, M | 1 |
| González-Cuevas, G; López-Moreno, JA; Navarro, M | 1 |
| Brody, AL; Cohen, MS; Ernst, M; Jarvik, M; London, ED; Mendrek, A; Monterosso, J; Rodriguez, P; Simon, S; Xu, J | 1 |
| Kosten, T; Mouratidis, M; Sofuoglu, M; Yoo, S | 1 |
| Liechti, ME; Markou, A | 2 |
| Diehl, A; Mann, K | 1 |
| Cedzynska, M; Tutka, P; West, R; Zatonski, W | 1 |
| Breland, AB; Eissenberg, T; Kleykamp, BA | 1 |
| Bisaga, A; Garawi, F; Haney, M; Padilla, M; Sullivan, MA | 1 |
| Fava, JL; Friedman, RH; Gulliver, SB; Keller, S; Prochaska, JO; Ramelson, H; Sun, X; Velicer, WF | 1 |
| Ferguson, SG; Gwaltney, CJ; Shiffman, S | 1 |
| Fujii, S; Jia, Y; Sumikawa, K; Yamazaki, Y | 1 |
| Conill Tobías, N; García Callejo, F; García Callejo, FJ; Ramírez Sabio, JB | 1 |
| Chen, TT; Cinciripini, PM; Lam, CY; Minna, JD; Minnix, JA; Robinson, JD; Tomlinson, GE; Wetter, DW | 1 |
| Dallery, J; Raiff, BR | 1 |
| Donny, EC; Houtsmuller, E; Stitzer, ML | 1 |
| Black, JJ; Caggiula, AR; Craven, L; Donny, EC; Liu, X; Matteson, GL; Palmatier, MI; Sved, AF | 1 |
| Bergström, E; de Vries, H; Panday, S; Reddy, SP; Ruiter, RA | 1 |
| Chakraborty, G; Morahan, G; O'Brien, D; Saito, M; Vadasz, C; Wang, R; Zavadil, J | 1 |
| Hahn, EJ; Kelly, T; Okoli, CT | 1 |
| Koob, GF; O'Dell, LE | 1 |
| Creeden, CL; George, TP; Jatlow, PI; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Hutchison, KE; Kaplan, GB; MacKinnon, SV; Monti, PM; Rohsenow, DJ; Sirota, AD; Swift, RM | 1 |
| Kaighobadi, F; Kelemen, WL | 1 |
| Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Schepis, TS; Toll, BA | 1 |
| Gulliver, SB; Kamholz, BW; Morissette, SB; Tull, MT; Zimering, RT | 1 |
| Flammino, F; Palamar, J; Raghavan, S; Reid, MS | 1 |
| Campbell, JL; Moody, RC; White, AR | 1 |
| Croghan, IT; Dale, LC; Ebbert, JO; Hurt, RD; Moyer, TP; Patten, CA; Schroeder, DR | 1 |
| Augustson, EM; Benowitz, NL; Mabry, PL; Malcolm, RJ; Moser, RP; Tooze, JA | 1 |
| Hughes, JR | 10 |
| Calderón-Ezquerro, C; Drucker-Colín, R; Moreno-Coutiño, A | 1 |
| Frishman, WH | 1 |
| Barnett, BC; Feuer, RM; Hatsukami, DK; Kotlyar, M; Li, ZZ; Mendoza-Baumgart, MI; Pentel, PR; Smith, EA | 1 |
| Grant, MD; Jefferson, AL; Kozlowski, LT; O'Connor, RJ; Strasser, AA; Vandenbergh, DJ; Vogler, GP | 1 |
| Heishman, SJ; Moolchan, ET; Myers, CS; Taylor, RC | 1 |
| Damaj, MI; Kota, D; Martin, BR; Robinson, SE | 1 |
| Afessa, B; Lee, AH | 1 |
| Jatlow, P; Martin, DJ; McKee, SA; O'Malley, SS; Toll, BA | 1 |
| Abreu-Villaça, Y; do E Queiroz-Gomes, F; Filgueiras, CC; Manhães, AC; Nunes, F | 1 |
| Crowley, T; Du, YP; Freedman, R; Hutchison, K; Johnson, G; Miller, D; Tanabe, J; Zerbe, G | 1 |
| Kim, G; Kim, GS; Kwak, SM; Lee, JH; Na, DL | 1 |
| Fraser, R; Lubman, DI; Olivier, D | 1 |
| Ryde, IT; Seidler, FJ; Slotkin, TA; Tate, CA | 1 |
| Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Salovey, P; Toll, BA | 1 |
| Gould, TJ; Kenney, JW; Portugal, GS | 1 |
| Levine, MD; Marcus, MD; Pomerleau, CS; Saules, KK | 1 |
| Cador, M; Guillem, K; Koob, GF; Stinus, L; Vouillac, C | 1 |
| Calapai, G; Caputi, AP; Firenzuoli, F; Mannucci, C; Pieratti, A | 1 |
| Shoaib, M; Wing, VC | 1 |
| Fisher, DJ; Knott, VJ | 1 |
| Chouaid, C; Trosini-Desert, V | 1 |
| Bermudez-Silva, FJ; Gallego, A; Lamota, L; Llorente, R; Marco, EM; Rodríguez de Fonseca, F; Viveros, MP | 1 |
| Bovbjerg, DH; Erblich, J; Tong, C | 1 |
| Mooney, M; Sofuoglu, M; Waters, AJ | 1 |
| Piasecki, TM; Richardson, AE; Smith, SM | 1 |
| AhnAllen, CG; McCarley, RW; Nestor, PG; Niznikiewicz, MA; Shenton, ME | 1 |
| Hoedemaekers, AW; Kox, M; Pickkers, P; Pompe, JC; van der Hoeven, JG | 1 |
| Alizadeh, AM; Haghparast, A; Khani, A; Motamedi, F; Naderi, N | 1 |
| Azar, MR; Cottone, P; George, O; Ghozland, S; Koob, GF; O'Dell, LE; Parsons, LH; Richardson, HN; Zorrilla, EP | 1 |
| Ceballos, N; Lawton-Craddock, A; Nixon, SJ; Tivis, R | 1 |
| Gould, TJ; Gulick, D | 1 |
| Barr, RS; Culhane, MA; Evins, AE; Goff, DC; Pizzagalli, DA | 1 |
| Cummings, KM; Hyland, A; Mahoney, MC; O'Connor, RJ; Rezaishiraz, H | 1 |
| Grunberg, NE | 1 |
| Gulick, EE; Kim, SH; Kim, SS; Seo, HG | 1 |
| Milbrandt, A; Ratcliffe, M; Smith, R; Spirling, LI; Stapleton, JA; Sutherland, G; Watson, L | 1 |
| Jain, R; Mohan, D; Mukherjee, K | 1 |
| Geyer, MA; Jonkman, S; Markou, A; Risbrough, VB | 1 |
| Fitzgerald, DP; Kollins, SH; Lutz, AM; McClernon, FJ; Murray, DW; Redman, C; Rose, JE | 1 |
| Chae, Y; Hahm, DH; Han, JH; Lee, H; Lee, HS; Park, HJ; Shim, I; Yeom, M | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R | 1 |
| Allen, TM; Creeden, CL; Dudas, MM; Feingold, A; George, TP; Jatlow, PI; Potenza, MN; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Changeux, JP; Damaj, MI; Jackson, KJ; Martin, BR | 1 |
| Amor, C; Cortner, C; Gould, JL; Hartman, N; Justice, M; Kleinman, L; Olmstead, RE; Schneider, NG | 1 |
| Bordnick, P; Carter, BL; Day, SX; Paris, M; Traylor, A | 1 |
| Aubin, HJ; Billing, CB; Bobak, A; Britton, JR; Gong, J; Oncken, C; Reeves, KR; Williams, KE | 1 |
| Hatsukami, DK | 1 |
| al'Absi, M; Cohen, LM; Morrell, HE | 1 |
| Blalock, JA; Cinciripini, PM; Robinson, JD; Schreindorfer, LS; Wetter, DW | 1 |
| Blank, MD; Eissenberg, T; Sams, C; Weaver, MF | 1 |
| Kerrin, K; Lerman, C; Patterson, F; Wileyto, EP | 1 |
| Damaj, MI; Kota, D; Martin, BR | 1 |
| Ferguson, SG; Shiffman, S | 1 |
| Stapleton, JA | 1 |
| Hadjiconstantinou, M; Isola, R; Neff, NH; Tejwani, GA; Zhang, H | 1 |
| André, JM; Gould, TJ; Gulick, D; Portugal, GS | 1 |
| Carus, CG | 1 |
| Lê, AD; Li, Z; Shram, MJ; Siu, EC; Tyndale, RF | 1 |
| Briski, JL; Chengappa, KN; Fonte, CA; Lerman, C; Perkins, KA; Scott, JA; Stitzer, M | 1 |
| Brown, RA; Gifford, EV; Hayes, SC; Kahler, CW; Lejuez, CW; Palm, KM; Strong, DR; Wilson, KG; Zvolensky, MJ | 1 |
| Marris, E | 1 |
| Hapke, U; John, U; Meyer, C; Rumpf, HJ | 1 |
| Markou, A; Paterson, NE; Semenova, S | 1 |
| Cortner, C; Gould, JL; Koury, MA; Olmstead, RE; Schneider, NG | 1 |
| Aveyard, P; Fillingham, S; Johnson, C; Murphy, M; Parsons, A | 1 |
| Damaj, MI; Lichtman, AH; Martin, BR; Merritt, LL; Walters, C | 1 |
| Balhara, YP; Jain, R; Mukherjee, K | 1 |
| Hollander, JA; Johnson, PM; Kenny, PJ | 1 |
| Boissoneault, J; Bruijnzeel, AW; Isaac, S; Prado, M; Rylkova, D; Shah, HP | 1 |
| Buchhalter, AR; Fant, RV; Henningfield, JE | 1 |
| al'Absi, M; Shaw, D | 1 |
| Clarke, PB; Kumar, R | 3 |
| Pomerleau, CS; Pomerleau, OF | 2 |
| Bööj, S; Dahlström, A; Heiwall, PO; Larsson, PA | 1 |
| Benhamou, S; Clavel, F | 1 |
| West, RJ | 1 |
| Jarvik, ME; Schneider, NG | 2 |
| Hatsukami, DK; Hughes, JR; Krahn, D; Luknic, A; Malin, S; Pickens, RW | 1 |
| Rawson, RA; Tarver, AL; Tennant, FS | 1 |
| Feyerabend, C; Jarvis, MJ; Russell, MA; West, RJ | 1 |
| Jones, RM; Pearce, AC | 1 |
| Hatsukami, DK; Hughes, JR; Pickens, RW; Svikis, DS | 1 |
| Carruthers, ME; Feyerabend, C; Jarvis, MJ; Russell, MA; West, RJ | 1 |
| Fertig, JB; Pomerleau, OF; Shanahan, SO | 1 |
| Bachman, J; Herning, RI; Jones, RT | 1 |
| Gothóni, P | 1 |
| Forsythe, AB; Jarvik, ME; Schneider, NG | 1 |
| Belitskaia, RA; Markelova, VF; Rudnev, SG | 1 |
| Griffiths, RR; Henningfield, JE; Jasinki, DR | 1 |
| Feyerabend, C; Jarvis, MJ; Raw, M; Russell, MA | 1 |
| Jarvis, MJ; Raw, M; Russell, MA | 1 |
| Stepney, R | 1 |
| Pomerleau, OF | 2 |
| Fee, WM; Stewart, MJ | 1 |
| McCarty, MF | 1 |
| Fuller, JA | 1 |
| Silverstein, B | 1 |
| Badawy, AA; Evans, M; Punjani, NF | 1 |
| Russell, MA | 5 |
| Krajnik, M; Zylicz, Z | 1 |
| Doucet, K; Parker, LA | 1 |
| Foulds, J; Ghodse, AH | 1 |
| Baker, TB; Croghan, IT; Fiore, MC; Hays, JT; Hurt, RD; Jorenby, DE; Lewis, SF; Offord, KP; Smith, SS | 1 |
| Croghan, IT; Dale, LC; Hurt, RD; Lawson, GM; Offord, KP; Schroeder, DR | 1 |
| Fagerström, KO; Leischow, SJ; Lunell, E; Molander, L | 1 |
| Cinciripini, PM; Kitchens, K; Lapitsky, L; Seay, S; Van Vunakis, H; Wallfisch, A | 1 |
| Gross, TM; Jarvik, ME; Rosenblatt, MR; Stein, RE | 1 |
| Bailey, D; Butschky, MF; Henningfield, JE; Pickworth, WB | 1 |
| Steele, C | 1 |
| Ochoa, EL | 1 |
| Dawe, S; Gerada, C; Gray, JA; Russell, MA | 1 |
| Patterson, JC; Sommese, T | 1 |
| Prignot, J | 1 |
| Behm, FM; Rose, JE; Westman, EC | 2 |
| Bostrom, AG; Hansen, MD; Leischow, SJ; Sachs, DP | 1 |
| Fagerström, KO; Kunze, M; Schoberberger, R | 1 |
| Fagerström, KO; Tönnesen, P | 1 |
| Burling, TA; Gaither, DE; Seidner, AL | 1 |
| Lumley, MA; Pomerleau, CS; Pomerleau, OF; Tate, JC | 1 |
| Balabanova, S; Krupienski, M | 1 |
| Wallbank, IW | 1 |
| Gross, TM; Jarvik, ME; Rosenblatt, MR | 1 |
| Bickel, WK; Higgins, ST; Hughes, JR | 2 |
| Helton, DR; Modlin, DL; Rasmussen, K; Tizzano, JP | 1 |
| Cogswell, BE | 1 |
| Carter, VA; Conrad, DL; Cunningham, JS; Hebert, KM; Lake, JR; Malin, DH; Wilson, OB | 1 |
| Anderson, J; Tejwani, GA; Wewers, ME | 1 |
| Pethica, D | 1 |
| Fagerström, KO; Lunell, E; Schneider, NG | 1 |
| Callies, A; Hatsukami, D; Huber, M; Skoog, K | 1 |
| Carter, VA; Cunningham, JS; Lake, JR; Malin, DH; Wilson, OB | 1 |
| Arnall, C; Warburton, DM | 1 |
| Hall, SM; Muñoz, RF; Reus, VI; Sees, KL | 1 |
| Frances, RJ; Glazer, WM; Kosten, TR; Ziedonis, DM | 1 |
| Arneric, SP; Brioni, JD; Buckley, MJ; Decker, MW; Kim, DJ; O'Neill, AB | 1 |
| Franzon, M; Hjalmarson, A; Westin, A; Wiklund, O | 1 |
| de Almeida Neto, A; Harris, K; Richmond, RL | 1 |
| Bunker, EB; Cohen, C; Henningfield, JE; Pickworth, WB | 1 |
| Behm, FM; Levin, ED; Ripka, GV; Rose, JE; Stein, RM; Westman, EC | 1 |
| Behm, FM; Rose, JE | 1 |
| Alegría, E; Aparici, M; Fernández González, AL | 1 |
| Flórez, S; Jiménez Ruiz, CA; Ramos, A; Ramos, L; Solano Reina, S | 1 |
| Benazzi, F; Mazzoli, M | 1 |
| Leischow, SJ; Sachs, DP; Säwe, U | 1 |
| Costello, J; Feyerabend, C; Fleming, T; Foulds, J; Hayward, M; Russell, MA; Stapleton, J | 1 |
| Hatterer, J; Pine, DS | 1 |
| Behm, FM; Carnahan, E; Herman, S; Levin, ED; Rose, JE; Sanchez, M; Stein, RM; Westman, EC | 1 |
| Alsagoff, F; Lee, HP | 1 |
| Warburton, DM | 1 |
| Richmond, R | 1 |
| Spilich, GJ | 1 |
| Parrott, A | 1 |
| Pomerleau, CS; Pomerleau, OF; Tate, JC | 1 |
| Ehrlich, E; Flessland, KA; Marks, JL; Pomerleau, CS; Pomerleau, OF; Tate, JC | 1 |
| Henningfield, JE; Keenan, RM | 1 |
| Levin, ED; Rose, JE; Westman, EC | 1 |
| Behm, F; Carnahan, E; LeClair, R; Levin, ED; Rose, JE; Shipley, R | 1 |
| Huber, T; Keller-Stanislawski, B; Merz, PG; Rietbrock, N; Woodcock, BG | 1 |
| Slade, J | 1 |
| Caldwell, CC; Dale, LC; Fredrickson, PA; Hurt, RD; Lauger, GG; Lee, GA; Lundberg, TG; Marŭsić, Z; Neese, LW; Offord, KP | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Kenford, SL; Smith, SS; Wetter, DW | 1 |
| Hughes, JR; Oliveto, AH | 1 |
| Gora, ML | 1 |
| Baskin, LB; Dale, LC; Hauri, PJ; Hurt, RD; Jiang, NS; Lauger, GG; Lawson, GM; Offord, KP | 1 |
| Carmelli, D; Robinette, D; Swan, GE | 1 |
| Briggs, SJ; Christopher, NC; Levin, ED; Rose, JE | 1 |
| Behm, FM; Levin, ED; Rose, JE; Schur, C; Tashkin, DP | 1 |
| Cardoni, AA | 1 |
| Frank, SH; Jaén, CR | 1 |
| Behm, FM; Levin, ED; Rose, JE | 1 |
| Nørregaard, J; Petersen, L; Tønnesen, P | 1 |
| Nørregaard, J; Säwe, U; Simonsen, K; Tønnesen, P | 2 |
| Lappi, SE; Seidler, FJ; Slotkin, TA | 1 |
| Andreski, P; Breslau, N | 1 |
| Stolz, RE | 1 |
| Campbell, IA | 1 |
| Connor, P; Feyerabend, C; Gustavsson, G; Russell, MA; Sawe, U; Stapleton, JA; Wiseman, SM | 1 |
| Dozois, DN; Farrow, JA; Miser, A | 1 |
| Feyerabend, C; Russell, MA; Stapleton, JA; Sutherland, G | 1 |
| Doan, K; Franzon, M; Jarvik, ME; Mody, FV; Olmstead, R; Schneider, NG; Steinberg, C | 1 |
| Smith, TM; Winters, FD | 1 |
| Batra, A; Buchkremer, G | 1 |
| Bhattacharya, SK; Chakrabarti, A; Glover, V; Sandler, M | 1 |
| Stapleton, J | 2 |
| Koob, GF | 1 |
| Jork, K | 1 |
| Czachura, JF; Rasmussen, K | 2 |
| Blossman, JB; Burgess, K; Lake, JR; Lawless, BA; Malin, DH; Sailer, EE; Schopen, CK; Short, PE; Wilson, OB | 1 |
| Martin, JE; Patten, CA | 1 |
| Bock, BC; Goldstein, MG; Marcus, BH | 1 |
| Czachura, JF; Helton, DR; Kallman, MJ; Rasmussen, K | 1 |
| Altman, J; Everitt, BJ; Glautier, S; Markou, A; Nutt, D; Oretti, R; Phillips, GD; Robbins, TW | 1 |
| Anderson, R; Eells, TD; Head, M; Lippmann, S; Mount, R; Ryabik, B; Velasco, J | 1 |
| Cinciripini, LG; Cinciripini, PM; Gray, CL | 1 |
| Comans, P; Gavish, A; Keren, A; Khoury, Z; Lerer, T; Tzivoni, D | 1 |
| Carter, VA; Cunningham, JS; Lake, JR; Malin, DH; Payne, MC; Short, PE; Wilson, OB | 1 |
| Anderson, TM; Fung, YK; Lau, YS; Schmid, MJ | 1 |
| Farzin, D; Zarrindast, MR | 1 |
| Colligan, RC; Croghan, IT; Gauvin, TR; Gomez-Dahl, LC; House, RF; Hurt, RD; Offord, KP; Smith, TA | 1 |
| Duncan, C; Hall, SM; Hartz, DT; Humfleet, GL; Muñoz, RF; Reus, VI; Sees, KL | 1 |
| Davis, L; Fortmann, SP; Killen, JD; Kraemer, HC; Newman, B; Varady, AN | 1 |
| Benca, RM; Obermeyer, WH | 1 |
| Butschky, MF; Fant, RV; Henningfield, JE; Pickworth, WB | 1 |
| Allen, SS; Christianson, D; Hatsukami, D; Nelson, D | 1 |
| Brown, HV; Daims, RM; Olmstead, RE; Schneider, NG; Sloan, K; Steinberg, C | 1 |
| Caggiula, A; Fonte, C; Grobe, JE; Perkins, KA; Weiss, D | 1 |
| Baumann, MH; Fant, RV; Henningfield, JE; Pickworth, WB; Rothman, RB | 1 |
| Allen, S; Baker, TB; Fiore, MC; Hatsukami, DK; Jensen, J; Jorenby, DE; Smith, SS | 1 |
| Gillespie, AM; Lowe, JB; Stanton, WR | 1 |
| Ise, Y; Maeda, J; Misawa, M; Suzuki, T; Tsuda, M | 1 |
| Balfour, DJ; Fagerström, KO | 1 |
| Behan, DP; Chan, RK; De Souza, EB; Heinrichs, SC; Lapsansky, J; Ling, N; Lorang, M; Sawchenko, PE; Vale, WW | 1 |
| Covey, LS; Glassman, AH; Stetner, F | 1 |
| Bondjers, C; Hildebrand, BE; Nisell, M; Nomikos, GG; Svensson, TH | 1 |
| Bättig, K; Hasenfratz, M; Kos, J | 1 |
| Pearlman, T | 1 |
| Butschky, MF; Fant, RV; Goffman, AL; Henningfield, JE; Pickworth, WB | 1 |
| Blöndal, T; Franzon, M; Westin, A | 1 |
| Aickin, M; Cook, G; Hill, AL; Holden, T; Kligman, E; Leischow, SJ; Otte, PS; Valente, SN | 1 |
| Fortmann, SP; Killen, JD | 1 |
| Helton, DR; Kallman, MJ; Rasmussen, K | 1 |
| Bierut, LJ; Bucholz, KK; Dinwiddie, SH; Dunne, MP; Heath, AC; Madden, PA; Martin, NG; Slutske, WS; Statham, DJ | 1 |
| Kirk, JW; Lake, JR; Lawless, BA; Malin, DH; Rajan, N; Sailer, EE; Schopen, CK; Shenoi, M; Upchurch, TP | 1 |
| Croghan, IT; Dale, LC; Glover, ED; Glover, PN; Hurt, RD; Johnston, JA; Khayrallah, MA; Offord, KP; Sachs, DP; Schroeder, DR; Sullivan, CR; Sullivan, PM | 1 |
| Ise, Y; Misawa, M; Mori, T; Suzuki, T | 1 |
| Arneric, SP; Bannon, AW; Bitner, RS; Curzon, P; Decker, MW; Diaz, A; Dickenson, AH; Donnelly-Roberts, D; Holladay, MW; Porsolt, RD; Puttfarcken, PS; Williams, M | 1 |
| Howard, TS; Hughes, JR | 1 |
| Biron, CR | 1 |
| Croghan, GA; Croghan, IT; Dale, LC; Gomez-Dahl, LC; Hurt, RD; Offord, KP | 1 |
| Hertel, P; Hildebrand, BE; Nomikos, GG; Schilström, B; Svensson, TH | 1 |
| Haydel, KF; Killen, JD; Robinson, TN; Rojas, NL | 1 |
| Hatsukami, DK; Hughes, JR | 1 |
| Allen, SS; Goldman, A; Hatsukami, D; Jensen, J; Nelson, D; Pentel, PR; Rafael, D | 1 |
| Ahtee, L; Attila, M; Lähde, T; Nordberg, A; Pietilä, K | 1 |
| Fant, RV; Henningfield, JE; Tomar, SL | 1 |
| Berger, SP; Delucchi, KL; Hall, SM; Mickalian, JD; Reid, MS | 1 |
| Gold, MS; Herkov, MJ | 1 |
| Jacobs, WM; Thiesbrummel, AW; Zylic, Z | 1 |
| Fagerström, KO; Lunell, E; Tejding, R; Westin, A | 1 |
| Epping-Jordan, MP; Koob, GF; Markou, A; Watkins, SS | 1 |
| Groman, E; Kunze, M; Kunze, U; Schmeiser-Rieder, A; Schoberberger, R | 2 |
| Adams, ML; Cicero, TJ | 1 |
| Baker, TB; Fiore, MC; Piasecki, TM | 1 |
| Fant, RV; Friedman, A; Gnjidic, M; Pickworth, WB; Stanton, JP | 1 |
| Fant, RV; Pickworth, WB | 1 |
| White, FJ | 1 |
| Day, J; Schmitz, J; Spiga, R | 1 |
| Jarvis, MJ; Sutton, SR; Waters, AJ | 1 |
| Dasgupta, R; Houdi, AA; Kindy, MS | 1 |
| Lake, JR; Malin, DH; Rajan, N; Schweinle, WE; Shenoi, M; Upchurch, TP | 1 |
| Rasmussen, DD | 1 |
| Ikeda, N; Nakamura, M; Saito, T; Sengoku, Y; Shirasaka, T | 1 |
| Hatsukami, DK; Hughes, J | 1 |
| Gallagher, R | 1 |
| Fryer, GE; Keller, RT; Licari, PA; Lofaso, D; Prochazka, AV; Weaver, MJ | 1 |
| Helmers, KF; Young, SN | 1 |
| Ernst, E; Resch, KL; White, AR | 1 |
| Miyata, H; Yanagita, T | 2 |
| Dhatt, R; Tejwani, GA; Wewers, ME | 1 |
| Croghan, GA; Croghan, IT; Dale, LC; Gomez-Dahl, LC; Hurt, RD; Moyer, TP; Offord, KP; Wolter, TD | 1 |
| Burton, D; Dent, CW; Flay, BR; Nezami, E; Stacy, AW; Sussman, S | 1 |
| Cadle, CD; Johnson, SC; Lake, JR; Malin, DH; Schweinle, WE; Shenoi, M; Upchurch, TP | 1 |
| Cartagena, M; Pristach, CA; Smith, CM | 1 |
| Farnam, CR | 1 |
| Baker, TB; Daughton, DM; Doan, K; Fiore, MC; Hughes, AR; Johnston, JA; Jorenby, DE; Leischow, SJ; Muramoto, ML; Nides, MA; Rennard, SI; Smith, SS | 1 |
| Engel, JA; Olausson, P; Söderpalm, B | 1 |
| Colby, SM; Gnys, M; Hutchison, KE; Monti, PM; Niaura, RS; Rohsenow, DJ; Sirota, AD; Swift, RM | 1 |
| Ise, Y; Maeda, J; Misawa, M; Suzuki, T | 1 |
| Hildebrand, BE; Nomikos, GG; Panagis, G; Svensson, TH | 2 |
| Alterman, AI; Barber, W; Bedi, N; Cnaan, A; Gariti, P; Luck, G | 1 |
| Pandey, SC; Xu, T; Zhang, D | 1 |
| Baker, TB; de Moor, CA; Fiore, MC; McClure, JB; Wetter, DW; Young, TB | 1 |
| Behm, FM; Brauer, LH; Patel, P; Rose, JE; Westman, EC | 1 |
| Paola, F | 1 |
| Bernabei, R; Gambassi, G | 1 |
| Forbes, A; Gourlay, SG; Marriner, T; McNeil, JJ | 1 |
| Fisher, H; Halladay, AK; Iba, MM; Schwartz, M; Sekowski, A; Wagner, GC | 1 |
| Becks, L; Dalack, GW; Hill, E; Meador-Woodruff, JH; Pomerleau, OF | 1 |
| Davis, L; Fortmann, SP; Killen, JD; Strausberg, L; Varady, A | 1 |
| Croghan, IT; Hurt, RD; Moyer, TP; Offord, KP; Ogburn, PL; Ramin, KD; Schroeder, DR | 1 |
| Haddock, CK; Klesges, RC; Lando, H; Talcott, GW | 1 |
| Djurić, VJ; Dragomir, A; Dunn, E; Overstreet, DH; Steiner, M | 1 |
| Lagrue, G | 1 |
| Hirvikoski, P; Tyynelä, K | 1 |
| Jiménez Ruiz, CA | 1 |
| Hildebrand, BE; Svensson, TH | 2 |
| Hadjiconstantinou, M; Isola, R; Neff, NH; Vogelsberg, V; Wemlinger, TA | 1 |
| Beede, SD; Croghan, GA; Croghan, IT; Hurt, RD; Patten, CA; Wolter, TD | 1 |
| Geier, A; Mucha, RF; Pauli, P | 1 |
| DeVeaugh-Geiss, J; Elash, CA; Evoniuk, G; Gnys, M; Gwaltney, CJ; Johnston, JA; Khayrallah, M; Paty, JA; Shiffman, S | 1 |
| Bortone, L; Carboni, E; Di Chiara, G; Giua, C | 1 |
| Koob, GF; Markou, A; Stinus, L; Watkins, SS | 1 |
| Fagerström, KO | 4 |
| Hutchison, K; Monti, PM; Ostafin, B; Palfai, TP | 1 |
| Leonard, CT; Lillington, GA; Sachs, DP | 1 |
| Colby, SM; Niaura, RS; Shiffman, S; Tiffany, ST | 1 |
| Cox, LS; Elash, CA; Tiffany, ST | 1 |
| Allen, S; Bliss, R; Boyle, R; Brown, S; Grillo, M; Hatsukami, DK; Jensen, J | 1 |
| Gatch, MB; Jung, ME; Lal, H; Wallis, CJ | 1 |
| Marzilli, TS; Shea, JB | 1 |
| Ahtee, L; Gäddnäs, H; Salminen, O; Seppä, T | 1 |
| Lebargy, F | 1 |
| Benowitz, NL; Elins, JL; Iwamoto-Schaap, PN; Jarvik, ME; Madsen, DC; Olmstead, RE | 1 |
| King, AC; Meyer, PJ | 1 |
| Branchek, TA; Calligaro, DO; Czachura, JF; Dreshfield-Ahmad, LJ; Evans, DC; Hemrick-Luecke, SK; Kallman, MJ; Kendrick, WT; Leander, JD; Nelson, DL; Overshiner, CD; Rasmussen, K; Wainscott, DB; Wolff, MC; Wong, DT; Xu, YC; Zgombick, JM | 1 |
| Ahtee, L; Gäddnäs, H; Pietilä, K | 1 |
| Ise, Y; Nagase, H; Narita, M; Suzuki, T | 2 |
| Harris, BR; Littleton, JM; Mayer, S; Prendergast, MA | 1 |
| Fortmann, SP; Hayward, C; Killen, JD; Rothman, M; Schatzberg, AF; Strausberg, L; Sussman, L; Varady, A | 1 |
| Henningfield, JE; Jude, NR | 1 |
| Abrams, DB; Borrelli, B; Britt, DM; Goldstein, MG; Niaura, R; Shadel, WG | 1 |
| Buchhalter, AR; Eissenberg, T | 1 |
| Doherty, K; Garvey, AJ; Kinnunen, T; Nordstrom, BL; Rosner, B; Utman, CH; Vokonas, PS | 1 |
| Fagerström, KO; Lunell, E; Molander, L | 1 |
| Bohadana, A; Martinet, Y; Nilsson, F; Rasmussen, T | 1 |
| Allen, SS; Brown, S; Christianson, D; Hatsukami, D | 1 |
| Clark, DB; Di Marino, ME; Elash, CA; Gwaltney, CJ; Liu, KS; Paton, SM; Paty, JA; Shiffman, S | 1 |
| Piotrovskaya, VR; Zhdanova, IV | 1 |
| Eissenberg, T; Gire, JT | 1 |
| File, SE; Kenny, PJ; Rattray, M | 1 |
| Clark, CP; Drummond, S; Gillin, JC; Golshan, S; Kelsoe, J; Patten, CA; Rapaport, M; Sutton, LD; Thorsteinsson, HS | 1 |
| Khayrallah, M; Nowak, R; Shiffman, S | 1 |
| Katsura, M; Ohkuma, S; Tsujimura, A | 1 |
| Abrams, DB; Goldstein, MG; Hutchinson, KE; Niaura, R; Shadel, WG | 1 |
| Cheeta, S; File, SE; Irvine, EE | 1 |
| Bagnalasta, M; Chiamulera, C; File, SE; Irvine, EE; Marcon, C; Motta, C; Tessari, M | 1 |
| Alvarado, CL; Balch, L; Basham, LE; Chandrasekara, H; Ennifar, S; Fattom, A; Hieda, Y; Irvin, ML; Keyler, DE; Lake, JR; Lin, A; Malin, DH; Naso, R; Pentel, PR; Saldaña, M | 1 |
| Changeux, JP; Damaj, MI; Epping-Jordan, MP; Marubio, LM; Merlo-Pich, E; Salmon, AM | 1 |
| Brouwer, RJ; Pomerleau, CS; Pomerleau, OF | 1 |
| Katsura, M | 1 |
| Champagnat, J; Menini, C; Silva-Barrat, C; Szente, M; Velluti, JC | 1 |
| Cheeta, S; File, SE; Irvine, EE; Kenny, PJ | 1 |
| Domino, EF; Guthrie, S; Koeppe, RA; Lombardi, U; Minoshima, S; Ni, L; Ohl, LE; Zubieta, J | 1 |
| Harrison, AA; Liem, YT; Markou, A | 1 |
| Shiffman, S; West, R | 1 |
| Buchhalter, AR; Eissenberg, T; Schrinel, L | 1 |
| Cousins, MS; de Wit, H; Stamat, HM | 1 |
| Conroy, JL; de Moor, CA; Hudmon, KS; Kelder, SH; Ordway, N; Prokhorov, AV | 1 |
| Netter, P; Reuter, M | 1 |
| Parrott, DJ; Zeichner, A | 1 |
| Starek, A | 1 |
| West, R | 4 |
| Nardi, AE; Nascimento, I; Valença, AM | 1 |
| Bernardini, GL; Chong, JY; Commichau, C; Mayer, SA; Min, KC; Ridgway, E | 1 |
| Eliasson, B; Hjalmarson, A; Kruse, E; Landfeldt, B | 1 |
| Hoebel, BG; Jensen, K; Rada, P | 1 |
| Ammerman, S; Haydel, F; Killen, JD; Robinson, TN; Rojas, N; Varady, J | 1 |
| Hashimoto, E; Ikeda, N; Saito, T; Sakaguchi, S; Shiga, M; Toki, S | 1 |
| Crews, FT; Hoplight, B; Obernier, J; Penland, S | 1 |
| Airaksinen, M; Kuoppasalmi, K; Tacke, U | 1 |
| Cheeta, S; File, SE; Irvine, EE; Marshall, M | 1 |
| Klein, LC | 1 |
| Gear, RW; Levine, JD; Schmidt, BL; Tambeli, CH | 1 |
| Behm, FM; Ramsey, C; Ritchie, JC; Rose, JE | 1 |
| Iwanami, M; Kuwana, S; Okada, Y | 1 |
| Katsura, M; Mohri, Y; Ohkuma, S; Shuto, K; Tsujimura, A | 1 |
| Araki, H; Gomita, Y; Kitamura, Y; Suemaru, K; Yasuda, K | 1 |
| Rimón, R; Tuunainen, A | 1 |
| Honisett, TD | 1 |
| Dybing, E; Sanner, T | 1 |
| Dupont, P; Fakhfakh, R; Lagrue, G; Lormier, S; Mautrait, C | 1 |
| Gallinat, J; Hellweg, R; Jockers-Scherübl, mC; Kuhn, S; Lang, UE | 1 |
| Araki, H; Gomita, Y; Suemaru, K | 1 |
| Duchemin, AM; Hadjiconstantinou, M; Isola, R; Neff, NH; Tejwani, GA; Zhang, H | 1 |
| Adams, A; Farris, K; Ryan, M; Yeager, B; Zillich, AJ | 1 |
| Taeron, C | 1 |
| Hutcherson, AB; Marzilli, TS | 1 |
| Broge, M; Cherry, C; Gerlach, D; Grobe, JE; Perkins, KA; Sanders, M; Wilson, AS | 1 |
| Schachter, S | 2 |
| Jarvik, ME | 2 |
| Krasnegor, NA | 1 |
| Jaffe, JH; Kanzler, M | 1 |
| Balfour, DJ; Benwell, ME | 1 |
| Shpilenia, LS | 1 |
| Jaffe, JH | 1 |
| Cole, PV; Feyerabend, C; Russell, MA; Sutton, SR | 1 |
| Halhuber, C | 1 |
| Gritz, ER; Jarvik, ME; Popek, P; Schneider, NG | 1 |
| Herman, CP; Kozlowski, LT; Liebling, B; Perlick, D; Schachter, S; Silverstein, B | 1 |
| Cameron, OG; Garcia, AW; Pomerleau, CS; Pomerleau, OF | 1 |
| Creese, I; Kirch, DG; Taylor, TR; Wyatt, RJ; Xu, SX | 1 |
| Fortmann, SP; Killen, JD; Kraemer, HC; Newman, B; Varady, A | 1 |
| Amos, JC; Coday, MC; Dykstra, T; Wilkins, DR; Wilson, MR; Winders, SE | 1 |
| Daughton, DM; Grimm, RH; Heim, C; Nett, L; Petty, TL; Prochazka, AV; Rennard, SI; Sachs, DP; Silvers, GW | 1 |
| Cruser, K; Fenwick, JW; Flynn, BS; Gulliver, SB; Hughes, JR; Pepper, S; Shea, P; Solomon, LJ; Valliere, WA | 1 |
| Carter, VA; Cunningham, JS; Lake, JR; Lanier, JG; Malin, DH; Newlin-Maultsby, P; Roberts, LK; Wilson, OB | 1 |
| Baker, TB; Brandon, TH; Jorenby, DE; Zelman, DC | 1 |
| Labbate, LA | 1 |
| Jones, RT | 1 |
| Andreski, P; Breslau, N; Kilbey, MM | 1 |
| Gritsch, S; Günther, V; Meise, U | 1 |
| Fourie, T | 1 |
| Wu, WH; Yang, CY; Zbuzek, VK | 1 |
| Lando, HA; McGovern, PG | 2 |
| Persico, AM | 1 |
| Coomber, JA; Craig, D; Parrott, A | 1 |
| Hughes, JR; Newhouse, PA | 1 |
| Chang, L; Chowdhury, P; Hosotani, R; Rayford, PL | 1 |
| Anton, D; Callies, A; Hatsukami, D; Keenan, R | 1 |
| Belcher, M; Hajek, P | 1 |
| Hatsukami, DK; Huber, M; Hughes, J; Skoog, K | 1 |
| Menninger, JA | 1 |
| Hatsukami, D; Hellerstedt, W; Lando, H; McBride, C; Pirie, P | 1 |
| Demaria, C; Grimaldi, B; Lagrue, G | 1 |
| Clarke, PB | 1 |
| Hajek, P | 2 |
| Leischow, SJ; Stitzer, ML | 1 |
| Abrams, D; Goldstein, M; Niaura, R | 1 |
| Levin, ED; Rose, JE | 1 |
| Tiffany, ST | 1 |
| Sutton, SR | 1 |
| Kuschinsky, W; Schröck, H | 1 |
| Colquhoun, JP | 1 |
| Bennett, RH; Cherek, DR; Spiga, R | 1 |
| Arezo, S; James, JR; Rosecrans, JA; Villaneuva, HF | 1 |
| Bowen, DJ; Fox, E; Spring, B | 1 |
| Cruz, SL; Salazar, LA; Villarreal, JE | 1 |
| Benowitz, NL; Chan, K; Denaro, CP; Jacob, P | 1 |
| Bennett, RH; Cherek, DR; Grabowski, J | 1 |
| Arilla, E; Barrios, V; Rodríguez-Sánchez, MN | 1 |
| Fenwick, JW; Gust, SW; Hughes, JR; Keenan, RM; Skoog, K | 1 |
| Glynn, SM; Hartman, N; Jarvik, ME; Leong, GB; Wilkins, JN | 1 |
| Bühler, A; Ehrsam, RE; Howald, H; Imhof, PR; Mauli, D; Müller, P; Schumacher, PM | 1 |
| Carr, CR; Gritz, ER; Marcus, AC | 1 |
| Causey, D; Cheney, RA; Daughton, DM; Hatlelid, K; Heatley, SA; Knowles, M; Prendergast, JJ; Rennard, SI; Rolf, CN; Thompson, AB | 1 |
| Arruda, MJ; Glynn, SM; Jarvik, ME; Mintz, J; Phipps, CC; Schneider, NG | 1 |
| Greeman, M; McClellan, TA | 1 |
| Grenhoff, J; Svensson, TH | 1 |
| Hack, S; West, R | 1 |
| Webb, CW | 1 |
| Costall, B; Jones, BJ; Kelly, ME; Naylor, RJ; Onaivi, ES; Tyers, MB | 1 |
| Collins, AC | 1 |
| Abelin, T | 1 |
| Dale, LC; Hurt, RD; Kottke, TE; Lauger, GG; Offord, KP | 1 |
| Peters, JA | 1 |
| Arezo, S; James, JR; Rosecrans, JA; Villanueva, HF | 1 |
| Collins, AC; Romm, E; Wehner, JM | 1 |
| Kloska, DD; Majchrzak, MJ; Malakuti, R; Pomerleau, CS; Pomerleau, OF | 1 |
| Fenwick, JW; Gust, SW; Hughes, JR; Keenan, RM | 1 |
| Ellison, G; Gritz, E; Jarvik, M; Lee, C; Levin, ED; Reyes, A; Rose, JE | 1 |
| Fellhauer, M | 1 |
| Cohen, SB | 1 |
| Costall, B; Kelly, ME; Naylor, RJ; Onaivi, ES | 2 |
| Henningfield, JE | 2 |
| Clayton, RR; Cooper, TM | 2 |
| Hendry, JS; Hong, JS; Rosecrans, JA | 1 |
| Amble, P; Fletcher, L; Hatsukami, D; Keenan, R; Morgan, S | 1 |
| Majchrzak, MJ; Pomerleau, CS; Pomerleau, OF | 1 |
| Benazzi, F | 1 |
| Henningfield, JE; Snyder, FR | 1 |
| Belcher, M; Feyerabend, C; Hajek, P; Jarvis, MJ; Sutherland, G | 1 |
| Gross, J; Stitzer, ML | 2 |
| Belcher, M; Hajek, P; West, R | 1 |
| Abelin, T; Buehler, A; Imhof, PR; Müller, P; Vesanen, K | 1 |
| Sudan, BJ | 1 |
| Coen, KM; Corrigall, WA; Herling, S | 1 |
| Hughes, JR; Keenan, RM; Yellin, A | 1 |
| Belcher, M; Hajek, P; West, RJ | 2 |
| Amori, G; Fenwick, JF; Gulliver, SB; Hughes, JR; Mireault, GC | 1 |
| Henningfield, JE; Herning, RI; Pickworth, WB | 1 |
| Martin, BR; Onaivi, ES; Todd, S | 1 |
| Anderson, BP; O'Hara, P; Portser, SA | 1 |
| Kuch, J; Mamcarz, A; Pietkiewicz, W; Sczaniecka, O | 1 |
| McGee, KH; Murray, KM | 1 |
| Bennett, RH; Cherek, DR; Grabowski, J; Roache, JD | 1 |
| Milhorn, HT | 1 |
| Abelin, T; Bühler-Reichert, A; Ehrsam, R; Imhof, PR; Müller, P; Thommen, A; Vesanen, K | 1 |
| Fagerstrom, KO; Schneider, NG | 1 |
| Benowitz, N; Sachs, DP | 1 |
| Fenwick, JW; Gust, SW; Huges, JR; Keenan, RM | 1 |
| Block, M; Buchkremer, G; Minneker, E | 1 |
| Andersson, K; Eneroth, P; Fuxe, K; Härfstrand, A; Jansson, A | 1 |
| Jacobson, TA | 1 |
| Abrams, DB; Goldstein, MG; Niaura, R; Ward, KD | 1 |
| Davis, FC; Henningfield, JE; Snyder, FR | 1 |
| Pasley, DR; Resnick, MP; Siemsen, FK; Yok, L | 1 |
| Bates, DF; Calhoun, KH; Longoria, JM; Philips, BU | 1 |
| Asencio, M; Carroll, ME; Keenan, RM; Lac, ST | 1 |
| Gothóni, P; Ikola, W | 1 |
| Chalmers, TC; Lam, W; Sacks, HS; Sze, PC | 1 |
| Burleson, J; Fertig, JB; Grunberg, NE; Judge, J; Pomerleau, CS; Pomerleau, OF; Scherzer, HH | 1 |
| Henningfield, JE; Jarvik, ME | 1 |
| Emmett-Oglesby, MW; Harris, CM; Lal, H; Robinson, NG | 1 |
| Bättig, K; Nil, R; Woodson, PP | 1 |
| Russell, MA; West, R | 1 |
| Schneider, N; West, R | 1 |
| Gross, J; Stitzer, M | 1 |
| Barrios, FX; Cutler, GH | 1 |
| Henningfield, JE; Nemeth-Coslett, R | 1 |
| Jarvis, M | 1 |
| Feyerabend, C; Hajek, P; Jarvis, MJ; Russell, MA; West, RJ | 1 |
| Fross, JD; Hughes, JR; Lombardo, TW | 1 |
| Downs, JM; Edwards, NB; Hoon, PW; Rosenthal, TL; Simmons, RC | 1 |
| Agustí Vidal, A; Castellví Barrera, E; González Quintana, J; Iniesta Torres, C; Marín Tuyà, D; Muriana Sáez, C; Salvador Llivina, T | 1 |
| Benhamou, S; Clavel, F; Flamant, R | 1 |
| Morgan, JP | 1 |
| Carroll, KM; Hatsukami, DK; Hughes, JR; Pickens, RW; Svikis, DS | 1 |
| Goldstein, A | 1 |
| Ellison, GD; Galvez, C; Levin, ED; Morgan, MM | 1 |
| Maritz, GS | 1 |
| Metelitsa, VI | 1 |
| Gottlieb, AM; Killen, JD; Marlatt, GA; Taylor, CB | 1 |
| Cummings, KM; Emont, SL | 1 |
| Hatsukami, DK; Hughes, JR; Skoog, KP | 1 |
| Allen, ME | 1 |
| Fertig, JB; Pomerleau, OF; Sanders, B | 1 |
| Camic, PM; deWit, H | 1 |
| Trojani, FT | 1 |
| Gust, SW; Hughes, JR; Pechacek, TF | 1 |
| Benowitz, NL; Jacob, P; Lee, BL | 1 |
| Orleans, CT | 1 |
| Jarvis, MJ; Russell, MA | 1 |
| Hall, SM; Killen, JD | 1 |
| Hatsukami, D; Hughes, JR; Pickens, R | 1 |
| Hatsukami, D; Hughes, JR | 2 |
| Russell, MA; West, RJ | 2 |
| Hughes, JR; Krahn, D | 1 |
| Benevolo, E; Carbone, R; Mantero, A | 1 |
| Johnson, RW; Levine, DJ | 1 |
| Collins, AC; Marks, MJ; Stitzel, JA | 1 |
| Cummings, KM; Emrich, LJ; Giovino, G; Jaén, CR | 1 |
| Hatsukami, DK; Hughes, JR; Pickens, RW | 1 |
| Johnston, L | 1 |
| Schmitz-Harbauer, R | 1 |
| Marlow, HF | 1 |
| Behrendt, H; Green, M; Zelson, C | 1 |
| Sato, T; Takagi, K; Takayanagi, I | 1 |
| Behrendt, H; Green, M | 1 |
| Richardson, BW | 1 |
| Luban-Plozza, B | 1 |
| Simm, HO; Werner, T; Woeber, K | 1 |
197 review(s) available for nicotine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
[Tobacco dependence, anxiety, and depression].
Topics: Adolescent; Anxiety; Depression; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2022 |
Development of Dependence in Smokers and Rodents With Voluntary Nicotine Intake: Similarities and Differences.
Topics: Adolescent; Animals; Female; Humans; Male; Mice; Nicotine; Rats; Rodentia; Smokers; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2023 |
Smoking reduction interventions for smoking cessation.
Topics: Bupropion; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Reduction; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2019 |
Unique, long-term effects of nicotine on adolescent brain.
Topics: Adolescent; Age Factors; Animals; Behavior, Animal; Brain; Cognition; Electronic Nicotine Delivery Systems; Emotions; Female; Humans; Male; Nicotine; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome; United States; Vaping | 2020 |
Rodent models for nicotine withdrawal.
Topics: Animals; Disease Models, Animal; Electronic Nicotine Delivery Systems; Humans; Mice; Nicotine; Rats; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2021 |
Neural Correlates of Depressive Symptoms in Smokers - A Systematic Review of Imaging Studies.
Topics: Brain; Correlation of Data; Depressive Disorder; Dopamine; Humans; Magnetic Resonance Imaging; Monoamine Oxidase; Nicotine; Smokers; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2017 |
Effect of nicotine replacement therapy on mortality, delirium, and duration of therapy in critically ill smokers: a systematic review and meta-analysis.
Topics: Critical Illness; Delirium; Hospital Mortality; Humans; Intensive Care Units; Nicotine; Randomized Controlled Trials as Topic; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Molecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions.
Topics: Drug Interactions; Ethanol; Humans; Nicotine; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
The Gamma-Aminobutyric Acid B Receptor in Depression and Reward.
Topics: Allosteric Regulation; Anhedonia; Animals; Antidepressive Agents; Brain; Depression; Depressive Disorder, Major; GABA-B Receptor Agonists; Humans; Nicotine; Receptors, GABA-B; Reward; Stress, Psychological; Substance Withdrawal Syndrome | 2018 |
The impact of smoking cessation on schizophrenia and major depression.
Topics: Depressive Disorder, Major; Humans; Nicotine; Recurrence; Schizophrenia; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |
[Psychiatric and psychological features of nicotine dependence].
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
[Nicotine replacement therapy].
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder | 2013 |
The "stop" and "go" of nicotine dependence: role of GABA and glutamate.
Topics: Animals; Behavior, Animal; Brain; Conditioning, Psychological; Dopamine; Excitatory Amino Acid Antagonists; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Limbic System; Nicotine; Nicotinic Antagonists; Receptors, Glutamate; Reinforcement, Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
The predicted impact of reducing the nicotine content in cigarettes on alcohol use.
Topics: Alcohol Drinking; Cues; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Products | 2014 |
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.
Topics: Cognition; Humans; Nicotine; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Translational Research, Biomedical | 2014 |
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.
Topics: Humans; Nicotine; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
Nicotine effects and the endogenous opioid system.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Enkephalin, Methionine; Humans; Hypothalamo-Hypophyseal System; Naloxone; Narcotic Antagonists; Nicotine; Opioid Peptides; Pituitary-Adrenal System; Spinal Cord; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
The management of substance abuse in the critically ill.
Topics: Alcoholic Intoxication; Benzodiazepines; Caffeine; Cocaine-Related Disorders; Critical Illness; Drug Overdose; Humans; Inhalant Abuse; Marijuana Abuse; Nicotine; Opioid-Related Disorders; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2014 |
Efficacy of electronic cigarettes for smoking cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2014 |
The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.
Topics: Animals; Behavior, Addictive; Humans; Nicotine; Nicotinic Agonists; Placebo Effect; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Electronic cigarettes for smoking cessation.
Topics: Electronic Nicotine Delivery Systems; Evidence-Based Practice; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2014 |
Is impulsivity a symptom of initial tobacco withdrawal? A meta-analysis and qualitative systematic review.
Topics: Adult; Female; Humans; Impulsive Behavior; Male; Nicotiana; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2015 |
New mechanisms and perspectives in nicotine withdrawal.
Topics: Animals; Brain; Disease Models, Animal; Humans; Neurons; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.
Topics: Animals; Habenula; Humans; Interpeduncular Nucleus; Mice; Neural Pathways; Neurons; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states.
Topics: Affect; Aggression; Animals; Anxiety; Clinical Trials as Topic; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Nicotine withdrawal.
Topics: Animals; Brain; Humans; Nicotine; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2015 |
Smoking abstinence and neurocognition: implications for cessation and relapse.
Topics: Animals; Executive Function; Humans; Nicotine; Reward; Smoking; Substance Withdrawal Syndrome | 2015 |
Withdrawal: Expanding a Key Addiction Construct.
Topics: Behavior, Addictive; Humans; Motivation; Nicotine; Smoking; Substance Withdrawal Syndrome | 2015 |
Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.
Topics: Female; Gender Identity; Humans; Male; Nicotine; Receptors, Androgen; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2015 |
A 2015 Update on The Natural History and Diagnosis of Nicotine Addiction.
Topics: Adolescent; Behavior, Addictive; Humans; Motivation; Nicotine; Smoking; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2015 |
Resting-state functional connectivity and nicotine addiction: prospects for biomarker development.
Topics: Biomarkers; Brain Mapping; Cognition; Humans; Limbic System; Neural Pathways; Nicotine; Rest; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
[Behavioral characteristics of nicotine seeking: a role of the nicotine-conditioned effects and other mechanisms].
Topics: Animals; Conditioning, Classical; Drug-Seeking Behavior; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2016 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2016 |
Neuropeptide systems and new treatments for nicotine addiction.
Topics: Animals; Anxiety; Corticotropin-Releasing Hormone; Humans; Neuropeptides; Nicotine; Receptors, Opioid, kappa; Self Administration; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2017 |
Endogenous opioid system: a promising target for future smoking cessation medications.
Topics: Analgesics, Opioid; Animals; Drug Delivery Systems; Forecasting; Humans; Nicotine; Opioid Peptides; Receptors, Opioid; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2017 |
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Animals, Genetically Modified; Anxiety Disorders; Arousal; Comorbidity; Depressive Disorder; Genotype; Humans; Mice; Mice, Knockout; Nicotine; Phenotype; Receptors, Nicotinic; Reward; Schizophrenia; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Serotonin receptors as potential targets for modulation of nicotine use and dependence.
Topics: Animals; Behavior; Brain; Humans; Nicotine; Nicotinic Agonists; Protein Isoforms; Receptors, Serotonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Nicotine self-medication of cognitive-attentional processing.
Topics: Attention; Brain; Cognition; Humans; Motivation; Neuropsychological Tests; Nicotine; Receptors, Nicotinic; Risk Factors; Self Medication; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Disrupting nicotine reinforcement: from cigarette to brain.
Topics: Animals; Brain; Cardiovascular System; Cats; Clinical Trials as Topic; Humans; Immunotherapy, Active; Neurotransmitter Agents; Nicotiana; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Reinforcement, Psychology; Respiratory System; Reward; Sensation; Smoke; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Synaptic plasticity within midbrain dopamine centers contributes to nicotine addiction.
Topics: Animals; Dopamine; Humans; Long-Term Potentiation; Mesencephalon; Motivation; Neuronal Plasticity; Nicotine; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Synapses; Tobacco Use Disorder; Young Adult | 2009 |
Multiple motivational forces contribute to nicotine dependence.
Topics: Animals; Arousal; Association Learning; Conditioning, Psychological; Ganglionic Stimulants; Humans; Motivation; Motor Activity; Nicotine; Rats; Reward; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking.
Topics: Administration, Intranasal; Association Learning; Cues; Dose-Response Relationship, Drug; Female; Humans; Male; Motivation; Nicotine; Reinforcement, Psychology; Reward; Self Administration; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2009 |
The functional significance of craving in nicotine dependence.
Topics: Adolescent; Adult; Aged; Alcoholic Intoxication; Cues; Humans; Middle Aged; Motivation; Nicotine; Secondary Prevention; Smoking; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2009 |
Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans?
Topics: Animals; Disease Models, Animal; Humans; Mice; Nicotine; Nicotinic Agonists; Rats; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
The neuronal pathways mediating the behavioral and addictive properties of nicotine.
Topics: Animals; Behavior, Addictive; Brain; Dopamine; Humans; Nicotine; Nicotinic Agonists; Receptors, Cannabinoid; Receptors, Metabotropic Glutamate; Serotonin; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Rodent models of nicotine withdrawal syndrome.
Topics: Animals; Disease Models, Animal; Gene Expression; Mice; Nicotine; Nicotinic Agonists; Rats; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Validation Studies as Topic | 2009 |
Effects of nicotine in experimental animals and humans: an update on addictive properties.
Topics: Animals; Behavior, Addictive; Conditioning, Classical; Discrimination Learning; Humans; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
A preliminary benefit-risk assessment of varenicline in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2009 |
Effects of nicotine on sleep during consumption, withdrawal and replacement therapy.
Topics: Animals; Humans; Nicotine; Sleep; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2009 |
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
Topics: Animals; Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
A tragic triad: coronary artery disease, nicotine addiction, and depression.
Topics: Coronary Artery Disease; Depression; Humans; Nicotine; Prevalence; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome; Syndrome; Tobacco Use Disorder; United States | 2009 |
Associative learning, the hippocampus, and nicotine addiction.
Topics: Animals; Association Learning; Conditioning, Classical; Cues; Drug Tolerance; Fear; Hippocampus; Humans; Long-Term Potentiation; Mental Recall; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Signal Transduction; Smoking; Social Environment; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Light and intermittent cigarette smokers: a review (1989-2009).
Topics: Behavior, Addictive; Health Surveys; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Nicotine: alcohol reward interactions.
Topics: Age Factors; Alcoholism; Animals; Brain; Drug Interactions; Ethanol; Female; Humans; Male; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Receptors, Neurotransmitter; Receptors, Nicotinic; Reward; Sex Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review.
Topics: Clinical Trials as Topic; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Odds Ratio; Outcome Assessment, Health Care; Predictive Value of Tests; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Pre-cessation nicotine replacement therapy: pragmatic randomized trial.
Topics: Administration, Cutaneous; Adult; Algorithms; Chewing Gum; Female; Hotlines; Humans; Male; Native Hawaiian or Other Pacific Islander; New Zealand; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking; Smoking Cessation; Smoking Prevention; Statistics as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Nicotine addiction.
Topics: Female; Humans; Limbic System; Male; Nicotine; Receptors, Nicotinic; Risk Factors; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Smoking cessation-recent advances.
Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline | 2010 |
[Why do not all smokers stop smoking?].
Topics: Health Knowledge, Attitudes, Practice; Humans; Lung Neoplasms; Nicotine; Physician-Patient Relations; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Switzerland; Tobacco Industry; Tobacco Use Disorder | 2010 |
Nicotine and endogenous opioids: neurochemical and pharmacological evidence.
Topics: Animals; Dopamine Agonists; Mice; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Opioid Peptides; Rats; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2011 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2010 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2011 |
Reward, addiction, withdrawal to nicotine.
Topics: Animals; Behavior, Addictive; Cerebral Cortex; Dopamine; Humans; Limbic System; Neuronal Plasticity; Neurons; Nicotine; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2011 |
Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence.
Topics: Cotinine; Humans; Nicotine; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2011 |
Mechanistic insights into nicotine withdrawal.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Humans; Nicotine; Receptors, Nicotinic; Reinforcement, Psychology; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Cognitive mechanisms underlying relapse to nicotine.
Topics: Animals; Cognition; Hippocampus; Humans; Neuronal Plasticity; Nicotine; Substance Withdrawal Syndrome | 2011 |
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Topics: Adolescent; Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Prescription Drugs; Quinoxalines; Randomized Controlled Trials as Topic; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2012 |
Altered amygdala function in nicotine addiction: insights from human neuroimaging studies.
Topics: Amygdala; Brain Mapping; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Nicotine; Nicotinic Agonists; Positron-Emission Tomography; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence.
Topics: Amidohydrolases; Animals; Endocannabinoids; Enzyme Inhibitors; Humans; Mice; Nicotine; Nicotinic Agonists; Rats; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
Abuse potential of non-nicotine tobacco smoke components: acetaldehyde, nornicotine, cotinine, and anabasine.
Topics: Acetaldehyde; Anabasine; Animals; Cotinine; Dopamine; Humans; Mesencephalon; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
Clinical efficacy of bupropion in the management of smoking cessation.
Topics: Body Weight; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Administration Schedule; Female; Humans; Male; Nicotine; Practice Guidelines as Topic; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Current approaches to the management of smoking cessation.
Topics: Bupropion; Delayed-Action Preparations; Hotlines; Humans; Nicotine; Practice Guidelines as Topic; Psychotherapy, Group; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Nicotine addiction: insights from recent animal studies.
Topics: Animals; Behavior, Animal; Circadian Rhythm; Dopamine; Ganglionic Stimulants; Limbic System; Models, Animal; Neurons; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Receptors, Opioid; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 2002 |
The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments.
Topics: Animals; Anxiety Disorders; Calcium Channels, L-Type; Discrimination, Psychological; Drug Interactions; GABA Antagonists; GABA-A Receptor Antagonists; Glycine Agents; Models, Animal; Nicotine; Pentylenetetrazole; Pituitary-Adrenal System; Receptors, GABA-A; Receptors, Glycine; Receptors, Nicotinic; Receptors, Serotonin; Serotonin; Sex Factors; Strychnine; Substance Withdrawal Syndrome | 2002 |
Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?
Topics: Bupropion; Clinical Trials as Topic; Drug Administration Schedule; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2002 |
Cigarette-derived nicotine is not a medicine.
Topics: Affect; Anxiety; Depression; Humans; Nicotine; Self Administration; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Smoking cessation in the elderly.
Topics: Administration, Cutaneous; Aged; Behavior Therapy; Clonidine; Counseling; Habits; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Effects of the nicotine patch on performance during the first week of smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cognition; Double-Blind Method; Female; Humans; Linguistics; Male; Mathematics; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Problem Solving; Reaction Time; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Visual Perception | 2003 |
Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence.
Topics: Animals; Dopamine; Humans; Limbic System; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Drug addiction.
Topics: Animals; Cannabinoids; Cocaine; Disease Models, Animal; Dopamine; Ethanol; Humans; Narcotics; Nicotine; Recurrence; Reinforcement, Psychology; Substance Withdrawal Syndrome; Substance-Related Disorders | 2003 |
Treating nicotine dependence.
Topics: Behavior Therapy; Brain; Depression; Dopamine; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Why people smoke.
Topics: Chronic Disease; Humans; Motivation; Nicotine; Reinforcement, Social; Smoking; Socioeconomic Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Does bupropion have advantages over other medical therapies in the cessation of smoking?
Topics: Administration, Cutaneous; Aged; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2004 |
Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.
Topics: Clinical Trials as Topic; Data Collection; Endpoint Determination; Ganglionic Stimulants; Humans; Nicotine; Patient Dropouts; Recurrence; Research Design; Smoking Cessation; Substance Withdrawal Syndrome; Terminology as Topic; Tobacco Use Disorder | 2004 |
Smoking and sleep disorders.
Topics: Humans; Nicotine; Nicotinic Agonists; Sleep; Sleep Wake Disorders; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2004 |
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: chronic nicotine treatment upregulates L-type high voltage-gated calcium channels.
Topics: Animals; Anxiety; Brain; Calcium; Calcium Channels, L-Type; Diazepam Binding Inhibitor; Drug Design; Humans; Neurons; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder; Up-Regulation | 2005 |
Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond.
Topics: Affect; Brain; Cognition; Electroencephalography; Evoked Potentials; Ganglionic Stimulants; Hemodynamics; Humans; Magnetic Resonance Imaging; Mental Processes; Monoamine Oxidase; Nicotine; Positron-Emission Tomography; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature.
Topics: Adolescent; Behavior, Addictive; Humans; Models, Neurological; Nicotine; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
Measuring impulsivity and modeling its association with cigarette smoking.
Topics: Animals; Decision Making; Ganglionic Stimulants; Humans; Impulsive Behavior; Models, Psychological; Nicotine; Reinforcement Schedule; Smoking; Substance Withdrawal Syndrome; Task Performance and Analysis | 2004 |
Novelty reward as a measure of anhedonia.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Depression; Disease Models, Animal; Exploratory Behavior; Humans; Nicotine; Nicotinic Agonists; Reward; Substance Withdrawal Syndrome; Weights and Measures | 2005 |
Smoking cessation in patients with coronary artery disease.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Atherosclerosis; Behavior Therapy; Bupropion; Carbon Monoxide; Coronary Disease; Double-Blind Method; Hemodynamics; Humans; Hypoxia; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Thrombophilia; Tobacco Use Disorder; Vasoconstriction | 2005 |
Distress tolerance and early smoking lapse.
Topics: Adaptation, Psychological; Affective Symptoms; Combined Modality Therapy; Humans; Nicotine; Personality Assessment; Psychotherapy, Group; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
How does bupropion work as a smoking cessation aid?
Topics: Administration, Cutaneous; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Nicotine; Norepinephrine; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2005 |
Medication screening for smoking cessation: a proposal for new methodologies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2006 |
Smoking cessation therapy and the return of aviators to flying duty.
Topics: Aerospace Medicine; Antidepressive Agents; Humans; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
Perioperative abstinence from cigarettes: physiologic and clinical consequences.
Topics: Animals; Cardiovascular Physiological Phenomena; Humans; Nervous System Physiological Phenomena; Nicotine; Nicotinic Agonists; Perioperative Care; Respiratory Physiological Phenomena; Risk; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Wound Healing | 2006 |
Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research.
Topics: Adolescent; Adult; Attention; Awareness; Chronic Disease; Cognitive Dissonance; Depression; Humans; Models, Psychological; Nicotine; Prospective Studies; Self Medication; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Bupropion for the treatment of nicotine withdrawal and craving.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nicotine; Practice Patterns, Physicians'; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
[Pharmacological relapse prevention in alcohol and tobacco dependence].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder | 2007 |
Secondhand smoke and nicotine exposure: a brief review.
Topics: Adolescent; Adult; Biomarkers; Cotinine; Environmental Exposure; Female; Hair; Humans; Male; Mental Disorders; Nicotine; Substance Withdrawal Syndrome; Tobacco Smoke Pollution | 2007 |
Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships.
Topics: Anxiety; Anxiety Disorders; Humans; Nicotine; Prevalence; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Effects of abstinence from tobacco: valid symptoms and time course.
Topics: Female; Humans; Male; Mental Disorders; Meta-Analysis as Topic; Nicotine; Psychomotor Agitation; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review.
Topics: Animals; Disease Models, Animal; Humans; Mental Disorders; Nicotine; Randomized Controlled Trials as Topic; Research Design; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective.
Topics: Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Interactions; Humans; Interpersonal Relations; Mental Disorders; Nicotine; Patient Compliance; Psychiatric Department, Hospital; Psychotropic Drugs; Reinforcement, Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Measurement of the effects of abstinence from tobacco: a qualitative review.
Topics: Anxiety; Humans; Nicotine; Predictive Value of Tests; Qualitative Research; Randomized Controlled Trials as Topic; Research Design; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2008 |
Nicotine patch therapy prior to quitting smoking: a meta-analysis.
Topics: Administration, Cutaneous; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Neurobiology of nicotine addiction: implications for smoking cessation treatment.
Topics: Humans; Neurobiology; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2008 |
The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.
Topics: Animals; Dizocilpine Maleate; Drug Tolerance; Excitatory Amino Acid Antagonists; Humans; Nicotine; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Clonidine; Cytochrome P-450 CYP2A6; Drug Delivery Systems; GABA Modulators; Humans; Narcotic Antagonists; Nicotine; Piperidines; Pyrazoles; Receptors, Nicotinic; Rimonabant; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vaccination | 2008 |
Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation.
Topics: Analgesics; Animals; Anti-Anxiety Agents; Humans; Hunger; Male; Nervous System Physiological Phenomena; Neurotransmitter Agents; Nicotine; Psychomotor Performance; Rats; Receptors, Neurotransmitter; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome | 1984 |
Psychology and pharmacology in cigarette withdrawal.
Topics: Chewing Gum; Heart Rate; Humans; Motivation; Nicotiana; Nicotine; Plants, Toxic; Random Allocation; Smoking Prevention; Substance Withdrawal Syndrome | 1984 |
Human dependence on tobacco and opioids: common factors.
Topics: Conditioning, Operant; Drug Tolerance; Feeding Behavior; Humans; Narcotic Antagonists; Narcotics; Nicotine; Opioid-Related Disorders; Personality; Reinforcement, Psychology; Self Administration; Smoking; Social Facilitation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1981 |
Clinical use of nicotine chewing-gum.
Topics: Body Weight; Chewing Gum; Clinical Trials as Topic; Humans; Nicotine; Patient Education as Topic; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 1980 |
Smoking behaviour: a psychology of the cigarette habit.
Topics: Arousal; Humans; Motivation; Nicotine; Psychology; Sensation; Smoking; Social Behavior; Stress, Psychological; Substance Withdrawal Syndrome; Task Performance and Analysis | 1980 |
Underlying mechanisms in substance abuse: examples from research on smoking.
Topics: Cues; Drug Tolerance; Environment; Humans; Models, Psychological; Nicotine; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 1981 |
The pharmacology of nicotine dependence: a working hypothesis.
Topics: Animals; Drug Tolerance; Humans; Models, Biological; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1981 |
Nicotine replacement therapy. What has been accomplished--can we do better?
Topics: Behavior Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Nicotine-related brain disorders: the neurobiological basis of nicotine dependence.
Topics: Adaptation, Physiological; Animals; Brain; Humans; Nicotine; Receptors, Nicotinic; Substance Withdrawal Syndrome; Substance-Related Disorders; Synapses; Synaptic Transmission; Tobacco Use Disorder | 1994 |
Acute effects of cigarette smoking withdrawal: a review of the literature.
Topics: Adult; Aerospace Medicine; Cognition; Drug Tolerance; Female; Humans; Male; Military Personnel; Nicotine; Occupational Health; Reaction Time; Smoking; Substance Withdrawal Syndrome; United States | 1995 |
[Nicotine substitution as an aid in smoking cessation. Mechanisms of action, methods and evaluation of the results].
Topics: Administration, Cutaneous; Chewing Gum; Evaluation Studies as Topic; Humans; Nicotine; Receptors, Dopamine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Nicotine chewing gum and nicotine patch.
Topics: Administration, Cutaneous; Chewing Gum; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Long-Term Care; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Neural mechanisms underlying nicotine dependence.
Topics: Animals; Brain; Dopamine; Drug Tolerance; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities.
Topics: Animals; Arousal; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Neurologic Examination; Nicotine; Pregnancy; Recurrence; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Nicotine withdrawal symptoms. A review for primary care practitioners.
Topics: Adult; Depression; Humans; Nicotine; Primary Health Care; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Nicotine, negative affect, and depression.
Topics: Combined Modality Therapy; Depression; Humans; Neurotransmitter Agents; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Nicotine dependence and schizophrenia.
Topics: Adult; Antipsychotic Agents; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Affective Disorders, Psychotic; Aged; Blood Pressure; Body Weight; Combined Modality Therapy; Dosage Forms; England; Female; Follow-Up Studies; Heart Rate; Hospitals, General; Humans; Male; Middle Aged; Nicotine; Outpatient Clinics, Hospital; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Nicotine-replacement products in smoking cessation: a review.
Topics: Administration, Cutaneous; Aerosols; Chewing Gum; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Ion Exchange Resins; Male; Nebulizers and Vaporizers; Nicotine; Placebos; Polymethacrylic Acids; Polyvinyls; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1993 |
Common errors in the pharmacologic treatment of drug dependence and withdrawal.
Topics: Behavior Therapy; Buprenorphine; Clonidine; Humans; Lithium; Methadone; Narcotics; Nicotine; Psychotherapy; Substance Withdrawal Syndrome; Thiamine | 1994 |
Nicotine delivery kinetics and abuse liability.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Dose-Response Relationship, Drug; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1993 |
Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies, and suggestions for future research.
Topics: Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Motivation; Nicotine; Psychotherapy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Nicotine transdermal systems.
Topics: Administration, Cutaneous; Choice Behavior; Drug Interactions; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1993 |
Office evaluation and treatment of the dependent smoker.
Topics: Combined Modality Therapy; Family Practice; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment.
Topics: Ambulatory Care; Hospitalization; Humans; Mental Disorders; Nicotine; Psychiatric Department, Hospital; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1993 |
Smoking cessation leads to reduced stress, but why?
Topics: Adaptation, Psychological; Affect; Arousal; Follow-Up Studies; Humans; Longitudinal Studies; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
[Smoking cessation with the nicotine patch].
Topics: Administration, Cutaneous; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Follow-Up Studies; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Drug addiction: the yin and yang of hedonic homeostasis.
Topics: Amphetamine; Amygdala; Brain; Cocaine; Drug Tolerance; Homeostasis; Humans; Narcotics; Neuropeptides; Nicotine; Receptors, Dopamine; Reinforcement, Psychology; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Nicotine addiction and treatment.
Topics: Humans; Nicotine; Psychotropic Drugs; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
Measuring tobacco withdrawal: a review of self-report questionnaires.
Topics: Arousal; Humans; Neurologic Examination; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association.
Topics: Adolescent; Adult; Aged; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Psychotherapy; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1996 |
Effects of drugs on sleep.
Topics: Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Ethanol; Glucocorticoids; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Narcotics; Nicotine; Sleep; Sleep, REM; Substance Withdrawal Syndrome | 1996 |
Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Clinical Trials as Topic; Drug Carriers; Humans; Nicotine; Nicotinic Agonists; Parkinson Disease; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Smokeless tobacco: an addicting drug.
Topics: Behavior, Addictive; Humans; Nicotine; Plants, Toxic; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless | 1997 |
Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse.
Topics: Central Nervous System Stimulants; Dopamine; Humans; Nicotine; Nucleus Accumbens; Polymethacrylic Acids; Polyvinyls; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Failure | 1998 |
Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans.
Topics: Animals; Endocrine Glands; Humans; Hypothalamo-Hypophyseal System; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Cigarette smoking prevalence, cessation and relapse.
Topics: Adolescent; Adult; Aged; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Odds Ratio; Prevalence; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; United Kingdom | 1998 |
[Mechanism of nicotine dependence].
Topics: Animals; Behavior, Addictive; Brain; Hormones; Humans; Neuropeptides; Neurotransmitter Agents; Nicotine; Self Administration; Substance Withdrawal Syndrome; Tachyphylaxis; Tobacco Use Disorder | 1998 |
[Therapeutic advances in breaking the tobacco habit].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Substance Withdrawal Syndrome; Tobacco Use Cessation | 1999 |
[New possibilities in pharmacological treatment of nicotine dependence].
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Humans; Nicotine; Rats; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Smoking cessation. Techniques and benefits.
Topics: Behavior Therapy; Humans; Nicotine; Nicotinic Antagonists; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Measuring nicotine dependence among youth: a review of available approaches and instruments.
Topics: Adolescent; Behavior, Addictive; Child; Humans; National Institute of Mental Health (U.S.); Nicotine; Nicotinic Agonists; Psychometrics; Research Design; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States | 2000 |
[Nicotine dependence].
Topics: Animals; Brain; Dopamine; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 2000 |
Prevention of nicotine addiction: neuropsychopharmacological issues.
Topics: Adolescent; Behavior, Addictive; Central Nervous System; Child; Humans; Nicotine; Psychopharmacology; Research; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Alterations in cerebral diazepam binding inhibitor expression in drug dependence: a possible biochemical alteration common to drug dependence.
Topics: Alcoholism; Animals; Brain; Brain Chemistry; Carrier Proteins; Diazepam Binding Inhibitor; Ethanol; Humans; Mice; Morphine; Morphine Dependence; Nicotine; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 2001 |
Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review.
Topics: Administration, Oral; Animals; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
[Empirical basis for breaking the tobacco smoking habit].
Topics: Brain; Drug Tolerance; Humans; Nicotine; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
Glucose for smoking cessation: does it have a role?
Topics: Glucose; Humans; Hunger; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
Neurobiological mechanisms of nicotine craving.
Topics: Animals; Conditioning, Psychological; Environment; Humans; Nicotine; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
[Drug addiction and withdrawal].
Topics: Benzodiazepines; Brain; Cannabis; Central Nervous System Stimulants; Delivery of Health Care; Dopamine; Health Policy; Humans; Illicit Drugs; Narcotics; Nicotine; Nucleus Accumbens; Phencyclidine Abuse; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
Neurobiology of the nicotine withdrawal syndrome.
Topics: Animals; Humans; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome | 2001 |
[Diagnostics and therapy of nicotine dependence].
Topics: Drug Interactions; Humans; Nicotine; Psychotropic Drugs; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
[Nicotine dependence--medico-biological aspects].
Topics: Brain; Dopamine; Humans; Nicotine; Receptors, Dopamine; Receptors, Nicotinic; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
[Nicotine substitution therapy: 10 years later].
Topics: Administration, Cutaneous; Chewing Gum; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Follow-Up Studies; Humans; Motivation; Nicotine; Placebos; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2002 |
Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine.
Topics: Animals; Anxiety; Behavior, Animal; Depression; Humans; Mental Disorders; Nicotine; Receptors, Nicotinic; Schizophrenia; Substance Withdrawal Syndrome | 2002 |
[Tobacco smoking and mental health].
Topics: Adolescent; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Health; Nicotine; Personality; Smoking; Social Behavior; Substance Withdrawal Syndrome; Substance-Related Disorders | 1979 |
What have we learned from nicotine, cocaine, and marijuana about addiction?
Topics: Brain; Cannabinoids; Cocaine; Humans; Marijuana Abuse; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Cigarette smoking and nicotine addiction.
Topics: Animals; Brain; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1992 |
The role of nicotine and nicotinic mechanisms in neuropsychiatric disease.
Topics: Brain; Humans; Neurocognitive Disorders; Neurotransmitter Agents; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
Nicotinic receptor blockade therapy and smoking cessation.
Topics: Aversive Therapy; Brain; Combined Modality Therapy; Humans; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome | 1991 |
Towards better diagnoses and more individual treatment of tobacco dependence.
Topics: Antidepressive Agents; Behavior Therapy; Clonidine; Combined Modality Therapy; Humans; Nicotine; Personality Tests; Smoking; Substance Withdrawal Syndrome | 1991 |
Individual differences in difficulty quitting smoking.
Topics: Adaptation, Psychological; Humans; Individuality; Nicotine; Smoking; Social Environment; Substance Withdrawal Syndrome | 1991 |
Beneficial effects of nicotine.
Topics: Affect; Animals; Arousal; Attention; Humans; Mental Recall; Neurocognitive Disorders; Nicotine; Smoking; Substance Withdrawal Syndrome | 1991 |
Smoking cessation and weight gain.
Topics: Combined Modality Therapy; Energy Metabolism; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Weight Gain | 1991 |
A bioinformational systems perspective on tobacco dependence.
Topics: Arousal; Humans; Individuality; Motivation; Nicotine; Psychophysiology; Smoking; Substance Withdrawal Syndrome | 1991 |
Research on stress and smoking: progress and problems.
Topics: Animals; Anxiety; Arousal; Humans; Nicotine; Psychophysiology; Recurrence; Smoking; Stress, Psychological; Substance Withdrawal Syndrome | 1991 |
Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking.
Topics: Arousal; Association Learning; Brain; Conditioning, Classical; Extinction, Psychological; Humans; Nicotine; Recurrence; Smoking; Substance Withdrawal Syndrome | 1991 |
Refining models of dependence: variations across persons and situations.
Topics: Humans; Individuality; Nicotine; Smoking; Social Environment; Substance Withdrawal Syndrome | 1991 |
The future of nicotine replacement.
Topics: Administration, Cutaneous; Chewing Gum; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1991 |
Great expectations: some suggestions for applying the balanced placebo design to nicotine and smoking.
Topics: Clinical Trials as Topic; Humans; Nicotine; Placebo Effect; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
[Neuropharmacology of smoking: basic research opens new therapeutic possibilities].
Topics: Brain; Humans; Nicotine; Receptors, Dopamine; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
An analysis of the addiction liability of nicotine.
Topics: Animals; Arousal; Humans; Nicotine; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
[Smoking and smoking cessation in the context of preventive cardiology].
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Prevention; Stress, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Understanding nicotine addiction and physical withdrawal process.
Topics: Humans; Nicotine; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Nicotine reduction therapy and relapse prevention for heavy smokers: 3-year follow-up.
Topics: Chewing Gum; Follow-Up Studies; Humans; Ion Exchange Resins; Nicotine; Polymethacrylic Acids; Polyvinyls; Recurrence; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1990 |
Nicotine dependence and the Fagerström Tolerance Questionnaire: a brief review.
Topics: Chewing Gum; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Nicotine; Personality Tests; Psychometrics; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1989 |
Nicotine dependence.
Topics: Family Practice; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Smoke Pollution; Tobacco Use Disorder | 1989 |
Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.
Topics: Drug Tolerance; Humans; Nicotine; Psychological Tests; Smoking; Substance Withdrawal Syndrome | 1989 |
Pharmacological treatment of tobacco dependence.
Topics: Affect; Body Weight; Chewing Gum; Humans; Nicotine; Psychomotor Performance; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1988 |
Nicotine dependence. Interface between tobacco and tobacco-related disease.
Topics: Absorption; Animals; Behavior Therapy; Chewing Gum; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 1988 |
Nicotine replacement as sole therapy or as adjunct.
Topics: Behavior Therapy; Chewing Gum; Combined Modality Therapy; Counseling; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1988 |
Smoking relapse: the role of pharmacological and behavioral factors.
Topics: Affective Symptoms; Behavior Therapy; Body Weight; Chewing Gum; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Recurrence; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1988 |
Nicotine: a dependence-producing substance.
Topics: Affective Symptoms; Chewing Gum; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1988 |
Understanding and promoting smoking cessation: overview and guidelines for physician intervention.
Topics: Behavior Therapy; Chewing Gum; Clinical Trials as Topic; Counseling; Follow-Up Studies; Humans; Methods; Motivation; Nicotine; Patient Education as Topic; Risk; Self-Help Groups; Smoking Prevention; Substance Withdrawal Syndrome | 1985 |
385 trial(s) available for nicotine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Comparison of withdrawal symptom intensity between hypnosis and nicotine-replacement-therapies: A pilot study.
Topics: Adult; Humans; Hypnosis; Nicotine; Pilot Projects; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2022 |
Characterizing nicotine withdrawal in smokers experiencing homelessness.
Topics: Humans; Ill-Housed Persons; Nicotine; Smokers; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2022 |
Time-Varying Mediation of Pharmacological Smoking Cessation Treatments on Smoking Lapse via Craving, Cessation Fatigue, and Negative Mood.
Topics: Craving; Fatigue; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Varenicline | 2022 |
Progesterone Increases Nicotine Withdrawal and Anxiety in Male but Not Female Smokers During Brief Abstinence.
Topics: Anxiety; Cross-Over Studies; Female; Humans; Male; Nicotine; Progesterone; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2022 |
The effect of three-part breathing exercise on smoking cessation: A 6-month cluster-randomized clinical trial.
Topics: Breathing Exercises; Cotinine; Humans; Nicotine; Quality of Life; Smoking Cessation; Substance Withdrawal Syndrome; Thailand | 2022 |
Effect of progesterone administration in male and female smokers on nicotine withdrawal and neural response to smoking cues: role of progesterone conversion to allopregnanolone.
Topics: Cross-Over Studies; Cues; Fatigue; Female; Humans; Neurosteroids; Nicotine; Pregnanolone; Progesterone; Smokers; Smoking; Substance Withdrawal Syndrome | 2022 |
Comparing the Effects of the EU- Versus the US-JUUL Pod in a Sample of UK Smokers: Nicotine Absorption, Satisfaction, and Other Nicotine-Related Subjective Effects.
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Personal Satisfaction; Smokers; Substance Withdrawal Syndrome; Tobacco Products; United Kingdom; United States; Vaping | 2023 |
Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study.
Topics: Double-Blind Method; Glucagon-Like Peptide 1; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Weight Gain | 2023 |
Acute nicotine abstinence amplifies subjective withdrawal symptoms and threat-evoked fear and anxiety, but not extended amygdala reactivity.
Topics: Amygdala; Anxiety; Fear; Humans; Nicotine; Septal Nuclei; Substance Withdrawal Syndrome | 2023 |
The impacts of actual and perceived nicotine administration on insula functional connectivity with the anterior cingulate cortex and nucleus accumbens.
Topics: Adult; Cerebral Cortex; Craving; Double-Blind Method; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nucleus Accumbens; Smokers; Smoking; Substance Withdrawal Syndrome; Young Adult | 2019 |
Pain characteristics and nicotine deprivation as predictors of performance during a laboratory paradigm of smoking cessation.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pain; Psychomotor Performance; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Twenty-four-hour subjective and pharmacological effects of ad-libitum electronic and combustible cigarette use among dual users.
Topics: Adult; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; San Francisco; Substance Withdrawal Syndrome; Tobacco Products; United States; Vaping; Young Adult | 2020 |
Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial.
Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Marijuana Smoking; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Young Adult | 2020 |
Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
Topics: Administration, Oral; Adult; Aged; Chewing Gum; Cross-Over Studies; Female; Flavoring Agents; Humans; Male; Middle Aged; Nicotine; Smokers; Substance Abuse Detection; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Products; Tobacco Use Cessation; Tobacco Use Cessation Devices | 2021 |
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder.
Topics: Adult; Craving; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking; Substance Withdrawal Syndrome | 2021 |
Correlates of the nicotine metabolite ratio in Alaska Native people who smoke cigarettes.
Topics: Adult; Alaskan Natives; Binge Drinking; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Humans; Male; Menthol; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2022 |
The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care.
Topics: Humans; Nicotine; Nicotinic Agonists; Primary Health Care; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2022 |
Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
Topics: Adult; Cerebral Cortex; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Impulsive Behavior; Limbic System; Male; Motivation; Nicotine; Receptors, Nicotinic; Reversal Learning; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.
Topics: Adult; Anhedonia; Bupropion; Craving; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Nicotine deprivation attenuates panic reactivity in smokers: Findings from a placebo-controlled nicotine patch study.
Topics: Administration, Cutaneous; Adult; Arousal; Culture; Double-Blind Method; Fear; Female; Humans; Male; Middle Aged; Nicotine; Panic Disorder; Prospective Studies; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2017 |
Mecamylamine treatment for alcohol dependence: a randomized controlled trial.
Topics: Adult; Alcohol Drinking; Alcoholism; Ambulatory Care; Comorbidity; Craving; Double-Blind Method; Female; Humans; Male; Mecamylamine; Middle Aged; Nicotine; Nicotinic Antagonists; Smoking; Substance Withdrawal Syndrome; Treatment Outcome | 2018 |
Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory.
Topics: Administration, Cutaneous; Adult; Cigarette Smoking; Estradiol; Female; Humans; Nicotine; Ovary; Progesterone; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2018 |
Electronic cigarette user plasma nicotine concentration, puff topography, heart rate, and subjective effects: Influence of liquid nicotine concentration and user experience.
Topics: Adolescent; Adult; Double-Blind Method; Electronic Nicotine Delivery Systems; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking; Substance Withdrawal Syndrome; Young Adult | 2017 |
Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotiana; Nicotine; Smoke; Smokers; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2018 |
Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.
Topics: Adult; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Self Report; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2018 |
Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations.
Topics: Adolescent; Affect; Breath Tests; Carbon Monoxide; Craving; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotiana; Nicotine; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Young Adult | 2018 |
Nicotine deprivation increases pain intensity, neurogenic inflammation, and mechanical hyperalgesia among daily tobacco smokers.
Topics: Adult; Female; Humans; Hyperalgesia; Male; Middle Aged; Neurogenic Inflammation; Nicotine; Pain Measurement; Pain Perception; Smokers; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Cognitive Dysfunction; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Cessation Devices | 2018 |
Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.
Topics: Adult; Carbon Monoxide; Chronic Pain; Cigarette Smoking; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotine; Patient Outcome Assessment; Smoking Cessation; Substance Withdrawal Syndrome | 2018 |
Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.
Topics: Acetylcysteine; Adult; Area Under Curve; Biomarkers; Breath Tests; Carbon Monoxide; Creatinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Phenanthrenes; Smoke; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2018 |
The Network Structure of Tobacco Withdrawal in a Community Sample of Smokers Treated With Nicotine Patch and Behavioral Counseling.
Topics: Adolescent; Adult; Behavior Therapy; Combined Modality Therapy; Community Networks; Counseling; Female; Humans; Male; Middle Aged; Minnesota; Nicotine; Smokers; Smoking Cessation; Social Networking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2020 |
A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
Topics: Adult; Benzazepines; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Neoplasms; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2019 |
Self-initiated gradual smoking reduction among community correction smokers.
Topics: Adult; Age of Onset; Black or African American; Bupropion; Cigar Smoking; Cigarette Smoking; Counseling; Criminal Law; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Cessation Agents; Smoking Reduction; Substance Withdrawal Syndrome; White People | 2019 |
Smoking abstinence symptoms across 67 days compared with randomized controls-Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.
Topics: Administration, Cutaneous; Adult; Anxiety; Behavior Therapy; Bupropion; Cigarette Smoking; Craving; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome | 2019 |
Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Topics: Adolescent; Adult; Anxiety Disorders; Child; Ecological Momentary Assessment; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smokers; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
A Pilot Study of E-Cigarette Naïve Cigarette Smokers and the Effects on Craving After Acute Exposure to E-Cigarettes in the Laboratory.
Topics: Adult; Carbon Monoxide; Cigarette Smoking; Craving; Double-Blind Method; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pilot Projects; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Vaping | 2019 |
The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
Topics: Adolescent; Adult; Brain; Dopamine; Double-Blind Method; Female; Humans; Male; Maryland; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2020 |
Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch.
Topics: Adolescent; Adult; Affect; Anhedonia; Depression; Humans; Linear Models; Logistic Models; Middle Aged; Nicotine; Predictive Value of Tests; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2013 |
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study.
Topics: Administration, Cutaneous; Adolescent; Adult; Blood Pressure; Breath Holding; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Panic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Young Adult | 2013 |
Effects of nicotine withdrawal on cognition in a clinical trial setting.
Topics: Adult; Cognition; Humans; Male; Middle Aged; Nicotine; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2013 |
Cigarette craving and withdrawal symptoms during temporary abstinence and the effect of nicotine gum.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2013 |
Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials.
Topics: Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Varenicline | 2013 |
A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.
Topics: Adolescent; Adult; Behavior Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Weight Gain; Young Adult | 2013 |
Development and preliminary randomized controlled trial of a distress tolerance treatment for smokers with a history of early lapse.
Topics: Adolescent; Adult; Affect; Aged; Behavior Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2013 |
Acute electronic cigarette use: nicotine delivery and subjective effects in regular users.
Topics: Administration, Inhalation; Adolescent; Adult; Behavior, Addictive; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Patient Satisfaction; Substance Withdrawal Syndrome; Young Adult | 2014 |
Pilot investigation of changes in readiness and confidence to quit smoking after E-cigarette experimentation and 1 week of use.
Topics: Adult; Electronics; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products | 2014 |
Overcoming limitations in previous research on exercise as a smoking cessation treatment: rationale and design of the "Quit for Health" trial.
Topics: Combined Modality Therapy; Exercise Therapy; Female; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2014 |
The effects of acute exercise on tobacco cravings and withdrawal symptoms in temporary abstinent pregnant smokers.
Topics: Adult; Exercise; Exercise Therapy; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2014 |
Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers.
Topics: Adolescent; Benzhydryl Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Modafinil; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Wakefulness-Promoting Agents; Young Adult | 2014 |
Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Cotinine; Female; Humans; Nicotine; Pregnancy; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Young Adult | 2014 |
Effect of exercise on cigarette cravings and ad libitum smoking following concurrent stressors.
Topics: Adult; Craving; Exercise; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Products; Young Adult | 2014 |
Association between nicotine withdrawal and reward responsiveness in humans and rats.
Topics: Adult; Animals; Conditioning, Operant; Depression; Humans; Male; Nicotine; Rats; Reward; Smoking; Substance Withdrawal Syndrome; Young Adult | 2014 |
The effects of nicotine stimulus and response expectancies on male and female smokers' responses to nicotine-free electronic cigarettes.
Topics: Adult; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebo Effect; Self Administration; Sex Factors; Smoking; Substance Withdrawal Syndrome; Young Adult | 2015 |
The moderating role of experiential avoidance in the relationships between internal distress and smoking behavior during a quit attempt.
Topics: Adult; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints.
Topics: Adult; Belgium; Biomarkers; Carbon Dioxide; Cotinine; Craving; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
Anhedonia as a component of the tobacco withdrawal syndrome.
Topics: Adult; Anhedonia; Double-Blind Method; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2015 |
The comparative efficacy of first- versus second-generation electronic cigarettes in reducing symptoms of nicotine withdrawal.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2015 |
Preliminary effects of progressive muscle relaxation on cigarette craving and withdrawal symptoms in experienced smokers in acute cigarette abstinence: a randomized controlled trial.
Topics: Adolescent; Adult; Craving; Female; Humans; Hypertension; Male; Middle Aged; Nicotine; Relaxation Therapy; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2015 |
Gender differences in responses to cues presented in the natural environment of cigarette smokers.
Topics: Adult; Cues; Female; Gender Identity; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Gender differences in a randomized controlled trial treating tobacco use among adolescents and young adults with mental health concerns.
Topics: Adolescent; Adolescent Health Services; Female; Gender Identity; Humans; Male; Mental Disorders; Mental Health Services; Nicotine; San Francisco; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Transdermal Patch; Young Adult | 2015 |
Does smoking reduction worsen mental health? A comparison of two observational approaches.
Topics: Adult; Emotions; Female; Humans; Male; Mental Health; Middle Aged; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Prospective Studies; Research Design; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Does smoking abstinence influence distress tolerance? An experimental study comparing the response to a breath-holding test of smokers under tobacco withdrawal and under nicotine replacement therapy.
Topics: Adult; Blood Pressure; Breath Holding; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Physiological; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2015 |
Randomized Trial of Reduced-Nicotine Standards for Cigarettes.
Topics: Biomarkers; Creatinine; Double-Blind Method; Humans; Inhalation Exposure; Linear Models; Nicotiana; Nicotine; Substance Withdrawal Syndrome; Tars; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2015 |
The coupling of nicotine and stimulant craving during treatment for stimulant dependence.
Topics: Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Craving; Humans; Methamphetamine; Models, Psychological; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Treatment Outcome | 2016 |
A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.
Topics: Administration, Inhalation; Adult; Aged; Breath Tests; Carbon Monoxide; Consumer Product Safety; Cross-Over Studies; Electronic Nicotine Delivery Systems; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Volatilization; Wales; Young Adult | 2016 |
Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Topics: Adult; Carbon Monoxide; Counseling; Female; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices; Varenicline | 2016 |
Correlates of nicotine withdrawal severity in smokers during a smoke-free psychiatric hospitalization.
Topics: Adult; California; Ethnicity; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Nicotine; Sex Factors; Smoke-Free Policy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 2016 |
The Impact of Smoking Very Low Nicotine Content Cigarettes on Alcohol Use.
Topics: Adult; Alcohol Drinking; Binge Drinking; Double-Blind Method; Humans; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Cessation Devices | 2016 |
Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low-income country setting.
Topics: Adolescent; Adult; Aged; Behavior Therapy; Counseling; Developing Countries; Female; Humans; Male; Middle Aged; Nicotine; Poverty; Smoking Cessation; Substance Withdrawal Syndrome; Syria; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Nicotine withdrawal alters neural responses to psychosocial stress.
Topics: Adult; Brain; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2016 |
Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.
Topics: Administration, Cutaneous; Adult; Anxiety; Counseling; Craving; Depression; Female; Humans; Longitudinal Studies; Male; Nicotine; Predictive Value of Tests; Prospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2016 |
Can brain games help smokers quit?: Results of a randomized clinical trial.
Topics: Adult; Attention; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome | 2016 |
A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks.
Topics: Administration, Inhalation; Adult; Biomarkers; Consumer Product Safety; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; United Kingdom; Volatilization; Young Adult | 2016 |
Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms.
Topics: Craving; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tablets; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2017 |
Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.
Topics: Administration, Intranasal; Adult; Craving; Cross-Over Studies; Female; Humans; Insulin; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Disorder | 2017 |
Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Individuality; Male; Middle Aged; Nicotine; Nicotinic Agonists; Olanzapine; Patient Compliance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
A placebo-controlled trial of modafinil for nicotine dependence.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Double-Blind Method; Female; Humans; Male; Middle Aged; Modafinil; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
Topics: Administration, Cutaneous; Adult; Alleles; Female; Follow-Up Studies; Gene Frequency; Genotype; Humans; Male; Meta-Analysis as Topic; Middle Aged; Nicotine; Pharmacogenetics; Polymorphism, Single Nucleotide; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Tryptophan Hydroxylase | 2008 |
Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.
Topics: Adult; Brain; Brain Mapping; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Positron-Emission Tomography; Pyridines; Receptors, Nicotinic; Smoking; Smoking Cessation; Statistics as Topic; Substance Withdrawal Syndrome; Time Factors; Tissue Distribution; Tobacco Use Disorder | 2009 |
Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2008 |
Extended cognitive behavior therapy for cigarette smoking cessation.
Topics: Adult; Bupropion; Carbon Monoxide; Cognitive Behavioral Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Topics: Administration, Oral; Adult; Affect; Attention; Cognition; Cross-Over Studies; Dosage Forms; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2008 |
Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.
Topics: Adult; Affect; Anti-Infective Agents; Attention; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Minocycline; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2009 |
The urge-to-cough and cough motor response modulation by the central effects of nicotine.
Topics: Anxiety; Capsaicin; Chewing Gum; Cough; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Nicotinic Agonists; Respiratory Mechanics; Sensory Thresholds; Stress, Psychological; Substance Withdrawal Syndrome; Young Adult | 2009 |
The role of cystine-glutamate exchange in nicotine dependence in rats and humans.
Topics: Acetylcysteine; Amino Acid Transport System y+; Amygdala; Animals; Brain; Carbon Monoxide; Excitatory Amino Acid Transporter 2; Female; Humans; Male; Middle Aged; Nicotine; Nucleus Accumbens; Pilot Projects; Prefrontal Cortex; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Ventral Tegmental Area | 2009 |
Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation.
Topics: Bupropion; Community Pharmacy Services; Cotinine; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2009 |
Severity of tobacco abstinence symptoms varies by time of day.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Nicotinic Agonists; Periodicity; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Wakefulness | 2009 |
Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.
Topics: Administration, Oral; Adolescent; Adult; Carbon Monoxide; Female; Heart Rate; Humans; Male; Marketing; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Industry; Tobacco Use Disorder; Tobacco, Smokeless; United States; Young Adult | 2010 |
Methadone-nicotine interactions in methadone maintenance treatment patients.
Topics: Adult; Double-Blind Method; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Nicotine; Nicotinic Agonists; Opioid-Related Disorders; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.
Topics: Administration, Cutaneous; Adolescent; Adult; Affect; Aged; Carbon Monoxide; Double-Blind Method; Extinction, Psychological; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Reinforcement, Psychology; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2009 |
A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Topics: Administration, Buccal; Administration, Cutaneous; Adult; Chewing Gum; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Patient Satisfaction; Single-Blind Method; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2009 |
Coping strategies for craving management in nicotine dependent patients.
Topics: Adaptation, Psychological; Adolescent; Adult; Analysis of Variance; Behavior, Addictive; Brazil; Cognition; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Self Efficacy; Smoking; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Young Adult | 2009 |
Alcohol-induced increases in smoking behavior for nicotinized and denicotinized cigarettes in men and women.
Topics: Adult; Analysis of Variance; Behavior, Addictive; Central Nervous System Depressants; Double-Blind Method; Ethanol; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pain Measurement; Reinforcement, Psychology; Sex Factors; Smoking; Substance Withdrawal Syndrome; Young Adult | 2009 |
Influence of smoking abstinence and nicotine replacement therapy on heart rate and QT time-series.
Topics: Adult; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nonlinear Dynamics; Prospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2010 |
A randomized clinical trial of nicotine lozenge for smokeless tobacco use.
Topics: Administration, Oral; Adult; Affect; Attention; Dosage Forms; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2009 |
Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures.
Topics: Administration, Oral; Adult; Bupropion; Chewing Gum; Combined Modality Therapy; Counseling; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motivation; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Effects of exercise on cravings to smoke: the role of exercise intensity and cortisol.
Topics: Adult; Cross-Over Studies; Exercise; Exercise Therapy; Female; Heart Rate; Humans; Hydrocortisone; Male; Nicotine; Physical Exertion; Running; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Walking; Young Adult | 2010 |
A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit.
Topics: Adult; Behavior, Addictive; Dose-Response Relationship, Drug; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Self Efficacy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless | 2010 |
The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.
Topics: Administration, Oral; Anxiety; Cerebral Cortex; Chewing Gum; Electroencephalography; Electrooculography; Evoked Potentials; Female; Humans; Male; Mechanotransduction, Cellular; Nicotine; Nicotinic Agonists; Perception; Reaction Time; Respiration; Respiratory Function Tests; Sensory Gating; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Young Adult | 2010 |
A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco users.
Topics: Adult; Counseling; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pilot Projects; Substance Withdrawal Syndrome; Telephone; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome | 2010 |
Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
Topics: Administration, Buccal; Administration, Cutaneous; Adult; Chewing Gum; Cross-Over Studies; Female; Humans; Male; Middle Aged; New Zealand; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2010 |
A bupropion smoking cessation clinical trial for cancer patients.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Prevalence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Acute negative affect relief from smoking depends on the affect situation and measure but not on nicotine.
Topics: Adult; Affect; Anxiety; Executive Function; Female; Humans; Male; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Social Environment; Stress, Psychological; Substance Withdrawal Syndrome | 2010 |
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
Topics: Administration, Cutaneous; Adult; Benzazepines; Emotions; Endpoint Determination; Female; Humans; Incidence; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2010 |
The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers.
Topics: Adult; Behavior, Addictive; Breath Tests; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Motivation; Nebulizers and Vaporizers; Nicotiana; Nicotine; Patient Satisfaction; Self Administration; Sex Characteristics; Smoking; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2010 |
OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.
Topics: Administration, Cutaneous; Adult; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Drug Therapy, Combination; Ethnicity; Female; Forecasting; Humans; Male; Methylphenidate; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.
Topics: Administration, Inhalation; Adult; Consumer Behavior; Cross-Over Studies; Data Interpretation, Statistical; Drug Delivery Systems; Electrons; Female; Humans; Irritants; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics.
Topics: Adult; Brain; Brain Mapping; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Smoking; Substance Withdrawal Syndrome; Young Adult | 2010 |
A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction.
Topics: Administration, Buccal; Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Satisfaction; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2010 |
Pre-cessation nicotine replacement therapy: pragmatic randomized trial.
Topics: Administration, Cutaneous; Adult; Algorithms; Chewing Gum; Female; Hotlines; Humans; Male; Native Hawaiian or Other Pacific Islander; New Zealand; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking; Smoking Cessation; Smoking Prevention; Statistics as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
A randomized clinical trial of St. John's wort for smoking cessation.
Topics: Adolescent; Adult; Aged; Carbon Monoxide; Female; Flowers; Humans; Hypericum; Intention to Treat Analysis; Male; Middle Aged; Nicotine; Phytotherapy; Plant Extracts; Single-Blind Method; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2010 |
Nicotine deprivation and pilot performance during simulated flight.
Topics: Adult; Aerospace Medicine; Aged; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Young Adult | 2010 |
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Catechol O-Methyltransferase; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Polymorphism, Genetic; Receptors, Dopamine D2; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome; Young Adult | 2010 |
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
Topics: Adolescent; Anxiety Disorders; Bupropion; Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Interview, Psychological; Logistic Models; Male; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2011 |
Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler.
Topics: Administration, Inhalation; Adult; Behavior, Addictive; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2011 |
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
Topics: Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Feasibility Studies; Humans; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco, Smokeless; Young Adult | 2011 |
Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment.
Topics: Adult; Depression; Female; Follow-Up Studies; Humans; Male; Multilevel Analysis; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2011 |
Study protocol for a randomised trial of nicotine-free cigarettes as an adjunct to usual NRT-based cessation practice, in people who wish to stop smoking.
Topics: Clinical Protocols; Female; Hotlines; Humans; Male; New Zealand; Nicotine; Research Design; Single-Blind Method; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2011 |
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.
Topics: Adult; Aged; Attention Deficit Disorder with Hyperactivity; Female; Humans; Male; Methylphenidate; Middle Aged; Nicotine; Pilot Projects; Placebos; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2011 |
Comparative analysis of waterpipe and cigarette suppression of abstinence and craving symptoms.
Topics: Adult; Behavior, Addictive; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Syria; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2011 |
Acceptability and effectiveness for withdrawal symptom relief of a novel oral nicotine delivery device: a randomised crossover trial.
Topics: Administration, Inhalation; Adolescent; Adult; Cross-Over Studies; Drug Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Satisfaction; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2011 |
Within-day temporal patterns of smoking, withdrawal symptoms, and craving.
Topics: Adult; Behavior, Addictive; Circadian Rhythm; Cross-Sectional Studies; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Prospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2011 |
Tobacco withdrawal components and their relations with cessation success.
Topics: Adult; Affect; Bupropion; Double-Blind Method; Humans; Multivariate Analysis; Nicotine; Nicotinic Agonists; Recurrence; Regression Analysis; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2011 |
Brain activity and emotional processing in smokers treated with varenicline.
Topics: Adolescent; Adult; Affect; Aged; Amygdala; Analysis of Variance; Benzazepines; Brain; Cross-Over Studies; Double-Blind Method; Emotions; Facial Expression; Female; Functional Neuroimaging; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxygen; Photic Stimulation; Placebos; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.
Topics: Adult; Brain; Brain Waves; Cognition; Cognition Disorders; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2011 |
The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.
Topics: Administration, Intranasal; Black People; Body Mass Index; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Recurrence; Self Report; Severity of Illness Index; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; White People | 2011 |
Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week.
Topics: Administration, Cutaneous; Adult; Affect; Female; Humans; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome | 2011 |
A comparison between quick-release nicotine lozenges and Swedish-style snus for the acute management of craving.
Topics: Double-Blind Method; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco Use Disorder; Tobacco, Smokeless | 2011 |
Nicotine withdrawal exacerbates fear reactivity to CO₂-induced bodily sensations among smokers.
Topics: Adult; Carbon Dioxide; Fear; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Panic Disorder; Regression Analysis; Sensation; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2011 |
Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Nicotine; Outpatients; Pregabalin; Psychomotor Performance; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2012 |
Nicotine withdrawal modulates frontal brain function during an affective Stroop task.
Topics: Adult; Brain Mapping; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Nicotine; Psychomotor Performance; Smoking; Stroop Test; Substance Withdrawal Syndrome; Young Adult | 2012 |
P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.
Topics: Adolescent; Adult; Evoked Potentials, Auditory; Family; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Schizophrenia; Sensory Gating; Smoking; Substance Withdrawal Syndrome | 2012 |
Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial.
Topics: Administration, Inhalation; Adult; Breath Tests; Carbon Monoxide; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome | 2012 |
Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine.
Topics: Adolescent; Adult; Analysis of Variance; Carbon Monoxide; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cotinine; Dose-Response Relationship, Drug; Heart Rate; Humans; Hydrocortisone; Injections, Intravenous; Male; Middle Aged; Nicotine; Nicotinic Agonists; Single-Blind Method; Substance Withdrawal Syndrome; Tandem Mass Spectrometry; Time Factors; Young Adult | 2012 |
Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2012 |
The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
Topics: Adolescent; Adult; Attention; Cognition; Female; Humans; Male; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2012 |
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Behavior, Addictive; Benzazepines; Biomarkers; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pennsylvania; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Varenicline; Young Adult | 2012 |
Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Topics: Behavior, Addictive; Blood Pressure; Cholinesterase Inhibitors; Cognition; Connecticut; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Heart Rate; Humans; Infusions, Intravenous; Logistic Models; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Task Performance and Analysis; Time Factors; Tobacco Use Disorder | 2012 |
Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
Topics: Benzazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Placebos; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Varenicline | 2013 |
Insula-specific H magnetic resonance spectroscopy reactions in heavy smokers under acute nicotine withdrawal and after oral nicotine substitution.
Topics: Administration, Oral; Adult; Behavior, Addictive; Carbon Monoxide; Case-Control Studies; Cerebral Cortex; Functional Neuroimaging; Glutamic Acid; Glutamine; Humans; Inositol; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2013 |
The neurocognitive effects of Hypericum perforatum Special Extract (Ze 117) during smoking cessation.
Topics: Adolescent; Adult; Drug Therapy, Combination; Humans; Hypericum; Memory, Short-Term; Middle Aged; Nicotine; Plant Extracts; Reaction Time; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2013 |
Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study.
Topics: Adaptation, Psychological; Anxiety; Cohort Studies; England; Female; Health Knowledge, Attitudes, Practice; Humans; Linear Models; Male; Mental Disorders; Nicotine; Recurrence; Smoking; Smoking Cessation; State Medicine; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome | 2013 |
Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia.
Topics: Administration, Cutaneous; Adult; Breath Tests; Carbon Monoxide; Cotinine; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation | 2002 |
Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Saliva; Sensitivity and Specificity; Smoking; Substance Withdrawal Syndrome | 2002 |
Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Carbon Monoxide; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Hydrocortisone; Male; Nicotine; Random Allocation; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2002 |
Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
Topics: Administration, Oral; Adult; Caffeine; Central Nervous System Stimulants; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2003 |
Brain metabolic changes during cigarette craving.
Topics: Adult; Arousal; Attention; Blood Glucose; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Motivation; Nicotine; Radionuclide Imaging; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Carbon Monoxide; Cotinine; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Psychotropic Drugs; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Onset of major depression during treatment for nicotine dependence.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Prolonged nicotine patch use in quitters with past abstinence-induced depressed mood.
Topics: Administration, Cutaneous; Adult; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2003 |
Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers.
Topics: Administration, Cutaneous; Double-Blind Method; Humans; Nicotine; Recurrence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Effects of the nicotine patch on performance during the first week of smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cognition; Double-Blind Method; Female; Humans; Linguistics; Male; Mathematics; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Problem Solving; Reaction Time; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Visual Perception | 2003 |
Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males.
Topics: Administration, Cutaneous; Adult; Blood Gas Monitoring, Transcutaneous; Carbon Monoxide; Cardiovascular Diseases; Cholesterol; Cotinine; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Recurrence; Risk Factors; Smoking; Substance Withdrawal Syndrome; Thiocyanates; Triglycerides | 2003 |
A contingent payment model of smoking cessation: effects on abstinence and withdrawal.
Topics: Adolescent; Adult; Carbon Monoxide; Female; Humans; Incidence; Male; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2003 |
Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence.
Topics: Administration, Oral; Adult; Female; Humans; Male; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine.
Topics: Administration, Cutaneous; Adult; Behavior; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Hemodynamics; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation; Treatment Outcome | 2003 |
Transdermal nicotine increases heart rate after endotracheal intubation.
Topics: Adjuvants, Anesthesia; Administration, Cutaneous; Adult; Anesthesia, General; Anesthetics, Intravenous; Blood Pressure; Diazepam; Double-Blind Method; Female; Fentanyl; Heart Rate; Humans; Intubation, Intratracheal; Male; Middle Aged; Nicotine; Perioperative Care; Prospective Studies; Smoking; Substance Withdrawal Syndrome; Thiopental | 2003 |
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
Topics: Adult; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Weight Gain | 2003 |
Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men.
Topics: Carbon Monoxide; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Humans; Luteinizing Hormone; Male; Nicotine; Prolactin; Smoking; Substance Withdrawal Syndrome; Testosterone | 2003 |
Treatment of adolescent smokers with the nicotine patch.
Topics: Administration, Cutaneous; Adolescent; Adolescent Behavior; Adult; Cognitive Behavioral Therapy; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Patient Compliance; Placebos; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Pharmacologic and sensorimotor components of satiation in cigarette smoking.
Topics: Adolescent; Adult; Arousal; Carbon Monoxide; Cross-Over Studies; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nicotine; Nicotinic Agonists; Satiation; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Mecamylamine acutely increases human intravenous nicotine self-administration.
Topics: Adolescent; Adult; Affect; Female; Humans; Injections, Intravenous; Male; Mecamylamine; Middle Aged; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Saliva; Self Administration; Smoking; Substance Withdrawal Syndrome | 2003 |
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.
Topics: Administration, Cutaneous; Bupropion; Chi-Square Distribution; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2003 |
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
Topics: Adrenergic alpha-Antagonists; Adult; Cross-Over Studies; Double-Blind Method; Female; Ganglionic Stimulants; Heart Rate; Humans; Infusions, Intravenous; Labetalol; Male; Nicotine; Placebos; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
Topics: Adult; Bupropion; Double-Blind Method; Female; Glucose; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2004 |
Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Caffeine; Central Nervous System Stimulants; Cocaine-Related Disorders; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 2004 |
Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2004 |
A two-year study on the effects of nicotine and its withdrawal on mood and sleep.
Topics: Administration, Cutaneous; Adult; Affect; Depressive Disorder, Major; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Male; Nicotine; Polysomnography; Severity of Illness Index; Single-Blind Method; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome; Surveys and Questionnaires; Wakefulness | 2004 |
A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nortriptyline; Probability; Reference Values; Risk Assessment; Smoking; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome; Treatment Outcome | 2004 |
Effects of different nicotine replacement therapies on postcessation psychological responses.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Affect; Aged; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Transdermal nicotine use in postmenopausal women: does the treatment efficacy differ in women using and not using hormone replacement therapy?
Topics: Administration, Cutaneous; Adult; Aged; Counseling; Depression; Double-Blind Method; Female; Ganglionic Stimulants; Hormone Replacement Therapy; Humans; Middle Aged; Motor Skills Disorders; Nicotine; Placebos; Postmenopause; Reaction Time; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2004 |
The effect of a novel smoking system--Accord--on ongoing smoking and toxin exposure.
Topics: Adult; Carbon Monoxide; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2004 |
Effects of smoking cessation and reduction in asthmatics.
Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Carbon Monoxide; Chewing Gum; Chi-Square Distribution; Cotinine; Denmark; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Prospective Studies; Quality of Life; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Thiocyanates; Time Factors | 2005 |
Effects of medicinal herb tea on the smoking cessation and reducing smoking withdrawal symptoms.
Topics: Adult; Antioxidants; Beverages; Cells, Cultured; Cotinine; Drugs, Chinese Herbal; Humans; Liver; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Taste; Treatment Outcome | 2005 |
Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Nicotine; Perioperative Care; Smoking; Stress, Psychological; Substance Withdrawal Syndrome | 2005 |
Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
Topics: Adult; Anticonvulsants; Arousal; Attention; Blood Pressure; Brain; Cross-Over Studies; Double-Blind Method; Female; gamma-Aminobutyric Acid; Heart Rate; Humans; Male; Neuropsychological Tests; Nicotine; Nipecotic Acids; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tiagabine | 2005 |
Instructed smoking expectancy modulates cue-elicited neural activity: a preliminary study.
Topics: Adult; Analysis of Variance; Brain; Brain Mapping; Cues; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Nicotine; Prefrontal Cortex; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
Topics: Administration, Intranasal; Adult; Alleles; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Genetic Variation; Genotype; Haplotypes; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Dopamine D2; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
Topics: Adult; Antidepressive Agents, Second-Generation; Appetite; Bupropion; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Nicotine; Pulmonary Gas Exchange; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2005 |
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
Topics: Adult; Attention; Bupropion; Cognition Disorders; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Placebos; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Affect; Attention; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
Topics: Adult; Antibodies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haptens; Humans; Immunotherapy; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Survival Analysis; Tobacco Use Disorder; Vaccines | 2005 |
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
Topics: Administration, Oral; Adult; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fructose; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Topiramate | 2006 |
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linear Models; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Treatment Outcome; Weight Gain | 2006 |
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Nicotine; Sex Characteristics; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
Topics: Administration, Cutaneous; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polysomnography; Sleep; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
The effects of smoking deprivation and nicotine administration on emotional reactivity.
Topics: Adult; Affect; Behavior, Addictive; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Reflex, Startle; Regression Analysis; Reinforcement, Psychology; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Polymorphism, Genetic; Receptors, Opioid, mu; Reinforcement, Psychology; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Memantine fails to facilitate partial cigarette deprivation in smokers--no role of Memantine in the treatment of nicotine dependency?
Topics: Adult; Dopamine Agents; Double-Blind Method; Female; Humans; Male; Memantine; Nicotine; Nicotinic Agonists; Pilot Projects; Placebos; Reward; Smell; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Failure | 2007 |
Changes in cough reflex sensitivity after cessation and resumption of cigarette smoking.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Non-Narcotic; Breath Tests; Capsaicin; Carbon Monoxide; Clonidine; Cough; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Reflex; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2007 |
A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Reward; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers.
Topics: Adrenergic Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Cross-Over Studies; Double-Blind Method; Female; Ganglionic Stimulants; Heart Rate; Humans; Male; Nicotine; Propanolamines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
An uncontrolled trial of cytisine (Tabex) for smoking cessation.
Topics: Adult; Alkaloids; Azocines; Female; Humans; Male; Nicotine; Poland; Quinolizines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
Evaluating nicotine replacement therapy and stage-based therapies in a population-based effectiveness trial.
Topics: Adult; Aged; Behavior Therapy; Combined Modality Therapy; Counseling; Expert Systems; Feedback, Psychological; Female; Humans; Male; Manuals as Topic; Middle Aged; Nicotine; Programmed Instructions as Topic; Recurrence; Retreatment; Smoking Cessation; Substance Withdrawal Syndrome; Telecommunications; Tobacco Use Disorder; Treatment Outcome; Veterans | 2006 |
Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial.
Topics: Adaptation, Psychological; Administration, Cutaneous; Adult; Affect; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Proportional Hazards Models; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Gene Frequency; Genotype; Homozygote; Humans; Linkage Disequilibrium; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Polymorphism, Genetic; Receptors, Dopamine D2; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2007 |
A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning.
Topics: Adult; Affect; Behavior, Addictive; Decision Making; Double-Blind Method; Female; Humans; Inhibition, Psychological; Male; Memory; Mental Processes; Middle Aged; Motor Skills; Nicotine; Nicotinic Agonists; Reaction Time; Saccades; Smoking; Substance Withdrawal Syndrome; Verbal Behavior | 2007 |
Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement.
Topics: Administration, Cutaneous; Adult; Affect; Choice Behavior; Female; Humans; Impulsive Behavior; Least-Squares Analysis; Male; Nicotiana; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Reinforcement, Psychology; Reproducibility of Results; Single-Blind Method; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Token Economy | 2007 |
Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days.
Topics: Adolescent; Adult; Affect; Aged; Female; Humans; Male; Middle Aged; Nicotine; Personal Satisfaction; Sleep; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2007 |
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
Topics: Acute Disease; Adult; Cotinine; Demography; Depression; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Prevalence; Psychotic Disorders; Receptors, Nicotinic; Recurrence; Schizophrenia; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Pressure; Breath Tests; Capsules; Carbon Monoxide; Demography; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tablets | 2007 |
Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design.
Topics: Adolescent; Adult; Analysis of Variance; Energy Metabolism; Female; Humans; Male; Mental Recall; Nicotine; Nicotinic Agonists; Self-Assessment; Smoking; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Task Performance and Analysis; Wakefulness | 2007 |
Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Circadian Rhythm; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Outcome Assessment, Health Care; Prognosis; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
Topics: Adult; Behavior, Addictive; Blood Pressure; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fructose; Ganglionic Stimulants; Heart Rate; Humans; Male; Middle Aged; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Topiramate | 2007 |
Acupressure for smoking cessation--a pilot study.
Topics: Acupressure; Adult; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Pilot Projects; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
Topics: Administration, Topical; Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Pilot Projects; Skin; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless | 2007 |
Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco, Smokeless | 2007 |
Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
Topics: Administration, Inhalation; Adult; Aerosols; Affect; Blood Pressure; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Memory, Short-Term; Nicotine; Nicotinic Agonists; Psychomotor Performance; Sex Characteristics; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
Topics: Adult; Affect; Analysis of Variance; Blood Pressure; Double-Blind Method; Electroencephalography; Female; Heart Rate; Humans; Male; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2007 |
Smoking-related videos for use in cue-induced craving paradigms.
Topics: Adult; Behavior, Addictive; Cues; Female; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Video Recording | 2007 |
Modafinil and nicotine interactions in abstinent smokers.
Topics: Adult; Benzhydryl Compounds; Blood Pressure; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Male; Modafinil; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pain Measurement; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Nicotine's effects on attentional efficiency in alcoholics.
Topics: Administration, Cutaneous; Adult; Alcoholism; Attention; Comorbidity; Dose-Response Relationship, Drug; Ethanol; Female; Ganglionic Stimulants; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotine; Smoking; Substance Withdrawal Syndrome | 2007 |
A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Bias; Double-Blind Method; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Reaction Time; Retrospective Studies; Reward; Smoking; Substance Withdrawal Syndrome | 2008 |
Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
Topics: Administration, Cutaneous; Adult; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2007 |
Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.
Topics: Adult; Affect; Arousal; Attention; Attention Deficit Disorder with Hyperactivity; Comorbidity; Cross-Sectional Studies; Cues; Female; Humans; Inhibition, Psychological; Male; Motivation; Neuropsychological Tests; Nicotine; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2008 |
Preferences among five nicotine treatments based on information versus sampling.
Topics: Adult; Aged; Chewing Gum; Cross-Over Studies; Drug Administration Routes; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Patient Education as Topic; Patient Satisfaction; Research Design; Self Administration; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2008 |
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Quinoxalines; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2008 |
Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment.
Topics: Adult; Counseling; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2008 |
Development of procedures for early screening of smoking cessation medications in humans.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Female; Humans; Male; Mass Screening; Motivation; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2008 |
Comparison of craving and withdrawal among four combination nicotine treatments.
Topics: Adult; Cross-Over Studies; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2008 |
Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Behavior Therapy; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nortriptyline; Quality of Life; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2008 |
Effect of smoking opportunity on responses to monetary gain and loss in the caudate nucleus.
Topics: Adult; Arousal; Caudate Nucleus; Cues; Dominance, Cerebral; Feedback, Psychological; Humans; Magnetic Resonance Imaging; Male; Motivation; Nicotine; Oxygen; Reward; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
[Tobacco withdrawal. Comparison of the efficacy of various methods. Intermediate results of a comparative study].
Topics: Acupuncture Therapy; Adult; Chewing Gum; Clinical Trials as Topic; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Volition | 1984 |
Smoking withdrawal in hospital patients: factors associated with outcome. Subcommittee of the Research Committee of the British Thoracic Society.
Topics: Adolescent; Adult; Age Factors; Aged; Chewing Gum; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Sex Factors; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1984 |
Time course of smoking withdrawal symptoms as a function of nicotine replacement.
Topics: Adult; Analysis of Variance; Double-Blind Method; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Time Factors | 1984 |
Effect of nicotine on the tobacco withdrawal syndrome.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Nicotine; Sleep Initiation and Maintenance Disorders; Smoking; Substance Withdrawal Syndrome; Time Factors | 1984 |
Does switching to an ultra-low nicotine cigarette induce nicotine withdrawal effects?
Topics: Adult; Carbon Monoxide; Female; Heart Rate; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1984 |
Effect of nicotine replacement on the cigarette withdrawal syndrome.
Topics: Adult; Chewing Gum; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1984 |
Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation.
Topics: Adult; Chewing Gum; Female; Humans; Male; Nicotine; Pulse; Smoking; Substance Withdrawal Syndrome | 1984 |
Randomised controlled trial of nicotine chewing-gum.
Topics: Adult; Chewing Gum; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Acceptance of Health Care; Random Allocation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 1982 |
Clinical use of nicotine chewing-gum.
Topics: Body Weight; Chewing Gum; Clinical Trials as Topic; Humans; Nicotine; Patient Education as Topic; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 1980 |
A controlled trial of nicotine chewing gum in a smoking withdrawal clinic.
Topics: Chewing Gum; Clinical Trials as Topic; Humans; Nicotine; Random Allocation; Smoking Prevention; Substance Withdrawal Syndrome | 1982 |
Varying nicotine patch dose and type of smoking cessation counseling.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Carbon Monoxide; Combined Modality Therapy; Cotinine; Counseling; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
Topics: Administration, Cutaneous; Adult; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1995 |
Environmental determinants of the reinforcing effects of nicotine in humans.
Topics: Adult; Arousal; Chewing Gum; Cross-Sectional Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Motivation; Nicotine; Placebo Effect; Reinforcement Schedule; Reinforcement, Social; Self Administration; Set, Psychology; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance Withdrawal Syndrome | 1989 |
Effect of nicotine vapour inhalation on the relief of tobacco withdrawal symptoms.
Topics: Administration, Inhalation; Adult; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1995 |
The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal?
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1995 |
Enhanced lexical processing of smoking stimuli during smoking abstinence.
Topics: Adult; Humans; Middle Aged; Nicotine; Perception; Semantics; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1995 |
Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers.
Topics: Adult; Blood Pressure; Humans; Male; Nicotine; Pulse; Pupil; Skin Temperature; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Nicotine intake in smokers increases following a single dose of haloperidol.
Topics: Adult; Haloperidol; Humans; Male; Nicotine; Reward; Self Administration; Smoking; Substance Withdrawal Syndrome | 1995 |
Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Citrates; Citric Acid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Logistic Models; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics.
Topics: Adult; Central Nervous System Stimulants; Chewing Gum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Sensation; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1995 |
Nicotine abstinence produces content-specific Stroop interference.
Topics: Adult; Breath Tests; Carbon Monoxide; Color Perception Tests; Humans; Male; Mental Processes; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Plasma nicotine, plasma beta-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement.
Topics: Adult; Affect; beta-Endorphin; Chronic Disease; Humans; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1994 |
Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms.
Topics: Administration, Cutaneous; Chewing Gum; Combined Modality Therapy; Cotinine; Double-Blind Method; Humans; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Physical dependence on nicotine gum: effect of duration of use.
Topics: Adult; Body Weight; Chewing Gum; Double-Blind Method; Energy Intake; Female; Hemodynamics; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome | 1993 |
Improvements in performance without nicotine withdrawal.
Topics: Adolescent; Adult; Female; Humans; Male; Nicotine; Psychomotor Performance; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study.
Topics: Adult; Aerosols; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Placebos; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
The transdermal nicotine patch: results of a randomised placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Age Factors; Attitude to Health; Behavior Therapy; Carbon Monoxide; Delayed-Action Preparations; Dermatitis, Irritant; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Placebos; Sleep Wake Disorders; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Caffeine antagonizes EEG effects of tobacco withdrawal.
Topics: Adult; Affect; Blood Pressure; Caffeine; Coffee; Drug Interactions; Electroencephalography; Heart Rate; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1994 |
Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
Topics: Administration, Cutaneous; Adult; Affect; Blood Pressure; Breath Tests; Carbon Monoxide; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Mecamylamine; Nicotine; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms.
Topics: Administration, Inhalation; Adult; Conditioning, Classical; Humans; Male; Menthol; Middle Aged; Nicotine; Oils; Plant Extracts; Smoking Cessation; Spices; Substance Withdrawal Syndrome; Taste | 1994 |
[Clonidine in the treatment of tobacco withdrawal. A comparison with nicotine chewing gum].
Topics: Adult; Chewing Gum; Clonidine; Female; Humans; Male; Nicotine; Prospective Studies; Smoking Cessation; Spain; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1994 |
[The nicotine patch. Short-term results in a group of hospital workers].
Topics: Administration, Cutaneous; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Personnel, Hospital; Smoking Cessation; Spain; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1994 |
Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.
Topics: Administration, Cutaneous; Adult; Aged; Body Weight; Cotinine; Delayed-Action Preparations; Double-Blind Method; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Psychotherapy, Group; Smoking; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1993 |
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Affective Disorders, Psychotic; Aged; Blood Pressure; Body Weight; Combined Modality Therapy; Dosage Forms; England; Female; Follow-Up Studies; Heart Rate; Hospitals, General; Humans; Male; Middle Aged; Nicotine; Outpatient Clinics, Hospital; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
Topics: Administration, Cutaneous; Adult; Arousal; Breath Tests; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
Topics: Administration, Cutaneous; Adult; Counseling; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Self-Help Groups; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Telephone | 1993 |
Clinical trials using ascorbic acid aerosol to aid smoking cessation.
Topics: Adult; Aerosols; Ascorbic Acid; Equipment Design; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Transdermal nicotine in smoking cessation and involvement of non-specific influences.
Topics: Administration, Cutaneous; Adult; Carboxyhemoglobin; Female; Humans; Male; Middle Aged; Nicotine; Single-Blind Method; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Topics: Administration, Cutaneous; Adult; Aged; Breath Tests; Carbon Monoxide; Cotinine; Counseling; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nurses; Physician's Role; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Topics: Administration, Cutaneous; Adult; Aged; Body Weight; Carbon Monoxide; Combined Modality Therapy; Cotinine; Counseling; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Placebos; Psychotherapy, Group; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Coffee and alcohol intake as predictors of smoking cessation and tobacco withdrawal.
Topics: Adult; Alcohol Drinking; Chewing Gum; Coffee; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurologic Examination; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Clinical evaluation of a citric acid inhaler for smoking cessation.
Topics: Adult; Aerosols; Affect; Behavior Therapy; Breath Tests; Carbon Monoxide; Citrates; Citric Acid; Double-Blind Method; Equipment Design; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches.
Topics: Administration, Cutaneous; Adult; Aged; Chi-Square Distribution; Cotinine; Female; Follow-Up Studies; Forecasting; Humans; Male; Middle Aged; Motivation; Nicotine; Outcome and Process Assessment, Health Care; Patient Compliance; Placebos; Prospective Studies; Regression Analysis; Saliva; Self-Assessment; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Time Factors; Weight Gain | 1993 |
Recycling with nicotine patches in smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cotinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Family Practice; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Skin Diseases; Sleep Wake Disorders; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Family Practice; Female; Health Education; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Naltrexone, smoking behaviour and cigarette withdrawal.
Topics: Adult; Affect; Behavior; Female; Humans; Male; Naltrexone; Nicotine; Placebo Effect; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome; Time Factors | 1995 |
Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial.
Topics: Administration, Intranasal; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Smoking cessation: a clinical study of the transdermal nicotine patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Prognosis; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Failure | 1995 |
Cessation of long-term nicotine gum use.
Topics: Chewing Gum; Drug Administration Schedule; Humans; Long-Term Care; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: a double-blind study in healthy smokers.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Randomised controlled trial of ondansetron in smoking cessation.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Ondansetron; Serotonin Antagonists; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Nicotine patch therapy in adolescent smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Cotinine; Female; Follow-Up Studies; Humans; Male; Minnesota; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Urban Population | 1996 |
Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study.
Topics: Adult; Affect; Aged; Chewing Gum; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Risk Factors; Self Concept; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse.
Topics: Algorithms; Behavior Therapy; Body Weight; Chewing Gum; Depression; Follow-Up Studies; Humans; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Survival Analysis; Treatment Outcome | 1996 |
Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Cognition; Cotinine; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Humans; Male; Nicotiana; Nicotine; Plants, Toxic; Psychomotor Performance; Substance Withdrawal Syndrome | 1996 |
Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Buspirone; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
Nicotine preference in smokers as a function of smoking abstinence.
Topics: Adult; Aerosols; Affect; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Endocrine responses during acute nicotine withdrawal.
Topics: Administration, Cutaneous; Adrenocorticotropic Hormone; Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Nicotiana; Nicotine; Plants, Toxic; Prolactin; Substance Withdrawal Syndrome | 1996 |
Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Erythema; Female; Headache; Humans; Hunger; Male; Minnesota; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain; Wisconsin | 1996 |
Evaluation of cranial electrostimulation therapy on short-term smoking cessation.
Topics: Adult; Brain; Carbon Monoxide; Double-Blind Method; Electric Stimulation Therapy; Female; Humans; Male; Middle Aged; Neurologic Examination; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1997 |
A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation.
Topics: Administration, Intranasal; Adult; Aerosols; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Nicotine; Prospective Studies; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 1997 |
Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.
Topics: Administration, Cutaneous; Adult; Affect; Blood Pressure; Carbon Monoxide; Central Nervous System Stimulants; Chewing Gum; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1997 |
A comparison of sustained-release bupropion and placebo for smoking cessation.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 1997 |
Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
Topics: Administration, Inhalation; Adult; Aged; Body Weight; Cotinine; Female; Humans; Linear Models; Male; Middle Aged; Nasal Mucosa; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1998 |
Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Appetite; Diet; Dietary Carbohydrates; Dietary Fats; Dose-Response Relationship, Drug; Double-Blind Method; Energy Intake; Feeding Behavior; Female; Humans; Hunger; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Weight Gain | 1997 |
Cotinine: effects with and without nicotine.
Topics: Administration, Topical; Adult; Affect; Blood Pressure; Cotinine; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
An acute dose of nicotine enhances cue-induced cocaine craving.
Topics: Adult; Analysis of Variance; Anxiety; Behavior, Addictive; Cocaine-Related Disorders; Conditioning, Psychological; Crack Cocaine; Cross-Over Studies; Cues; Double-Blind Method; Drive; Female; Galvanic Skin Response; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Skin Temperature; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
Topics: Adult; Carbon Monoxide; Cotinine; Cross-Over Studies; Female; Humans; Infant; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 1997 |
Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Delayed auditory feedback during smoking cessation.
Topics: Adult; Auditory Perception; Feedback; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Effects of nicotine on methadone self-administration in humans.
Topics: Adult; Analysis of Variance; Behavior, Addictive; Carbon Monoxide; Drug Interactions; Female; Heroin Dependence; Humans; Male; Methadone; Narcotics; Nicotine; Nicotinic Agonists; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
A randomized trial of nortriptyline for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nortriptyline; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
The effect of sucrose on acute tobacco withdrawal in women.
Topics: Adult; Analysis of Variance; Anxiety; Demography; Double-Blind Method; Female; Food Preferences; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Sucrose | 1998 |
Randomized trial of acupuncture for nicotine withdrawal symptoms.
Topics: Adult; Electroacupuncture; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
Naltrexone administration affects ad libitum smoking behavior.
Topics: Adult; Affect; Double-Blind Method; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Nicotine; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome | 1998 |
Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Single-Blind Method; Substance Withdrawal Syndrome | 1998 |
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 1999 |
Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results.
Topics: Adult; Analysis of Variance; Cues; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Nicotine; Smoking; Substance Withdrawal Syndrome | 1999 |
Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting.
Topics: Administration, Cutaneous; Adult; Biomarkers; Chi-Square Distribution; Cholinergic Agents; Cotinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 1999 |
Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal.
Topics: Adult; Affect; Aged; Double-Blind Method; Female; Humans; Hunger; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polysomnography; Sex Characteristics; Sleep; Sleep Stages; Smoking; Substance Withdrawal Syndrome | 1999 |
Naltrexone blockade of nicotine effects in cigarette smokers.
Topics: Adult; Affect; Analysis of Variance; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Placebos; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1999 |
Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Humans; Male; Middle Aged; Nicotine; Prevalence; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Do heavy smokers benefit from higher dose nicotine patch therapy?
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Drug Tolerance; Female; Follow-Up Studies; Humans; Interviews as Topic; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Telephone | 1999 |
Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
Topics: Administration, Cutaneous; Adolescent; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 2000 |
Modulation of craving by cues having differential overlap with pharmacological effect: evidence for cue approach in smokers and social drinkers.
Topics: Adult; Alcohol Drinking; Central Nervous System Depressants; Cues; Ethanol; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Smoking; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1999 |
The effect of bupropion on nicotine craving and withdrawal.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Humans; Male; Nicotine; Patient Compliance; Psychiatric Status Rating Scales; Psychomotor Performance; Sleep; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2000 |
Effects of nicotine deprivation on alcohol-related information processing and drinking behavior.
Topics: Adult; Alcohol Drinking; Alcoholism; Analysis of Variance; Cognition; Cues; Female; Humans; Male; Models, Psychological; Nicotine; Psychiatric Status Rating Scales; Smoking; Substance Withdrawal Syndrome | 2000 |
Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.
Topics: Administration, Cutaneous; Adult; Arousal; Cues; Female; Humans; Male; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Treatment of spit tobacco users with transdermal nicotine system and mint snuff.
Topics: Administration, Cutaneous; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Lamiaceae; Nicotine; Plants, Toxic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco, Smokeless | 2000 |
Nicotine blood levels and subjective craving for cigarettes.
Topics: Adult; Behavior, Addictive; Humans; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2000 |
Naltrexone alteration of acute smoking response in nicotine-dependent subjects.
Topics: Adult; Affect; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2000 |
Nicotine patch and paroxetine for smoking cessation.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2000 |
Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior.
Topics: Adult; Analysis of Variance; Carbon Monoxide; Equipment and Supplies; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Smoke Pollution | 2000 |
Effects of nicotine gum dose by level of nicotine dependence.
Topics: Adult; Analysis of Variance; Chewing Gum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Nicotine; Recurrence; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome | 2000 |
Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: a placebo controlled study.
Topics: Administration, Sublingual; Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Nicotinic Agonists; Plants, Toxic; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2000 |
Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Inhalation; Administration, Topical; Adult; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle.
Topics: Administration, Cutaneous; Adult; Female; Humans; Menstrual Cycle; Nicotine; Premenstrual Syndrome; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 2000 |
Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Drug Administration Schedule; Female; Humans; Male; Microcomputers; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome | 2000 |
Placebo control study of acute smokeless tobacco abstinence in young adult men.
Topics: Adult; Analysis of Variance; Humans; Male; Nicotine; Placebos; Plants, Toxic; Single-Blind Method; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless | 2000 |
The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.
Topics: Administration, Cutaneous; Affect; Behavior; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2001 |
Efficacy of the nicotine patch for relief of craving and withdrawal 7-10 weeks after cessation.
Topics: Administration, Cutaneous; Adult; Affect; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2000 |
Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Arousal; Behavior, Addictive; Blood Pressure; Dizziness; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Mecamylamine; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Smoking; Substance Withdrawal Syndrome | 2001 |
Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes.
Topics: Adolescent; Adult; Body Temperature; Choice Behavior; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
Topics: Acute Disease; Adult; Affect; Baclofen; Dose-Response Relationship, Drug; Double-Blind Method; Female; GABA Agonists; Humans; Male; Nicotine; Self Disclosure; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2001 |
The influence of personality on nicotine craving: a hierarchical multivariate statistical prediction model.
Topics: Adult; Arousal; Cross-Over Studies; Dopamine; Fluphenazine; Humans; Limbic System; Lisuride; Male; Mesencephalon; Motivation; Nicotine; Personality; Personality Inventory; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 2001 |
Do adolescent smokers experience withdrawal effects when deprived of nicotine?
Topics: Administration, Cutaneous; Adolescent; Adult; Carbon Monoxide; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Male; Nicotine; Nicotinic Agonists; Prospective Studies; Psychiatric Status Rating Scales; Psychology, Adolescent; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation | 2001 |
Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Mecamylamine; Monoamine Oxidase; Neostigmine; Nicotine; Nicotinic Antagonists; Parasympathomimetics; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life.
Topics: Administration, Topical; Adult; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pharmacists; Prospective Studies; Quality of Life; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Nicotine deprivation effects on the dissociated components of simple reaction time.
Topics: Adult; Double-Blind Method; Electromyography; Humans; Male; Motivation; Nicotine; Psychomotor Performance; Reaction Time; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking.
Topics: Administration, Intranasal; Adult; Cognitive Behavioral Therapy; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Motivation; Nicotine; Recurrence; Reinforcement, Psychology; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Female; Humans; Male; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
Topics: Administration, Cutaneous; Adult; Anxiety; Behavior Therapy; Clonidine; Double-Blind Method; Female; Humans; Irritable Mood; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1992 |
Measures of affect and nicotine dependence predict differential response to smoking cessation treatments.
Topics: Affect; Arousal; Aversive Therapy; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking; Smoking Cessation; Social Support; Substance Withdrawal Syndrome | 1992 |
Smoking cessation--gradual or sudden stopping?
Topics: Behavior Therapy; Follow-Up Studies; Humans; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
An assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics.
Topics: Adult; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Predictors of smoking cessation in a sample of Italian smokers.
Topics: Adaptation, Psychological; Affective Symptoms; Chewing Gum; Cross-Cultural Comparison; Double-Blind Method; Dreams; Female; Humans; Italy; Male; Nicotine; Patient Compliance; Prognosis; Sleep Stages; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Smokeless tobacco abstinence effects and nicotine gum dose.
Topics: Adult; Carbon Monoxide; Chewing Gum; Cotinine; Double-Blind Method; Humans; Nicotine; Plants, Toxic; Reaction Time; Saliva; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless | 1992 |
Signs and symptoms from nicotine gum abstinence.
Topics: Adult; Chewing Gum; Cotinine; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1991 |
Effects of nicotine gum on prevalence and severity of withdrawal in female cigarette smokers.
Topics: Adult; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Energy Intake; Female; Humans; Neurologic Examination; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1991 |
Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy.
Topics: Adolescent; Adult; Anxiety; Behavior Therapy; Combined Modality Therapy; Diet; Dietary Carbohydrates; Humans; Middle Aged; Nicotine; Placebos; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Tryptophan; Weight Gain | 1991 |
Symptoms of tobacco withdrawal. A replication and extension.
Topics: Adult; Chewing Gum; Female; Humans; Hunger; Male; Nicotine; Placebos; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Weight Gain | 1991 |
Transdermal nicotine and smoking behavior in psychiatric patients.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Humans; Mental Disorders; Middle Aged; Nicotine; Placebos; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1991 |
[Weaning of young smokers using a transdermal nicotine patch].
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1991 |
Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome | 1991 |
Combined use of alcohol and nicotine gum.
Topics: Adult; Alcohol Drinking; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Prevention; Substance Withdrawal Syndrome | 1991 |
Reduced nicotine exposure and abstinence outcome in two nicotine fading methods.
Topics: Adult; Behavior Therapy; Breath Tests; Carbon Monoxide; Cotinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking; Substance Withdrawal Syndrome | 1991 |
A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Behavior Therapy; Body Weight; Chewing Gum; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Prevention; Substance Withdrawal Syndrome | 1991 |
Nicotine-replacement therapy with use of a transdermal nicotine patch--a randomized double-blind placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking; Substance Withdrawal Syndrome | 1990 |
Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
Topics: Adult; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotine; Random Allocation; Saliva; Self Administration; Smoking Prevention; Substance Withdrawal Syndrome | 1990 |
Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks.
Topics: Adult; Carbon Monoxide; Humans; Male; Memory; Middle Aged; Nicotine; Psychomotor Performance; Reaction Time; Smoking; Substance Withdrawal Syndrome | 1989 |
Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study.
Topics: Adult; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
Nicotine replacement: ten-week effects on tobacco withdrawal symptoms.
Topics: Adolescent; Adult; Aged; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Random Allocation; Substance Withdrawal Syndrome; Time Factors | 1989 |
Controlled trial of transdermal nicotine patch in tobacco withdrawal.
Topics: Administration, Cutaneous; Adult; Body Weight; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Patient Dropouts; Random Allocation; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1989 |
Effect of tobacco withdrawal on sustained attention.
Topics: Adult; Attention; Dose-Response Relationship, Drug; Humans; Male; Nicotine; Reaction Time; Smoking; Substance Withdrawal Syndrome | 1989 |
Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-administration of nicotine gum.
Topics: Adult; Chewing Gum; Female; Humans; Male; Nicotine; Self Administration; Smoking; Substance Withdrawal Syndrome | 1989 |
Spontaneous EEG changes during tobacco abstinence and nicotine substitution in human volunteers.
Topics: Adult; Electroencephalography; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
Effectiveness of a transdermal nicotine system in smoking cessation studies.
Topics: Administration, Cutaneous; Adult; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Irritants; Male; Nicotine; Random Allocation; Smoking; Substance Withdrawal Syndrome | 1989 |
Are smokers trying to stop and smokers not trying to stop the same experimental model?
Topics: Chewing Gum; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Randomized Controlled Trials as Topic; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1989 |
Effect of dose on nicotine's withdrawal-suppressing, adverse and discriminative stimulus effects in humans.
Topics: Chewing Gum; Dose-Response Relationship, Drug; Humans; Nicotine; Randomized Controlled Trials as Topic; Set, Psychology; Smoking; Substance Withdrawal Syndrome | 1989 |
The effect of different dosages of a transdermal nicotine substitution system on the success rate of smoking cessation therapy.
Topics: Administration, Cutaneous; Behavior Therapy; Combined Modality Therapy; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Time Factors | 1989 |
Meta-analysis of randomised controlled trials of nicotine chewing-gum.
Topics: Carbon Monoxide; Chewing Gum; Clinical Trials as Topic; Evaluation Studies as Topic; Humans; Nicotine; Random Allocation; Smoking Prevention; Statistics as Topic; Substance Withdrawal Syndrome; Time Factors | 1987 |
The effects of acute exercise on subsequent cigarette smoking.
Topics: Adult; Arousal; beta-Endorphin; Endorphins; Epinephrine; Humans; Hydrocortisone; Nicotine; Norepinephrine; Physical Exertion; Psychological Tests; Smoking; Substance Withdrawal Syndrome | 1987 |
Effects of deprivation on smokers' mood during the operation of a complex computer simulation.
Topics: Adult; Affect; Computer Simulation; Female; Humans; Male; Nicotine; Psychological Tests; Smoking; Substance Withdrawal Syndrome | 1988 |
Nasal nicotine solution as an aid to cigarette withdrawal: a pilot clinical trial.
Topics: Administration, Intranasal; Adult; Clinical Trials as Topic; Female; Humans; Male; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1987 |
[Treatment of smoking: efficacy of the use of nicotine chewing gum. Double-blind study].
Topics: Adult; Chewing Gum; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Random Allocation; Recurrence; Smoking; Substance Withdrawal Syndrome | 1988 |
Nicotine dependence and secondary effects of smoking cessation.
Topics: Behavior Therapy; Follow-Up Studies; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1987 |
Sex differences in tobacco withdrawal syndrome.
Topics: Chewing Gum; Clinical Trials as Topic; Female; Humans; Male; Nicotine; Prospective Studies; Sex Factors; Smoking; Substance Withdrawal Syndrome | 1986 |
Reducing the weight gain after stopping smoking.
Topics: Body Weight; Chewing Gum; Female; Humans; Male; Nicotine; Substance Withdrawal Syndrome | 1987 |
Psychological and pharmacological influences in cigarette smoking withdrawal: effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse.
Topics: Adult; Chewing Gum; Female; Humans; Male; Nicotine; Set, Psychology; Smoking; Substance Withdrawal Syndrome | 1987 |
Physical dependence on nicotine in gum. A placebo substitution trial.
Topics: Adult; Chewing Gum; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Placebos; Random Allocation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 1986 |
Nicotine-produced antinociception in minimally deprived smokers and ex-smokers.
Topics: Adult; Humans; Male; Nicotiana; Nicotine; Pain; Plants, Toxic; Reinforcement, Psychology; Sensory Thresholds; Substance Withdrawal Syndrome; Tobacco, Smokeless | 1986 |
Understanding and promoting smoking cessation: overview and guidelines for physician intervention.
Topics: Behavior Therapy; Chewing Gum; Clinical Trials as Topic; Counseling; Follow-Up Studies; Humans; Methods; Motivation; Nicotine; Patient Education as Topic; Risk; Self-Help Groups; Smoking Prevention; Substance Withdrawal Syndrome | 1985 |
Nicotine gum vs. placebo gum: comparisons of withdrawal symptoms and success rates.
Topics: Body Weight; Chewing Gum; Emotions; Female; Humans; Male; Nicotine; Pulse; Sex Factors; Smoking; Substance Withdrawal Syndrome; Time Factors | 1985 |
Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms.
Topics: Adult; Aged; Breath Tests; Carbon Monoxide; Female; Humans; Hunger; Male; Middle Aged; Motivation; Nicotine; Psychomotor Agitation; Smoking; Substance Withdrawal Syndrome | 1985 |
Signs and symptoms of tobacco withdrawal.
Topics: Adult; Chewing Gum; Female; Humans; Male; Manuals as Topic; Mental Disorders; Nicotiana; Nicotine; Plants, Toxic; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1986 |
Blindness and the validity of the double-blind procedure.
Topics: Chewing Gum; Double-Blind Method; Humans; Nicotine; Random Allocation; Research Design; Smoking Prevention; Substance Withdrawal Syndrome | 1985 |
967 other study(ies) available for nicotine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Nicotine preference and affective behavior of Cd81 knockout mice.
Topics: Animals; Anxiety; Behavior, Animal; Depression; Female; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Substance Withdrawal Syndrome | 2021 |
How nicotine withdrawal symptoms fight each other: interpeduncular GABA neuron activity dynamically controls negative affect vs. coping behavior.
Topics: Adaptation, Psychological; GABAergic Neurons; Humans; Interpeduncular Nucleus; Nicotine; Substance Withdrawal Syndrome | 2022 |
Lacidipine Attenuates Symptoms of Nicotine Withdrawal in Mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Catalase; Dihydropyridines; Elevated Plus Maze Test; Female; Glutathione; Hindlimb Suspension; Lipid Peroxidation; Male; Mice; Nicotine; Substance Withdrawal Syndrome; Superoxide Dismutase | 2021 |
Exploration of potential role of Rho GTPase in nicotine dependence-induced withdrawal syndrome in mice.
Topics: Animals; Mecamylamine; Mice; Nicotine; rho GTP-Binding Proteins; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2022 |
Preliminary Evaluation of Short-Term Abstinence Effects Among Never-Smoking Experienced Users of Modern Electronic Cigarettes.
Topics: Humans; Nicotine; Non-Smokers; Substance Withdrawal Syndrome; Vaping | 2022 |
A mouse model of weight gain after nicotine withdrawal.
Topics: Agouti-Related Protein; Animals; Calorimetry; Cell Respiration; Disease Models, Animal; Energy Intake; Exenatide; Feeding Behavior; Gene Expression Regulation; Hypothalamus; Male; Mice, Inbred C57BL; Nicotine; RNA, Messenger; Substance Withdrawal Syndrome; Weight Gain | 2022 |
Not all smokers are alike: the hidden cost of sustained attention during nicotine abstinence.
Topics: Humans; Magnetic Resonance Imaging; Neuroimaging; Nicotine; Smokers; Smoking Cessation; Substance Withdrawal Syndrome | 2022 |
Using crowdsourcing to study the differential effects of cross-drug withdrawal for cigarettes and opioids in a behavioral economic demand framework.
Topics: Analgesics, Opioid; Crowdsourcing; Economics, Behavioral; Humans; Nicotine; Opioid-Related Disorders; Substance Withdrawal Syndrome; Tobacco Products | 2022 |
Bupropion/zonisamide combination to assist smokers to switch from combustible cigarettes to electronic nicotine delivery systems (ENDS).
Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Substance Withdrawal Syndrome; Tobacco Products; Zonisamide | 2022 |
Sex and age differences in approach behavior toward a port that delivers nicotine vapor.
Topics: Animals; Anxiety; Choice Behavior; Cotinine; Female; Male; Nicotine; Rats; Substance Withdrawal Syndrome | 2022 |
Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia.
Topics: Craving; Double-Blind Method; Humans; Nicotiana; Nicotine; Nicotinic Agonists; Schizophrenia; Smokers; Smoking; Substance Withdrawal Syndrome; Varenicline | 2022 |
Role of noradrenergic transmission within the ventral bed nucleus of the stria terminalis in nicotine withdrawal-induced aversive behavior.
Topics: Animals; Nicotine; Norepinephrine; Rats; Rats, Sprague-Dawley; Septal Nuclei; Substance Withdrawal Syndrome | 2022 |
Development of pulsed intravenous nicotine infusions as a model for inhaled nicotine in humans.
Topics: Adult; Cross-Over Studies; Heart Rate; Humans; Infusions, Intravenous; Nicotine; Smokers; Substance Withdrawal Syndrome | 2022 |
Overnight Abstinence Is Associated With Smaller Secondary Somatosensory Cortical Volumes and Higher Somatosensory-Motor Cortical Functional Connectivity in Cigarette Smokers.
Topics: Humans; Magnetic Resonance Imaging; Nicotine; Smokers; Somatosensory Cortex; Substance Withdrawal Syndrome; Tobacco Products | 2022 |
Age-specific impacts of nicotine and withdrawal on hippocampal neuregulin signalling.
Topics: Age Factors; Animals; Hippocampus; Humans; Mice; Neuregulins; Nicotine; Receptor, ErbB-4; RNA, Messenger; Substance Withdrawal Syndrome | 2022 |
Nicotine withdrawal as an unusual cause of terminal delirium.
Topics: Delirium; Humans; Nicotine; Substance Withdrawal Syndrome | 2022 |
Alcohol self-administration and nicotine withdrawal alter biomarkers of stress and inflammation and prefrontal cortex changes in Gβ subunits.
Topics: Animals; Corticosterone; Ethanol; Leptin; Male; Nicotine; Prefrontal Cortex; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2023 |
Discrimination and insomnia: Examining depressive symptoms and nicotine withdrawal through a serial mediation model in a sample of smokers.
Topics: Cross-Sectional Studies; Depression; Female; Humans; Male; Nicotine; Sleep Initiation and Maintenance Disorders; Smokers; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2023 |
Chronic oral nicotine exposure decreases aversive taste of nicotine, increases nicotine withdrawal and reinstatement, but cherry flavor does not alter nicotine's effects in adolescent rats.
Topics: Animals; Benzaldehydes; Electronic Nicotine Delivery Systems; Female; Flavoring Agents; Male; Nicotine; Rats; Substance Withdrawal Syndrome; Taste | 2023 |
Effects of Dextromethorphan on Nicotine-Induced Reward, Behavioral Sensitization, Withdrawal Signs, and Drug Seeking-Related Behavior in Rats.
Topics: Animals; Dextromethorphan; Dopamine; Nicotine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2023 |
The Role of Emotion Differentiation in the Association Between Momentary Affect and Tobacco/Nicotine Craving in Young Adults.
Topics: Adolescent; Adult; Craving; Emotions; Female; Humans; Male; Nicotiana; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2023 |
Identification of candidate genes for nicotine withdrawal in C57BL/6J × DBA/2J recombinant inbred mice.
Topics: Animals; Genome-Wide Association Study; Humans; Intracellular Signaling Peptides and Proteins; Kinesins; LDL-Receptor Related Proteins; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nicotine; Substance Withdrawal Syndrome | 2023 |
Omega-3 fatty acids prevent nicotine withdrawal-induced exacerbation of anxiety and depression by affecting oxidative stress balance, inflammatory response, BDNF and serotonin metabolism in rats.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Depression; Fatty Acids, Omega-3; Male; Nicotine; Oxidative Stress; Rats; Serotonin; Substance Withdrawal Syndrome | 2023 |
Impact of the gut microbiome on nicotine's motivational effects and glial cells in the ventral tegmental area in male mice.
Topics: Animals; Dopamine; Gastrointestinal Microbiome; Male; Mice; Neuroglia; Nicotine; Reward; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2023 |
L-theanine attenuates nicotine reward and withdrawal signs in mice.
Topics: Animals; Humans; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2023 |
Acute effects of exercise among individuals with schizophrenia who smoke cigarettes.
Topics: Cigarette Smoking; Craving; Cues; Humans; Nicotine; Schizophrenia; Substance Withdrawal Syndrome; Tobacco Products | 2023 |
Hyperconnectivity of Two Separate Long-Range Cholinergic Systems Contributes to the Reorganization of the Brain Functional Connectivity during Nicotine Withdrawal in Male Mice.
Topics: Animals; Brain; Cholinergic Agents; Male; Mice; Nicotine; Receptors, Cholinergic; Receptors, Nicotinic; RNA, Messenger; Substance Withdrawal Syndrome | 2023 |
Differences in biobehavioral measures of cigarette smoking by depression symptomology.
Topics: Cigarette Smoking; Depression; Humans; Nicotiana; Nicotine; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2023 |
Differential roles of diacylglycerol lipase (DAGL) enzymes in nicotine withdrawal.
Topics: Animals; Endocannabinoids; Lipoprotein Lipase; Mice; Mice, Knockout; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2023 |
The role of miRNA-144-3p/Oprk1/KOR in nicotine dependence and nicotine withdrawal in male rats.
Topics: Animals; Male; MicroRNAs; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2023 |
Fluoxetine rescues the depressive-like behaviour induced by reserpine and the altered emotional behaviour induced by nicotine withdrawal in zebrafish: Involvement of tyrosine hydroxylase.
Topics: Anhedonia; Animals; Calcitonin Gene-Related Peptide; Fluoxetine; Nicotine; Reserpine; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase; Zebrafish | 2023 |
Omega-3 fatty acids prevent nicotine withdrawal-induced impairment of learning and memory via affecting oxidative status, inflammatory response, cholinergic activity, BDNF and amyloid-B in rat hippocampal tissues.
Topics: Acetylcholinesterase; Amyloid; Animals; Brain-Derived Neurotrophic Factor; Cholinergic Agents; Fatty Acids, Omega-3; Hippocampus; Male; Maze Learning; Memory Disorders; Nicotine; Oxidative Stress; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2023 |
Stress effects on spatial memory retrieval and brain c-Fos expression pattern in adults are modulated by early nicotine exposure.
Topics: Animals; Brain; Male; Nicotine; Rats; Rats, Wistar; Spatial Memory; Substance Withdrawal Syndrome | 2023 |
Distress intolerance and withdrawal severity among daily smokers: The role of smoking abstinence expectancies.
Topics: Adult; Attitude; Cigarette Smoking; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Patient Health Questionnaire; Psychological Distress; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome | 2019 |
Adolescent nicotine challenge promotes the future vulnerability to opioid addiction: Involvement of lateral paragigantocellularis neurons.
Topics: Aging; Animals; Brain Stem; Male; Morphine Dependence; Neurons; Nicotine; Opioid-Related Disorders; Rats, Wistar; Substance Withdrawal Syndrome | 2019 |
Exposure to passive nicotine vapor in male adolescent rats produces a withdrawal-like state and facilitates nicotine self-administration during adulthood.
Topics: Administration, Inhalation; Administration, Intravenous; Age Factors; Animals; Conditioning, Operant; Drug Administration Schedule; Male; Nicotine; Rats; Self Administration; Substance Withdrawal Syndrome | 2019 |
Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
Topics: Animals; Anxiety; Brain; Estrous Cycle; Female; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Self Stimulation; Sex Characteristics; Substance Withdrawal Syndrome | 2019 |
I wake up and hit the JUUL: Analyzing Twitter for JUUL nicotine effects and dependence.
Topics: Data Collection; Electronic Nicotine Delivery Systems; Humans; Nicotine; Qualitative Research; Reproducibility of Results; Social Media; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2019 |
Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal.
Topics: Animals; Anxiety; Disease Models, Animal; Locomotion; Male; Mice; Mice, Inbred C57BL; Microglia; NADPH Oxidase 2; Nicotine; Nucleus Accumbens; Organic Chemicals; Reactive Oxygen Species; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction; Substance Withdrawal Syndrome | 2019 |
Differential expression of nicotine withdrawal as a function of developmental age in the rat.
Topics: Age Factors; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Infusions, Subcutaneous; Locomotion; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2019 |
The mechanism of chronic nicotine exposure and nicotine withdrawal on pain perception in an animal model.
Topics: Animals; Baclofen; Bicuculline; Disease Models, Animal; Down-Regulation; Endorphins; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hyperalgesia; Male; Naloxone; Nicotine; Pain Perception; Pain Threshold; Rats; Receptors, Opioid, mu; Spinal Cord; Substance Withdrawal Syndrome; Time Factors; Up-Regulation | 2020 |
Cognitive rigidity and BDNF-mediated frontostriatal glutamate neuroadaptations during spontaneous nicotine withdrawal.
Topics: Adaptation, Physiological; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Conditioning, Operant; Corpus Striatum; Discrimination, Psychological; Frontal Lobe; Glutamic Acid; Male; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Synaptic Transmission | 2020 |
Nicotine e-cigarette vapor inhalation effects on nicotine & cotinine plasma levels and somatic withdrawal signs in adult male Wistar rats.
Topics: Administration, Inhalation; Age Factors; Animals; Atmosphere Exposure Chambers; Cotinine; Dose-Response Relationship, Drug; Electronic Nicotine Delivery Systems; Male; Medically Unexplained Symptoms; Nicotine; Random Allocation; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Vaping | 2020 |
Effects of electronic cigarette heating coil resistance and liquid nicotine concentration on user nicotine delivery, heart rate, subjective effects, puff topography, and liquid consumption.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Female; Heart Rate; Hot Temperature; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Young Adult | 2020 |
Integrated miRNA-/mRNA-Seq of the Habenulo-Interpeduncular Circuit During Acute Nicotine Withdrawal.
Topics: Animals; Anxiety; Gene Expression Profiling; Gene Knockdown Techniques; Habenula; Interpeduncular Nucleus; Male; Mice, Inbred C57BL; MicroRNAs; Nicotine; Profilins; RNA, Messenger; Substance Withdrawal Syndrome | 2020 |
Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Opioid-Related Disorders; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Smoking | 2020 |
Subjective social status is indirectly associated with short-term smoking cessation through nicotine withdrawal symptoms.
Topics: Adult; Anxiety Disorders; Humans; Nicotine; Psychological Distance; Smoking Cessation; Substance Withdrawal Syndrome | 2021 |
Differential Effects of Nicotine and Nicotine Withdrawal on Fear Conditioning in Male Rats.
Topics: Acoustic Stimulation; Animals; Conditioning, Classical; Cues; Fear; Infusion Pumps, Implantable; Injections, Intravenous; Injections, Subcutaneous; Light; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Long-Evans; Reflex, Startle; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal.
Topics: Animals; Anxiety; Conditioning, Psychological; Depression; Female; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Pituitary Adenylate Cyclase-Activating Polypeptide; Sex Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Lack of Authoritative Measures to Support Abstinence From Nicotine.
Topics: Employment; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Estradiol promotes and progesterone reduces anxiety-like behavior produced by nicotine withdrawal in female rats.
Topics: Animals; Anxiety; Behavior, Animal; Estradiol; Female; Male; Nicotine; Ovariectomy; Progesterone; Rats; Rats, Wistar; Sex Characteristics; Substance Withdrawal Syndrome | 2020 |
Exposure to smoke from high- but not low-nicotine cigarettes leads to signs of dependence in male rats and potentiates the effects of nicotine in female rats.
Topics: Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Female; Locomotion; Male; Nicotine; Rats; Rats, Wistar; Sex Factors; Smoke; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2020 |
Chronic nicotine impairs sparse motor learning via striatal fast-spiking parvalbumin interneurons.
Topics: Action Potentials; Animals; Anxiety; Corpus Striatum; Designer Drugs; Interneurons; Locomotion; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Parvalbumins; Substance Withdrawal Syndrome | 2021 |
Effects of anxiety sensitivity on cannabis, alcohol, and nicotine use among adolescents: evaluating pathways through anxiety, withdrawal symptoms, and coping motives.
Topics: Adaptation, Psychological; Adolescent; Alcohol Drinking; Anxiety; Cannabis; Humans; Motivation; Nicotine; Substance Withdrawal Syndrome | 2021 |
The impact of chronic daily nicotine exposure and its overnight withdrawal on the structure of anxiety-related behaviors in rats: Role of the lateral habenula.
Topics: Animals; Anxiety; Exploratory Behavior; Habenula; Male; Neurons; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2021 |
The relative impact of acute nicotine and tobacco administration on craving, withdrawal, and cigarette self-administration in dependent and nondependent smokers.
Topics: Craving; Humans; Nicotiana; Nicotine; Smokers; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Smoking | 2021 |
Can exercise alleviate sleep disturbances during acute nicotine withdrawal in cigarette smokers?
Topics: Female; Humans; Male; Nicotine; Sleep; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
Effect of 4-Fluoro-N-(4-sulfamoylbenzyl) Benzene Sulfonamide on cognitive deficits and hippocampal plasticity during nicotine withdrawal in rats.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition Disorders; Dose-Response Relationship, Drug; Fear; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Neuronal Plasticity; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Increased Response to 3,4-Methylenedioxymethamphetamine (MDMA) Reward and Altered Gene Expression in Zebrafish During Short- and Long-Term Nicotine Withdrawal.
Topics: Animals; Conditioning, Classical; Female; Gene Expression Regulation; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Receptors, Dopamine; Receptors, Oxytocin; Receptors, Purinergic P1; Reward; RNA, Messenger; Substance Withdrawal Syndrome; Swimming; Time Factors; Zebrafish | 2021 |
Tobacco Withdrawal Symptoms Before and After Nicotine Deprivation in Veteran Smokers with Posttraumatic Stress Disorder and with Major Depressive Disorder.
Topics: Depressive Disorder, Major; Humans; Male; Nicotiana; Nicotine; Smokers; Stress Disorders, Post-Traumatic; Substance Withdrawal Syndrome; Tobacco Products; Veterans | 2021 |
Nicotine chronic tolerance development and withdrawal in the planaria (Schmidtea mediterranea).
Topics: Animals; Behavior, Addictive; Behavior, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Locomotion; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Planarians; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2021 |
Depression and Nicotine Withdrawal Associations with Combustible and Electronic Cigarette Use.
Topics: Adult; Cigarette Smoking; Cross-Sectional Studies; Depression; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Substance Withdrawal Syndrome; Vaping | 2020 |
The Multi-Component Smoking Cessation Support Programme (McSCSP) is effective in patients with severe mental disorder without gender differences.
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Prospective Studies; Reproducibility of Results; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome | 2022 |
Time-Varying Functional Connectivity Decreases as a Function of Acute Nicotine Abstinence.
Topics: Brain; Brain Mapping; Humans; Magnetic Resonance Imaging; Nicotine; Substance Withdrawal Syndrome | 2021 |
Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats.
Topics: Animals; Benzazepines; Doublecortin Protein; Drug-Seeking Behavior; Hippocampus; Locomotion; Male; Neurons; Nicotine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2021 |
Electronic cigarettes' withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Fasting; Female; Humans; Islam; Jordan; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2021 |
Female rats display greater nicotine withdrawal-induced cellular activation of a central portion of the interpeduncular nucleus versus males: A study of Fos immunoreactivity within provisionally assigned interpeduncular subnuclei.
Topics: Animals; Female; Infusion Pumps; Interpeduncular Nucleus; Male; Neurons; Nicotine; Nicotinic Antagonists; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Sex Characteristics; Substance Withdrawal Syndrome | 2021 |
Nicotine withdrawal induces hyperalgesia via downregulation of descending serotonergic pathway in the nucleus raphe magnus.
Topics: Animals; Down-Regulation; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Nicotine; Nucleus Raphe Magnus; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonergic Neurons; Serotonin; Substance Withdrawal Syndrome | 2021 |
Amino acid systems in the interpeduncular nucleus are altered in a sex-dependent manner during nicotine withdrawal.
Topics: Amino Acids; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Interpeduncular Nucleus; Male; Nicotine; Receptors, Corticotropin-Releasing Hormone; Serotonin; Substance Withdrawal Syndrome | 2022 |
Magnitude of open-field thigmotaxis during mecamylamine-precipitated nicotine withdrawal in rats is influenced by mecamylamine dose, duration of nicotine infusion, number of withdrawal episodes, and age.
Topics: Age Factors; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Locomotion; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Taxis Response; Time Factors | 2021 |
Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
Topics: Allosteric Regulation; Animals; Behavior, Animal; Hydrocarbons, Brominated; Indole Alkaloids; Isoxazoles; Mice; Nicotine; Nicotinic Agonists; Protein Isoforms; Pyrazoles; Receptors, Nicotinic; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2021 |
Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats.
Topics: Animals; Anticonvulsants; Cannabidiol; Female; Infusion Pumps; Male; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2021 |
Evaluating Nicotine Abstinence, Smoking Cessation, Reduction and its Relapsed Among Electronic Cigarettes Single and Dual Malaysian Users: A One Year Observational Study.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Malaysia; Male; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Young Adult | 2021 |
Serotonin neurons in the median raphe nucleus bidirectionally regulate somatic signs of nicotine withdrawal in mice.
Topics: Animals; Female; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nicotine; Optogenetics; Raphe Nuclei; Receptors, Nicotinic; Serotonergic Neurons; Serotonin; Substance Withdrawal Syndrome | 2021 |
Reinforcement enhancement by nicotine: A novel abuse-liability assessment of e-cigarettes in young adults.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Reinforcement, Psychology; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2022 |
Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects.
Topics: Animals; Behavior, Animal; Male; Nicotine; Oxazoles; Rats; Receptors, G-Protein-Coupled; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2022 |
Tobacco withdrawal increases junk food intake: The role of the endogenous opioid system.
Topics: Analgesics, Opioid; Eating; Humans; Naltrexone; Nicotiana; Nicotine; Substance Withdrawal Syndrome | 2021 |
Further pharmacological characterization of a preclinical model of the early development of nicotine withdrawal.
Topics: Animals; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Self Stimulation; Substance Withdrawal Syndrome | 2021 |
Dynamic activity of interpeduncular nucleus GABAergic neurons controls expression of nicotine withdrawal in male mice.
Topics: Animals; GABAergic Neurons; Interpeduncular Nucleus; Male; Mecamylamine; Mice; Nicotine; Substance Withdrawal Syndrome | 2022 |
Anthocyanins in Lycium ruthenicum Murray reduce nicotine withdrawal-induced anxiety and craving in mice.
Topics: Animals; Anthocyanins; Anxiety; Craving; Disease Models, Animal; Humans; Lycium; Male; Mice; Network Pharmacology; Nicotine; Substance Withdrawal Syndrome | 2021 |
Chronic oral nicotine administration and withdrawal regulate the expression of neuropeptide Y and its receptors in the mesocorticolimbic system.
Topics: Administration, Oral; Animals; Behavior, Animal; Limbic System; Male; Mesencephalon; Motor Activity; Neuropeptide Y; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2021 |
The effect of varenicline and nicotine patch on smoking rate and satisfaction with smoking: an examination of the mechanism of action of two pre-quit pharmacotherapies.
Topics: Humans; Nicotine; Nicotinic Agonists; Personal Satisfaction; Research Design; Smartphone; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2017 |
Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.
Topics: Animals; Conditioning, Psychological; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Rodentia; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2017 |
Nicotine Withdrawal Induces Neural Deficits in Reward Processing.
Topics: Adult; Brain; Electroencephalography; Female; Humans; Male; Middle Aged; Nicotine; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2017 |
Nicotine deprivation elevates neural representation of smoking-related cues in object-sensitive visual cortex: a proof of concept study.
Topics: Adult; Attention; Brain Mapping; Cues; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Proof of Concept Study; Smoking; Substance Withdrawal Syndrome; Visual Cortex; Young Adult | 2017 |
Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α
Topics: Adult; Cigarette Smoking; Electric Stimulation; Evoked Potentials, Motor; Female; Humans; Male; Motor Cortex; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Transcranial Direct Current Stimulation; Varenicline; Young Adult | 2017 |
Safety of nicotine replacement therapy in critically ill patients.
Topics: Critical Illness; Humans; Intensive Care Units; Nicotine; Renal Replacement Therapy; Substance Withdrawal Syndrome | 2017 |
Changes in resting state functional brain connectivity and withdrawal symptoms are associated with acute electronic cigarette use.
Topics: Adult; Brain; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Nicotine; Nicotinic Agonists; Oxygen; Principal Component Analysis; Rest; Self Report; Substance Withdrawal Syndrome; Vaping | 2018 |
Five minutes with . . . Debbie Robson.
Topics: Aggression; Attitude of Health Personnel; Humans; Inpatients; Mental Disorders; Nicotine; Nicotinic Agonists; Psychiatric Department, Hospital; Smoke-Free Policy; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2017 |
Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence.
Topics: Adolescent; Adult; Craving; Cross-Over Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2017 |
The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Cholinergic Agonists; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder; Yohimbine | 2017 |
Measures and predictors of varenicline adherence in the treatment of nicotine dependence.
Topics: Adult; Affect; Craving; Female; Humans; Logistic Models; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Saliva; Self Report; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2017 |
Smoking relapse situations among a community-recruited sample of Spanish daily smokers.
Topics: Adult; Affect; Aged; Aged, 80 and over; Craving; Female; Habits; Humans; Life Change Events; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Smokers; Smoking; Smoking Cessation; Smoking Prevention; Spain; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2017 |
Similar precipitated withdrawal effects on intracranial self-stimulation during chronic infusion of an e-cigarette liquid or nicotine alone.
Topics: Animals; Behavior, Addictive; Electric Stimulation; Electronic Nicotine Delivery Systems; Infusion Pumps, Implantable; Infusions, Subcutaneous; Male; Medial Forebrain Bundle; Nicotine; Rats; Rats, Sprague-Dawley; Self Stimulation; Substance Withdrawal Syndrome | 2017 |
Neuregulin signaling pathway in smoking behavior.
Topics: Aged; Female; Finland; Genetic Linkage; Humans; Male; Middle Aged; Neuregulin-1; Neuregulins; Nicotine; Phenotype; Polymorphism, Single Nucleotide; Receptor, ErbB-4; Schizophrenia; Signal Transduction; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Twins, Dizygotic; Twins, Monozygotic | 2017 |
Studying the interactive effects of menthol and nicotine among youth: An examination using e-cigarettes.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Glucuronates; Humans; Menthol; Nicotine; Substance Withdrawal Syndrome; Taste; Tobacco Products | 2017 |
Assessment of nicotine withdrawal-induced changes in sucrose preference in mice.
Topics: Anhedonia; Animals; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Sucrose; Tobacco Use Disorder | 2017 |
Evaluating the effect of smoking cessation treatment on a complex dynamical system.
Topics: Bupropion; Craving; Drug Therapy, Combination; Fatigue; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco Use Cessation Devices; Treatment Outcome | 2017 |
Amino acid modulation of dopamine in the nucleus accumbens mediates sex differences in nicotine withdrawal.
Topics: Amino Acids; Animals; Disease Models, Animal; Dopamine; Female; Glutamic Acid; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Sex Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Progressive modulation of accumbal neurotransmission and anxiety-like behavior following protracted nicotine withdrawal.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Corpus Striatum; Dendritic Spines; Diazepam; Disease Models, Animal; Evoked Potentials; Excitatory Postsynaptic Potentials; Locomotion; Male; Neurons; Nicotine; Nucleus Accumbens; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, GABA; Substance Withdrawal Syndrome; Synaptic Transmission | 2018 |
Abstinence-induced withdrawal severity among adolescent smokers with and without ADHD: disentangling effects of nicotine and smoking reinstatement.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Female; Humans; Male; Nicotine; Smokers; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2018 |
Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers.
Topics: Affect; Craving; Female; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2018 |
Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice: Evidence for the modulation of hippocampal pCREB levels during nicotine-withdrawal.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Behavior, Animal; Body Weight; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Depression; Drinking; Hippocampus; Locomotion; Male; Mice; Mice, Inbred C57BL; Nicotine; Phosphoproteins; Substance Withdrawal Syndrome | 2018 |
Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Male Mice.
Topics: Allosteric Regulation; Animals; Hydrocarbons, Brominated; Indole Alkaloids; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2018 |
Behavioral changes after nicotine challenge are associated with α7 nicotinic acetylcholine receptor-stimulated glutamate release in the rat dorsal striatum.
Topics: Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Corpus Striatum; Glutamic Acid; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2017 |
Reduction of anxiety sensitivity in relation to nicotine withdrawal symptoms during smoking cessation: an examination among successful quitters.
Topics: Adult; Alcoholism; Anxiety; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Self Concept; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Neuropeptide CART prevents memory loss attributed to withdrawal of nicotine following chronic treatment in mice.
Topics: Animals; CA3 Region, Hippocampal; Dentate Gyrus; Hippocampus; Mice; Nerve Tissue Proteins; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Recognition, Psychology; RNA, Messenger; Substance Withdrawal Syndrome; Synaptophysin | 2019 |
Predicting Short-Term Uptake of Electronic Cigarettes: Effects of Nicotine, Subjective Effects, and Simulated Demand.
Topics: Adult; Cigarette Smoking; Craving; Electronic Nicotine Delivery Systems; Female; Forecasting; Humans; Male; Middle Aged; New Zealand; Nicotine; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Vaping | 2018 |
Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers.
Topics: Adult; Brain; Carbon Isotopes; Cotinine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nicotine; Nicotinic Agonists; Oxazines; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Disorder | 2018 |
The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption.
Topics: Alcohol Drinking; Animals; Azetidines; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Self Administration; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2018 |
Tobacco withdrawal among opioid-dependent smokers.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cigarette Smoking; Comorbidity; Craving; Female; Humans; Male; Methadone; Middle Aged; Nicotiana; Nicotine; Opioid-Related Disorders; Prevalence; Substance Withdrawal Syndrome | 2018 |
Nicotine Abstinence Influences the Calculation of Salience in Discrete Insular Circuits.
Topics: Adult; Brain Mapping; Cerebral Cortex; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Nicotine; Rest; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzamides; Bridged Bicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Infusion Pumps; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Substance Withdrawal Syndrome | 2018 |
N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice.
Topics: Animals; Brain Injuries, Traumatic; Cerebral Cortex; Conditioning, Classical; Glycine; Male; Mecamylamine; Mice; Nicotine; Oleic Acids; Oxazoles; PPAR alpha; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine | 2019 |
Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
Topics: Adaptation, Psychological; Adult; Craving; Cues; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anxiety Disorders; Drug Evaluation, Preclinical; Enzyme Activation; Feeding Behavior; Gene Knockdown Techniques; Hippocampus; Male; Metformin; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nerve Tissue Proteins; Nicotine; Ribonucleotides; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Transgenic; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Reward; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2018 |
'Real-world' compensatory behaviour with low nicotine concentration e-liquid: subjective effects and nicotine, acrolein and formaldehyde exposure.
Topics: Acetylcysteine; Acrolein; Adult; Cotinine; Craving; England; Female; Formaldehyde; Formates; Humans; Inhalation Exposure; Male; Middle Aged; Nicotine; Nicotinic Agonists; Saliva; Substance Withdrawal Syndrome; Vaping; Young Adult | 2018 |
c-Fos marking of identified midbrain neurons coactive after nicotine administration in-vivo.
Topics: Animals; Autonomic Nervous System; Cocaine; Dopamine Uptake Inhibitors; Dopaminergic Neurons; gamma-Aminobutyric Acid; Immunohistochemistry; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Nicotine; Nicotinic Agonists; Proto-Oncogene Proteins c-fos; Reward; Substance Withdrawal Syndrome; Transcriptional Activation; Ventral Tegmental Area | 2018 |
Nicotine-Induced Conditional Place Preference Is Affected by Head Injury: Correlation with Dopamine Release in the Nucleus Accumbens Shell.
Topics: Animals; Conditioning, Psychological; Craniocerebral Trauma; Dopamine; Male; Microinjections; Nicotine; Nucleus Accumbens; Rats; Substance Withdrawal Syndrome | 2018 |
Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats.
Topics: Animals; Autoantigens; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Infusion Pumps, Implantable; Iodine Radioisotopes; Limbic Lobe; Male; Nicotine; Nucleus Accumbens; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome; Up-Regulation; Ventral Tegmental Area | 2018 |
A retrospective analysis of the association between providing nicotine replacement therapy at admission and motivation to quit and nicotine withdrawal symptoms during an inpatient psychiatric hospitalization.
Topics: Adult; Anger; Anxiety; Attention; Craving; Depression; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Substance Withdrawal Syndrome | 2018 |
Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers.
Topics: Adolescent; Brain Mapping; Craving; Female; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Nicotine; Nicotinic Agonists; Raphe Nuclei; Rest; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2018 |
Chrna5-Expressing Neurons in the Interpeduncular Nucleus Mediate Aversion Primed by Prior Stimulation or Nicotine Exposure.
Topics: Animals; Avoidance Learning; Crosses, Genetic; Exploratory Behavior; Female; Genes, Reporter; Injections, Subcutaneous; Interpeduncular Nucleus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nicotine; Optogenetics; Patch-Clamp Techniques; Receptors, Nicotinic; Recombinant Fusion Proteins; Smoking; Substance Withdrawal Syndrome | 2018 |
A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat.
Topics: Analgesics, Opioid; Animals; Male; Morphine; Nicotine; Opioid-Related Disorders; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Prevalence of withdrawal symptoms from electronic cigarette cessation: A cross-sectional analysis of the US Population Assessment of Tobacco and Health.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prevalence; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States; Vaping; Young Adult | 2019 |
Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.
Topics: Adult; Case-Control Studies; Cigarette Smoking; Craving; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Orexins; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2019 |
Impact of early life adversity on the stress biobehavioral response during nicotine withdrawal.
Topics: Adrenocorticotropic Hormone; Adult; Adverse Childhood Experiences; Affect; Behavior, Addictive; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Nicotine; Pituitary-Adrenal System; Saliva; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence.
Topics: Adult; Cigarette Smoking; Female; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2019 |
[Health Effects Accompanying the Transition from Cigarettes to Heat-not-burn Tobacco: Nicotine Dependence, Nicotine Withdrawal Symptoms, and Changes in Smoking Behaviors].
Topics: Acetaldehyde; Adult; Ammonia; Breath Tests; Carbon Monoxide; Cotinine; Dust; Formaldehyde; Humans; Male; Middle Aged; Nicotiana; Nicotine; Saliva; Smoke; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Products; Tobacco Use Disorder; Young Adult | 2018 |
Beliefs and reality of e-cigarette smoking.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chills; Depressive Disorder; Electronic Nicotine Delivery Systems; Health Knowledge, Attitudes, Practice; Humans; Male; Nausea; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tachycardia; Tobacco Use Disorder; Vaping | 2018 |
Metabolic Profiling of the Hippocampus of Rats Experiencing Nicotine-Withdrawal Symptoms.
Topics: Animals; Creatine; gamma-Aminobutyric Acid; Hippocampus; Male; Metabolome; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2018 |
Neural basis of smoking-induced relief of craving and negative affect: Contribution of nicotine.
Topics: Adolescent; Adult; Affect; Brain; Cerebral Cortex; Cigarette Smoking; Craving; Dose-Response Relationship, Drug; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Prefrontal Cortex; Substance Withdrawal Syndrome; Young Adult | 2019 |
Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Female; Health Behavior; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2018 |
An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse.
Topics: Animals; Bacterial Proteins; Behavior, Animal; Compulsive Behavior; Conditioning, Operant; Hyperalgesia; Male; Nicotine; Oxidoreductases; Pseudomonas putida; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Topics: Adult; Cigarette Smoking; Comorbidity; Dronabinol; Female; Humans; Male; Marijuana Abuse; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2019 |
The effects of oral nicotine administration and abstinence on sleep in male C57BL/6J mice.
Topics: Administration, Oral; Animals; Electroencephalography; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Sleep; Sleep Wake Disorders; Sleep, REM; Substance Withdrawal Syndrome; Wakefulness | 2019 |
Lifelong exposure to caffeine increases anxiety-like behavior in adult mice exposed to tobacco smoke during adolescence.
Topics: Aging; Animals; Anxiety; Behavior, Animal; Caffeine; Cotinine; Exploratory Behavior; Female; Male; Mice; Nicotiana; Nicotine; Substance Withdrawal Syndrome | 2019 |
Tobacco smoke and ethanol during adolescence: Both combined- and single-drug exposures lead to short- and long-term disruption of the serotonergic system in the mouse brain.
Topics: Age Factors; Alcohol Drinking; Animals; Brain; Ethanol; Female; Hippocampus; Male; Mice; Nicotiana; Nicotine; Nicotinic Agonists; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome; Tobacco Smoking | 2019 |
Changes in striatal dopamine release and locomotor activity following acute withdrawal from chronic nicotine are mediated by CRF1, but not CRF2, receptors.
Topics: Animals; Corpus Striatum; Corticotropin-Releasing Hormone; Dopamine; Dopaminergic Neurons; Locomotion; Male; Motor Activity; Nicotine; Peptide Fragments; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome | 2019 |
N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking.
Topics: Acetylcysteine; Animals; Craving; Cues; Disease Models, Animal; Drug-Seeking Behavior; Estrous Cycle; Extinction, Psychological; Female; Free Radical Scavengers; Male; Nicotine; Rats; Rats, Sprague-Dawley; Sex Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Abuse liability assessment of an electronic cigarette in combustible cigarette smokers.
Topics: Adult; Cross-Over Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smokers; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2019 |
Exploring the interoceptive stimulus effects of nicotine and varenicline.
Topics: Animals; Appetitive Behavior; Conditioning, Classical; Discrimination Learning; Discrimination, Psychological; Drug Substitution; Extinction, Psychological; Injections, Subcutaneous; Interoception; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Saline Solution; Smoking Cessation; Substance Withdrawal Syndrome; Sucrose; Varenicline | 2019 |
The Alarming Increase in Vaping among Youth.
Topics: Adolescent; Child; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Nicotine; Nurse's Role; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome; Vaping | 2019 |
Brain Marker Links Stress and Nicotine Abstinence.
Topics: Adolescent; Adult; Aged; Brain; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2020 |
The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice.
Topics: Animals; Anxiety; Behavior, Animal; Female; Gene Knockout Techniques; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Receptors, Nicotinic; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2019 |
Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice.
Topics: Animals; Behavior, Addictive; Choice Behavior; Dose-Response Relationship, Drug; Drug Interactions; Female; Male; Mice; Mice, Knockout; Nicotine; Nucleus Accumbens; Quinine; Receptors, Nicotinic; Self Administration; Sex Characteristics; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine 3-Monooxygenase; Varenicline | 2019 |
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
Topics: Adult; Affect; Anxiety; Benzamides; Cigarette Smoking; Craving; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pyrrolidines; Random Allocation; Receptors, Opioid, kappa; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Recent Updates in Animal Models of Nicotine Withdrawal: Intracranial Self-Stimulation and Somatic Signs.
Topics: Animals; Disease Models, Animal; Male; Nicotine; Rats; Self Stimulation; Substance Withdrawal Syndrome; Symptom Assessment; Tobacco Use Disorder | 2019 |
Sex differences in cholinergic systems in the interpeduncular nucleus following nicotine exposure and withdrawal.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anxiety; Behavior, Animal; Female; Gene Expression; Interpeduncular Nucleus; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Receptors, Nicotinic; RNA, Messenger; Sex Factors; Substance Withdrawal Syndrome | 2019 |
The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse.
Topics: Animals; Conotoxins; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2013 |
COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers.
Topics: Catechol O-Methyltransferase; Cognition; Humans; Infusions, Intravenous; Methionine; Nicotine; Smoking; Substance Withdrawal Syndrome; Valine | 2013 |
Neurosteroid allopregnanolone attenuates development of nicotine withdrawal behavior in mice.
Topics: Animals; Anxiety; Finasteride; Indomethacin; Male; Maze Learning; Mice; Motor Activity; Neurotransmitter Agents; Nicotine; Pregnanolone; Progesterone; Substance Withdrawal Syndrome; Time Factors | 2013 |
Anhedonia and anxiety sensitivity: prospective relationships to nicotine withdrawal symptoms during smoking cessation.
Topics: Adult; Anhedonia; Anxiety; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2013 |
Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice.
Topics: Amino Acid Transport Systems; Animals; Anti-Bacterial Agents; Ceftriaxone; Conditioning, Psychological; Cysteine; Excitatory Amino Acid Transporter 2; Extinction, Psychological; Glutamic Acid; Male; Mice; Mice, Inbred ICR; Nicotine; Reinforcement, Psychology; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on performance of a cued appetitive response.
Topics: Animals; Attention; Behavior, Animal; Conditioning, Operant; Cues; Male; Mice; Nicotine; Reaction Time; Substance Withdrawal Syndrome | 2013 |
Greater BOLD activity but more efficient connectivity is associated with better cognitive performance within a sample of nicotine-deprived smokers.
Topics: Adult; Brain; Cognition Disorders; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
Predictors of success for smoking cessation at the workplace: a longitudinal study.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Bupropion; Counseling; Dyspnea; Educational Status; Female; Health Care Sector; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Motivational Interviewing; Multivariate Analysis; Nicotine; Nicotinic Agonists; Occupational Health Services; Prognosis; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Switzerland; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Workplace; Young Adult | 2014 |
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Topics: Animals; Anxiety; Azetidines; Benzazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Partial Agonism; Evoked Potentials; Hippocampus; Male; Mice; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Up-Regulation; Varenicline | 2013 |
Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors.
Topics: Analysis of Variance; Animals; Anxiety; Conditioning, Classical; Drug Administration Schedule; Escape Reaction; Exploratory Behavior; Fear; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Psychomotor Performance; Reaction Time; Receptors, Nicotinic; Reflex; Reflex, Startle; Substance Withdrawal Syndrome | 2013 |
The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.
Topics: Animals; Anisoles; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclohexanols; Dose-Response Relationship, Drug; Female; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Receptor, Cannabinoid, CB2; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.
Topics: Adult; Attention; Cognition Disorders; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Substance Withdrawal Syndrome | 2013 |
Withdrawal from chronic nicotine and subsequent sensitivity to nicotine challenge on contextual learning.
Topics: Analysis of Variance; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Delivery Systems; Electroshock; Fear; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Time Factors | 2013 |
Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.
Topics: Animals; Behavior, Animal; Dopamine; Habenula; Humans; Limbic System; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Reinforcement, Psychology; Signal Transduction; Substance Withdrawal Syndrome | 2013 |
Nicotine deprivation influences P300 markers of cognitive control.
Topics: Adult; Aged; Brain; Cognition; Electroencephalography; Event-Related Potentials, P300; Executive Function; Female; Humans; Male; Middle Aged; Nicotine; Substance Withdrawal Syndrome | 2013 |
The histidine triad nucleotide binding 1 protein is involved in nicotine reward and physical nicotine withdrawal in mice.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Nicotine; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine.
Topics: Animals; Conditioning, Operant; Male; Mice; Mice, Knockout; Nicotine; Nucleus Accumbens; Receptor, Cannabinoid, CB2; Reinforcement, Psychology; Reward; Self Administration; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2013 |
Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats.
Topics: Animals; Anxiety; Behavior, Animal; Hyperalgesia; Male; Nicotine; Nicotinic Agonists; Pyrimidines; Rats; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Infusion Pumps, Implantable; Male; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Varenicline | 2014 |
Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Topics: Animals; Brain; Clorgyline; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nicotine; Rats; Rats, Sprague-Dawley; Selegiline; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |
Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.
Topics: Adolescent; Adult; Afatinib; Aged; Animals; Behavior, Animal; Cyclic AMP Response Element-Binding Protein; DNA; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Hippocampus; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Middle Aged; Mutation; Neuregulins; Nicotine; Polymorphism, Single Nucleotide; Quinazolines; Rats; Receptor, ErbB-4; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; White People; Young Adult | 2014 |
Trait differences in response to chronic nicotine and nicotine withdrawal in rats.
Topics: Animals; Chronic Disease; Conditioning, Operant; Delay Discounting; Ganglionic Stimulants; Impulsive Behavior; Male; Neuropsychological Tests; Nicotine; Rats; Substance Withdrawal Syndrome; Task Performance and Analysis; Time Factors; Tobacco Use Disorder | 2014 |
Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons.
Topics: Animals; Biological Clocks; Cardiotonic Agents; Cholinergic Neurons; Habenula; Humans; Mice; Nicotine; Nicotinic Agonists; Pyrimidines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |
Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA).
Topics: Amygdala; Animals; Corticotropin-Releasing Hormone; Hyperalgesia; Male; Nicotine; Pain Threshold; Pyrimidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Repeated transcranial direct current stimulation prevents abnormal behaviors associated with abstinence from chronic nicotine consumption.
Topics: Age Factors; Animals; Body Weight; Conditioning, Operant; Disease Models, Animal; Drinking; Eating; Female; Maze Learning; Memory; Mental Disorders; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Recognition, Psychology; Substance Withdrawal Syndrome; Swimming; Transcranial Magnetic Stimulation | 2014 |
Clinical management of tobacco dependence in inpatient psychiatry: provider practices and patient utilization.
Topics: Adult; Cross-Sectional Studies; Female; Hospitalization; Hospitals, Psychiatric; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Nicotine; Patient Education as Topic; Smoke-Free Policy; Smoking; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2013 |
Pharmacological modulation of farnesyltransferase subtype I attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Male; Mecamylamine; Methionine; Mice; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Substance Withdrawal Syndrome | 2013 |
Activation of GABAergic neurons in the interpeduncular nucleus triggers physical nicotine withdrawal symptoms.
Topics: Animals; GABAergic Neurons; Glutamic Acid; Light; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phototherapy; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Rhodopsin; Somatostatin; Substance Withdrawal Syndrome; Synaptic Transmission | 2013 |
Effects of oxytocin on nicotine withdrawal in rats.
Topics: Animals; Male; Nicotine; Oxytocin; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2014 |
Effects of resistance exercise on the HPA axis response to psychological stress during short-term smoking abstinence in men.
Topics: Adolescent; Adrenocorticotropic Hormone; Exercise; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Nicotine; Nicotinic Agonists; Pituitary-Adrenal System; Resistance Training; Saliva; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Young Adult | 2014 |
Cigarette smoking and mental illness: a study of nicotine withdrawal.
Topics: Adult; Female; Humans; Male; Mental Disorders; Nicotine; Patient Acuity; Prevalence; Smoking; Smoking Cessation; Socioeconomic Factors; Substance Withdrawal Syndrome | 2014 |
Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase.
Topics: Administration, Intravenous; Adolescent; Adult; Affect; Cognition; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Female; Follicular Phase; Humans; Luteal Phase; Male; Middle Aged; Nicotine; Nicotinic Agonists; Sex Factors; Smoking; Substance Withdrawal Syndrome; Young Adult | 2014 |
Clinical significance of early smoking withdrawal effects and their relationships with nicotine metabolism: preliminary results from a pilot study.
Topics: Adult; Affect; Anxiety; Attention; Cotinine; Craving; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Greater externalizing personality traits predict less error-related insula and anterior cingulate cortex activity in acutely abstinent cigarette smokers.
Topics: Adolescent; Adult; Case-Control Studies; Cerebral Cortex; Female; Functional Neuroimaging; Gyrus Cinguli; Humans; Impulsive Behavior; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Personality; Reaction Time; Smoking; Substance Withdrawal Syndrome; Task Performance and Analysis; Young Adult | 2015 |
Possible involvement of endogenous opioid system located downstream of α7 nicotinic acetylcholine receptor in mice with physical dependence on nicotine.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Biomarkers; Corticosterone; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Nicotine; Opioid Peptides; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Time-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamine.
Topics: Animals; Cocaine; Dopamine Uptake Inhibitors; Male; Mecamylamine; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2014 |
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Azetidines; Benzazepines; Brain Chemistry; Drug Evaluation, Preclinical; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Up-Regulation; Varenicline; Weight Gain | 2014 |
Enhanced corticobulbar excitability in chronic smokers during visual exposure to cigarette smoking cues.
Topics: Chronic Disease; Craving; Cues; Electromyography; Evoked Potentials, Motor; Female; Forearm; Humans; Male; Muscle, Skeletal; Nicotine; Nicotinic Agonists; Photic Stimulation; Pyramidal Tracts; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tongue; Transcranial Magnetic Stimulation; Visual Perception; Young Adult | 2014 |
Nicotine administration in adolescence reprograms the subsequent response to nicotine treatment and withdrawal in adulthood: sex-selective effects on cerebrocortical serotonergic function.
Topics: Aging; Animals; Cerebral Cortex; Female; Hydroxyindoleacetic Acid; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Serotonin; Sex Characteristics; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents.
Topics: Alkaloids; Anabasine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Male; Mice; Nicotiana; Nicotine; Pyridines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome | 2014 |
Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokers.
Topics: Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Nicotine; Phenotype; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Self Report; Smoking; Substance Withdrawal Syndrome | 2014 |
Implicit alcohol cognitions in risky drinking nicotine users with and without co-morbid major depressive disorder.
Topics: Adolescent; Adult; Alcohol Drinking; Analysis of Variance; Association; Comorbidity; Depressive Disorder, Major; Female; Humans; Linear Models; Male; Motivation; Neuropsychological Tests; Nicotine; Risk-Taking; Set, Psychology; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use | 2014 |
Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.
Topics: Animals; Anxiety; Avoidance Learning; Baclofen; Conditioning, Psychological; GABA-B Receptor Agonists; Male; Mice; Movement; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Receptors, GABA-B; Reward; Space Perception; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Comparison of the effectiveness of virtual cue exposure therapy and cognitive behavioral therapy for nicotine dependence.
Topics: Adaptation, Psychological; Adult; Aged; Cognitive Behavioral Therapy; Cues; Humans; Implosive Therapy; Male; Middle Aged; Nicotine; Patient Education as Topic; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2014 |
Amplified reacquisition of nicotine self-administration in rats by repeated stress during abstinence.
Topics: Animals; Circadian Rhythm; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement Schedule; Restraint, Physical; Self Administration; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear.
Topics: Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Tolerance; Fear; Freezing Reaction, Cataleptic; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Up-Regulation | 2014 |
A critical role for the melanocortin 4 receptor in stress-induced relapse to nicotine seeking in rats.
Topics: Animals; Drug-Seeking Behavior; Nicotine; Nicotinic Agonists; Peptides, Cyclic; Rats; Receptor, Melanocortin, Type 4; Recurrence; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Large-scale brain network coupling as a potential neural metric for nicotine abstinence effects on craving and cognitive function.
Topics: Brain; Cognition Disorders; Female; Humans; Male; Motivation; Nerve Net; Neuropsychological Tests; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function.
Topics: Adult; Brain; Brain Mapping; Cognition Disorders; Dominance, Cerebral; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Motivation; Nerve Net; Neuropsychological Tests; Nicotine; Oxygen; Psychometrics; Resource Allocation; Smoking; Smoking Cessation; Statistics as Topic; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2014 |
Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Drug Partial Agonism; Indoles; Male; Mice; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Quinuclidines; Radioligand Assay; Receptors, Nicotinic; Substance Withdrawal Syndrome; Time Factors; Up-Regulation | 2014 |
Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system.
Topics: Adolescent; Adult; Aged; Drug Delivery Systems; Female; Heart Rate; Humans; Los Angeles; Male; Middle Aged; Nicotine; Patient Satisfaction; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Tobacco Products; Tobacco Use Cessation; Tobacco Use Cessation Devices; Young Adult | 2014 |
Development and validation of a smoking expectancies measure for adolescents seeking to quit smoking.
Topics: Adolescent; Adolescent Behavior; Emotions; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Reinforcement, Psychology; Reproducibility of Results; Risk; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2015 |
Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling.
Topics: Action Potentials; Animals; Female; Habenula; Male; Mice; Mice, Inbred C57BL; Neurokinin B; Neurokinin-1 Receptor Antagonists; Neurons; Nicotine; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Receptors, Nicotinic; Signal Transduction; Substance P; Substance Withdrawal Syndrome | 2014 |
Young adult waterpipe smokers: Smoking behaviors and associated subjective and physiological effects.
Topics: Adult; Affect; Blood Pressure; Carbon Monoxide; Dizziness; Fatigue; Female; Follow-Up Studies; Heart Rate; Hemodynamics; Humans; Male; Nicotine; Personal Satisfaction; Pilot Projects; Smoking; Social Behavior; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2014 |
The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cotinine; Cyclic AMP Response Element-Binding Protein; Depression; Disease Models, Animal; Hippocampus; Lobeline; Male; Mice, Inbred C57BL; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Norepinephrine; Prefrontal Cortex; Receptors, Nicotinic; Substance Withdrawal Syndrome; Swimming; Tobacco Use Disorder | 2014 |
The electronic cigarette. Official statement of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on the efficacy, safety and regulation of electronic cigarettes.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Equipment Design; Europe; Hot Temperature; Humans; Medical Device Legislation; Multicenter Studies as Topic; Nicotine; Organic Chemicals; Randomized Controlled Trials as Topic; Respiration Disorders; Smoke; Smoking Cessation; Solutions; Substance Withdrawal Syndrome; United States; Young Adult | 2014 |
Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal.
Topics: Animals; Behavior, Animal; Central Amygdaloid Nucleus; Corticotropin-Releasing Hormone; Dependovirus; Male; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Reward; Self Stimulation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Effect of activated peripheral κ-opioid receptors on the action of nicotine and its withdrawal in nicotine-dependent rats.
Topics: Animals; Energy Intake; Male; Motor Activity; Nicotine; Pyrrolidines; Rats, Wistar; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
The effects of nicotine dose expectancy and motivationally relevant distracters on vigilance.
Topics: Adult; Anticipation, Psychological; Arousal; Attention; Craving; Cues; Emotions; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Psychomotor Performance; Reaction Time; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Products; Tobacco Use Disorder; Young Adult | 2014 |
Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking.
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Cotinine; Male; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Parasympathetic Nervous System; Rats; Rats, Wistar; Smoking; Substance Withdrawal Syndrome; Synaptic Transmission | 2014 |
Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.
Topics: Animals; Anxiety; Aryl Hydrocarbon Hydroxylases; Conditioning, Psychological; Cytochrome P450 Family 2; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hyperalgesia; Male; Mecamylamine; Methoxsalen; Mice, Inbred ICR; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Reward; Severity of Illness Index; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Influence of calcium channel antagonists on nonsomatic signs of nicotine and D-amphetamine withdrawal in mice.
Topics: Animals; Anxiety; Calcium; Calcium Channel Blockers; Calcium Channels; Depression; Dextroamphetamine; Memory; Mice; Nicotine; Nociception; Substance Withdrawal Syndrome | 2014 |
Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Psychological; Donepezil; Electroshock; Fear; Freezing Reaction, Cataleptic; Indans; Locomotion; Male; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nootropic Agents; Piperidines; Substance Withdrawal Syndrome | 2014 |
CHRNA5 variants moderate the effect of nicotine deprivation on a neural index of cognitive control.
Topics: Adult; Attention; Cognition; Female; Humans; Linkage Disequilibrium; Male; Middle Aged; Nerve Tissue Proteins; Nicotine; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Nicotine withdrawal and stress-induced changes in pain sensitivity: a cross-sectional investigation between abstinent smokers and nonsmokers.
Topics: Adult; Blood Pressure; Body Mass Index; Cross-Sectional Studies; Female; Heart Rate; Humans; Male; Nicotine; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Young Adult | 2014 |
Effects of chronic mild stress on the development of drug dependence in rats.
Topics: Animals; Chronic Disease; Citalopram; Depressive Disorder; Diazepam; Disease Models, Animal; Flumazenil; GABA Modulators; Male; Mecamylamine; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders | 2014 |
The discriminative stimulus effects of mecamylamine in nicotine-treated and untreated rhesus monkeys.
Topics: Animals; Discrimination Learning; Female; Macaca mulatta; Male; Mecamylamine; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2014 |
Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice.
Topics: Animals; Baclofen; Basal Ganglia; Brain-Derived Neurotrophic Factor; Hippocampus; Male; Mecamylamine; Mice; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Organ Specificity; Proto-Oncogene Proteins c-fos; Substance Withdrawal Syndrome | 2014 |
Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.
Topics: Anhedonia; Animals; Gene Deletion; Male; Mecamylamine; Mice; Mice, Knockout; Microinjections; Nicotine; Receptors, Nicotinic; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2015 |
Differential associations between components of anxiety sensitivity and smoking-related characteristics.
Topics: Adult; Anxiety; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects.
Topics: Administration, Inhalation; Adult; Behavior; Electronic Nicotine Delivery Systems; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome | 2015 |
Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
Topics: Animals; Benzodioxoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Monoacylglycerol Lipases; Nicotine; Piperidines; RNA, Messenger; Substance Withdrawal Syndrome | 2015 |
Craving and nicotine withdrawal in a Spanish smoking cessation sample.
Topics: Adult; Craving; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2014 |
Effect of nicotine withdrawal on pain sensitivity in rats to mechanical stimulation and thermal stimulation.
Topics: Animals; Hot Temperature; Injections, Subcutaneous; Male; Nicotine; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Random Allocation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Effects of nicotine and nicotine expectancy on attentional bias for emotional stimuli.
Topics: Adolescent; Adult; Affect; Attention; Double-Blind Method; Emotions; Facial Expression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Random Allocation; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2015 |
Withdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice.
Topics: Animals; Conditioning, Psychological; Fear; Hippocampus; Hypothyroidism; Learning; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Thyroid Gland; Thyroid Hormones; Thyroxine; Tobacco Use Disorder | 2015 |
Reinforcer devaluation as a consequence of acute nicotine exposure and withdrawal.
Topics: Anhedonia; Animals; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Substance Withdrawal Syndrome; Sucrose | 2015 |
VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.
Topics: Animals; Corticotropin-Releasing Hormone; Humans; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Neurons; Nicotine; Organ Culture Techniques; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2014 |
First- versus second-generation electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms.
Topics: Adolescent; Adult; Choice Behavior; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Preference; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2015 |
ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.
Topics: Animals; Cognition; Conditioning, Psychological; Cues; Dose-Response Relationship, Drug; Drug Partial Agonism; Fear; Hippocampus; Indoles; Learning; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Quinuclidines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal.
Topics: Analysis of Variance; Animals; Carbon Radioisotopes; Craving; Female; Flumazenil; Humans; Iodine Radioisotopes; Macaca mulatta; Male; Nicotine; Positron-Emission Tomography; Receptors, GABA-A; Smoking; Substance Withdrawal Syndrome; Tomography, Emission-Computed, Single-Photon | 2014 |
Lack of GABAB receptors modifies behavioural and biochemical alterations induced by precipitated nicotine withdrawal.
Topics: Animals; Anxiety; Brain; Brain-Derived Neurotrophic Factor; Corticosterone; Disease Models, Animal; Male; Mecamylamine; Mice, Inbred BALB C; Mice, Knockout; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, GABA-A; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Cortical activity differs during nicotine deprivation versus satiation in heavy smokers.
Topics: Adolescent; Adult; Aged; Alpha Rhythm; Beta Rhythm; Cerebral Cortex; Cognition Disorders; Electroencephalography; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Theta Rhythm; Tobacco Use Disorder; Young Adult | 2015 |
[Tobacco smoking and psychiatric intensive care unit: Impact of the strict smoking ban on the risk of violence].
Topics: Adult; Aggression; Female; France; Humans; Intensive Care Units; Male; Mentally Ill Persons; Nicotine; Patient Isolation; Psychiatric Department, Hospital; Retrospective Studies; Risk; Smoke-Free Policy; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Violence | 2015 |
FKBP5 variation is associated with the acute and chronic effects of nicotine.
Topics: Alleles; Black or African American; Blood Pressure; Diagnostic and Statistical Manual of Mental Disorders; Gene Frequency; Genotype; Heart Rate; Humans; Hydrocortisone; Injections, Intravenous; Nicotine; Nicotinic Agonists; RNA; RNA, Messenger; Smoking; Substance Withdrawal Syndrome; Tacrolimus Binding Proteins; White People | 2015 |
Nicotine withdrawal in selectively bred high and low nicotine preferring rat lines.
Topics: Animals; Female; Male; Motor Activity; Nicotine; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice.
Topics: Agmatine; Animals; Anxiety; Behavior, Animal; Brain; Depression; Infusions, Intraventricular; Male; Mice; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Female; Gene Knock-In Techniques; Male; Methionine; Mice; Mice, Transgenic; Nicotine; Polymorphism, Single Nucleotide; Substance Withdrawal Syndrome; Tobacco Use Disorder; Valine | 2015 |
The effects of nicotine dependence and acute abstinence on the processing of drug and non-drug rewards.
Topics: Carbon Monoxide; Choice Behavior; Craving; Cross-Over Studies; Depression; Female; Humans; Male; Motivation; Nicotine; Pleasure; Psychomotor Performance; Reading; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2015 |
Nicotine withdrawal increases stress-associated genes in the nucleus accumbens of female rats in a hormone-dependent manner.
Topics: Animals; Corticotropin-Releasing Hormone; Female; Gender Identity; Maze Learning; Nicotine; Nucleus Accumbens; Ovariectomy; Rats; Rats, Wistar; Smoking; Stress, Physiological; Substance Withdrawal Syndrome | 2015 |
Sex differences in acute relief of abstinence-induced withdrawal and negative affect due to nicotine content in cigarettes.
Topics: Adult; Affective Symptoms; Female; Gender Identity; Humans; Male; Nicotine; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Sex differences in time perception during smoking abstinence.
Topics: Adolescent; Adult; Aged; Decision Making; Female; Gender Identity; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Perception | 2015 |
Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey.
Topics: Adolescent; Adult; Australia; Benzazepines; Canada; Female; Gender Identity; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; United Kingdom; United States; Varenicline | 2015 |
Nicotinic Mechanisms Modulate Ethanol Withdrawal and Modify Time Course and Symptoms Severity of Simultaneous Withdrawal from Alcohol and Nicotine.
Topics: Animals; Central Nervous System Depressants; Disease Models, Animal; Ethanol; Female; Habenula; Interpeduncular Nucleus; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Microinjections; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Time Factors | 2015 |
Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers.
Topics: Adult; Aged; Australia; Female; Hospitalization; Humans; Inpatients; Male; Middle Aged; Motivation; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2015 |
Effects of Cigarette Smoking on Plasma Concentration of the Appetite-Regulating Peptide Ghrelin.
Topics: Acetylation; Adult; Cotinine; Female; Ghrelin; Humans; Male; Nicotine; Postprandial Period; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2015 |
Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal.
Topics: Animals; Anxiety; Corticotropin-Releasing Hormone; Habenula; Interpeduncular Nucleus; Male; Mice; Mice, Inbred C57BL; Nerve Net; Nicotine; Receptors, Corticotropin-Releasing Hormone; Signal Transduction; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2015 |
A case of nicotine withdrawal delirium.
Topics: Delirium; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia, Paranoid; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2015 |
A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
Topics: Adult; Blood Pressure; Cognition Disorders; Cotinine; Female; Genome-Wide Association Study; Heart Rate; Humans; Male; Middle Aged; Nerve Tissue Proteins; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Comparison of the characteristics of long-term users of electronic cigarettes versus nicotine replacement therapy: A cross-sectional survey of English ex-smokers and current smokers.
Topics: Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Female; Humans; Male; Nicotine; Patient Satisfaction; Self-Assessment; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2015 |
Discovering the mechanisms underlying serotonin (5-HT)2A and 5-HT2C receptor regulation following nicotine withdrawal in rats.
Topics: Animals; Brain; Immobilization; Male; Nicotine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Substance Withdrawal Syndrome | 2015 |
Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
Topics: Animals; Anxiety; Benzamides; Conditioning, Psychological; Disease Models, Animal; Hot Temperature; Hyperalgesia; Male; Mice, Inbred ICR; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pyrrolidines; Receptors, Opioid, kappa; Spatial Behavior; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats.
Topics: Animals; Brain; Indoles; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Pyrrolidines; Rats, Wistar; Receptors, Vasopressin; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2015 |
Associations between adrenocortical activity and nicotine response in female smokers by menstrual phase.
Topics: Adolescent; Adult; Craving; Cross-Over Studies; Female; Follicular Phase; Humans; Hydrocortisone; Luteal Phase; Menstrual Cycle; Nicotine; Saliva; Smoking; Substance Withdrawal Syndrome; Young Adult | 2015 |
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice.
Topics: Animals; Body Weight; Brain; Cotinine; Disease Models, Animal; Eating; Electronic Nicotine Delivery Systems; Emotions; Male; Mecamylamine; Memory, Short-Term; Mice, Inbred BALB C; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Respiration, Artificial; Spatial Memory; Substance Withdrawal Syndrome; Tobacco Smoke Pollution; Tobacco Use Disorder | 2015 |
Changes in circulating leptin levels during the initial stage of cessation are associated with smoking relapse.
Topics: Adult; Carbon Monoxide; Cotinine; Craving; Female; Humans; Leptin; Male; Nicotine; Nicotinic Agonists; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Comparison of Regional Brain Perfusion Levels in Chronically Smoking and Non-Smoking Adults.
Topics: Adult; Alzheimer Disease; Brain; Cerebrovascular Circulation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Smoking; Spin Labels; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Topics: Administration, Cutaneous; Analysis of Variance; Anxiety; Biomarkers; Cotinine; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder.
Topics: Acoustic Stimulation; Adult; Arousal; Attention; Humans; Male; Nicotine; Prepulse Inhibition; Recurrence; Reflex, Startle; Smoking; Smoking Cessation; Stress Disorders, Post-Traumatic; Substance Withdrawal Syndrome; Time Factors | 2015 |
Damage to the insula leads to decreased nicotine withdrawal during abstinence.
Topics: Brain Diseases; Brain Ischemia; Cerebral Cortex; Female; Hospitalization; Humans; Longitudinal Studies; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Stroke; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2015 |
Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice.
Topics: Animals; Body Temperature; Brain; Female; Hyperalgesia; Hypothermia, Induced; Male; Maze Learning; Menthol; Mice, Inbred ICR; Nicotine; Nociception; Receptors, Nicotinic; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2015 |
CX3CR1 Mediates Nicotine Withdrawal-Induced Hyperalgesia via Microglial P38 MAPK Signaling.
Topics: Animals; Antibodies, Neutralizing; Calcium-Binding Proteins; CX3C Chemokine Receptor 1; Hot Temperature; Hyperalgesia; Injections, Spinal; Macrophage Activation; Male; Microfilament Proteins; Microglia; Nicotine; Nicotinic Agonists; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Chemokine; Signal Transduction; Substance Withdrawal Syndrome | 2015 |
Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes.
Topics: Adolescent; Alleles; Child; Craving; Female; Gene-Environment Interaction; Genotype; Humans; Longitudinal Studies; Male; Minisatellite Repeats; Nicotine; Nicotinic Agonists; Parents; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Opioid, mu; Smoking; Social Environment; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Quitters Never Sleep: The Effect of Nicotine Withdrawal Upon Sleep.
Topics: Animals; Humans; Nicotine; Sleep Wake Disorders; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Cue-reactivity in experienced electronic cigarette users: Novel stimulus videos and a pilot fMRI study.
Topics: Adult; Craving; Cues; Electronic Nicotine Delivery Systems; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Pilot Projects; Self Report; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Vaping | 2016 |
Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Cognition Disorders; Depression; Hindlimb Suspension; Male; Maze Learning; Nicotine; Physical Conditioning, Animal; Rats; Substance Withdrawal Syndrome | 2016 |
Coronary angiogenesis during morphine and nicotine withdrawal in two-kidney one clip hypertensive (2K1C) rats.
Topics: Analgesics, Opioid; Animals; Blood Pressure; Cardiovascular System; Disease Models, Animal; Heart; Heart Rate; Hypertension, Renovascular; Male; Morphine; Morphine Dependence; Neovascularization, Physiologic; Nicotine; Nicotinic Agonists; Nitric Oxide; Rats; Rats, Wistar; Renal Artery; Substance Withdrawal Syndrome; Surgical Instruments; Tobacco Use Disorder | 2015 |
Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner.
Topics: Animals; Brain; Male; Mice, Inbred C57BL; Nicotine; Receptors, Glutamate; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Stress response genes and the severity of nicotine withdrawal.
Topics: Animals; Humans; Nicotine; Polymorphism, Single Nucleotide; Severity of Illness Index; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tacrolimus Binding Proteins; Tobacco Use Disorder | 2016 |
A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation.
Topics: Animals; Infusions, Intravenous; Male; Mecamylamine; Nicotine; Rats, Wistar; Self Stimulation; Substance Withdrawal Syndrome | 2015 |
N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.
Topics: Acetylcysteine; Animals; Association Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Cognitive control deficits during mecamylamine-precipitated withdrawal in mice: Possible links to frontostriatal BDNF imbalance.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognition; Corpus Striatum; Executive Function; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prefrontal Cortex; Substance Withdrawal Syndrome | 2016 |
Craving and Withdrawal Symptoms During Smoking Cessation: Comparison of Pregnant and Non-Pregnant Smokers.
Topics: Adolescent; Adult; Craving; Female; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Pregnancy; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2016 |
Chronic Pain Status, Nicotine Withdrawal, and Expectancies for Smoking Cessation Among Lighter Smokers.
Topics: Adult; Case-Control Studies; Chronic Pain; Female; Humans; Male; Nicotine; Self Efficacy; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2016 |
Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence.
Topics: Adaptation, Physiological; Alcohol Abstinence; Alcoholism; Animals; Ethanol; Macaca mulatta; Male; Nicotine; Positron-Emission Tomography; Receptors, GABA-A; Self Administration; Substance Withdrawal Syndrome | 2016 |
Progression of nicotine dependence, mood level, and mood variability in adolescent smokers.
Topics: Adolescent; Affect; Disease Progression; Ecological Momentary Assessment; Female; Humans; Male; Mood Disorders; Nicotine; Nicotinic Agonists; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Adolescents and adults differ in the immediate and long-term impact of nicotine administration and withdrawal on cardiac norepinephrine.
Topics: Age Factors; Animals; Female; Heart; Male; Myocardium; Nicotine; Nicotinic Agonists; Norepinephrine; Rats; Rats, Sprague-Dawley; Smoking Cessation; Substance Withdrawal Syndrome | 2016 |
Habenula cholinergic neurons regulate anxiety during nicotine withdrawal via nicotinic acetylcholine receptors.
Topics: Animals; Anxiety; Cholinergic Neurons; Habenula; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2016 |
Does acute tobacco smoking prevent cue-induced craving?
Topics: Adult; Craving; Cues; Female; Humans; Male; Nicotiana; Nicotine; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke.
Topics: Adult; Black or African American; Cadherins; Diagnostic and Statistical Manual of Mental Disorders; Female; Gene Expression Regulation; Genome-Wide Association Study; Humans; Male; Multigene Family; Nicotine; Polymorphism, Single Nucleotide; Protocadherins; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; White People | 2017 |
Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.
Topics: Alcohol Abstinence; Amygdala; Analgesics, Opioid; Animals; Anxiety; Behavior, Animal; Brain; Cannabinoid Receptor Agonists; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Dronabinol; Drug-Seeking Behavior; Emotions; Ethanol; Male; Mice; Morphine; Motivation; Nicotine; Nicotinic Agonists; Proto-Oncogene Proteins c-fos; Social Behavior; Stereotyped Behavior; Substance Withdrawal Syndrome | 2017 |
Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Electronic Nicotine Delivery Systems; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Self Administration; Self Report; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Vaping; Young Adult | 2016 |
Smoking Cessation and the Risk of Hyperactive Delirium in Hospitalized Patients: A Retrospective Study.
Topics: Aged; Aged, 80 and over; Delirium; Female; Hospitalization; Humans; Incidence; Length of Stay; Male; Middle Aged; Mortality; Multivariate Analysis; Nicotine; Nicotinic Agonists; Odds Ratio; Psychiatry; Psychomotor Agitation; Referral and Consultation; Retrospective Studies; Risk Factors; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2016 |
Voluntary co-consumption of alcohol and nicotine: Effects of abstinence, intermittency, and withdrawal in mice.
Topics: Alcohol Abstinence; Alcohol Drinking; Animals; Dose-Response Relationship, Drug; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nicotine; Species Specificity; Substance Withdrawal Syndrome; Substance-Related Disorders | 2016 |
[Chemical Constituents from Saururus chinensis].
Topics: Lignans; Nicotine; Phytochemicals; Plants, Medicinal; Saururaceae; Substance Withdrawal Syndrome | 2015 |
Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Motivation; Nicotine; Qualitative Research; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Impairment of contextual fear extinction by chronic nicotine and withdrawal from chronic nicotine is associated with hippocampal nAChR upregulation.
Topics: Animals; Drug Administration Schedule; Extinction, Psychological; Fear; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nicotine; Protein Binding; Receptors, Nicotinic; Substance Withdrawal Syndrome; Up-Regulation | 2016 |
Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine.
Topics: Animals; Male; Nicotine; Nicotinic Agonists; Probability Learning; Psychomotor Performance; Rats; Reaction Time; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2017 |
Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.
Topics: Adult; Cannabinoids; Cognition; Electroencephalography; Female; Haplotypes; Humans; Male; Memory; Middle Aged; Nicotine; Receptor, Cannabinoid, CB1; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; White People | 2016 |
Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.
Topics: Animals; Anxiety; Corticotropin-Releasing Hormone; Dependovirus; Disease Models, Animal; Genetic Vectors; Male; Mecamylamine; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Receptors, Nicotinic; Reward; Self Stimulation; Septal Nuclei; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Dyskinesia in an unmedicated adolescent with a 5-year history of tobacco use: a case report.
Topics: Adolescent; Appetite; Chewing Gum; Conduct Disorder; Directive Counseling; Dyskinesias; Humans; Hygiene; Male; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Role of Central Amygdala Neuronal Ensembles in Incubation of Nicotine Craving.
Topics: Age Factors; Animals; Animals, Newborn; beta-Galactosidase; Central Amygdaloid Nucleus; Craving; Daunorubicin; Extinction, Psychological; Female; Neurons; Nicotine; Nicotinic Agonists; Oncogene Proteins v-fos; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Self Administration; Substance Withdrawal Syndrome; Sucrose; Time Factors | 2016 |
Use of an automated mobile application to assess effects of nicotine withdrawal on verbal fluency: A pilot study.
Topics: Articulation Disorders; Cognition; Female; Humans; Male; Middle Aged; Mobile Applications; Nicotine; Pilot Projects; Substance Withdrawal Syndrome; Verbal Behavior | 2016 |
Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice.
Topics: Animals; Anxiety; Corticosterone; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Hypothalamo-Hypophyseal System; Infusions, Intraventricular; Male; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Pituitary-Adrenal System; Psychotropic Drugs; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Tobacco Use Disorder; Urocortins | 2016 |
Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Opioid-Related Disorders; Personal Satisfaction; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder; Vulnerable Populations | 2017 |
CB
Topics: Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Antagonists; Endocannabinoids; GABAergic Neurons; Glycerides; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyramidal Cells; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, GABA; Recognition, Psychology; Rimonabant; Substance Withdrawal Syndrome | 2017 |
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Depression; Habenula; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Self Administration; Substance Withdrawal Syndrome | 2017 |
Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers.
Topics: Adolescent; Adult; Carbon Monoxide; Electronic Nicotine Delivery Systems; Female; Humans; Laboratories; Male; Middle Aged; Nebulizers and Vaporizers; Nicotiana; Nicotine; Public Health; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vaping; Young Adult | 2016 |
Activation of Peripheral κ-Opioid Receptors Normalizes Caffeine Effects Modified in Nicotine-Dependent Rats during Nicotine Withdrawal.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Gastric Absorption; Gastric Mucosa; Male; Maze Learning; Motor Activity; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Withdrawal from Chronic Nicotine Exposure Produces Region-Specific Tolerance to Alcohol-Stimulated GluA1 Phosphorylation.
Topics: Administration, Inhalation; Animals; Brain; Drug Interactions; Drug Tolerance; Ethanol; Male; Nicotine; Phosphorylation; Rats; Rats, Wistar; Receptors, AMPA; Substance Withdrawal Syndrome | 2016 |
Safety of nicotine replacement therapy in critically ill smokers: a retrospective cohort study.
Topics: Adult; Aged; Cohort Studies; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Nicotine; Retrospective Studies; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Distinct Roles of CREB Within the Ventral and Dorsal Hippocampus in Mediating Nicotine Withdrawal Phenotypes.
Topics: Animals; Anxiety; Conditioning, Psychological; Cyclic AMP Response Element-Binding Protein; Fear; Female; Gene Expression; Hippocampus; Male; Mice; Mice, Knockout; Nicotine; Substance Withdrawal Syndrome | 2017 |
Nicotine levels, withdrawal symptoms, and smoking reduction success in real world use: A comparison of cigarette smokers and dual users of both cigarettes and E-cigarettes.
Topics: Adult; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder; Young Adult | 2017 |
Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.
Topics: Adult; Affective Symptoms; Anger; Anxiety; Craving; Depression; Female; Humans; Logistic Models; Male; Motivation; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Recurrence; Risk; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2017 |
Relationship of nicotine deprivation and indices of alcohol use behavior to implicit alcohol and cigarette approach cognitions in smokers.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Cognition; Comorbidity; Craving; Female; Humans; Male; Middle Aged; Motivation; Neuropsychological Tests; New England; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2017 |
Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects.
Topics: Adolescent; Adult; Affect; Attention; Consumer Behavior; Cotinine; Craving; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Young Adult | 2017 |
A debate: Can we recommend electronic cigarettes to our patients? Opinion 1.
Topics: Attitude to Health; Electronic Nicotine Delivery Systems; Humans; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2017 |
A debate: Can we recommend electronic cigarettes to our patients? Opinion 2.
Topics: Attitude to Health; Electronic Nicotine Delivery Systems; Humans; Nebulizers and Vaporizers; Nicotine; Public Opinion; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2017 |
Effects of Nicotine Metabolites on Nicotine Withdrawal Behaviors in Mice.
Topics: Animals; Anxiety; Behavior, Animal; Cotinine; Male; Mice; Mice, Inbred ICR; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2017 |
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Anesthetics, Local; Animals; Benzamides; Bridged Bicyclo Compounds; Cocaine; Conditioning, Operant; Disease Models, Animal; Fenofibrate; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Oxazoles; PPAR alpha; Pyrimidines; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine | 2017 |
Spinal microglial P2X4 receptor-brain-derived neurotrophic factor signaling regulates nicotine withdrawal-induced hyperalgesia.
Topics: Analgesics, Non-Narcotic; Animals; Brain-Derived Neurotrophic Factor; Calcium-Binding Proteins; Disease Models, Animal; Hot Temperature; Hyperalgesia; Male; Microfilament Proteins; Microglia; Minocycline; Nicotine; Nicotinic Agonists; Pain Threshold; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; Spinal Cord; Substance Withdrawal Syndrome | 2017 |
The latency to the onset of nicotine withdrawal: a test of the sensitization-homeostasis theory.
Topics: Adolescent; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Schools; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Young Adult | 2008 |
Motives for smoking and their correlates in clients attending Stop Smoking treatment services.
Topics: Adult; Female; Humans; Logistic Models; London; Male; Middle Aged; Motivation; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2008 |
Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL/6 mice.
Topics: Animals; Anxiety; Behavior, Animal; Choice Behavior; Drinking Behavior; Exploratory Behavior; Female; Ganglionic Stimulants; Male; Maze Learning; Mice; Mice, Inbred C57BL; Nicotine; Self Administration; Substance Withdrawal Syndrome | 2008 |
Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Bupropion; Conditioning, Psychological; Drug Administration Schedule; Electric Stimulation; Male; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2008 |
Correspondence of Interactive Voice Response (IVR) reports of nicotine withdrawal, craving, and negative mood with questionnaire ratings.
Topics: Adult; Comorbidity; Depression; Female; Humans; Irritable Mood; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Self Disclosure; Self-Assessment; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Nicotine administration and withdrawal affect survival in systemic inflammation models.
Topics: Animals; Body Temperature; Cecum; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Infusion Pumps, Implantable; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Sepsis; Substance Withdrawal Syndrome; Systemic Inflammatory Response Syndrome; Time Factors; Tobacco Use Disorder | 2008 |
What's new in Nicotine & Tobacco Research?
Topics: Depression; Flavoring Agents; Humans; Nicotine; Primary Prevention; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Industry; United States | 2008 |
Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity.
Topics: Animals; Avoidance Learning; Catheterization; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motivation; Nicotine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Signal Transduction; Substance Withdrawal Syndrome; Tegmentum Mesencephali; Tissue Distribution | 2008 |
How do we solve the puzzle of unintended consequences of inflammation? Systematically.
Topics: Animals; Biomedical Research; Body Temperature; Cecum; Disease Models, Animal; Disease Progression; Humans; Lipopolysaccharides; Nicotine; Nicotinic Agonists; Research Design; Sepsis; Substance Withdrawal Syndrome; Systemic Inflammatory Response Syndrome; Tobacco Use Disorder | 2008 |
Subliminal processing of smoking-related and affective stimuli in tobacco addiction.
Topics: Adolescent; Adult; Affect; Attention; Awareness; Cues; Discrimination Learning; Facial Expression; Female; Humans; Male; Motivation; Nicotine; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Size Perception; Smoking; Subliminal Stimulation; Substance Withdrawal Syndrome; Young Adult | 2008 |
Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers.
Topics: Adolescent; Air; Breath Tests; California; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Gas Chromatography-Mass Spectrometry; Humans; Incidence; Male; Nicotine; Nicotinic Agonists; Retrospective Studies; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Nicotine differentially inhibits the acoustic startle reflex in African American and Caucasian American smokers.
Topics: Adult; Behavior, Addictive; Black People; Cues; Female; Humans; Male; Nicotine; Nicotinic Agonists; Prospective Studies; Reflex, Acoustic; Reflex, Startle; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; White People | 2008 |
Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Topics: Animals; Bupropion; Depression; Dose-Response Relationship, Drug; Drug Administration Routes; Gene Expression; Male; Nicotine; Raphe Nuclei; Rats; Rats, Wistar; RNA, Messenger; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Psychosocial withdrawal characteristics of nicotine compared with alcohol and caffeine.
Topics: Adult; Aged; Behavior, Addictive; Blood Pressure; Caffeine; Central Nervous System Depressants; Central Nervous System Stimulants; Ethanol; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Social Behavior; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Behavioral effects of nicotine withdrawal in adult male and female rats.
Topics: Animals; Behavior, Animal; Data Interpretation, Statistical; Estrous Cycle; Female; Lighting; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Sex Characteristics; Substance Withdrawal Syndrome | 2009 |
The role of nicotine in smoking: a dual-reinforcement model.
Topics: Animals; Association Learning; Conditioning, Psychological; Cues; Disease Models, Animal; Ganglionic Stimulants; Humans; Motivation; Nicotine; Rats; Reward; Self Administration; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Nicotine withdrawal disrupts new contextual learning.
Topics: Animals; Conditioning, Operant; Cues; Fear; Handling, Psychological; Learning; Mental Recall; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome | 2009 |
Nicotine and Delta(9)-tetrahydrocannabinol withdrawal induce Narp in the central nucleus of the amygdala.
Topics: Amygdala; Animals; C-Reactive Protein; Cell Count; Dronabinol; Male; Morpholines; Nerve Tissue Proteins; Neurons; Nicotine; Pyrazoles; Rats; Stress, Psychological; Substance Withdrawal Syndrome | 2009 |
Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.
Topics: Amygdala; Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Mood Disorders; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome | 2009 |
Nicotine withdrawal and reward responsivity in a card-sorting task.
Topics: Adult; Female; Humans; Inhibition, Psychological; Male; Motivation; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Psychomotor Performance; Reaction Time; Reinforcement Schedule; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Token Economy | 2009 |
Of common nicotine withdrawal symptoms, depression and increased appetite are covered, with other contributions concerning endocrine, cardiovascular and respiratory changes. Preface.
Topics: Appetite; Depression; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2009 |
Management of emergent psychiatric symptoms during smoking cessation.
Topics: Humans; Mental Disorders; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2009 |
Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors.
Topics: Animals; Avoidance Learning; Conditioning, Psychological; Disease Models, Animal; Drug Administration Schedule; Fear; Male; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
Topics: Animals; Benzenesulfonates; Brain; Corticotropin-Releasing Hormone; Extinction, Psychological; Food; Injections, Intraventricular; Male; Nicotine; Peptide Fragments; Psychomotor Performance; Quinolines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Recurrence; Reward; Self Stimulation; Stress, Psychological; Substance Withdrawal Syndrome | 2009 |
Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators.
Topics: Adolescent; Adult; Affect; Alleles; Attention; Data Interpretation, Statistical; DNA; Electroencephalography; Evoked Potentials; Female; Genotype; Humans; Linear Models; Male; Middle Aged; Models, Psychological; Models, Statistical; Nicotine; Nicotinic Agonists; Receptors, Dopamine D2; Smoking; Substance Withdrawal Syndrome; Young Adult | 2009 |
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits.
Topics: Animals; Cerebral Cortex; Conditioning, Operant; Dihydro-beta-Erythroidine; Fear; Hippocampus; Learning Disabilities; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microinjections; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Thalamus | 2009 |
Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice.
Topics: Animals; Female; Habenula; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Nicotine; Nicotinic Antagonists; Protein Subunits; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tegmentum Mesencephali | 2009 |
Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Topics: Animals; Arginine; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Eating; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Injections, Intraventricular; Male; Microinjections; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substance Withdrawal Syndrome; Time Factors | 2009 |
Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention.
Topics: Adult; Attention; Cognition; Female; Humans; Impulsive Behavior; Inhibition, Psychological; Male; Neuropsychological Tests; Nicotine; Reaction Time; Regression Analysis; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2009 |
L-type calcium channels and calcium/calmodulin-dependent kinase II differentially mediate behaviors associated with nicotine withdrawal in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Behavior, Addictive; Calcium Channel Agonists; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Female; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Substance Withdrawal Syndrome | 2009 |
Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence.
Topics: Adolescent; Adult; Aged; Female; Humans; Inhibition, Psychological; London; Male; Middle Aged; Motivation; Nicotine; Reward; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2009 |
Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinence.
Topics: Humans; Motivation; Nicotine; Outcome Assessment, Health Care; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 2009 |
Enhanced nicotine sensitivity in nociceptin/orphanin FQ receptor knockout mice.
Topics: Animals; Anxiety; Drug Tolerance; Hypothermia; Male; Maze Learning; Mice; Mice, Knockout; Motor Activity; Nicotine; Nociceptin Receptor; Receptors, Opioid; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Nicotine exposure in adolescence alters the response of serotonin systems to nicotine administered subsequently in adulthood.
Topics: Affect; Aging; Animals; Brain Stem; Data Interpretation, Statistical; Female; Male; Neurons; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome | 2009 |
Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin.
Topics: Animals; Anxiety; beta-Endorphin; Conditioning, Classical; Crosses, Genetic; Exploratory Behavior; Female; Hyperkinesis; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Antagonists; Pain Measurement; Pro-Opiomelanocortin; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats.
Topics: Animals; Antibodies, Monoclonal; Brain; Dose-Response Relationship, Drug; Immunization, Passive; Immunoglobulin G; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Self Stimulation; Stereotaxic Techniques; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Nicotine withdrawal symptoms following a quit attempt: an ecological momentary assessment study among adolescents.
Topics: Adolescent; Adolescent Behavior; Female; Follow-Up Studies; Humans; Linear Models; Male; Netherlands; Nicotine; Secondary Prevention; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2009 |
Combined exposure to nicotine and ethanol in adolescent mice: effects on the central cholinergic systems during short and long term withdrawal.
Topics: Age Factors; Animals; Biomarkers; Body Weight; Brain; Choline O-Acetyltransferase; Cotinine; Drinking; Drug Interactions; Ethanol; Female; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nicotine; Protein Binding; Radioligand Assay; Receptors, Nicotinic; Substance Withdrawal Syndrome; Synapses; Time Factors | 2009 |
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.
Topics: Adult; Azetidines; Brain; Brain Mapping; Dominance, Cerebral; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tomography, Emission-Computed, Single-Photon | 2009 |
Sequencing of DSM-IV criteria of nicotine dependence.
Topics: Adolescent; Behavior, Addictive; Chicago; Child; Diagnostic and Statistical Manual of Mental Disorders; Disease Progression; Ethnicity; Female; Humans; Male; Nicotine; Prevalence; Sex Factors; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms.
Topics: Animals; Behavior, Animal; Carbachol; Diterpenes; Motor Activity; Nicotiana; Nicotine; Planarians; Substance Withdrawal Syndrome | 2009 |
Measurement of affective state during chronic nicotine treatment and withdrawal by affective taste reactivity in mice: the role of endocannabinoids.
Topics: Affect; Animals; Avoidance Learning; Cannabinoid Receptor Modulators; Endocannabinoids; Male; Mice; Mice, Inbred C57BL; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Taste; Tobacco Use Disorder | 2009 |
Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Premedication; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2009 |
Anxiety sensitivity, acute nicotine withdrawal symptoms, and anxious and fearful responding to bodily sensations: a laboratory test.
Topics: Acute Disease; Adolescent; Adult; Anxiety; Breath Tests; Fear; Female; Humans; Male; Middle Aged; Nicotine; Sensation; Smoking; Substance Withdrawal Syndrome | 2009 |
Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers.
Topics: Administration, Cutaneous; Adult; Alcohol Drinking; Counseling; Data Interpretation, Statistical; Exploratory Behavior; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Psychiatric Status Rating Scales; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2009 |
Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice.
Topics: Animals; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Conditioning, Classical; Drug Tolerance; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pain; Phenotype; Space Perception; Species Specificity; Substance Withdrawal Syndrome | 2009 |
Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
Topics: Animals; Anorexia; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Hyperphagia; Injections, Intraperitoneal; Kinetics; Male; Nicotine; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Urocortins; Weight Gain; Weight Loss | 2009 |
The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.
Topics: Animals; Anxiety; Avoidance Learning; Body Temperature; Calcium Channel Blockers; Conditioning, Operant; Conotoxins; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain Measurement; Reaction Time; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2009 |
Distinguishing risk factors for the onset of cravings, withdrawal symptoms and tolerance in novice adolescent smokers.
Topics: Adolescent; Adolescent Behavior; Child; Drug Tolerance; Epidemiologic Methods; Female; Humans; Male; Nicotine; Quebec; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Habituation, Psychophysiologic; Infusion Pumps, Implantable; Infusions, Subcutaneous; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Reinforcement, Psychology; Substance Withdrawal Syndrome; Time Factors | 2009 |
Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Bicuculline; Dopamine; Extracellular Space; GABA Antagonists; GABA-A Receptor Antagonists; Hydroxyindoleacetic Acid; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, GABA-A; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2010 |
Anxiety sensitivity and panic reactivity to bodily sensations: relation to quit-day (acute) nicotine withdrawal symptom severity among daily smokers making a self-guided quit attempt.
Topics: Adolescent; Adult; Anxiety; Carbon Monoxide; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Heart Rate; Humans; Male; Nicotine; Panic; Personality Inventory; Psychiatric Status Rating Scales; Regression Analysis; Respiration; Sensation; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Young Adult | 2009 |
Nicotine withdrawal and kappa-opioid receptors.
Topics: Adenylyl Cyclase Inhibitors; Animals; Basal Ganglia; Benzeneacetamides; Caudate Nucleus; Dynorphins; GTP-Binding Proteins; Male; Mice; Nicotine; Nucleus Accumbens; Putamen; Pyrrolidines; Receptors, Opioid, kappa; RNA, Messenger; Substance Withdrawal Syndrome | 2010 |
Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward.
Topics: Adolescent; Adult; Aged; Appetite; Behavior, Addictive; Case-Control Studies; Female; Humans; Intracellular Signaling Peptides and Proteins; Leptin; Male; Middle Aged; Motivation; Neuropeptides; Nicotine; Orexins; Reward; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2010 |
Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal.
Topics: Animals; Biomarkers; Corpus Striatum; Dopamine; Male; Mice; Neurons; Nicotine; RNA, Messenger; Substance Withdrawal Syndrome; Substantia Nigra; Ventral Tegmental Area; Vesicular Monoamine Transport Proteins | 2009 |
The effect of chewing gum on self-reported nicotine withdrawal: is it the flavor, the act of chewing, or both?
Topics: Adolescent; Adult; Chewing Gum; Female; Humans; Male; Mastication; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Taste; Texas; Young Adult | 2010 |
Comparing the predictive validity of five cigarette dependence questionnaires.
Topics: Adult; Female; Follow-Up Studies; Health Surveys; Humans; Internet; Male; Nicotine; Predictive Value of Tests; Psychometrics; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Switzerland; Time Factors; Tobacco Use Disorder | 2010 |
Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
Topics: Animals; Anxiety; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Plant Extracts; Rhodiola; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
The associative basis of cue-elicited drug taking in humans.
Topics: Anxiety; Association Learning; Attention; Behavior, Addictive; Conditioning, Psychological; Cues; Humans; Nicotine; Nicotinic Agonists; Pleasure; Recurrence; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
Topics: Animals; Antidepressive Agents, Tricyclic; Depression; Imipramine; Male; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Substance Withdrawal Syndrome; Swimming; Time Factors; Treatment Outcome | 2010 |
Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
Topics: Animals; Immunization, Passive; Male; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
Topics: Animals; Avoidance Learning; Behavior, Animal; Body Weight; Cotinine; Electric Stimulation; Environmental Exposure; Male; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reaction Time; Reward; Self Stimulation; Sexual Maturation; Substance Withdrawal Syndrome; Time Factors; Tobacco Smoke Pollution; Tobacco Use Disorder | 2010 |
Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.
Topics: Analgesics; Animals; Anxiety; Buprenorphine; Dose-Response Relationship, Drug; Hyperalgesia; Hypothermia; Male; Mice; Morphine; Nicotine; Piperidines; Receptors, Opioid, kappa; Reward; Substance Withdrawal Syndrome; Tetrahydroisoquinolines | 2010 |
Severity of dependence modulates smokers' neuronal cue reactivity and cigarette craving elicited by tobacco advertisement.
Topics: Adult; Advertising; Arousal; Brain; Brain Mapping; Cues; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neurons; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Whole Body Imaging | 2011 |
Exposure to chronic intermittent nicotine vapor induces nicotine dependence.
Topics: Administration, Inhalation; Animals; Dose-Response Relationship, Drug; Male; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Out for a smoke: the impact of cigarette craving on zoning out during reading.
Topics: Adolescent; Adult; Attention; Awareness; Comprehension; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Reading; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2010 |
Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Measurement of nicotine withdrawal symptoms: linguistic validation of the Wisconsin Smoking Withdrawal Scale (WSWS) in Malay.
Topics: Humans; Language; Linguistics; Malaysia; Nicotine; Psychological Tests; Smoking Cessation; Substance Withdrawal Syndrome; Translations | 2010 |
Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats.
Topics: Administration, Inhalation; Animals; Brain; Carboxyhemoglobin; Male; Models, Animal; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Self Stimulation; Substance Withdrawal Syndrome; Time Factors; Tobacco Smoke Pollution | 2010 |
Enhanced dopamine transporter function in striatum during nicotine withdrawal.
Topics: Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Gene Expression Regulation; Male; Mice; Nicotine; Nicotinic Agonists; RNA, Messenger; Substance Withdrawal Syndrome; Time Factors | 2011 |
Effects of nicotine withdrawal on verbal working memory and associated brain response.
Topics: Adult; Affect; Brain; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Verbal Learning | 2010 |
Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.
Topics: Amphetamine; Animals; Body Weight; Central Nervous System Stimulants; Conditioning, Operant; Depression; Drinking; Eating; Interpersonal Relations; Male; Motivation; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Reinforcement Schedule; Reward; Substance Withdrawal Syndrome; Sucrose; Weight Gain | 2010 |
Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.
Topics: Animals; Anxiety; Behavior, Animal; Bupropion; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Emotions; Hydroxylation; Hyperalgesia; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Emergence of dormant conditioned incentive approach by conditioned withdrawal in nicotine addiction.
Topics: Animals; Behavior, Addictive; Choice Behavior; Conditioning, Psychological; Cues; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Reinforcement, Psychology; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Brain; Dihydro-beta-Erythroidine; Electrodes, Implanted; Fluorobenzenes; Ganglionic Stimulants; Idazoxan; Male; Nicotine; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Serotonin Antagonists; Substance Withdrawal Syndrome | 2010 |
A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.
Topics: Adolescent; Adult; Carbon Monoxide; Clinical Laboratory Techniques; Consumer Behavior; Electronics; Female; Heart Rate; Humans; Male; Marketing; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Young Adult | 2010 |
Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction.
Topics: Adult; Anxiety; Electric Stimulation; Fear; Female; Humans; Male; Nicotine; Reflex, Startle; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
[Motivating discussions, change of attitude and handling with stress - nursing aspects of smoking cessation].
Topics: Attitude to Health; Humans; Motivation; Nicotine; Nurse-Patient Relations; Smoking Cessation; Social Support; Stress, Psychological; Substance Withdrawal Syndrome; Switzerland | 2010 |
Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Behavior, Animal; Clonidine; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prazosin; Propranolol; Rats; Rats, Wistar; Reaction Time; Reinforcement, Psychology; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Nicotine withdrawal symptoms in adolescent and adult twins.
Topics: Adolescent; Adult; Australia; Cohort Studies; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Twins | 2010 |
Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study.
Topics: Adult; Arousal; Attention; Brain; Brain Mapping; Cues; Dominance, Cerebral; Emotions; Female; Frontal Lobe; Gambling; Humans; Image Processing, Computer-Assisted; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Nerve Net; Nicotine; Oxygen Consumption; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal.
Topics: Adenylyl Cyclases; Animals; Autoradiography; Enkephalins; Male; Mice; Nicotine; Nucleus Accumbens; Protein Binding; Receptors, Opioid, delta; RNA, Messenger; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2011 |
Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity.
Topics: Animals; Behavior, Animal; Corpus Striatum; Domperidone; Dopamine; Humans; Male; Nicotine; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Self Administration; Substance Withdrawal Syndrome; Tritium; Up-Regulation | 2010 |
Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition.
Topics: Adult; Attention; Brain Mapping; Cerebral Cortex; Discrimination, Psychological; Dominance, Cerebral; Female; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Nerve Net; Nicotine; Oxygen Consumption; Pattern Recognition, Visual; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2010 |
Various facets of anxiety in nicotinic consumption and cessation.
Topics: Anxiety; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2010 |
Behavioral effects of nicotine withdrawal differ by genetic strain in male and female adolescent rats.
Topics: Adolescent; Adolescent Behavior; Age Factors; Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Models, Animal; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Wistar; Sex Factors; Species Specificity; Substance Withdrawal Syndrome | 2010 |
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.
Topics: Animals; Benzazepines; Cerebral Cortex; Hippocampus; Male; Mice; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Thalamus; Up-Regulation; Varenicline | 2011 |
NICO-TEEN: neural substrates that mediate adolescent tobacco abuse.
Topics: Adolescent; Aging; Dopamine; Humans; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Ventral Tegmental Area | 2011 |
Effect of nicotine on feeding and body weight in rats: involvement of cocaine- and amphetamine-regulated transcript peptide.
Topics: Animals; Anorexia; Arcuate Nucleus of Hypothalamus; Body Weight; Eating; Feeding Behavior; Hyperphagia; Hypothalamus, Middle; Immunohistochemistry; Injections, Intraventricular; Male; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2011 |
Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice.
Topics: Administration, Oral; Animals; Brain; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Dopamine; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Male; Mice; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Phosphorylation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.
Topics: Animals; Benzoates; Depression; Drug Synergism; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Male; Nicotine; Phosphinic Acids; Pyrimidines; Rats; Rats, Wistar; Receptors, GABA-B; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2011 |
Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal.
Topics: Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Disease Models, Animal; Drug Interactions; Endocannabinoids; Male; Mice; Mood Disorders; Motor Activity; Nicotine; Piperazines; Piperidines; Pyrazoles; Pyridines; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Male; Motor Activity; Nicotine; Rats; Rats, Wistar; Receptors, Serotonin; Secondary Prevention; Serotonin Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders; Sulfonamides; Thiophenes; Time Factors | 2011 |
L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
Topics: Animals; Behavior, Animal; Depression; Dopamine Agents; Levodopa; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Quinoxalines; Retrospective Studies; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2011 |
Exposure to nicotine and ethanol in adolescent mice: effects on depressive-like behavior during exposure and withdrawal.
Topics: Animals; Body Weight; Choice Behavior; Depression; Disease Models, Animal; Drug Interactions; Ethanol; Female; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Nicotine; Physical Endurance; Sex Characteristics; Substance Withdrawal Syndrome; Sucrose; Time Factors | 2011 |
Nicotine replacement prescribing trends in a large psychiatric hospital, before and after implementation of a hospital-wide smoking ban.
Topics: Health Promotion; Hospitals, Psychiatric; Humans; Nicotine; Organizational Policy; Pennsylvania; Practice Patterns, Physicians'; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Smoking and chronic pain: a real-but-puzzling relationship.
Topics: Chronic Disease; Humans; Nicotine; Pain; Pain Threshold; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Nicotine replacement therapy in critically ill patients: a prospective observational cohort study.
Topics: Adult; Aged; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Nicotine; Pain; Prospective Studies; Psychomotor Agitation; Severity of Illness Index; Substance Withdrawal Syndrome | 2011 |
A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Electrodes, Implanted; Extinction, Psychological; Infusion Pumps, Implantable; Male; Nicotine; Rats; Rats, Sprague-Dawley; Self Administration; Sensory Thresholds; Substance Withdrawal Syndrome | 2011 |
Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.
Topics: Amygdala; Animals; Anxiety; Benzamides; CA3 Region, Hippocampal; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Exploratory Behavior; Interpersonal Relations; Male; Motor Activity; Neuropeptide Y; Nicotine; Phenotype; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2011 |
Shifting topographic activation and 5-HT1A receptor-mediated inhibition of dorsal raphe serotonin neurons produced by nicotine exposure and withdrawal.
Topics: Animals; Ganglionic Stimulants; Male; Neurons; Nicotine; Proto-Oncogene Proteins c-fos; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Substance Withdrawal Syndrome | 2011 |
Nicotine withdrawal-induced negative affect is a function of nicotine dependence and not liability to depression or anxiety.
Topics: Adult; Anxiety; Depression; Female; Humans; Male; Nicotine; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Twins; Young Adult | 2011 |
The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Administration Schedule; Fear; Galantamine; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome | 2011 |
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nasal Sprays; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; Treatment Outcome; Varenicline | 2011 |
Nicotine behavioral pharmacology: clues from planarians.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Motor Activity; Movement; Nicotine; Nicotinic Agonists; Planarians; Stereotyped Behavior; Substance Withdrawal Syndrome | 2011 |
Positive reactions to tobacco predict relapse after cessation.
Topics: Adult; Affect; Chronic Disease; Female; Humans; Male; Nicotine; Nicotinic Agonists; Phenotype; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy.
Topics: Adult; Analysis of Variance; Consumer Behavior; Data Collection; Electronics; Female; Health Knowledge, Attitudes, Practice; Humans; Linear Models; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Social Media; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2011 |
Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Benzothiazoles; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Implants; Injections, Subcutaneous; Male; Nicotine; Nicotinic Agonists; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D5; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Neonatal hypothyroidism caused by maternal nicotine exposure is reversed by higher T3 transfer by milk after nicotine withdraw.
Topics: Animals; Animals, Newborn; Female; Hypothyroidism; Lactation; Maternal Exposure; Milk; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Thyrotropin; Triiodothyronine | 2011 |
Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
Topics: Animals; Baclofen; Behavior, Animal; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Mecamylamine; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2011 |
Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.
Topics: Animals; Anxiety; Behavior, Addictive; Cognition; Conditioning, Classical; Fear; Genetic Variation; Learning; Memory; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program.
Topics: Adaptation, Psychological; Adult; Carbon Monoxide; Counseling; Depression; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2011 |
Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens.
Topics: Animals; Dihydro-beta-Erythroidine; Dopamine; Drug Administration Schedule; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Self Administration; Substance Withdrawal Syndrome; Time Factors | 2012 |
Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network.
Topics: Amygdala; Animals; Behavior, Addictive; Brain; Cluster Analysis; Disease Models, Animal; Dronabinol; Ethanol; Gene Expression; Gene Regulatory Networks; Male; Mice; Mice, Inbred C57BL; Morphine; Nicotine; Principal Component Analysis; Real-Time Polymerase Chain Reaction; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders; Temperance; Time; Transcriptional Activation | 2012 |
5-Hydroxytryptophan attenuates somatic signs of nicotine withdrawal.
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Hydrazines; Male; Nicotine; Rats; Rats, Sprague-Dawley; Serotonin Agents; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
Topics: Affect; alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Drug Implants; Electrodes, Implanted; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Self Stimulation; Substance Withdrawal Syndrome | 2012 |
SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mecamylamine; Mice; Narcotic Antagonists; Nicotine; src-Family Kinases; Substance Withdrawal Syndrome; Sulfonamides; Tobacco Use Disorder | 2012 |
Nicotine replacement therapy use at home after use during a hospitalization.
Topics: Counseling; Female; Health Surveys; Hospitalization; Humans; Male; Middle Aged; Nicotine; Patient Discharge; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2012 |
Effects of chronic nicotine, nicotine withdrawal and subsequent nicotine challenges on behavioural inhibition in rats.
Topics: Animals; Animals, Outbred Strains; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Administration Schedule; Infusion Pumps, Implantable; Inhibition, Psychological; Male; Nicotine; Rats; Substance Withdrawal Syndrome | 2012 |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
Topics: Acute Disease; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cotinine; Endocannabinoids; Glycerides; Implants, Experimental; Locomotion; Male; Maze Learning; Nicotine; Polyunsaturated Alkamides; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Weight Gain | 2011 |
Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.
Topics: Anhedonia; Animals; Brain; Cocaine; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reward; Self Stimulation; Substance Withdrawal Syndrome; Time Factors | 2012 |
Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm.
Topics: Animals; Avoidance Learning; Calcium Channel Blockers; Drug Administration Schedule; Flunarizine; Male; Morphine; Motivation; Nicotine; Nimodipine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Verapamil | 2012 |
Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Amygdala; Animals; Benzenesulfonates; Clonidine; Electrodes, Implanted; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prazosin; Quinolines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Precipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats.
Topics: Animals; Conditioning, Operant; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Photic Stimulation; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Substance Withdrawal Syndrome; Time Factors | 2012 |
Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal.
Topics: Animals; Behavior, Animal; Deep Brain Stimulation; Male; Models, Animal; Nicotine; Rats; Self Administration; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 2012 |
The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.
Topics: Animals; Conditioning, Psychological; Fear; Hippocampus; Mice; Nicotine; Receptors, Nicotinic; Substance Withdrawal Syndrome; Up-Regulation | 2012 |
Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal.
Topics: Animals; Dissociative Disorders; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Motivation; Nicotine; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Signal Transduction; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2012 |
Shifting pharmacology of nicotine use and withdrawal: breaking the cycle of drug abuse.
Topics: Animals; Dissociative Disorders; Male; Motivation; Nicotine; Receptors, Dopamine D1; Receptors, Dopamine D2; Signal Transduction; Substance Withdrawal Syndrome | 2012 |
Predictors of risk for smoking relapse in men and women: a prospective examination.
Topics: Adult; Anger; Anxiety; Depression; Female; Follow-Up Studies; Ganglionic Stimulants; Humans; Male; Motivation; Nicotine; Prospective Studies; Recurrence; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving.
Topics: Adult; Affective Symptoms; Analysis of Variance; Animals; Brain; Female; Flumazenil; GABA Modulators; Humans; Male; Middle Aged; Nicotine; Pain Perception; Receptors, GABA-A; Sex Characteristics; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tomography, Emission-Computed, Single-Photon; Young Adult | 2013 |
Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.
Topics: Age Factors; Animals; Conditioning, Psychological; CREB-Binding Protein; Fear; Hippocampus; Male; Mice; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder; Up-Regulation | 2012 |
Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence.
Topics: Animals; Behavior, Addictive; Conditioning, Operant; Male; Monoamine Oxidase Inhibitors; Nicotine; Phenelzine; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Substance Withdrawal Syndrome; Time Factors | 2012 |
Adult mice voluntarily progress to nicotine dependence in an oral self-selection assay.
Topics: Administration, Oral; Animals; Behavior, Animal; Choice Behavior; Disease Models, Animal; Drinking Water; Drug Resistance; Feeding Behavior; Female; Male; Mice; Mice, Inbred A; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Self Administration; Sex Characteristics; Species Specificity; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Aging; Animals; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Male; Naltrexone; Nicotine; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Lower but not higher doses of transdermal nicotine facilitate cognitive performance in smokers on gender non-preferred tasks.
Topics: Administration, Cutaneous; Adult; Arousal; Cognition; Contraceptives, Oral, Hormonal; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Humans; Male; Mathematics; Mental Recall; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Psychomotor Performance; Sex Characteristics; Smoking; Stimulation, Chemical; Stroop Test; Substance Withdrawal Syndrome; Verbal Behavior | 2012 |
Influence of environmental enrichment on hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine by osmotic mini-pumps, and nicotine withdrawal by mecamylamine in male and female rats.
Topics: Adrenocorticotropic Hormone; Animals; Corticosterone; Female; Hypothalamus; Male; Mecamylamine; Nicotine; Osmotic Pressure; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Sex Characteristics; Stress, Physiological; Substance Withdrawal Syndrome | 2012 |
Circulating ghrelin levels are not associated with craving and withdrawal symptoms in acute nicotine withdrawal.
Topics: Acute Disease; Adult; Ghrelin; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.
Topics: Analysis of Variance; Animals; Brain; Conditioning, Operant; Electric Stimulation; Mecamylamine; Mice; Microelectrodes; Microinjections; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Up-Regulation | 2012 |
Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus.
Topics: Animals; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Conditioning, Psychological; Fear; Hippocampus; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Species Specificity; Substance Withdrawal Syndrome; Tobacco Use Disorder; Up-Regulation | 2013 |
Associations of functional and dysfunctional impulsivity to smoking characteristics.
Topics: Adolescent; Adult; Awareness; Decision Making; Emotions; Female; Humans; Impulsive Behavior; Male; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2012 |
Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Quality of Life; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2012 |
The interaction of nicotine withdrawal and panic disorder in the prediction of panic-relevant responding to a biological challenge.
Topics: Adolescent; Adult; Aged; Anxiety; Fear; Female; Humans; Male; Middle Aged; Nicotine; Panic; Panic Disorder; Smoking; Substance Withdrawal Syndrome | 2013 |
Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
Topics: Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Self Stimulation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal.
Topics: Adaptation, Physiological; Age Factors; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Dialysis; Dopamine; Electrochemistry; gamma-Aminobutyric Acid; Glutamic Acid; Limbic System; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Statistics as Topic; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2012 |
Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Male; Nicotine; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Rhodiola; Serotonin; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251.
Topics: Aging; Amygdala; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Corticotropin-Releasing Hormone; Exploratory Behavior; In Situ Hybridization; Interpersonal Relations; Male; Microfilament Proteins; Motor Activity; Nerve Tissue Proteins; Neuronal Plasticity; Neuropeptide Y; Neuropeptides; Nicotine; Nicotinic Agonists; Phenotype; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome | 2012 |
It only gets better: a comment on Schlam et Al.
Topics: Female; Humans; Male; Nicotine; Quality of Life; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2012 |
Handling relapse in smoking cessation: strategies and recommendations.
Topics: Algorithms; Ganglionic Stimulants; Humans; Nicotine; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2013 |
Smokeless tobacco cessation in South Asian communities: a multi-centre prospective cohort study.
Topics: Adult; Ambulatory Care; Asian People; Bangladesh; Behavior Therapy; England; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome and Process Assessment, Health Care; Patient Satisfaction; Prospective Studies; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless | 2012 |
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
Topics: Animals; Avoidance Learning; Brain; Cocaine; Corpus Striatum; Dopamine; Dynorphins; G-Protein-Coupled Receptor Kinase 3; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microinjections; Naltrexone; Narcotic Antagonists; Nicotine; Nucleus Accumbens; p38 Mitogen-Activated Protein Kinases; Raphe Nuclei; Receptors, Opioid, kappa; Reward; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Stress, Psychological; Substance Withdrawal Syndrome; Synaptosomes | 2012 |
Nicotine reward and affective nicotine withdrawal signs are attenuated in calcium/calmodulin-dependent protein kinase IV knockout mice.
Topics: Animals; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Cocaine; Female; Haplotypes; Humans; Linkage Disequilibrium; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nucleus Accumbens; Phenotype; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
[Current concepts in tobacco cessation and prevention].
Topics: Counseling; Dentists; Humans; Interview, Psychological; Motivation; Nicotine; Nicotinic Agonists; Oral Hygiene; Physician's Role; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2012 |
Nicotine vapor inhalation escalates nicotine self-administration.
Topics: Analysis of Variance; Animals; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Molecular Sequence Data; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Volatilization | 2014 |
Stress response dysregulation and stress-induced analgesia in nicotine dependent men and women.
Topics: Adult; Affect; Analgesia; Blood Pressure; Female; Humans; Hydrocortisone; Male; Nicotine; Pain Measurement; Pain Perception; Pain Threshold; Saliva; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2013 |
Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; G-Protein-Coupled Receptor Kinase 5; Indoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrroles; Substance Withdrawal Syndrome | 2013 |
Nicotine withdrawal upregulates nitrergic and galaninergic activity in the rat dorsal raphe nucleus and locus coeruleus.
Topics: Animals; Galanin; Locus Coeruleus; Male; Nicotine; Nitric Oxide Synthase Type I; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Up-Regulation | 2013 |
[Nicotine withdrawal syndrome after cardiac surgery: a case about].
Topics: Cardiac Surgical Procedures; Humans; Male; Middle Aged; Nicotine; Postoperative Complications; Psychomotor Agitation; Substance Withdrawal Syndrome | 2012 |
Beta2-containing nicotinic acetylcholine receptors mediate calcium/calmodulin-dependent protein kinase-II and synapsin I protein levels in the nucleus accumbens after nicotine withdrawal in mice.
Topics: Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dihydro-beta-Erythroidine; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Phosphoproteins; Phosphorylation; Receptors, Nicotinic; Signal Transduction; Substance Withdrawal Syndrome; Synapsins; Time Factors; Tobacco Use Disorder | 2013 |
Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers.
Topics: Electrical Equipment and Supplies; Humans; Memory, Episodic; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2013 |
Effect of wheel-running during abstinence on subsequent nicotine-seeking in rats.
Topics: Aging; Animals; Behavior, Animal; Conditioning, Operant; Cues; Drug-Seeking Behavior; Extinction, Psychological; Male; Nicotine; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Self Administration; Substance Withdrawal Syndrome | 2013 |
Increase of transcriptional levels of egr-1 and nur77 genes due to both nicotine treatment and withdrawal in pheochromocytoma cells.
Topics: Animals; DNA-Binding Proteins; Early Growth Response Protein 1; Immediate-Early Proteins; Nicotine; Nuclear Receptor Subfamily 4, Group A, Member 1; PC12 Cells; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger; Substance Withdrawal Syndrome; Transcription Factors; Transcription, Genetic | 2002 |
Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Female; Injections, Intraventricular; Neuropeptide Y; Nicotine; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2002 |
Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala.
Topics: Adenylyl Cyclases; Amygdala; Animals; Cyclic AMP; Ganglionic Stimulants; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Signal Transduction; Stress, Psychological; Substance Withdrawal Syndrome; Up-Regulation | 2002 |
Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors.
Topics: Amphetamines; Analysis of Variance; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Head Movements; Injections, Intraventricular; Ketanserin; Male; Mice; Mice, Inbred BALB C; Nicotine; Receptors, Nicotinic; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2002 |
Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Aging; Animals; Brain Chemistry; Colforsin; Female; GTP-Binding Proteins; Isoproterenol; Male; Nicotine; Nicotinic Agonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Signal Transduction; Substance Withdrawal Syndrome; Up-Regulation | 2002 |
[Acute confusional syndrome due to acute nicotine withdrawal].
Topics: Acute Disease; Aged; Delirium; Hospitalization; Humans; Lung Diseases, Obstructive; Male; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Syndrome | 2002 |
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
Topics: Analgesics; Animals; Behavior, Animal; Conditioning, Operant; Hot Temperature; Immersion; Male; Mecamylamine; Mice; Mice, Knockout; Motor Activity; Neural Pathways; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain Measurement; Reaction Time; Receptors, Cannabinoid; Receptors, Drug; Reward; Substance Withdrawal Syndrome | 2002 |
Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking.
Topics: Adolescent; Adult; Cues; Dose-Response Relationship, Drug; Humans; Middle Aged; Motivation; Neurologic Examination; Nicotine; Reaction Time; Smoking; Substance Withdrawal Syndrome | 2003 |
Acute effects of Advance: a potential reduced exposure product for smokers.
Topics: Adolescent; Adult; Air Pollutants; Carbon Monoxide; Cross-Over Studies; Environmental Exposure; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Information from your family doctor. Smoking: do I want to quit?
Topics: Attitude to Health; Humans; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.
Topics: Analgesics; Animals; Behavior, Animal; Conditioning, Psychological; Locomotion; Mecamylamine; Mice; Mice, Knockout; Nicotine; Nicotinic Antagonists; Receptors, Opioid, mu; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Acute effects of nicotine withdrawal syndrome in pilots during flight.
Topics: Adult; Aerospace Medicine; Anxiety; Attention; Blood Pressure; Fatigue; Ganglionic Stimulants; Heart Rate; Humans; Male; Nicotine; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Task Performance and Analysis; Tobacco Use Disorder | 2003 |
Effects of nicotine deprivation on craving response covariation in smokers.
Topics: Adult; Affect; Choice Behavior; Cues; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Judgment; Male; Middle Aged; Nicotine; Random Allocation; Reaction Time; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome | 2003 |
Nicotine and its withdrawal modify dorsal raphe 8-hydroxy-2-(di-n-propylamino) tetralin feeding.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Weight; Eating; Feeding Behavior; Female; Nicotine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2003 |
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
Topics: Animals; Azepines; Behavior, Animal; Body Temperature; Brain; Cardiovascular System; Cells, Cultured; Dextroamphetamine; Discrimination Learning; Drug Interactions; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mecamylamine; Microdialysis; Motor Activity; Nicotine; Nicotinic Agonists; Oocytes; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transfection; Xenopus laevis | 2003 |
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Bupropion; Drug Administration Schedule; Electric Stimulation; Male; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2003 |
Impact of nicotine withdrawal on novelty reward and related behaviors.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Drug Interactions; Ganglionic Blockers; Ganglionic Stimulants; Male; Mecamylamine; Motor Activity; Nicotine; Rats; Reaction Time; Reward; Social Environment; Substance Withdrawal Syndrome; Time Factors | 2003 |
Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
Topics: Animals; Central Nervous System Stimulants; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Infusion Pumps, Implantable; Male; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Self Stimulation; Sensory Thresholds; Substance Withdrawal Syndrome | 2003 |
Hypericum perforatum attenuates nicotine withdrawal signs in mice.
Topics: Animals; Hypericum; Male; Mice; Models, Animal; Motor Activity; Nicotine; Phytotherapy; Plant Extracts; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2003 |
Nicotine dependence: development, mechanisms, individual differences and links to possible neurophysiological correlates.
Topics: Arousal; Brain; Drug Tolerance; Emotions; Humans; Individuality; Motivation; Nicotine; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Up-Regulation | 2003 |
The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit.
Topics: Adult; Humans; Logistic Models; Male; Middle Aged; Nicotine; Prevalence; Registries; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Failure; Twins | 2003 |
Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: a comparison of postmenopausal women using and not using hormone replacement therapy.
Topics: Adult; Aged; Counseling; Depression; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nicotine; Postmenopause; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2003 |
Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Topics: Animals; Bridged Bicyclo Compounds; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Male; Nicotine; Pyridines; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Reward; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2003 |
Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers.
Topics: Adult; Alcoholism; Breath Tests; Carbon Monoxide; Cotinine; Cues; Female; Humans; Imagery, Psychotherapy; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Salivation; Smoking; Substance Withdrawal Syndrome | 2003 |
C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence.
Topics: Adolescent; Blood Pressure; C-Reactive Protein; Depression; Female; Heart Rate; Humans; Interleukin-1; Interleukin-6; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Decreased prepulse inhibition during nicotine withdrawal in DBA/2J mice is reversed by nicotine self-administration.
Topics: Animals; Behavior, Animal; Injections, Intravenous; Male; Mecamylamine; Mice; Mice, Inbred DBA; Nicotine; Nicotinic Antagonists; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Effect of i.c.v. infusion of the alpha-MSH agonist MTII on meal patterns in male rats following nicotine withdrawal.
Topics: alpha-MSH; Animals; Body Weight; Dose-Response Relationship, Drug; Feeding Behavior; Injections, Intraventricular; Male; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2003 |
[Girl with asthma suffering from nicotine craving and feeling dizzy].
Topics: Acute Disease; Adolescent; Asthma; Dizziness; Female; Humans; Medication Errors; Nicotine; Nitroglycerin; Polymethacrylic Acids; Polyvinyls; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Vasodilator Agents | 2003 |
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.
Topics: Animals; Disease Models, Animal; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Antagonists; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2003 |
Bupropion-induced somnambulism.
Topics: Adult; Amnesia; Bupropion; Dopamine Uptake Inhibitors; Humans; Male; Nicotine; Smoking Cessation; Somnambulism; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
[Autosuggestion & its role in tobacco withdrawal].
Topics: Autosuggestion; Humans; Nicotiana; Nicotine; Smoking; Substance Withdrawal Syndrome; Suggestion | 1959 |
[On the effect of lobeline in nicotine withdrawal].
Topics: Lobeline; Nicotine; Serotonin; Smoking; Substance Withdrawal Syndrome | 1963 |
[GENERAL EXPERIENCES IN NICOTINE WITHDRAWAL].
Topics: Family Practice; General Practice; Humans; Lobeline; Nicotine; Smoking; Substance Withdrawal Syndrome | 1964 |
[NICOTINE DAMAGE--NICOTINE WITHDRAWAL].
Topics: Central Nervous System Stimulants; Drug Therapy; Hungary; Nicotine; Smoking; Statistics as Topic; Substance Withdrawal Syndrome; Toxicology | 1964 |
TOBACCO ADDICTION: A FURTHER INQUIRY.
Topics: Humans; Nicotiana; Nicotine; Psychology; Research; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1964 |
[POSTOPERATIVE INTESTINAL ATONY IN THE SMOKER].
Topics: Humans; Intestinal Obstruction; Muscle, Smooth; Nicotine; Postoperative Complications; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1964 |
[TOBACCO SMOKING AND TRAFFIC].
Topics: Accidents; Accidents, Traffic; Automobile Driving; Automobiles; Drug Therapy; Humans; Lobeline; Nicotine; Research; Smoking; Substance Withdrawal Syndrome; Toxicology | 1965 |
[Smokers' habits and nicotine withdrawal. Practical neurological bases and experiences].
Topics: Habits; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 1961 |
[Acute confusional syndrome due to acute nicotine withdrawal].
Topics: Accidents, Traffic; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychomotor Agitation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Smoke free hospitals: withdrawal from cigarettes should not be confused with withdrawal from nicotine.
Topics: Hospitals; Humans; Nicotine; Nicotinic Agonists; Patients' Rooms; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Smoking abstinence impairs time estimation accuracy in cigarette smokers.
Topics: Adolescent; Adult; Attention; Female; Humans; Male; Neuropsychological Tests; Nicotine; Smoking; Substance Withdrawal Syndrome; Time Factors; Time Perception; Young Adult | 2003 |
Nicotine reversal effects of the benzoflavone moiety from Passiflora incarnata Linneaus in mice.
Topics: Animals; Benzoflavones; Drug Administration Schedule; Drug Therapy, Combination; Female; Locomotion; Male; Mice; Naloxone; Narcotic Antagonists; Nicotine; Passiflora; Phytotherapy; Plant Preparations; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation.
Topics: Adaptation, Physiological; Adrenal Cortex Function Tests; Animals; Corticosterone; Depression; Dexamethasone; Disease Models, Animal; Glucocorticoids; Hippocampus; Hypothalamo-Hypophyseal System; Male; Nicotine; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucocorticoid; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2004 |
Stopping smoking can cause constipation.
Topics: Bupropion; Constipation; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Effect of cue exposure, urge to smoke, and nicotine deprivation on cognitive performance in smokers.
Topics: Adolescent; Adult; Cognition; Cues; Female; Humans; Male; Motivation; Nicotine; Smoking; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine.
Topics: Affective Symptoms; Amphetamine; Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Male; Nicotine; Rats; Rats, Wistar; Reward; Substance Withdrawal Syndrome | 2003 |
Individual self-administration of nicotine by rats.
Topics: Animals; Dose-Response Relationship, Drug; Female; Male; Nicotine; Nicotinic Agonists; Rats; Self Administration; Sex Characteristics; Substance Withdrawal Syndrome | 2003 |
Sex-selective hippocampal alterations after adolescent nicotine administration: effects on neurospecific proteins.
Topics: Adolescent; Animals; Biomarkers; Disease Models, Animal; Ganglionic Stimulants; Glial Fibrillary Acidic Protein; Hippocampus; Humans; Neurofilament Proteins; Nicotine; Rats; Rats, Sprague-Dawley; Sex Factors; Substance Withdrawal Syndrome | 2003 |
Craving for cigarettes among low and high dependent smokers: impact of norharman.
Topics: Adult; Carbolines; Circadian Rhythm; Female; Harmine; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Ganglionic Stimulants; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2004 |
[Delirium after sudden interruption of nicotine consumption].
Topics: Aged; Delirium; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2004 |
Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates?
Topics: Adult; Cotinine; Female; Fetal Blood; Humans; Infant; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Nervous System Diseases; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking; Statistics as Topic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal.
Topics: Alkaloids; Animals; Azocines; Body Weight; Cerebral Cortex; Choline O-Acetyltransferase; Female; Male; Membrane Transport Proteins; Mesencephalon; Nicotine; Nicotinic Agonists; Parasympathetic Nervous System; Pregnancy; Prenatal Exposure Delayed Effects; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Substance Withdrawal Syndrome | 2004 |
Hedonic capacity, cigarette craving, and diminished positive mood.
Topics: Adolescent; Adult; Aged; Behavior, Addictive; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Leisure Activities; Male; Middle Aged; Mood Disorders; Nicotine; Severity of Illness Index; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2004 |
Reduction of withdrawal signs after chronic nicotine exposure of alpha-calcitonin gene-related peptide knock-out mice.
Topics: Animals; Calcitonin Gene-Related Peptide; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence.
Topics: Adult; Apomorphine; Dopamine D2 Receptor Antagonists; Human Growth Hormone; Humans; Male; Motivation; Neuropsychological Tests; Nicotine; Receptors, Dopamine D2; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Advances in pharmacotherapy for tobacco dependence.
Topics: Animals; Blood-Brain Barrier; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Drug Administration Routes; Drug Design; Drug Evaluation, Preclinical; Drug Therapy, Combination; Health Education; Humans; Marketing; Mental Disorders; Nicotine; Nicotinic Antagonists; Rats; Smoking; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vaccines | 2004 |
[Recommendation of good practice: Therapeutic strategies, with or without the assistance of medicine-based treatment, for stopping smoking (May 2003)].
Topics: Adolescent; Alcohol Drinking; Bupropion; Cotinine; Female; Humans; MEDLINE; Nicotine; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal.
Topics: Adult; Affect; Analysis of Variance; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotine; Psychomotor Agitation; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats.
Topics: Analysis of Variance; Animals; Drug Implants; Kinetics; Male; Nicotine; Nucleus Accumbens; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 2004 |
Decrease of ventral tegmental area dopamine neuronal activity in nicotine withdrawal rats.
Topics: Animals; Dopamine; Electrophysiology; Male; Neurons; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tobacco Use Disorder; Ventral Tegmental Area | 2004 |
What's new in nicotine & tobacco research?
Topics: Antidepressive Agents; Counseling; Ganglionic Stimulants; Humans; Internet; Nicotine; Radon; Research; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
[Restlessness in intensive care unit: think to the nicotinic withdrawal syndrome].
Topics: Administration, Cutaneous; Critical Care; Female; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Psychomotor Agitation; Respiration, Artificial; Respiratory Distress Syndrome; Resuscitation; Substance Withdrawal Syndrome; Ventilator Weaning | 2004 |
Nicotine withdrawal in adolescent and adult rats.
Topics: Adolescent; Age Factors; Analysis of Variance; Animals; Blinking; Disease Models, Animal; Drug Administration Schedule; Humans; Infusion Pumps, Implantable; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
Topics: Acoustic Stimulation; Animals; Cues; Dopamine; Environment; Extinction, Psychological; Light; Male; Motivation; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2005 |
Modulation of CREB expression and phosphorylation in the rat nucleus accumbens during nicotine exposure and withdrawal.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation; Male; Nicotine; Nucleus Accumbens; Phosphorylation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2004 |
Deficits in a sustained attention task following nicotine withdrawal in rats.
Topics: Animals; Attention; Choice Behavior; Male; Nicotine; Rats; Receptors, Dopamine D1; Serial Learning; Substance Withdrawal Syndrome | 2005 |
Nicotine physical dependence and tolerance in the mouse following chronic oral administration.
Topics: Administration, Oral; Animals; Arousal; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Mice, Inbred ICR; Motor Activity; Nicotine; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2005 |
What's new in nicotine & tobacco research?
Topics: Ganglionic Stimulants; Genetic Predisposition to Disease; Humans; Indians, North American; Nicotine; Recurrence; Smoking; Smoking Cessation; Social Conditions; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats.
Topics: Adaptation, Physiological; Animals; Cholinergic Fibers; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Male; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Synaptic Transmission; Ventral Tegmental Area | 2004 |
Salivary cortisol concentrations are associated with acute nicotine withdrawal.
Topics: Acute Disease; Adult; Biomarkers; Humans; Hydrocortisone; Male; Nicotine; Saliva; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Anxiety sensitivity: association with intensity of retrospectively-rated smoking-related withdrawal symptoms and motivation to quit.
Topics: Adult; Anxiety; Female; Humans; Male; Motivation; Nicotine; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2004 |
Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study.
Topics: Adaptation, Physiological; Animals; Chromatography, High Pressure Liquid; Conditioning, Operant; Dopamine; Extracellular Space; Infusions, Intravenous; Male; Microdialysis; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Long-Evans; Self Administration; Substance Withdrawal Syndrome; Synaptic Transmission | 2004 |
Treatment of tobacco use in an inpatient psychiatric setting.
Topics: Adult; Alcoholism; Combined Modality Therapy; Comorbidity; Drug Administration Routes; Female; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Nicotine; Patient Acceptance of Health Care; Patient Discharge; Psychiatric Department, Hospital; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome | 2004 |
Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit.
Topics: Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Female; Genotype; Grooming; Hyperalgesia; Infusion Pumps, Implantable; Male; Mastication; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Nicotine; Pyridines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tremor | 2004 |
Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Benzoxazines; Brain; Calcium Channel Blockers; Cell Count; Conditioning, Operant; Dronabinol; Drug Administration Schedule; Drug Interactions; Immunohistochemistry; In Vitro Techniques; Male; Mecamylamine; Mice; Morpholines; Motivation; Naloxone; Naphthalenes; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Proto-Oncogene Proteins c-fos; Radioligand Assay; Substance Withdrawal Syndrome | 2004 |
Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement.
Topics: Animals; Central Nervous System Depressants; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Reinforcement, Psychology; Reward; Self Administration; Substance Withdrawal Syndrome | 2004 |
Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.
Topics: Analgesics; Animals; Conditioning, Classical; Dopamine; Enkephalins; Female; Hot Temperature; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Motor Activity; Nicotine; Nucleus Accumbens; Opioid Peptides; Pain Measurement; Pain Threshold; Protein Precursors; Reward; Spatial Behavior; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
Effects of short-term nicotine deprivation on decision-making: delay, uncertainty and effort discounting.
Topics: Adult; Decision Making; Female; Ganglionic Stimulants; Humans; Impulsive Behavior; Male; Nicotine; Reinforcement, Psychology; Substance Withdrawal Syndrome; Task Performance and Analysis; Tobacco Use Disorder | 2004 |
A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence.
Topics: Adolescent; Adult; Aged; Confidence Intervals; Female; Follow-Up Studies; Health Surveys; Humans; Internet; Male; Middle Aged; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; ROC Curve; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Switzerland; Tobacco Use Disorder | 2005 |
Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence.
Topics: Adult; Behavior, Addictive; Brain; Brain Mapping; Cerebellum; Circadian Rhythm; Corpus Striatum; Female; Gyrus Cinguli; Hippocampus; Humans; Male; Middle Aged; Nicotine; Oxygen Radioisotopes; Positron-Emission Tomography; Regional Blood Flow; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Visual Cortex; Water | 2005 |
Cigarette smoking, stress-induced analgesia and pain perception in men and women.
Topics: Adrenocorticotropic Hormone; Adult; beta-Endorphin; Blood Pressure; Cold Temperature; Female; Heart Rate; Hot Temperature; Humans; Hydrocortisone; Ischemia; Male; Nicotine; Nociceptors; Norepinephrine; Pain Threshold; Perception; Sex Characteristics; Smoking; Stress, Psychological; Substance Withdrawal Syndrome | 2005 |
Reliability and validity of the French version of the tobacco craving questionnaire.
Topics: Adult; Female; France; Humans; Language; Male; Nicotine; Reproducibility of Results; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2005 |
Expression levels of Rab2, a G protein, and Bag-1, a Bcl-2 binding protein are controlled by withdrawal of nicotine from cultured pheochromocytoma PC12 cells.
Topics: Animals; Blotting, Western; DNA-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation; Nicotine; Nicotinic Agonists; PC12 Cells; rab2 GTP-Binding Protein; Rats; Substance Withdrawal Syndrome; Transcription Factors | 2005 |
Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain.
Topics: Adult; Aged; Aged, 80 and over; Anxiety; Depression; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Phenotype; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2005 |
The smoking gun: many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine.
Topics: Anxiety; Autonomic Nervous System; Humans; Hypertension; Inflammation; Models, Biological; Neoplasms; Nicotine; Receptors, Nicotinic; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Sympathetic Nervous System; Tachycardia; Th2 Cells; Tobacco, Smokeless; Tumor Escape; Vagus Nerve | 2005 |
Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders.
Topics: Adult; Female; Ganglionic Stimulants; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Risk Factors; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Exaggeration of epileptic-like patterns by nicotine receptor activation during the GABA withdrawal syndrome.
Topics: Animals; Epilepsy; gamma-Aminobutyric Acid; Male; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2005 |
[Delirium from nicotine withdrawal in a post-operative adult patient].
Topics: Delirium; Humans; Intensive Care Units; Male; Middle Aged; Nicotine; Postoperative Period; Substance Withdrawal Syndrome | 2005 |
Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Body Weight; Female; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Tobacco Use Disorder | 2005 |
Mild anxiogenic effects of nicotine withdrawal in mice.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Darkness; Dose-Response Relationship, Drug; Ganglionic Stimulants; Inhibition, Psychological; Light; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nicotine; Reflex, Startle; Substance Withdrawal Syndrome | 2005 |
Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems.
Topics: Animals; Brain; Disease Models, Animal; Male; Nicotine; Rats; Rats, Wistar; Reward; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
The airway sensory impact of nicotine contributes to the conditioned reinforcing effects of individual puffs from cigarettes.
Topics: Adult; Analysis of Variance; Conditioning, Operant; Female; Ganglionic Stimulants; Heart Rate; Humans; Male; Middle Aged; Nicotine; Reinforcement, Psychology; Respiratory System; Reward; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2005 |
Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats.
Topics: Animals; Association Learning; Conditioning, Operant; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Oxygen as a therapy for reducing nicotine withdrawal symptoms.
Topics: Brain; Dopamine; Humans; Models, Biological; Nicotine; Oxygen; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
Topics: Animals; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Drug Tolerance; Hypothalamus, Posterior; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Ventral Tegmental Area | 2005 |
Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery.
Topics: Adult; Arousal; Association Learning; Attention; Behavior, Addictive; Brain; Brain Mapping; Cues; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imagination; Linear Models; Magnetic Resonance Imaging; Male; Memory; Motivation; Nicotine; Oxygen; Psychomotor Performance; Smoking; Statistics as Topic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Neurosteroids in nicotine and morphine dependence.
Topics: Analgesics, Opioid; Animals; Cerebral Cortex; Male; Mecamylamine; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nicotine; Nicotinic Antagonists; Pregnanolone; Pregnenolone; Progesterone; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2006 |
Ask the doctor. On the day I stopped smoking a few weeks ago, I started using a nicotine patch. When I smoked, my blood pressure was great--100/70. NOw it is up to 160/90. I would hate to stop the patch, since it really helps, but I'm worried that it coul
Topics: Administration, Cutaneous; Humans; Hypertension; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
Smoking cessation among Chinese young smokers: does gender and age difference matters and what are the predictors?
Topics: Adolescent; Adult; Age Factors; Asian People; Cross-Sectional Studies; Educational Status; Female; Hong Kong; Humans; Longitudinal Studies; Male; Motivation; Nicotine; Occupations; Patient Compliance; Prognosis; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Bupropion attenuates nicotine abstinence syndrome in the rat.
Topics: Animals; Association Learning; Avoidance Learning; Bupropion; Conditioning, Classical; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Premedication; Rats; Rats, Sprague-Dawley; Social Environment; Substance Withdrawal Syndrome | 2006 |
Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice.
Topics: Animals; Conditioning, Psychological; Fear; Male; Mice; Mice, Inbred C57BL; Nicotine; Substance Withdrawal Syndrome | 2005 |
Nicotine and acute stress: effects of nicotine versus nicotine withdrawal on stress-induced hemoconcentration and cardiovascular reactivity.
Topics: Acute Disease; Administration, Cutaneous; Adolescent; Adult; Affect; Blood Pressure; Blood Viscosity; Body Height; Body Weight; Female; Heart Rate; Hematocrit; Hemodynamics; Hemoglobins; Humans; Male; Nicotine; Stress, Psychological; Substance Withdrawal Syndrome | 2006 |
Nicotine withdrawal and nicotine replacement in the palliative care setting.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Nicotine; Nicotinic Agonists; Palliative Care; Parotid Neoplasms; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Dihydro-beta-Erythroidine; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Withdrawal Syndrome; Time Factors | 2006 |
Effects of intrahippocampal nicotine and neurosteroid administration on withdrawal in voluntary and chronic alcohol-drinking rats.
Topics: Animals; Body Weight; Ethanol; Hippocampus; Male; Motor Activity; Nicotine; Pregnanolone; Pregnenolone; Rats; Rats, Wistar; Seizures; Substance Withdrawal Syndrome | 2005 |
Nicotine as a typical drug of abuse in experimental animals and humans.
Topics: Animals; Conditioning, Operant; Disease Models, Animal; Humans; Nicotine; Recurrence; Reinforcement, Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Acute nicotine withdrawal symptoms and anxious responding to bodily sensations: a test of incremental predictive validity among young adult regular smokers.
Topics: Adult; Anxiety; Female; Humans; Male; Nicotine; Panic Disorder; Prospective Studies; Psychological Tests; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bacterial Toxins; Biological Transport; Conotoxins; Cyanobacteria Toxins; Dihydro-beta-Erythroidine; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Male; Marine Toxins; Microcystins; Neurons; Nicotine; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tetrodotoxin; Tropanes | 2006 |
Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Topics: Animals; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Conotoxins; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Iodine Radioisotopes; Male; Mesencephalon; Neural Pathways; Nicotine; Nicotinic Agonists; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Nicotinic; Substance Withdrawal Syndrome; Substantia Nigra; Tobacco Use Disorder; Ventral Tegmental Area | 2006 |
Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs.
Topics: Animals; Dopamine; Male; Mecamylamine; Microdialysis; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2005 |
Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales.
Topics: Adolescent; Adult; Aged; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Personality Inventory; Psychometrics; Recurrence; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling.
Topics: Age Factors; Analysis of Variance; Animals; Brain; Colforsin; Female; Male; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Protein Binding; Rats; Receptors, Serotonin; Sex Factors; Signal Transduction; Substance Withdrawal Syndrome | 2006 |
Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Avoidance Learning; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Time Factors | 2006 |
Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse.
Topics: Adult; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Motivation; Nicotine; Pituitary-Adrenal System; Prognosis; Recurrence; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
Topics: Amygdala; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Dihydro-beta-Erythroidine; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Nicotine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Nicotinic; Septal Nuclei; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Bupropion; Counseling; Epinephrine; Female; Heart Rate; Humans; Hydrocortisone; Male; Middle Aged; Nicotine; Norepinephrine; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors | 2006 |
Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study.
Topics: Adult; Brain; Brain Mapping; Cognition; Cues; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Photic Stimulation; Prefrontal Cortex; Reward; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction.
Topics: Age Factors; Animals; Behavior, Animal; Cotinine; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Self Stimulation; Sensory Thresholds; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Effects of chronic nicotine administration and its withdrawal on striatal FosB/DeltaFosB and c-Fos expression in rats and mice.
Topics: Animals; Blotting, Western; Brain Chemistry; Data Interpretation, Statistical; Gene Expression; Immunohistochemistry; Male; Mice; Motor Activity; Neostriatum; Nicotine; Nicotinic Agonists; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Species Specificity; Substance Withdrawal Syndrome | 2006 |
Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats.
Topics: Animals; Male; Motivation; Nicotine; Rats; Reinforcement Schedule; Self Administration; Self Stimulation; Substance Withdrawal Syndrome; Sucrose | 2006 |
Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke.
Topics: Animals; Blotting, Western; Depression; Male; Mice; Nicotine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Smoke; Stress, Physiological; Substance Withdrawal Syndrome; Swimming | 2006 |
Genetic analyses of DSM-IV nicotine withdrawal in adult twins.
Topics: Adult; Australia; Cohort Studies; Disease Progression; Female; Humans; Irritable Mood; Male; Models, Statistical; Nicotine; Smoking; Substance Withdrawal Syndrome | 2006 |
Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome.
Topics: Animals; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Nicotine; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Ventral Tegmental Area | 2006 |
Attenuation of nicotine-induced rewarding effects in A2A knockout mice.
Topics: Animals; Avoidance Learning; Behavior, Animal; Conditioning, Psychological; Dopamine; Dose-Response Relationship, Drug; Mice; Mice, Knockout; Microdialysis; Motor Activity; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Receptor, Adenosine A2A; Reward; Substance Withdrawal Syndrome; Taste | 2006 |
Nicotine gum withdrawal and migraine headaches.
Topics: Central Nervous System Stimulants; Chewing Gum; Female; Humans; Middle Aged; Migraine Disorders; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice.
Topics: Analysis of Variance; Animals; Behavior, Animal; Biogenic Monoamines; Central Nervous System Stimulants; Cocaine; Dopamine; Drug Interactions; Male; Mice; Morphine; Motor Activity; Narcotics; Neostriatum; Nicotine; Norepinephrine; Nucleus Accumbens; Serotonin; Substance Withdrawal Syndrome | 2006 |
Physicians' counseling of patients when prescribing nicotine replacement therapy.
Topics: Attitude of Health Personnel; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Patient Education as Topic; Physician-Patient Relations; Physician's Role; Polymethacrylic Acids; Polyvinyls; Practice Patterns, Physicians'; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2007 |
Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: an in vivo microdialysis study.
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Arginine; Brain Chemistry; Central Nervous System Depressants; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Ethanol; Extracellular Fluid; Glutamic Acid; Male; Microdialysis; Nicotine; Nicotinic Agonists; Nitric Oxide; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.
Topics: Adult; Brain; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Positron-Emission Tomography; Pyridines; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Tissue Distribution; Tobacco Use Disorder | 2006 |
Nicotine stimulation on extracellular glutamate levels in the nucleus accumbens of ethanol-withdrawn rats in vivo.
Topics: Alcoholic Intoxication; Animals; Ethanol; Extracellular Fluid; Glutamic Acid; Male; Nicotine; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2006 |
Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
Topics: Animals; Behavior, Animal; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Reward; Self Administration; Substance Withdrawal Syndrome | 2007 |
Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Behavior, Animal; Diarrhea; Diazoxide; Dose-Response Relationship, Drug; Ganglionic Stimulants; Glyburide; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Nicotine; Potassium Channels, Inwardly Rectifying; Substance Withdrawal Syndrome | 2006 |
Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats.
Topics: Animals; Circadian Rhythm; Eating; Extinction, Psychological; Male; Mecamylamine; Nicotine; Rats; Rats, Wistar; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Nicotine withdrawal increases body weight, neuropeptide Y and Agouti-related protein expression in the hypothalamus and decreases uncoupling protein-3 expression in the brown adipose tissue in high-fat fed mice.
Topics: Adipose Tissue, Brown; Agouti Signaling Protein; Agouti-Related Protein; Analysis of Variance; Animals; Body Weight; Dietary Fats; Hypothalamus; Intercellular Signaling Peptides and Proteins; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Neuropeptide Y; Nicotine; Nicotinic Agonists; Receptors, Adrenergic, beta; Substance Withdrawal Syndrome; Uncoupling Protein 3 | 2007 |
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Anxiety Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Synergism; Male; Maze Learning; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Secondary Prevention; Substance Withdrawal Syndrome; Sucrose | 2007 |
Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: a preliminary study.
Topics: Adult; Arousal; Attention; Brain; Dominance, Cerebral; Female; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Nicotine; Pattern Recognition, Visual; Prefrontal Cortex; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Topics: Amino Acids; Animals; Dose-Response Relationship, Drug; Drug Interactions; Eating; Excitatory Amino Acid Antagonists; Ganglionic Stimulants; Infusions, Intravenous; Injections, Intraperitoneal; Male; Nicotine; Pyridines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Reward; Self Administration; Substance Withdrawal Syndrome; Time Factors; Xanthenes | 2007 |
Clinical laboratory evaluation of potential reduced exposure products for smokers.
Topics: Adult; Biomarkers; Carbon Monoxide; Carcinogens; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Respiratory Function Tests; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory.
Topics: Adult; Choice Behavior; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Tobacco Use Disorder; Token Economy | 2007 |
Nicotine withdrawal suppresses nicotinic modulation of long-term potentiation induction in the hippocampal CA1 region.
Topics: Animals; Azetidines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; GABA Antagonists; Hippocampus; Inhibitory Postsynaptic Potentials; Long-Term Potentiation; Male; Nicotine; Nicotinic Agonists; Picrotoxin; Quinoxalines; Rats; Substance Withdrawal Syndrome; Time Factors; Up-Regulation | 2006 |
[Effect of smoking withdrawal on hearing loss induced by occupational exposure to noise. A preliminary study].
Topics: Adult; Audiometry, Pure-Tone; Hearing Loss, Noise-Induced; Hearing Loss, Sensorineural; Humans; Male; Nicotine; Occupational Diseases; Severity of Illness Index; Smoking; Substance Withdrawal Syndrome | 2006 |
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Freezing Reaction, Cataleptic; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Propylamines; Substance Withdrawal Syndrome | 2007 |
The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections.
Topics: Animals; Association Learning; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Motivation; Nicotine; Rats; Reinforcement, Psychology; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Nicotine dependence and withdrawal symptoms among occasional smokers.
Topics: Adolescent; Adolescent Behavior; Analysis of Variance; Chi-Square Distribution; Cross-Sectional Studies; Depression; Female; Humans; Male; Nicotine; Psychology, Adolescent; Risk-Taking; Smoking Cessation; South Africa; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Ventral tegmental transcriptome response to intermittent nicotine treatment and withdrawal in BALB/cJ, C57BL/6ByJ, and quasi-congenic RQI mice.
Topics: Animals; Cluster Analysis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Motor Activity; Multivariate Analysis; Nerve Tissue Proteins; Nicotine; Oligonucleotide Array Sequence Analysis; Quantitative Trait Loci; Recombination, Genetic; Substance Withdrawal Syndrome; Transcription, Genetic; Ventral Tegmental Area | 2007 |
'Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administration.
Topics: Animals; Conditioning, Operant; Food; Infusions, Intravenous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Water | 2007 |
Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men.
Topics: Administration, Intranasal; Adult; Algorithms; Black or African American; Cotinine; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Ganglionic Stimulants; Humans; Male; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
What's new in Nicotine & Tobacco Research?
Topics: Age Factors; Antidepressive Agents; Counseling; Female; Ganglionic Stimulants; Humans; Internet; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States | 2007 |
Long-term changes in sleep and depressive symptoms of smokers in abstinence.
Topics: Adult; Cotinine; Depression; Female; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Male; Mexico; Middle Aged; Nicotine; Polysomnography; Sleep Initiation and Maintenance Disorders; Sleep, REM; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.
Topics: Adult; Aged; Alleles; Female; Gene Frequency; Genetic Markers; Humans; Introns; Male; Middle Aged; Nicotine; Phenotype; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Smoking; Substance Withdrawal Syndrome; Tandem Repeat Sequences; Tobacco Use Disorder | 2007 |
Nicotine dependence and reward differ between adolescent and adult male mice.
Topics: Age Factors; Animals; Brain; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Mice, Inbred ICR; Nicotine; Reward; Rubidium; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
The association of nicotine replacement therapy with mortality in a medical intensive care unit.
Topics: Adult; APACHE; Case-Control Studies; Critical Illness; Female; Hospital Mortality; Hospitals, University; Humans; Intensive Care Units; Length of Stay; Male; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Retrospective Studies; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit.
Topics: Adult; Attitude to Health; Factor Analysis, Statistical; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Nicotine; Patient Compliance; Psychometrics; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Combined exposure to nicotine and ethanol in adolescent mice differentially affects anxiety levels during exposure, short-term, and long-term withdrawal.
Topics: Aging; Animals; Anxiety; Body Weight; Central Nervous System Depressants; Data Interpretation, Statistical; Drinking; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome | 2008 |
Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine.
Topics: Adult; Algorithms; Blood Pressure; Cerebrovascular Circulation; Chewing Gum; Female; Heart Rate; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neostriatum; Nicotine; Nicotinic Agonists; Sex Characteristics; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Thalamus | 2008 |
Use of eye movement to measure smokers' attentional bias to smoking-related cues.
Topics: Adolescent; Adult; Anxiety; Attention; Cues; Eye Movements; Female; Fixation, Ocular; Humans; Male; Motivation; Nicotine; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Lasting effects of nicotine treatment and withdrawal on serotonergic systems and cell signaling in rat brain regions: separate or sequential exposure during fetal development and adulthood.
Topics: Adenylyl Cyclases; Adolescent; Adult; Age Factors; Animals; Biomarkers; Brain; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Signal Transduction; Substance Withdrawal Syndrome | 2007 |
Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale.
Topics: Adult; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Minnesota; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Syndrome; Tobacco Use Disorder | 2007 |
Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning.
Topics: Acoustic Stimulation; Animals; Conditioning, Classical; Cues; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Environment; Fear; Female; Infusion Pumps, Implantable; Injections, Subcutaneous; Learning; Male; Mice; Mice, Inbred C57BL; Nicotine; Psychomotor Performance; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2008 |
Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.
Topics: Amino Acids; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Male; Nicotine; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Reward; Substance Withdrawal Syndrome | 2007 |
Differences in smoking patterns among women smokers with childhood versus later onset of weight problems.
Topics: Adolescent; Adult; Age Factors; Body Image; Body Mass Index; Body Weight; Child; Diet, Reducing; Female; Health Behavior; Humans; Middle Aged; Motivation; Nicotine; Obesity; Overweight; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Male; Mecamylamine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2008 |
Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs.
Topics: Administration, Oral; Animals; Antidepressive Agents; Brain; Hypericum; Male; Mice; Motor Activity; Nicotine; Phytotherapy; Plant Extracts; Receptors, Serotonin, 5-HT1; Substance Withdrawal Syndrome | 2007 |
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nortriptyline; Rats; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
[Smoking cessation and air travel: what problems, what solutions?].
Topics: Aerospace Medicine; Aviation; Central Nervous System Stimulants; Government Regulation; Humans; Industry; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Travel | 2007 |
Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Blood Glucose; Body Weight; Cholesterol, HDL; Disease Models, Animal; Eating; Enzyme-Linked Immunosorbent Assay; Female; Hormones; Lipid Metabolism; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sex Factors; Substance Withdrawal Syndrome | 2008 |
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.
Topics: Animals; Bupropion; Conditioning, Psychological; Dopamine; Dose-Response Relationship, Drug; Fear; Male; Mental Recall; Mice; Mice, Inbred C57BL; Nicotine; Norepinephrine; Smoking Cessation; Substance Withdrawal Syndrome | 2007 |
Self-monitored motives for smoking among college students.
Topics: Adolescent; Adult; Computers, Handheld; Cues; Female; Habits; Humans; Male; Medical Records; Motivation; Nicotine; Smoking; Students; Substance Withdrawal Syndrome | 2007 |
Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia.
Topics: Administration, Cutaneous; Adolescent; Adult; Attention; Cognition Disorders; Comorbidity; Control Groups; Humans; Middle Aged; Neuropsychological Tests; Nicotine; Psychomotor Performance; Reaction Time; Schizophrenia; Schizophrenic Psychology; Skin Absorption; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2008 |
A possible role for the cholinergic anti-inflammatory pathway in increased mortality observed in critically ill patients receiving nicotine replacement therapy.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Critical Illness; Humans; Nicotine; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vagus Nerve | 2007 |
Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Topics: Analgesics, Opioid; Animals; Atropine; Dose-Response Relationship, Drug; Drug Tolerance; Ganglionic Blockers; Hexamethonium Compounds; Male; Mecamylamine; Mice; Morphine; Morphine Dependence; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain Measurement; Substance Withdrawal Syndrome | 2008 |
CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats.
Topics: Amygdala; Animals; Anxiety; Behavior, Addictive; Behavior, Animal; Corticotropin-Releasing Hormone; Feeding Behavior; Male; Mecamylamine; Nicotine; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Administration; Substance Withdrawal Syndrome | 2007 |
Interactive effects of ethanol and nicotine on learning in C57BL/6J mice depend on both dose and duration of treatment.
Topics: Animals; Central Nervous System Depressants; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Ethanol; Fear; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Time Factors | 2008 |
A neurobiological basis for nicotine withdrawal.
Topics: Humans; Nicotiana; Nicotine; Substance Withdrawal Syndrome; Substance-Related Disorders | 2007 |
Psychometric properties of the Minnesota Nicotine Withdrawal Scale: a Korean version.
Topics: Adult; Asian; Child; Factor Analysis, Statistical; Humans; Korea; Middle Aged; Nicotine; Psychological Tests; Psychometrics; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome; Translating; United States | 2007 |
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Topics: Adult; Benzazepines; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; London; Male; Mental Disorders; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
Topics: Animals; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mecamylamine; Motor Activity; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2008 |
Spontaneous nicotine withdrawal potentiates the effects of stress in rats.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Behavior, Animal; Dihydro-beta-Erythroidine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Reflex, Startle; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors | 2008 |
Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
Topics: Acupuncture; Amygdala; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Maze Learning; Motor Activity; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2008 |
Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Conditioning, Psychological; Mice; Mice, Knockout; Nicotine; Protein Subunits; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2008 |
Location and longing: the nicotine craving experience in virtual reality.
Topics: Adult; Affect; Arousal; Attention; Cues; Female; Humans; Male; Motivation; Nicotine; Pain Measurement; Psychometrics; Reproducibility of Results; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; User-Computer Interface | 2008 |
Nicotine withdrawal in subthreshold smokers.
Topics: Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 2008 |
Nicotine addiction: past, present and future. Marian Fischman lecture given at the 2007 meeting of CPDD.
Topics: Animals; Chewing Gum; Humans; Nicotine; Nicotinic Agonists; Rats; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; United States; United States Food and Drug Administration | 2008 |
Physiological and psychological symptoms and predictors in early nicotine withdrawal.
Topics: Adult; Anxiety; Blood Pressure; Depression; Female; Heart Rate; Humans; Linear Models; Male; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers.
Topics: Administration, Sublingual; Adult; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco, Smokeless | 2008 |
Comparing the validity of the Cigarette Dependence Scale and the Fagerström Test for Nicotine Dependence.
Topics: Adult; Cues; Female; Follow-Up Studies; Health Surveys; Humans; Internet; Male; Motivation; Nicotine; Psychometrics; Reproducibility of Results; Self Efficacy; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires; Switzerland; Tobacco Use Disorder | 2008 |
Increase in anger symptoms after smoking cessation predicts relapse.
Topics: Administration, Cutaneous; Anger; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Nicotine; Prognosis; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Age-dependent differences in nicotine reward and withdrawal in female mice.
Topics: Aging; Animals; Anxiety; Body Temperature; Conditioning, Operant; Drug Tolerance; Female; Mice; Mice, Inbred ICR; Motor Activity; Nicotine; Nicotinic Agonists; Pain Measurement; Reaction Time; Reinforcement Schedule; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Breaking away from a narrow prescribing protocol for medicinal nicotine.
Topics: Administration, Cutaneous; Adult; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2008 |
Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Mapping; Corpus Striatum; Drug Administration Schedule; Dynorphins; Enkephalins; Gene Expression Regulation; Male; Mice; Nicotine; Protein Precursors; Radioimmunoassay; RNA, Messenger; Substance Withdrawal Syndrome; Time Factors | 2008 |
Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Association Learning; Attention; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Perception; Reflex, Startle; Signal Transduction; Substance Withdrawal Syndrome; Time Factors | 2008 |
[Research--why do smokers gain weight in nicotine withdrawal?].
Topics: Appetite; Ghrelin; Humans; Hypothalamus; Insulin; Leptin; Magnetic Resonance Imaging; Nicotine; Research; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2008 |
Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.
Topics: Aging; Animals; Avoidance Learning; Conditioning, Operant; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Distress tolerance treatment for early-lapse smokers: rationale, program description, and preliminary findings.
Topics: Adult; Female; Humans; Male; Nicotine; Pilot Projects; Program Development; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 2008 |
Immune to the high.
Topics: Humans; Methamphetamine; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Vaccines | 2008 |
Nicotine dependence criteria and nicotine withdrawal symptoms in relation to pain among an adult general population sample.
Topics: Adolescent; Adult; Alcoholism; Data Interpretation, Statistical; Female; Germany; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Pain; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2009 |
The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.
Topics: Animals; Antidepressive Agents, Tricyclic; Conditioning, Operant; Depression; Desipramine; Food; Infusion Pumps, Implantable; Injections, Intravenous; Nicotine; Nicotinic Agonists; Rats; Reward; Self Administration; Self Stimulation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Hooked from the first cigarette.
Topics: Adolescent; Brain; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2008 |
The endogenous cannabinoid system modulates nicotine reward and dependence.
Topics: Animals; Cannabinoid Receptor Modulators; Conditioning, Psychological; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward; Rimonabant; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies.
Topics: Animals; Brain; Drug Implants; Electrodes, Implanted; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Reward; Self Stimulation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
Topics: Animals; Arginine; Brain; Drug Implants; Electric Stimulation; Electrodes, Implanted; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2008 |
Attenuated beta endorphin response to acute stress is associated with smoking relapse.
Topics: Acute Disease; Adult; beta-Endorphin; Cotinine; Data Interpretation, Statistical; Female; Humans; Male; Nicotine; Nicotinic Agonists; Psychomotor Performance; Recurrence; Risk; Smoking; Smoking Cessation; Social Environment; Stress, Psychological; Substance Withdrawal Syndrome | 2008 |
The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.
Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Hexamethonium; Hexamethonium Compounds; Humans; Male; Mecamylamine; Motor Activity; Nicotine; Rats; Substance Withdrawal Syndrome | 1983 |
The effect of chronic nicotine and withdrawal on intra-neuronal dynamics of acetylcholine and related enzymes in a preganglionic neuron system of the rat.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Autonomic Fibers, Preganglionic; Axonal Transport; Choline O-Acetyltransferase; Ganglia, Sympathetic; Humans; Male; Neurons; Nicotine; Rats; Substance Withdrawal Syndrome | 1980 |
Nicotine does not improve discrimination of brain stimulation reward by rats.
Topics: Animals; Brain; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Male; Mecamylamine; Nicotine; Rats; Self Stimulation; Substance Withdrawal Syndrome; Time Factors | 1983 |
Clinical evaluation of mecamylamine for withdrawal from nicotine dependence.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Mecamylamine; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Smoking and anesthesia: preoperative abstinence and perioperative morbidity.
Topics: Analgesics; Anesthesia; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular System; Hemostasis; Humans; Immune System; Mucus; Nicotine; Pharmaceutical Preparations; Postoperative Complications; Respiratory System; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1984 |
Consistency of the tobacco withdrawal syndrome.
Topics: Humans; Nicotine; Psychological Tests; Recurrence; Smoking; Substance Withdrawal Syndrome | 1984 |
Some effects of nicotine on food and water intake in undeprived rats.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Drinking Behavior; Feeding Behavior; Humans; Male; Nicotine; Rats; Rats, Inbred Strains; Sodium Chloride; Substance Withdrawal Syndrome | 1984 |
Nicotine dependence in cigarette smoking: an empirically-based, multivariate model.
Topics: Cotinine; Drug Tolerance; Heart Rate; Humans; Male; Models, Psychological; Nicotine; Skin Temperature; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Tobacco Use Disorder | 1983 |
EEG changes during tobacco withdrawal.
Topics: Adult; Alpha Rhythm; Brain; Electroencephalography; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome | 1983 |
Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol.
Topics: Animals; Ethanol; Humans; Male; Nicotine; Propranolol; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Tremor | 1983 |
Nicotine gum.
Topics: Chewing Gum; Humans; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome | 1984 |
Is nicotine gum effective in treating patients who wish to quit smoking?
Topics: Chewing Gum; Humans; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome | 1984 |
[Certain mechanisms of the effect of acupuncture on the sympatho-adrenal system of tobacco smokers].
Topics: Acupuncture Therapy; Adrenal Medulla; Adult; Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Middle Aged; Nicotine; Norepinephrine; Smoking; Substance Withdrawal Syndrome; Sympathetic Nervous System | 1981 |
Nutritional support of central catecholaminergic tone may aid smoking withdrawal.
Topics: Catecholamines; Humans; Nicotine; Nutritional Physiological Phenomena; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1982 |
Smoking withdrawal and acupuncture.
Topics: Acupuncture Therapy; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Substance Withdrawal Syndrome | 1982 |
Cigarette smoking, nicotine addiction, and relaxation.
Topics: Adolescent; Adult; Anxiety; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 1982 |
The role of liver tryptophan pyrrolase in the opposite effects of chronic administration and subsequent withdrawal of drugs of dependence on rat brain tryptophan metabolism.
Topics: Animals; Brain; Humans; Liver; Male; Methylphenazonium Methosulfate; Morphine; Naloxone; Nicotine; Phenobarbital; Rats; Substance Withdrawal Syndrome; Tryptophan; Tryptophan Oxygenase | 1981 |
Nicotine intake and its regulation.
Topics: Adolescent; Adult; Age Factors; Humans; Nicotine; Reinforcement, Social; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; United Kingdom | 1980 |
Terminal restlessness and nicotine withdrawal.
Topics: Aged; Akathisia, Drug-Induced; Humans; Hypnotics and Sedatives; Male; Midazolam; Nicotine; Substance Withdrawal Syndrome; Terminal Care | 1995 |
The effects of nicotine and nicotine withdrawal on taste reactivity.
Topics: Animals; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Sucrose; Taste | 1995 |
The role of nicotine in tobacco smoking: implications for tobacco control policy.
Topics: Adolescent; Adult; Child; Drug and Narcotic Control; Ganglionic Stimulants; Health Policy; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1995 |
Treatment of nicotine dependence. Is more better?
Topics: Administration, Cutaneous; Behavior Therapy; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1995 |
Helping patients to stop smoking.
Topics: Counseling; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Survey details stranglehold of nicotine addiction on teenagers.
Topics: Adolescent; Adult; Health Surveys; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; United States | 1995 |
[Psychological and physiological dependence in smokers and there effect on motivation for smoking cessation].
Topics: Austria; Cross-Sectional Studies; Female; Humans; Incidence; Male; Motivation; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
A computer-directed program for smoking cessation treatment.
Topics: Cotinine; Drug Administration Schedule; Follow-Up Studies; Health Promotion; Humans; Metabolic Clearance Rate; Nicotine; Smoking Cessation; Software; Substance Withdrawal Syndrome; Treatment Outcome; Workplace | 1994 |
Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms.
Topics: Adult; Cotinine; Female; Humans; Male; Neurologic Examination; Nicotine; Prospective Studies; Retrospective Studies; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
[Detection of nicotine in eccrine sweat after stimulation of sweat glands during nicotine withdrawal].
Topics: Adolescent; Adult; Cotinine; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nicotine; Pilocarpine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoke Pollution | 1995 |
Is smoking good for you?
Topics: Aged; Aortic Aneurysm, Abdominal; Humans; Male; Nicotine; Postoperative Care; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Indicators of nicotine addiction among women--United States, 1991-1992.
Topics: Adolescent; Adult; Age Distribution; Female; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States | 1995 |
Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity.
Topics: Acoustic Stimulation; Animals; Body Weight; Conditioning, Operant; Infusion Pumps; Light; Male; Motor Activity; Nicotine; Rats; Reflex, Startle; Reinforcement Schedule; Self Administration; Substance Withdrawal Syndrome | 1993 |
The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
Topics: Animals; Behavior, Animal; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Nicotine-sensitive myasthenia gravis.
Topics: Humans; Male; Middle Aged; Myasthenia Gravis; Nicotine; Substance Withdrawal Syndrome | 1994 |
From the Centers for Disease Control and Prevention. Indicators of nicotine addiction among women--United States, 1991-1992.
Topics: Adolescent; Adult; Age Distribution; Female; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States | 1995 |
Naloxone precipitates nicotine abstinence syndrome in the rat.
Topics: Animals; Male; Morphine; Naloxone; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users--United States, 1993.
Topics: Adolescent; Adolescent Behavior; Adult; Age Distribution; Humans; Nicotine; Plants, Toxic; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco, Smokeless; United States | 1994 |
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Cognition Disorders; Diazepam; Isoxazoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1994 |
From the Centers for Disease Control and Prevention. Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users--United States, 1993.
Topics: Adolescent; Adolescent Behavior; Adult; Age Distribution; Humans; Nicotine; Plants, Toxic; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco, Smokeless; United States | 1994 |
Psychotic affective disorder after nicotine withdrawal.
Topics: Adult; Affective Disorders, Psychotic; Humans; Male; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Transdermal nicotine after smoking cessation.
Topics: Administration, Cutaneous; Chewing Gum; Depressive Disorder; Female; Humans; Microsomes, Liver; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1994 |
Protracted withdrawal.
Topics: Humans; Hunger; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Weight Gain | 1994 |
The reality of the beneficial effects of nicotine.
Topics: Arousal; Cognition; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Beneficial effects of nicotine: fact or fiction?
Topics: Adult; Arousal; Cognition; Cross-Cultural Comparison; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Social Facilitation; Substance Withdrawal Syndrome | 1994 |
Cognitive benefits of nicotine: fact or fiction?
Topics: Arousal; Cognition; Humans; Neuropsychological Tests; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Does cigarette smoking increase stress?
Topics: Affect; Anxiety; Arousal; Humans; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 1994 |
Temporal stability and within-subject consistency of nicotine withdrawal symptoms.
Topics: Adult; Affective Symptoms; Female; Humans; Male; Neurologic Examination; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
The female weight-control smoker: a profile.
Topics: Adult; Appetite; Diet, Reducing; Female; Humans; Middle Aged; Motivation; Nicotine; Personality Inventory; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 1993 |
Nicotine dependence: intervention strategies for the physician.
Topics: Administration, Cutaneous; Adolescent; Adult; Child; Delayed-Action Preparations; Hospitalization; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Serum nicotine and cotinine levels during nicotine-patch therapy.
Topics: Administration, Cutaneous; Adult; Aged; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome | 1993 |
The relationship between quitting smoking and changes in drinking in World War II veteran twins.
Topics: Adult; Alcohol Drinking; Alcoholism; Cohort Studies; Comorbidity; Cross-Sectional Studies; Diseases in Twins; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Veterans | 1993 |
Sertraline attenuates hyperphagia in rats following nicotine withdrawal.
Topics: 1-Naphthylamine; Animals; Body Weight; Dose-Response Relationship, Drug; Drinking Behavior; Eating; Female; Nicotine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1993 |
Psychopharmacology of nicotine: implications for pharmacotherapy in psychiatry.
Topics: Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Role of nicotine dose and sensory cues in the regulation of smoke intake.
Topics: Adult; Aerosols; Affect; Arousal; Carbon Monoxide; Cues; Heart Rate; Humans; Male; Nicotine; Respiratory System; Smoking; Substance Withdrawal Syndrome | 1993 |
Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal?
Topics: Animals; Animals, Newborn; Birth Weight; Body Weight; Brain; Cell Differentiation; Cell Division; Dendrites; Female; Membranes; Nicotine; Organ Size; Ornithine Decarboxylase; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome | 1993 |
Smoking and nicotine dependence in young adults: differences between blacks and whites.
Topics: Adult; Black or African American; Cross-Sectional Studies; Female; Humans; Male; Michigan; Nicotine; Personality Inventory; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; White People | 1993 |
The physician's role in preventing nicotine addiction. Interview by Juli C. McGreevy.
Topics: Humans; Nicotine; Physician's Role; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1993 |
Nicotine patches in general practice.
Topics: Administration, Cutaneous; Family Practice; Humans; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Smoking patterns and cessation motivations during adolescence.
Topics: Adolescent; Comorbidity; Female; Humans; Juvenile Delinquency; Male; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Washington | 1995 |
Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during drug withdrawal anxiety.
Topics: Animals; Anxiety; Brain; Brain Chemistry; Cannabis; Ethanol; Isatin; Isoenzymes; Lorazepam; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morphine; Nicotine; Ondansetron; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1995 |
[Tobacco smoking cessation. Methods and aids].
Topics: Follow-Up Studies; Humans; Nicotine; Patient Care Team; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons.
Topics: Acoustic Stimulation; Action Potentials; Animals; Dopamine; Drug Tolerance; Male; Neurons; Nicotine; Rats; Reflex, Startle; Substance Withdrawal Syndrome; Substantia Nigra; Ventral Tegmental Area | 1995 |
Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF.
Topics: Amino Acid Sequence; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Molecular Sequence Data; Narcotic Antagonists; Neuropeptides; Nicotine; Nicotinic Agonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Depression following smoking cessation in women.
Topics: Administration, Cutaneous; Adult; Depressive Disorder; Female; Humans; Middle Aged; Nicotine; Personality Inventory; Recurrence; Self Medication; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Strategies for smoking cessation.
Topics: Administration, Cutaneous; Adult; Bronchodilator Agents; Health Education; Humans; Lung Diseases; Middle Aged; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoke Pollution; Tobacco Use Disorder | 1996 |
The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle.
Topics: Animals; Hormone Antagonists; Male; Nicotine; Pyrazoles; Rats; Receptors, Cholecystokinin; Reflex, Startle; Substance Withdrawal Syndrome | 1996 |
The biological, social and clinical bases of drug addiction: commentary and debate.
Topics: Brain; Drug Tolerance; Ethanol; Humans; Narcotics; Nicotine; Risk Factors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
A two-year follow-up on the effects of a smoking ban in an inpatient psychiatric service.
Topics: Adolescent; Adult; Aged; Anxiety; Female; Humans; Kentucky; Male; Middle Aged; Nicotine; Organizational Policy; Patient Acceptance of Health Care; Patient Admission; Prospective Studies; Psychiatric Department, Hospital; Psychotic Disorders; Risk Management; Smoking; Smoking Cessation; Smoking Prevention; Social Behavior; Substance Withdrawal Syndrome; Tobacco Smoke Pollution; Violence | 1996 |
The relationship of gender, diet patterns, and body type to weight change following smoking reduction: a multivariate approach.
Topics: Adult; Body Mass Index; Energy Intake; Feeding Behavior; Female; Humans; Male; Middle Aged; Nicotine; Regression Analysis; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 1995 |
Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Effects of nicotine withdrawal on central dopaminergic systems.
Topics: Animals; Binding, Competitive; Body Weight; Drinking; Eating; Locomotion; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Substance Withdrawal Syndrome; Time Factors | 1996 |
Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
Topics: Animals; Atropine; Behavior, Animal; Benzazepines; Hexamethonium; Male; Mecamylamine; Mice; Morphine Dependence; Naloxone; Narcotic Antagonists; Nicotine; Phenoxybenzamine; Propranolol; Substance P; Substance Withdrawal Syndrome; Sulpiride | 1996 |
Symptomatology and energy intake during the menstrual cycle in smoking women.
Topics: Adolescent; Adult; Appetite; Energy Intake; Female; Humans; Menstrual Cycle; Motivation; Nicotine; Personality Inventory; Premenstrual Syndrome; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Adolescents' experiences of smoking cessation.
Topics: Adolescent; Cross-Sectional Studies; Female; Health Education; Humans; Incidence; Male; Nicotine; Peer Group; Queensland; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1996 |
Mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Topics: Analysis of Variance; Animals; Avoidance Learning; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Injections, Subcutaneous; Male; Mecamylamine; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal.
Topics: Animals; Carrier Proteins; Cerebral Ventricles; Corticotropin-Releasing Hormone; Feeding Behavior; Humans; Infusions, Parenteral; Injections, Intraventricular; Male; Nicotine; Obesity; Rats; Rats, Zucker; Recombinant Fusion Proteins; Substance Withdrawal Syndrome; Weight Gain | 1996 |
Major depression following smoking cessation.
Topics: Depressive Disorder; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Nicotine; Odds Ratio; Personality Inventory; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1997 |
Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms.
Topics: Animals; Behavior, Animal; Male; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1997 |
Effects of a 2-day abstinence from smoking on dietary, cognitive, subjective, and physiologic parameters among younger and older female smokers.
Topics: Adult; Aged; Aging; Arousal; Blood Pressure; Body Weight; Cotinine; Energy Intake; Female; Food Preferences; Heart Rate; Humans; Middle Aged; Nicotine; Problem Solving; Reaction Time; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1997 |
Impact of a smoking ban on a locked psychiatric unit.
Topics: Aggression; Humans; Mental Disorders; Nicotine; Psychiatric Department, Hospital; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1997 |
Craving is associated with smoking relapse: findings from three prospective studies.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Drug Tolerance; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1997 |
Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Auditory Perception; Male; Nicotine; Piperazines; Pyridines; Rats; Reflex, Startle; Serotonin Antagonists; Substance Withdrawal Syndrome | 1997 |
Nicotine withdrawal in women.
Topics: Adult; Diseases in Twins; Female; Humans; Mental Disorders; Middle Aged; Nicotine; Personality; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1997 |
Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium.
Topics: Animals; Behavior, Animal; Central Nervous System; Dose-Response Relationship, Drug; Hexamethonium; Injections, Intraventricular; Injections, Subcutaneous; Male; Nicotine; Nicotinic Antagonists; Peripheral Nervous System; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1997 |
Treating tobacco addiction--nicotine or no nicotine?
Topics: Antidepressive Agents; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1997 |
Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.
Topics: Animals; Conditioning, Psychological; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Ondansetron; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Substance Withdrawal Syndrome | 1997 |
Nicotine withdrawal leads to increased sensitivity of serotonergic neurons to the 5-HT1A agonist 8-OH-DPAT.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Electrophysiology; Male; Neurons; Nicotine; Nicotinic Agonists; Raphe Nuclei; Rats; Serotonin; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 1997 |
Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
Topics: Analgesics, Non-Narcotic; Animals; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Capsaicin; Dose-Response Relationship, Drug; In Vitro Techniques; Ligands; Mecamylamine; Morphine; Nerve Fibers; Neuromuscular Junction; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pain Measurement; Pyridines; Rats; Receptors, Nicotinic; Spinal Cord; Substance Withdrawal Syndrome; Synaptic Transmission | 1998 |
Nicotine and caffeine use as confounds in psychiatric studies.
Topics: Caffeine; Case-Control Studies; Central Nervous System Stimulants; Humans; Nicotine; Nicotinic Agonists; Research Design; Schizophrenic Psychology; Substance Withdrawal Syndrome; Treatment Outcome | 1997 |
Smoking deterrents can help kick the habit, but side effects need to be closely monitored.
Topics: Cardiovascular Diseases; Cardiovascular System; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1998 |
Nicotine dependence among adolescent smokers.
Topics: Adolescent; Cotinine; Cross-Sectional Studies; Depression; Female; Humans; Linear Models; Male; Nicotine; Prevalence; Psychological Tests; Saliva; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment.
Topics: Administration, Oral; Animals; Brain Chemistry; Cerebellum; Cerebral Cortex; Mesencephalon; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Substance Withdrawal Syndrome; Up-Regulation | 1998 |
[Treatment of restlessness in dying patients: more than just sedation].
Topics: Aged; Aged, 80 and over; Constipation; Female; Humans; Hypoglycemia; Male; Nicotine; Psychomotor Agitation; Substance Withdrawal Syndrome; Terminal Care; Urinary Retention | 1998 |
Dramatic decreases in brain reward function during nicotine withdrawal.
Topics: Animals; Brain; Dihydro-beta-Erythroidine; Disease Models, Animal; Infusion Pumps, Implantable; Male; Motivation; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Self Stimulation; Sensory Thresholds; Substance Withdrawal Syndrome | 1998 |
[Vienna standard in diagnosis of nicotine dependence: Vienna Standard Smoking Inventory].
Topics: Adult; Female; Humans; Male; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal.
Topics: Animals; Male; Mecamylamine; Naloxone; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nitric Oxide; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1998 |
Nicotine addiction and the lure of reward.
Topics: Animals; Brain; Cartoons as Topic; Humans; Nicotine; Reward; Self Stimulation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
Nicotine withdrawal and accident rates.
Topics: Accidents, Occupational; London; Nicotine; Substance Withdrawal Syndrome | 1998 |
Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA.
Topics: Animals; Blotting, Northern; Brain; Enkephalins; Gene Expression; Male; Nicotine; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance Withdrawal Syndrome; Tissue Distribution | 1998 |
Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine.
Topics: Animals; Cholinergic Agents; Dihydro-beta-Erythroidine; Injections, Intraventricular; Male; Muscarinic Antagonists; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Scopolamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
Effects of chronic nicotine treatment and withdrawal on hypothalamic proopiomelanocortin gene expression and neuroendocrine regulation.
Topics: Animals; beta-Endorphin; Brain Mapping; Gene Expression; Hypothalamus; Male; Neurosecretory Systems; Nicotine; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
[Epidemiological studies on tobacco smoking and dependence in Hokkaido prefecture--relation to alcoholism].
Topics: Adult; Alcoholism; Female; Humans; Japan; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 1998 |
Errors in using tobacco withdrawal scale.
Topics: Diagnostic Errors; Humans; Nicotine; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1998 |
Nicotine withdrawal as an etiologic factor in delirium.
Topics: Aged; Delirium; Female; Humans; Middle Aged; Nicotine; Substance Withdrawal Syndrome | 1998 |
Reasons for quitting and smoking temptation among adolescent smokers: gender differences.
Topics: Adolescent; Adolescent Behavior; Adult; Affect; Female; Humans; Male; Nicotine; Nicotinic Agonists; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
Topics: Animals; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
Obligatory cessation of smoking by psychiatric inpatients.
Topics: Adult; Female; Humans; Male; Mental Disorders; Middle Aged; New York; Nicotine; Patient Admission; Psychiatric Status Rating Scales; Psychopathology; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1999 |
Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?
Topics: Antidepressive Agents, Second-Generation; Bupropion; Drug Interactions; Drug Therapy, Combination; Humans; Mental Disorders; Nicotine; Psychotropic Drugs; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Behavioral sensitization to nicotine is associated with behavioral disinhibition; counteraction by citalopram.
Topics: Animals; Citalopram; Drug Interactions; Male; Maze Learning; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 1999 |
[Diagnosis of nicotine dependence. Vienna Standard Smoking Questionnaire].
Topics: Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 1998 |
Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains.
Topics: Animals; Ganglionic Stimulants; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Inbred F344; Rats, Inbred Lew; Species Specificity; Substance Withdrawal Syndrome | 1999 |
Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha7 Nicotinic Acetylcholine Receptor; Animals; Dopamine; Homovanillic Acid; Male; Microdialysis; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Nicotinic; Substance Withdrawal Syndrome; Ventral Tegmental Area | 1999 |
Regulation of AP-1 gene transcription factor binding activity in the rat brain during nicotine dependence.
Topics: Animals; Cerebral Cortex; DNA; Injections, Subcutaneous; Male; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Transcription Factor AP-1 | 1999 |
Acupuncture and nicotine withdrawal.
Topics: Acupuncture Therapy; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Antidepressants and smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Affect; Animals; Antidepressive Agents, Tricyclic; Appetite; Humans; Nicotine; Nortriptyline; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Predictors and timing of adverse experiences during trandsdermal nicotine therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Cohort Studies; Cotinine; Erythema; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Severity of Illness Index; Sleep Wake Disorders; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Efficacy of providing nicotine in a liquid diet to rats.
Topics: Administration, Oral; Animals; Body Weight; Cotinine; Diet; Eating; Male; Motor Activity; Nicotine; Psychotropic Drugs; Rats; Rats, Long-Evans; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects.
Topics: Administration, Cutaneous; Adult; Cotinine; Female; Fetus; Heart Rate, Fetal; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
An examination of cigarette brand switching to reduce health risks.
Topics: Adaptation, Psychological; Adult; Female; Health Behavior; Humans; Male; Military Personnel; Nicotine; Population Surveillance; Prospective Studies; Self Efficacy; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; United States | 1999 |
Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines.
Topics: Animals; Antidepressive Agents; Cotinine; Depressive Disorder; Drinking; Female; Nicotine; Nicotinic Agonists; Rats; Rats, Inbred Strains; Species Specificity; Substance Withdrawal Syndrome; Swimming; Weight Gain | 1999 |
Nicotine withdrawal up-regulates c-Fos transcription in pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Amino Acid Sequence; Animals; Antisense Elements (Genetics); Gene Expression Regulation, Neoplastic; Genes, fos; Genes, jun; Humans; Mice; Molecular Sequence Data; Nicotine; Oligonucleotide Probes; PC12 Cells; Pheochromocytoma; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; Substance Withdrawal Syndrome; Transcription, Genetic | 1999 |
[Nicotine replacement therapy and smoking cessation: what choice for its status?].
Topics: Depression; Humans; Mental Disorders; Nicotine; Self Medication; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1999 |
Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Topics: Amygdala; Animals; Behavior, Animal; Biological Transport; Brain Chemistry; Dopamine; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2000 |
[Tremor during radiation therapy].
Topics: Carcinoma, Squamous Cell; Humans; Ischemic Attack, Transient; Lip Neoplasms; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Treatment Outcome; Tremor | 1996 |
Nicotine abstinence in the mouse.
Topics: Animals; Behavior, Animal; Body Weight; Injections, Subcutaneous; Male; Mecamylamine; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Substance Withdrawal Syndrome; Time Factors | 1999 |
Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Dopamine; Infusion Pumps, Implantable; Male; Mecamylamine; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2000 |
Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
Topics: Animals; Brain; Chlorisondamine; Injections, Intraventricular; Male; Mecamylamine; Naloxone; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2000 |
Tobacco withdrawal symptoms and treatment.
Topics: Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Sex differences in nicotine substitution to a pentylenetetrazol discriminative stimulus during ethanol withdrawal in rats.
Topics: Animals; Central Nervous System Depressants; Discrimination Learning; Ethanol; Female; GABA Antagonists; Male; Nicotine; Nicotinic Agonists; Ovariectomy; Pentylenetetrazole; Rats; Rats, Long-Evans; Sex Factors; Substance Withdrawal Syndrome | 2000 |
Effects of smoking abstinence on movement regulation.
Topics: Adult; Humans; Male; Motor Skills; Nicotine; Psychomotor Performance; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Effect of acute nicotine on Fos protein expression in rat brain during chronic nicotine and its withdrawal.
Topics: Adrenocorticotropic Hormone; Animals; Brain; Male; Nicotine; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Nicotinic; Substance Withdrawal Syndrome; Supraoptic Nucleus | 2000 |
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Body Temperature; Columbidae; Corticosterone; Depression; Discrimination Learning; Drug Interactions; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lip; Male; Microdialysis; Neurons; Nicotine; Piperidines; Posture; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Sulfur Radioisotopes | 2000 |
Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice.
Topics: Animals; Brain; Brain Mapping; Disease Models, Animal; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurotransmitter Agents; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2000 |
Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Topics: Analgesics; Animals; Male; Mecamylamine; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Antagonists; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Substance Withdrawal Syndrome | 2000 |
Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chronic Disease; Dopamine; Extracellular Space; Homovanillic Acid; Male; Mecamylamine; Microdialysis; Microinjections; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2000 |
Chronic, but not acute, nicotine exposure attenuates ethanol withdrawal-induced hippocampal damage in vitro.
Topics: Animals; Animals, Newborn; Culture Techniques; Dose-Response Relationship, Drug; Ethanol; Hippocampus; Mecamylamine; Nervous System Diseases; Nicotine; Propidium; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2000 |
History and symptoms of depression among smokers during a self-initiated quit attempt.
Topics: Adult; Depressive Disorder; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Prognosis; Prospective Studies; Recurrence; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
What's new in Nicotine & Tobacco Research?
Topics: Animals; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Weight Gain | 2000 |
Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans.
Topics: Adult; Female; Humans; Male; Melatonin; Middle Aged; Nicotine; Psychomotor Performance; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus.
Topics: Acetylcholine; Acute Disease; Animals; Brain-Derived Neurotrophic Factor; Chronic Disease; Dentate Gyrus; Gene Expression; In Situ Hybridization; Male; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Rats; Rats, Inbred Strains; RNA, Messenger; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2000 |
Individual differences in responses to the first cigarette following overnight abstinence in regular smokers.
Topics: Adult; Affect; Cluster Analysis; Female; Heart Rate; Humans; Male; Nicotine; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2001 |
Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal.
Topics: Animals; Anxiety; Drug Tolerance; Hippocampus; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Substance Withdrawal Syndrome | 2001 |
Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats.
Topics: Animals; Anxiety; Conditioning, Operant; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Self Administration; Social Behavior; Substance Withdrawal Syndrome | 2001 |
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome.
Topics: Analysis of Variance; Animals; Antibodies; Brain; Drug Implants; Immunization, Passive; Immunoglobulin G; Injections, Subcutaneous; Male; Nicotine; Nicotinic Agonists; Protein Binding; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2001 |
Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice.
Topics: Acetic Acid; Analgesics, Opioid; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Carrageenan; Fixatives; Formaldehyde; Ganglionic Stimulants; Inflammation; Magnesium Sulfate; Mice; Mice, Transgenic; Morphine; Naloxone; Narcotic Antagonists; Nicotine; Opioid-Related Disorders; Pain; Substance Withdrawal Syndrome | 2001 |
Emergence of depression during early abstinence in depressed and non-depressed women smokers.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Clinical Trials as Topic; Depressive Disorder; Female; Follow-Up Studies; Humans; Motivation; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
[Functional involvement of cerebral diazepam binding inhibitor (DBI) in the establishment of drug dependence].
Topics: Animals; Brain; Carrier Proteins; Diazepam Binding Inhibitor; Ethanol; Humans; Morphine; Nicotine; Substance Withdrawal Syndrome; Substance-Related Disorders | 2001 |
Muscarinic depression of synaptic transmission in the epileptogenic GABA withdrawal syndrome focus.
Topics: Action Potentials; Animals; Atropine Derivatives; Disease Models, Animal; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Male; Motor Cortex; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Reaction Time; Receptors, Muscarinic; Status Epilepticus; Substance Withdrawal Syndrome; Synaptic Transmission | 2001 |
The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Drug Tolerance; Ganglionic Stimulants; Male; Motor Activity; Nicotine; Raphe Nuclei; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Substance Withdrawal Syndrome | 2001 |
Regional cerebral blood flow effects of nicotine in overnight abstinent smokers.
Topics: Adolescent; Adult; Brain; Cerebrovascular Circulation; Circadian Rhythm; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Temporal Lobe; Thalamus; Tomography, Emission-Computed | 2001 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; Disease Models, Animal; Drug Combinations; Electric Stimulation; Fluoxetine; Male; Mecamylamine; Neurons; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Wistar; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2001 |
Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking.
Topics: Adolescent; Adolescent Behavior; Attitude; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Prevalence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2001 |
Effects of nicotine deprivation and irritability on physical aggression in male smokers.
Topics: Adolescent; Adult; Aggression; Humans; Male; Mood Disorders; Nicotine; Random Allocation; Reaction Time; Smoking; Substance Withdrawal Syndrome | 2001 |
Smoking and panic disorder.
Topics: Adult; Anticonvulsants; Clonazepam; Female; Humans; Nicotine; Panic Disorder; Psychiatric Status Rating Scales; Smoking; Substance Withdrawal Syndrome | 2001 |
Delirium from nicotine withdrawal in neuro-ICU patients.
Topics: Administration, Cutaneous; Adult; Aged; Delirium; Female; Humans; Intensive Care Units; Male; Nervous System Diseases; Nicotine; Substance Withdrawal Syndrome | 2001 |
Effect of smoking reduction and cessation on cardiovascular risk factors.
Topics: Adult; Cardiovascular Diseases; Cotinine; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Lipoproteins, HDL; Male; Nicotine; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Triglycerides | 2001 |
Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens.
Topics: Acetylcholine; Animals; Dopamine; Male; Mecamylamine; Microdialysis; Nicotine; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2001 |
Epidemiological studies of tobacco smoking and dependence in Japan.
Topics: Adult; Aged; Humans; Japan; Middle Aged; Nicotine; Prevalence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
Effects of nicotine on ethanol dependence and brain damage.
Topics: Alcoholic Intoxication; Animals; Brain; Brain Damage, Chronic; Central Nervous System Depressants; Ethanol; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2001 |
Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects.
Topics: Animals; Anxiety; Drug Tolerance; Infusions, Intravenous; Injections, Intravenous; Injections, Subcutaneous; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2001 |
Effects of adolescent nicotine exposure on opioid consumption and neuroendocrine responses in adult male and female rats.
Topics: Adrenocorticotropic Hormone; Aging; Analgesics, Opioid; Animals; Body Weight; Corticosterone; Drinking; Eating; Female; Fentanyl; Male; Naloxone; Narcotic Antagonists; Neurosecretory Systems; Nicotine; Nicotinic Agonists; Opioid-Related Disorders; Rats; Rats, Wistar; Sex Characteristics; Substance Withdrawal Syndrome | 2001 |
Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.
Topics: Analgesia; Animals; Capsaicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Hyperalgesia; Male; Mecamylamine; Morphine; Narcotics; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.
Topics: Aconitine; Animals; Behavior, Animal; Brain; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Male; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
Respiratory suppression induced by nicotine withdrawal in the neonatal rat brainstem: implications in the SIDS risk factor.
Topics: Animals; Animals, Newborn; Brain Stem; Ganglionic Stimulants; Humans; Infant; Neurons; Nicotine; Organ Culture Techniques; Rats; Rats, Wistar; Respiratory Mechanics; Risk Factors; Spinal Cord; Substance Withdrawal Syndrome; Sudden Infant Death | 2001 |
Withdrawal from nicotine facilitates diazepam binding inhibitor mRNA expression in mouse cerebral cortex.
Topics: Animals; Anxiety; Cerebral Cortex; Diazepam Binding Inhibitor; Gene Expression; Mice; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; RNA, Messenger; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
Cessation of chronic nicotine administration enhances wet-dog shake responses to 5-HT2 receptor stimulation in rats.
Topics: Amphetamines; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2001 |
Nicotine replacement therapy for smokers admitted to intensive care.
Topics: Adult; Humans; Intensive Care Units; Male; Nicotine; Substance Withdrawal Syndrome | 2001 |
Nerve growth factor and smoking cessation.
Topics: Adult; Arousal; Female; Humans; Male; Middle Aged; Nerve Growth Factor; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Aversive Therapy; Conditioning, Psychological; Male; Mecamylamine; Morphinans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Spiro Compounds; Substance Withdrawal Syndrome | 2002 |
Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse.
Topics: Animals; Behavior, Animal; Blotting, Northern; Corpus Striatum; Enkephalin, Methionine; Enkephalins; In Situ Hybridization; Male; Mice; Nicotine; Nucleus Accumbens; Protein Precursors; Radioimmunoassay; RNA, Messenger; Substance Withdrawal Syndrome; Time Factors; Tissue Distribution | 2002 |
[Bupropion. An antidepressant used to help smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Patient Education as Topic; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2002 |
Pharmacological and psychological determinants of smoking. A New York University honors program lecture.
Topics: Adult; Affective Symptoms; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nicotine; Smoking; Stress, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders; Urine | 1978 |
Biological influences on cigarette smoking.
Topics: Animals; Brain; Carbon Monoxide; Drug Tolerance; Hemodynamics; Humans; Neurotransmitter Agents; Nicotine; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Tars | 1979 |
Tobacco dependence: is nicotine rewarding or aversive?
Topics: Adaptation, Physiological; Female; Humans; Male; Motivation; Nicotiana; Nicotine; Plants, Toxic; Reinforcement, Psychology; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tars | 1979 |
Regulation, withdrawal, and nicotine addiction.
Topics: Humans; Nicotine; Smoking; Stress, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1979 |
Cigarette smoking as a dependence process. Implications and directions for future research.
Topics: Alcoholism; Forecasting; Humans; Longitudinal Studies; Nicotine; Research; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1979 |
Smoking as an addictive disorder.
Topics: History, 16th Century; History, 17th Century; History, 20th Century; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1979 |
Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles.
Topics: Animals; Brain; Corticosterone; Hippocampus; Humans; Hydroxyindoleacetic Acid; Hypothalamus; Male; Nicotine; Rats; Serotonin; Substance Withdrawal Syndrome; Time Factors | 1979 |
Behavioral factors in the establishment, maintenance, and cessation of smoking.
Topics: Aversive Therapy; Behavior Therapy; Humans; Nicotine; Reinforcement, Social; Smoking; Smoking Prevention; Substance Withdrawal Syndrome | 1979 |
Tobacco use as a mental disorder: the rediscovery of a medical problem.
Topics: Attitude of Health Personnel; Attitude to Health; Cardiovascular System; History, 16th Century; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Mental Disorders; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1977 |
Adjustment of smokers to dilution of tobacco smoke by ventilated cigarette holders.
Topics: Adult; Carboxyhemoglobin; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Respiration; Smoke; Smoking; Substance Withdrawal Syndrome | 1978 |
Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.
Topics: Adult; Body Temperature; Drug Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 1978 |
[Problems in nonsmoker training].
Topics: Adult; Ambulatory Care; Hospitalization; Humans; Motivation; Myocardial Infarction; Nicotine; Smoking Prevention; Socioenvironmental Therapy; Substance Withdrawal Syndrome | 1977 |
The use of nicotine gum during cessation of smoking.
Topics: Chewing Gum; Drug Evaluation; Humans; Male; Nicotine; Placebos; Smoking Prevention; Substance Withdrawal Syndrome | 1977 |
Studies of the interaction of psychological and pharmacological determinants of smoking.
Topics: Adult; Consumer Behavior; Economics; Emotions; Female; Humans; Legislation, Drug; Male; Middle Aged; Nicotine; Psychology; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tars; United States | 1977 |
The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report.
Topics: Adult; Estradiol; Female; Humans; Hydrocortisone; Menstrual Cycle; Methoxyhydroxyphenylglycol; Nicotine; Norepinephrine; Progesterone; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
Topics: Animals; Benzazepines; Corpus Striatum; Male; Nicotine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Substance Withdrawal Syndrome | 1992 |
Tobacco withdrawal in self-quitters.
Topics: Adult; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats.
Topics: Animals; Body Weight; Drinking; Eating; Male; Nicotine; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Weight Gain | 1992 |
Smoking cessation among self-quitters.
Topics: Adult; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Nicotine; Recurrence; Self Care; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Rodent model of nicotine abstinence syndrome.
Topics: Animals; Behavior, Animal; Body Weight; Disease Models, Animal; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1992 |
Nicotine cessation, mania, and depression.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults.
Topics: Adult; Alcoholism; Anxiety Disorders; Black or African American; Comorbidity; Depressive Disorder; Educational Status; Female; Humans; Male; Marriage; Nicotine; Severity of Illness Index; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
The 'nicotine replacement paradox' in smoking cessation: how does nicotine gum really work?
Topics: Anxiety; Chewing Gum; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Postoperative nicotine withdrawal.
Topics: Administration, Cutaneous; Aged; Female; Humans; Nicotine; Postoperative Complications; Smoking; Substance Withdrawal Syndrome; Urinary Diversion | 1992 |
Antinociceptive effect of chronic nicotine and nociceptive effect of its withdrawal measured by hot-plate and tail-flick in rats.
Topics: Analgesics; Animals; Body Weight; Drug Implants; Male; Nicotine; Nociceptors; Pain Measurement; Rats; Rats, Inbred Strains; Reaction Time; Substance Withdrawal Syndrome | 1992 |
Smoking cessation in women: effects of the menstrual cycle.
Topics: Adaptation, Psychological; Adult; Affective Symptoms; Female; Humans; Male; Menstrual Cycle; Motivation; Nicotine; Personality Inventory; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats.
Topics: Amylases; Animals; Blood Glucose; Body Weight; Cholecystokinin; Digestive System; Drinking; Eating; Insulin; Male; Nicotine; Pancreas; Peptic Ulcer Hemorrhage; Radioimmunoassay; Rats; Rats, Inbred Strains; Stomach Ulcer; Substance Withdrawal Syndrome | 1990 |
Dream of absent-minded transgression: an empirical study of a cognitive withdrawal symptom.
Topics: Adult; Dreams; Female; Guilt; Humans; Male; Mental Recall; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1991 |
Tobacco dependence and smoke-free psychiatric units.
Topics: Chewing Gum; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Psychiatric Department, Hospital; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices | 1991 |
[The nurse and tobacco withdrawal].
Topics: Counseling; Humans; Motivation; Nicotine; Substance Withdrawal Syndrome | 1991 |
Pharmacodynamics of nicotine: implications for rational treatment of nicotine addiction.
Topics: Administration, Cutaneous; Arousal; Behavior Therapy; Chewing Gum; Emotions; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1991 |
The application of 1980s psychology to 1990s smoking research.
Topics: Forecasting; Humans; Motivation; Nicotine; Research; Smoking; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
The focus and conduct of clinical trials.
Topics: Clinical Trials as Topic; Combined Modality Therapy; Follow-Up Studies; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1991 |
Effects of nicotine withdrawal on the local cerebral glucose utilization in conscious rats.
Topics: Animals; Brain; Cerebral Cortex; Deoxyglucose; Glucose; Limbic System; Male; Nerve Fibers, Myelinated; Nicotine; Organ Specificity; Rats; Rats, Inbred Strains; Reference Values; Substance Withdrawal Syndrome | 1991 |
Withdrawal wobblies.
Topics: Humans; Male; Middle Aged; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome | 1991 |
Human avoidance responding with added point loss during acute tobacco abstinence.
Topics: Avoidance Learning; Chewing Gum; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1990 |
Withdrawal from nicotine fails to produce a conditioned taste aversion to saccharine in rats and mice.
Topics: Animals; Avoidance Learning; Male; Mice; Mice, Inbred ICR; Morphine Dependence; Nicotine; Rats; Rats, Inbred Strains; Saccharin; Substance Withdrawal Syndrome | 1990 |
A methodological basis for improving the reliability of measurements of opiate abstinence responses in the guinea-pig ileum made dependent in vitro.
Topics: Animals; Electric Stimulation; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Naloxone; Narcotics; Nicotine; Receptors, Nicotinic; Reference Standards; Substance Withdrawal Syndrome | 1991 |
Stable isotope method for studying transdermal drug absorption: the nicotine patch.
Topics: Administration, Cutaneous; Adult; Biological Availability; Deuterium; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nicotine; Skin Absorption; Smoking; Substance Withdrawal Syndrome | 1991 |
[Weight increase following nicotine abstinence].
Topics: Humans; Nicotine; Risk Factors; Sex Factors; Substance Withdrawal Syndrome; Weight Gain | 1991 |
Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum.
Topics: Adult; Aggression; Carbon Monoxide; Chewing Gum; Conditioning, Operant; Humans; Male; Nicotine; Placebos; Reinforcement Schedule; Smoking; Substance Withdrawal Syndrome | 1991 |
The effect of chronic administration of nicotine and withdrawal on somatostatin concentration and binding in brain of rat.
Topics: Animals; Binding, Competitive; Brain; Drug Administration Schedule; Hippocampus; Kinetics; Male; Mecamylamine; Nicotine; Organ Specificity; Parietal Lobe; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Somatostatin; Reference Values; Somatostatin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
The tobacco withdrawal syndrome in unaided quitters.
Topics: Adult; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Nicotine; Prospective Studies; Smoking; Substance Withdrawal Syndrome | 1991 |
Negative effects of a smoking ban on an inpatient psychiatry service.
Topics: Adult; Aged; Bipolar Disorder; Chronic Disease; Hospitals, Veterans; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Professional-Patient Relations; Psychiatric Department, Hospital; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Social Environment; Substance Withdrawal Syndrome; Violence | 1991 |
Effect of cigarettes on memory search and subjective ratings.
Topics: Adult; Carbon Monoxide; Female; Humans; Male; Memory; Nicotine; Psychomotor Performance; Smoking; Substance Withdrawal Syndrome | 1991 |
Withdrawal from nicotine gum.
Topics: Chewing Gum; Humans; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 1991 |
Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.
Topics: Animals; Cocaine; Ethanol; Exploratory Behavior; Illicit Drugs; Imidazoles; Male; Mice; Nicotine; Ondansetron; Rats; Rats, Inbred Strains; Serotonin Antagonists; Social Behavior; Substance Withdrawal Syndrome | 1990 |
Nicotine-replacement therapy in cessation of smoking.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1990 |
Withdrawal from chronic nicotine fails to produce a conditioned taste aversion to saccharin in rats.
Topics: Animals; Avoidance Learning; Choice Behavior; Conditioning, Psychological; Male; Nicotine; Rats; Rats, Inbred Strains; Saccharin; Substance Withdrawal Syndrome; Taste; Time Factors | 1990 |
Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors.
Topics: Animals; Body Temperature; Bungarotoxins; Drug Tolerance; Female; Half-Life; Infusions, Intravenous; Iodine Radioisotopes; Kinetics; Motor Activity; Nicotine; Proteins; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Substance Withdrawal Syndrome; Up-Regulation | 1990 |
Relationship between nicotine tolerance questionnaire scores and plasma cotinine.
Topics: Adult; Arousal; Cotinine; Drug Tolerance; Female; Humans; Male; Nicotine; Personality Tests; Pyrrolidinones; Risk Factors; Smoking; Substance Withdrawal Syndrome | 1990 |
Chronic nicotine and withdrawal effects on radial-arm maze performance in rats.
Topics: Animals; Attention; Choice Behavior; Discrimination Learning; Drug Implants; Male; Mental Recall; Nicotine; Orientation; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1990 |
[Drug treatment of nicotine dependence].
Topics: Clonidine; Doxepin; Humans; Imipramine; Mecamylamine; Nicotine; Smoking; Substance Withdrawal Syndrome | 1990 |
Mania after nicotine withdrawal.
Topics: Bipolar Disorder; Humans; Male; Middle Aged; Nicotine; Renal Dialysis; Smoking Prevention; Substance Withdrawal Syndrome | 1990 |
The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.
Topics: Animals; Anxiety; Behavior, Animal; Cocaine; Conditioning, Operant; Diazepam; Ethanol; Ketotifen; Male; Mice; Nicotine; Rats; Rats, Inbred Strains; Species Specificity; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse.
Topics: Animals; beta-Endorphin; Endorphins; Enkephalin, Methionine; Humans; Hypothalamus; Male; Mice; Mice, Inbred ICR; Neurotensin; Nicotine; Pituitary Gland; Substance P; Substance Withdrawal Syndrome | 1985 |
The effects of varying cigarette deprivation duration on cognitive and performance tasks.
Topics: Adolescent; Adult; Arousal; Attention; Cognition; Female; Humans; Male; Neuropsychological Tests; Nicotine; Psychomotor Performance; Reaction Time; Serial Learning; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1989 |
Severe mania following abrupt nicotine withdrawal.
Topics: Bipolar Disorder; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
Time course of cigarette withdrawal symptoms while using nicotine gum.
Topics: Female; Humans; Male; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome | 1989 |
Transdermal nicotine and placebo.
Topics: Dermatitis, Contact; Humans; Nicotine; Patch Tests; Substance Withdrawal Syndrome | 1989 |
Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Food; Male; Nicotine; Rats; Reaction Time; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking.
Topics: Adult; Depression; Female; Humans; Male; Nicotine; Recurrence; Smoking; Substance Withdrawal Syndrome | 1989 |
Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration.
Topics: Animals; Behavior, Animal; Ethanol; Locomotion; Male; Mice; Mice, Inbred ICR; Nicotine; Substance Withdrawal Syndrome; Time Factors | 1989 |
The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women.
Topics: Adult; Arousal; Female; Follow-Up Studies; Humans; Male; Menstrual Cycle; Menstruation Disturbances; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
[Relation between ischemic heart disease and tobacco smoking].
Topics: Adolescent; Adult; Age Factors; Aged; Cohort Studies; Coronary Disease; Humans; Male; Middle Aged; Nicotine; Poland; Smoking; Substance Withdrawal Syndrome; Time Factors | 1989 |
Clonidine in nicotine withdrawal.
Topics: Administration, Oral; Clonidine; Humans; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1989 |
Nicotine abstinence effects.
Topics: Animals; Arousal; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
Human aggressive and non-aggressive responding during acute tobacco abstinence.
Topics: Adult; Aggression; Chewing Gum; Conditioning, Operant; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat.
Topics: Animals; Catecholamines; Corticosterone; Cotinine; Hypothalamus; Male; Nerve Endings; Nicotine; Norepinephrine; Pituitary Hormones; Preoptic Area; Rats; Rats, Inbred Strains; Smoking; Substance Withdrawal Syndrome; Testosterone; Thyrotropin | 1989 |
Quitting smoking: nicotine vs placebo gum.
Topics: Counseling; Humans; Nicotine; Physician's Role; Placebos; Research Design; Smoking; Substance Withdrawal Syndrome | 1989 |
Withdrawal-oriented therapy for smokers.
Topics: Adult; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
Reasons for smoking and severity of residual nicotine withdrawal symptoms when using nicotine chewing gum.
Topics: Adult; Aged; Chewing Gum; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Substance Withdrawal Syndrome | 1989 |
The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery.
Topics: Adult; Cognition; Humans; Male; Microcomputers; Nicotine; Psychological Tests; Psychometrics; Smoking; Substance Withdrawal Syndrome | 1989 |
Nicotine gum use with nicotine addiction.
Topics: Chewing Gum; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Psychiatric Department, Hospital; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1989 |
Behavioral prescription writing in smoking cessation counseling: a new use for a familiar tool.
Topics: Adult; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Counseling; Evaluation Studies as Topic; Follow-Up Studies; Goals; Humans; Motivation; Nicotine; Patient Compliance; Prescriptions; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 1989 |
The Addiction Research Unit of the Institute of Psychiatry University of London--II. The work of the unit's smoking section.
Topics: Humans; London; Nicotine; Psychiatric Department, Hospital; Research; Risk Factors; Smoking; Substance Withdrawal Syndrome | 1989 |
The actions of nicotine and cocaine in a mouse model of anxiety.
Topics: Animals; Anxiety; Behavior, Animal; Cocaine; Discrimination, Psychological; Disease Models, Animal; Light; Male; Mice; Mice, Inbred Strains; Nicotine; Substance Withdrawal Syndrome | 1989 |
Nicotine dependence in rats.
Topics: Animals; Behavior, Animal; Cotinine; Drinking Behavior; Feeding Behavior; Nicotine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1989 |
Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine.
Topics: Animals; Ethanol; Hexamethonium; Hexamethonium Compounds; Male; Nicotine; Propranolol; Rats; Rats, Inbred Strains; Seizures; Substance Withdrawal Syndrome; Tremor | 1985 |
Stop-smoking program using nicotine reduction therapy and behavior modification for heavy smokers.
Topics: Adult; Aged; Behavior Therapy; Chewing Gum; Female; Humans; Irritable Mood; Longitudinal Studies; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Prospective Studies; Random Allocation; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1989 |
Withdrawal from chronic nicotine substitutes partially for the interoceptive stimulus produced by pentylenetetrazol (PTZ).
Topics: Animals; Diazepam; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Pentylenetetrazole; Rats; Substance Withdrawal Syndrome | 1986 |
Effects of smoking deprivation on smoking behavior and heart rate response in high and low CO absorbing smokers.
Topics: Absorption; Adult; Carbon Monoxide; Heart Rate; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1987 |
Loss of acute nicotine tolerance and severity of cigarette withdrawal.
Topics: Adult; Drug Tolerance; Female; Heart Rate; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1988 |
Drop in heart rate following smoking cessation may be permanent.
Topics: Adult; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome | 1988 |
Nicotine replacement effects on post-cessation withdrawal symptoms and weight gain.
Topics: Adult; Body Weight; Chewing Gum; Female; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1988 |
Failure to support the validity of the Fagerstrom Tolerance Questionnaire as a measure of physiological tolerance to nicotine.
Topics: Adult; Arousal; Blood Pressure; Drug Tolerance; Female; Galvanic Skin Response; Heart Rate; Humans; Male; Nicotine; Skin Temperature; Smoking; Substance Withdrawal Syndrome | 1988 |
Doxepin in the treatment of nicotine withdrawal.
Topics: Adult; Aged; Doxepin; Female; Humans; Middle Aged; Nicotine; Patient Compliance; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1988 |
Improving the diagnosis and treatment of nicotine dependence.
Topics: Humans; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1988 |
Characterization and treatment of dependence on tobacco cigarettes.
Topics: Humans; Nicotine; Smoking; Substance Withdrawal Syndrome | 1986 |
Criteria of a pharmacologic withdrawal syndrome.
Topics: Diagnosis, Differential; Humans; Nicotine; Self Medication; Smoking; Substance Withdrawal Syndrome | 1987 |
Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats.
Topics: Animals; Body Weight; Drinking Behavior; Drug Tolerance; Feeding Behavior; Female; Nicotine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1987 |
Maternal nicotine exposure and carbohydrate metabolism of fetal and neonatal lung tissue: response to nicotine withdrawal.
Topics: Animals; Animals, Newborn; Carbohydrate Metabolism; Female; Fetus; Glycogen; Lung; Maternal-Fetal Exchange; Nicotine; Pregnancy; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1987 |
[Pharmacological agents in controlling smoking].
Topics: Alkaloids; Anabasine; Azocines; Chewing Gum; Drug Evaluation; Female; Humans; Male; Mouthwashes; Nicotiana; Nicotine; Plants, Toxic; Quinolizines; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1987 |
Weight gain following smoking cessation: a possible role for nicotine replacement in weight management.
Topics: Adult; Aged; Body Weight; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1987 |
Time course of cigarette withdrawal symptoms during four weeks of treatment with nicotine chewing gum.
Topics: Adult; Chewing Gum; Female; Humans; Male; Nicotine; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1987 |
Nicotine withdrawal at 10 000 m.
Topics: Aircraft; Canada; Humans; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome | 1986 |
Behavioral and pharmacological treatment of cigarette smoking: end of treatment comparisons.
Topics: Adult; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Drug Tolerance; Female; Humans; Internal-External Control; Male; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1986 |
[The smoking problem].
Topics: Cardiovascular Diseases; Cardiovascular System; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Smoke Pollution | 1986 |
Prevalence of tobacco dependence and withdrawal.
Topics: Humans; Male; Manuals as Topic; Middle Aged; Minnesota; Nicotine; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1987 |
Cigarette abstinence, nicotine gum, and theophylline disposition.
Topics: Adult; Chewing Gum; Drug Interactions; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Theophylline | 1987 |
Theoretical background and clinical use of nicotine chewing gum.
Topics: Chewing Gum; Emotions; Female; Humans; Male; Nicotine; Receptors, Nicotinic; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 1985 |
Psychological and pharmacological approaches to smoking relapse prevention.
Topics: Adult; Chewing Gum; Cotinine; Female; Humans; Male; Nicotine; Recurrence; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1985 |
Characterization of tobacco withdrawal: physiological and subjective effects.
Topics: Behavior; Chewing Gum; Energy Intake; Heart Rate; Humans; Nicotine; Sleep; Smoking; Substance Withdrawal Syndrome | 1985 |
Short-term effects of nicotine gum.
Topics: Behavior; Body Weight; Chewing Gum; Humans; Nicotine; Smoking; Substance Withdrawal Syndrome; Time Factors | 1985 |
[Prevention of the cigarette smoking habit by the administration of a chewing gum containing nicotine].
Topics: Chewing Gum; Female; Humans; Male; Nicotine; Respiratory Function Tests; Smoking Prevention; Substance Withdrawal Syndrome | 1985 |
Psychiatric aspects of cigarette smoking.
Topics: Behavior Therapy; Chewing Gum; Humans; Lung Diseases, Obstructive; Nicotine; Personality; Primary Health Care; Psychoanalytic Theory; Recurrence; Smoking; Smoking Prevention; Social Environment; Substance Withdrawal Syndrome | 1985 |
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
Topics: Animals; Body Temperature; Brain Chemistry; Bungarotoxins; Drug Tolerance; Female; Mice; Mice, Inbred DBA; Motor Activity; Nicotine; Receptors, Nicotinic; Substance Withdrawal Syndrome; Time Factors | 1985 |
Effects of withdrawal from long-term nicotine gum use.
Topics: Adult; Chewing Gum; Female; Heart Rate; Humans; Nicotine; Substance Withdrawal Syndrome | 1985 |
Reports of smoking withdrawal symptoms over a 21 day period of abstinence.
Topics: Adult; Constipation; Cough; Dizziness; Female; Humans; Irritable Mood; Male; Middle Aged; Mouth Diseases; Nicotine; Recurrence; Respiration Disorders; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1985 |
Blood nicotine, smoke exposure and tobacco withdrawal symptoms.
Topics: Adult; Confusion; Cotinine; Female; Humans; Male; Nicotine; Sleep Wake Disorders; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1985 |
Craving for tobacco.
Topics: Humans; Nicotiana; Nicotine; Plants, Toxic; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders | 1972 |
[Change of diet as an aid to stopping smoking (author's transl)].
Topics: Animals; Blood Coagulation; Bread; Diet; Diet Therapy; Health Education; Humans; Milk; Nicotine; Smoking; Substance Withdrawal Syndrome; Tea | 1974 |
The pharmacological basis of drug dependence.
Topics: Amphetamine; Barbiturates; Cannabis; Central Nervous System; Cocaine; Ethanol; Hallucinogens; Heroin; Humans; Morphine; Nicotine; Pharmacology; Substance Withdrawal Syndrome; Substance-Related Disorders; Synaptic Transmission | 1970 |
Sweating function in the heroin withdrawal syndrome of neonates.
Topics: Acetylcholine; Dose-Response Relationship, Drug; Epinephrine; Female; Heroin Dependence; Humans; Hyperhidrosis; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Injections, Intradermal; Maternal-Fetal Exchange; Nicotine; Pregnancy; Stimulation, Chemical; Substance Withdrawal Syndrome; Sweat Glands; Sweating | 1974 |
Action of 5-hydroxytryptamine on electrical activity of Auerbach's plexus in the ileum of the morphine dependent guinea pig.
Topics: Animals; Body Weight; Ceruletide; Electrophysiology; Guinea Pigs; Humans; In Vitro Techniques; Morphine; Myenteric Plexus; Nicotine; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1974 |
Nature of the sweating deficit of prematurely born neonates. Observations on babies with the heroin withdrawal syndrome.
Topics: Acetylcholine; Birth Weight; Central Nervous System; Epinephrine; Female; Gestational Age; Heroin; Humans; Infant, Newborn; Infant, Premature, Diseases; Nicotine; Pregnancy; Pregnancy Complications; Substance Withdrawal Syndrome; Substance-Related Disorders; Sweat Glands; Sweating | 1972 |
Do other problems such as behaviour, nervousness and overweight arise for people who stop smoking?
Topics: Behavior; Humans; Nicotine; Obesity; Personality; Smoking; Substance Withdrawal Syndrome | 1972 |
Cigarette dependence. I. Nature and classification.
Topics: Adolescent; Humans; Nicotine; Reward; Smoking; Social Behavior; Substance Withdrawal Syndrome; Substance-Related Disorders | 1971 |
[The spell of smoking].
Topics: Adolescent; Adult; Female; Habits; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome | 1967 |
[Breaking the smoking habit. An important and urgent medical task of the physician].
Topics: Chlorothiazide; Humans; Hydrotherapy; Lobeline; Methods; Nicotine; Psychotherapy, Group; Smoking; Substance Withdrawal Syndrome | 1969 |